2023 AAN Annual Meeting Scientific Abstracts

Introduction

The 75th AAN Annual Meeting will be held from April 22-27, 2023, in a hybrid format offering the option to participate in person in Boston or live online

This digital book lists 2023 Annual Meeting abstracts available in the following two formats:

Scientific Sessions: A group of abstracts covering a similar topic presented in an oral format . Presentations are eight minutes in length with four minutes for question and answer with the author .

Posters: A series of thematic abstract presentations in an electronic format .

Abstracts will be accessible during distinct periods in Boston as well as available to registrants via the online conference platform To search a complete library of abstracts online after the embargo lifts on March 2, 2023, at 4:00 p .m . ET, visit AAN.com/AMAbstracts .

To register for the meeting or to learn about all of the science, education, and networking opportunities at the 2023 Annual Meeting, visit AAN.com/AM .

Tuesday, April 25

Wednesday, April 26 97

Thursday, April 27 117

IS IT LEMS OR MG?

Test your knowledge of the symptoms of Lambert-Eaton myasthenic syndrome (LEMS)

Indicate with a check mark whether the symptoms below are a sign of LEMS or myasthenia gravis (MG).

SYMPTOMS 1

Symmetrical muscle weakness

Caudal-to-cranial pattern of spread

Early and prominent oculobulbar involvement

Absent or diminished tendon reflexes

Autonomic dysfunction (eg, dry mouth, constipation, orthostatic hypotension)2

Transient improvement of muscle strength with exercise, with fatigue that follows

BOOTH 1779

MG

Stop by, check your answers, and learn more about the distinguishing symptoms of LEMS.

References: 1. Merino-Ramírez MÁ, Bolton CF. Review of the diagnostic challenges of Lambert-Eaton syndrome revealed through three case reports. Can J Neurol Sci. 2016;43(5):635-647.

2. Titulaer MJ, Lang B, Verschuuren

JJ. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011;10(12):1098-1107.

© 2023 Catalyst Pharmaceuticals, Inc. All Rights Reserved. Printed in USA. 23LEM0314(3) February 2023

SCIENTIFIC SESSIONS

Scientific Sessions are a group of abstracts covering a similar topic presented in an oral format Presentations are 12 minutes in length with eight minutes for presentation and four minutes for questions and answers with the author .

April 23

ET

1:00 p.m. S1.001

Impact of a Free Anti-seizure Medication Intervention on Anxiety and Depression in People Living with Epilepsy in the Republic of Guinea– Dylan R. Rice, Guelngar Carlos Othon, Société Traore, Mohamed Lamine Conde, Djenabou Diallo, Nathanael Jong Lee, Fode Abass Cisse, Farrah J. Mateen

1:12 p.m. S1.002

Stroke Epidemiology Among Young Adults with Stroke in Zambia–Aparna Nutakki, Mashina Chomba, Lorraine Chishimba, Stanley Zimba, Deanna Saylor

1:24 p.m. S1.003

Evaluation of the Public Health Surveillance System for Bacterial Meningitis in Colombia– Gabriel D. Pinilla Monsalve, Edgar Fabian Manrique Hernandez

1:00 p.m. S2.001

Transmission of Behavioral Deficits in Rats Exposed to Folate Receptor Alpha Antibody In Utero.–Jonathan Ryan Amaro-Barron, Natasha Bobrowski-Khoury, Edward Quadros

1:12 p.m. S2.002

Advancing Team-Based Care for Spinal Muscular Atrophy: A Multi-State Project ECHO Initiative and National Education Strategy– Donna Gabriel, Ana Carolina Tesi Rocha, Jenna Marie Klotz, Ruth Adewuya, Lisa Hack, Whitney Hess

1:24 p.m. S2.003

Cross-disease Transcriptomic Analysis Elucidating the Roles of Astrocytic Signaling Pathways Regulating Neuroinflammation in Autism Spectrum Disorder–Valentina Zhang

1:36 p.m. S2.004

Pdgfra-dependent Polr3b Exon Loss Recapitulates POLR3-related Hypomyelinating Leukodystrophy Phenotypes in vivo– Mackenzie A. MichellRobinson, Kristin Watt, Vladimir Grouza, Julia Macintosh, Maxime Pinard, Marius Tuznik, Xiaoru Chen, Lama Darbelli, Chia-Lun Wu, Stefanie Perrier, Daryan Chitsaz, Nonthue Uccelli, Hanwen Liu, Timothy Chilton Cox, Christoph W Mueller, Timothy Kennedy, Benoit Coulombe, David Rudko, Paul Trainor, Geneviève Bernard

1:48 p.m. S2.005

Prevalence of Elevated Intracranial Pressure in Alexander Disease–Joshua Joung, John Rainer Sollee, Kathryn Gallison, Geraldine Liu, Hannah Rose Cooper, Walter Faig, Heather McClung, Elizabeth Drum, Sona Narula, Grant Liu, Robert Avery, Arastoo Vossough, Amy T. Waldman

2:00 p.m. S2.006

Outcome Predictors in Pediatric Nonfatal Drowning: Results of a Family Caregiver Survey– Muslima Sonia Razaqyar, Eri Osta, Jonathan Michael Towne, Mariam Ishaque, Florence Chiang, Peter T. Fox

2:12 p.m. S2.007

Post-traumatic Seizures in Children with Abusive Head Trauma– Mahjabeen Ahmed Khan, Sean Goretzke, Nandini Calamur

2:24 p.m. S2.008

Distinguishing Features of MOG Positive and MOG Negative Pediatric Patients with ADEM– Cynthia X. Wang, Patricia Plumb, Lana Harder, Benjamin M. Greenberg

2:36 p.m. S2.009

Phenotype and Genotype Heterogeneity of PLA2G6-associated Neurodegeneration–Alireza Tavasoli, Ali Zare Dehnavi, Maryam Bemanalizadeh, Mohammad Kahani, Mohammad Rohani, Mehran Beriraghi Toosi, Mahmoud Reza Ashrafi, Morteza Heidari, Manouchehr Amanat, Sareh Hosseinpour

2:48 p.m. S2.010

MANOEUVRE Study Design: A Study of GYM329 (RO7204239) in Patients with Facioscapulohumeral Muscular Dystrophy (FSHD)–Jeffrey Statland, Katy Eichinger, Jasper Morrow, Giorgio Tasca, John Vissing, Angela Dodman, Birgit Jaber, Heidemarie Kletzl, Tammy McIver, Renata Scalco, Wai Yin Yeung, Eleni Gaki, Kathryn Rae Wagner

1:00 p.m.–3:00 p.m. ET

SCIENTIFIC SESSIONS

Sunday, April 23

S3 Cerebrovascular Disease and Interventional Neurology: Diagnosis, Prognosis, and Population Health

1:00 p.m. S3.001

Walk Your Dizzy Patients! Gait Assessment as a Screening Tool for Posterior Circulation Stroke– Isaac Smith, Eduard Humberto Valdes, Jose L. Torres, Kara R. Melmed

1:12 p.m. S3.002

Aspirin and Statins Reduce the Risk of Stroke in Women with Endometriosis–Alison Seitz, Leslie E. Bull, Neal S. Parikh, Babak Navi, Alexander Merkler, Hooman Kamel, Ava L. Liberman

1:24 p.m. S3.003

Genetically-Determined LDL Negatively Impacts Clinical Evolution of Ischemic Stroke Survivors– Kane Wu, Cyprien Rivier, Zachariah Demarais, Carolyn Conlon, Daniela Brenda Renedo, Victor Manuel Torres-Lopez, Richa Sharma, Adam De Havenon, Kevin N. Sheth, Guido Jose Falcone

1:36 p.m. S3.004

Preexisting Cerebrovascular Disease in Pregnancy: a Case Series on Pregnancy Outcomes–Sarah Lott Wyckoff, Gular Mammadli, Whitney Alexandra Booker, Mary E. D’Alton, Anita Parnes LaSala, Stephanie Purisch, Linda Valeri, Joshua Z. Willey, Eliza Cushman Miller

1:48 p.m. S3.005

Incidence of Ischemic Stroke in US Veterans Living with Spinal Cord Injury: Preliminary Data– Rafer Willenberg, Bridget Smith, Kevin Stroupe, Jennifer Sippel, Zhiping Huo, Sunil Sabharwal

2:00 p.m. S3.006

Is Dual Antiplatelet Therapy Underutilized Following TIA and Minor Stroke?–Jonathan Solomonow, Jamie R. Marks, Karen Yarbrough, Prachi Mehndiratta, Seemant Chaturvedi

2:12 p.m. S3.007

Layperson Knowledge of Stroke Still Woefully Poor- A National Survey–Shaan Patel, Rohan Mangal, Thor Shiva Stead, Latha Ganti

2:24 p.m. S3.008

Ischemic Stroke Despite Direct Oral Anticoagulants for Non-valvular Atrial Fibrillation: A Population-based Analysis on Outcomes of Alternative Antithrombotic Regimens– Bonaventure Ip, Gary KK Lau, Ho Ko, Xinyi Leng, David Seiffge, Thomas Wai Hong Leung

2:36 p.m. S3.009

Country-Wide Costs of Chronic Conditions Among Stroke Survivors in the United States–Yunting Yu, Alain Zingraff Lekoubou Looti, Kinfe Bishu, Bruce I. Ovbiagele

2:48 p.m. S3.010

Area Deprivation Index Predicts Early Severity and Infarct Growth Rate in Anterior Circulation Large Vessel Occlusion Stroke– Murat Sari, Vanessa Dwairi, Floyd W. Thoma, Jared W. Magnani, Marcelo Rocha

1:00 p.m.–3:00 p.m. ET

1:00 p.m. S4.001

Combined MRI Ischemic Burden and Early EEG Background Improve Outcome Prediction After Pediatric Cardiac Arrest–Ashley Mei Bach, Matthew Kirschen, France W. Fung, Nicholas Scott Abend, Antara Mondal, Steve Boateng Ampah, Jimmy W. Huh, Shih-Shan Lang Chen, Ian Yuan, Kathryn Graham, Jeffrey I. Berman, Arastoo Vossough, Alexis Topjian

1:12 p.m. S4.002

Discrepancies Between Neuroprognostication Assessments and End-of-Life Decision-Making in Post-Cardiac Arrest Patients–Alexandra Rubenstein, Rebecca Stafford, Carolina B. Maciel, Gisele Sampaio Silva, Rachel Beekman, Emily Jean Gilmore, David M. Greer

1:24 p.m. S4.003

Predictors of Better Shared Decision Making in Goals-Of-Care ClinicianFamily Meetings for Critically Ill Neurologic Patients: A Multi-Center Mixed Methods Pilot Study–Victoria Fleming, Abhinav Vibhas Prasad, Connie Ge, Shazeb Meraj, Camarlin Franco, Catherine Hough, Bernard Lo, Shannon Carson, Jay Steingrub, Douglas White, Susanne Muehlschlegel

1:36 p.m. S4.004

A Meta-Analysis on the Neurovascular Complications Of Extracorporeal Membrane Oxygenation In Critically Ill COVID-19 Patients– Meng Fei Li, Daisy Xiaoxiao Deng, Yu Fei Ma, Carol Li, Emily Dawson, Lynn Huong, Dong Yao Wang, Teneille Gofton, Dave Nagpal, Marat Slessarev

1:48 p.m. S4.005

Microvascular Cerebral Blood Flow Monitoring Detects Response to Intrathecal Nicardipine Treatment for Vasospasm– Eashani Sathialingam, Kyle Robert Cowdrick, Tara Urner, Amanda Liew, Erika Sigman, Feras Akbik, Owen B. Samuels, Prem Kandiah, Erin M. Buckley, Ofer Sadan

2:00 p.m. S4.006

A Prospective Study of Optimal Dosing Strategies of Levetiracetam for Seizure Prophylaxis in Critically Ill Patients– Eduard Humberto Valdes, Taolin Fang, Jennifer A. Frontera

2:12 p.m. S4.007

Resident-Driven Quality Improvement Project to Improve Treatment of Status Epilepticus– Christopher Alan Houck, Joseph C. Alario, Micaela Rose Owens, Joseph Seemiller

2:24 p.m. S4.008

Association Between Hemodynamics After Endovascular Thrombectomy and Cerebral Edema Development–Yelyzaveta Begunova, David Bartolome, Madelynne Olexa, Atul Kumar, Yasheng Chen, Teng Jiao Peng, Santiago Ortega Gutierrez, Kevin N. Sheth, Rajat Dhar, Nils Petersen

2:36 p.m. S4.009

Sex-based Single-Cell Heterogeneity after Murine Contusional Traumatic Brain Injury in Genes Related to Sulfonylurea Receptor-1– Ruchira M. Jha, Zujian Xiong, Chaim T. Sneiderman, Dennis William Simon, Joshua Catapano, Jarrod Rulney, Sudhanshu P. Raikwar, Anupama Rani, Shima Shahjouei, Sandra Mihaljevic, Ethan Winkler, Margaux Miller, Lance Lim, Keri Feldman, Vincent Vagni, Patrick M. Kochanek, Gary Kohanbash, Dhivyaa Rajasundaram

2:48 p.m. S4.010

Modulating CNS neuroinflammation in animal models of intracerebral hemorrhage by nasal anti-CD3–Saef Izzy, Taha Yahya, Tian Cao, Mokalad Waed, Thais Garcias Moreira, Rafael Rezende, Howard L. Weiner

1:00 p.m.–3:00 p.m. ET

SCIENTIFIC SESSIONS

Sunday, April 23

1:00 p.m. S5.001

Long-term Efficacy of Satralizumab in Adults with Aquaporin-4-IgGseropositive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from SAkuraMoon–Anthony Traboulsee, Ingo Kleiter, Jacqueline Palace, Kazuo Fujihara, Albert Saiz, Ivana Vodopivec, Gaelle Klingelschmitt, Carole Marcillat, Jeffrey L. Bennett

1:12 p.m. S5.002

Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: outcomes from the phase 3 CHAMPION-NMOSD trial–Sean J. Pittock, Michael Barnett, Jeffrey L. Bennett, Achim Berthele, Jerome De Seze, Michael Levy, Ichiro Nakashima, Celia Oreja Guevara, Jacqueline Palace, Friedemann Paul, Carlo Pozzilli, Kerstin Allen, Yasmin Mashhoon, Marcus Yountz, Ho Jin Kim

1:24 p.m. S5.003

Efficacy subgroup analyses from the phase 3 CHAMPION-NMOSD trial in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder– Michael Levy, Sean J. Pittock, Michael Barnett, Jeffrey L. Bennett, Achim Berthele, Jerome De Seze, Ichiro Nakashima, Celia Oreja Guevara, Jacqueline Palace, Friedemann Paul, Carlo Pozzilli, Kerstin Allen, Yasmin Mashhoon, Marcus Yountz, Ho Jin Kim

1:36 p.m. S5.004

Pharmacokinetics and Pharmacodynamics of Ravulizumab in Adults with Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder

During the Phase 3 CHAMPION-NMOSD trial–Stephan Ortiz, Sean J. Pittock, Achim Berthele, Michael Levy, Ichiro Nakashima, Celia Oreja Guevara, Ho Jin Kim

1:48 p.m.

S5.005

Association of B cell Subsets and Aquaporin-4 antibody titers with Disease Activity in Participants in the N-MOmentum trial Receiving Inebilizumab Treatment–Sean J. Pittock, Friedemann Paul, Ho Jin Kim, Michael Smith, William Rees, Kristina Rae Patterson, Bruce A. C. Cree, Jeffrey L. Bennett

2:00 p.m. S5.006

Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT+ Study– Mamatha Pasnoor, Vera Bril, Chafic Y. Karam, Stojan Peric, Jan L. De Bleecker, Hiroyuki Murai, Andreas Meisel, Said R. Beydoun, Tuan Hoang Vu, Peter Ulrichts, Benjamin Van Hoorick, Caroline T’joen, Kimiaki Utsugisawa, Jan Verschuuren, Renato Mantegazza, James F. Howard, In Collaboration With ADAPT-SC Investigator Study Group

2:12 p.m. S5.007

Efficacy of Rozanolixizumab in Generalized Myasthenia Gravis: Subgroup Analyses from the Randomized Phase 3 MycarinG Study–Tuan Hoang Vu, Artur Druzdz, Julian Grosskreutz, Ali A. Habib, Henry J. Kaminski, Renato Mantegazza, Kimiaki Utsugisawa, John Vissing, Raphaelle Beau-Lejdstrom, Marion Boehnlein, Teresa De Jesus Gasalla, Fiona Grimson, Thais Tarancon Heras, Vera Bril

2:24 p.m. S5.008

Achievement of Improved Post-Intervention Status in Patients with Generalized Myasthenia Gravis Treated with Ravulizumab during the CHAMPION MG Study–Srikanth Muppidi, Pushpa Narayanaswami, Andreas Meisel, Tuan Hoang Vu, Kimiaki Utsugisawa, Renato Mantegazza, Kathleen Beasley, Serena Liao, James F. Howard

2:36 p.m. S5.009

A Phase 3, Open-Label, Multicenter Study To Evaluate Eculizumab In Adolescents With Refractory Generalized Myasthenia Gravis–John Brandsema, Matthew Ginsberg, Hideki Hoshino, Masakazu Mimaki, Satoru Nagata, Vamshi Rao, Katherine Ruzhansky, Niraja Sathyamarayanan Suresh, Emmanuelle R. Tiongson, Hideo Yamanouchi, Glen Frick, Eden Hicks, Serena Liao, James F. Howard

2:48 p.m. S5.010

CD11c+ B cells Are Fundamentally Altered in Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis– Patricia Sikorski, Henry J. Kaminski, Linda Kusner

3:30 p.m.–5:30 p.m. ET

SCIENTIFIC SESSIONS

Sunday, April 23

3:30 p.m.–5:30 p.m. ET

S7 Outcome Measures and Observational Studies of Neuromuscular Diseases

3:30 p.m.

2023 Wayne A. Hening Sleep Medicine Investigator Award: This award recognizes scientific contributions in sleep from promising junior investigators.–Joseph Cheung, MD, MS, Jacksonville, FL

3:42 p.m.

2023 Sleep Science Award: This award recognizes distinguished academic contributions by neurologists to the field of sleep medicine or the contributions of non-neurologists to the interface area of sleep neurology.–Tiffany Braley, MD, MS, Ann Arbor, MI

4:06 p.m. S6.004

Reduced Slow-Wave Sleep and Severe Sleep Apnea are Associated with Neuroimaging Biomarkers of Cerebrovascular Disease– Diego Z. Carvalho, Stuart McCarter, Erik Kent St. Louis, Scott Przybelski, Timothy Morgenthaler, Bradley F. Boeve, Ronald C. Petersen, Clifford R. Jack, Jonathan Graff-Radford, Prashanthi Vemuri

4:18 p.m. S6.005

A Longitudinal evaluation of early Sleep and Respiratory Impairment in ALS patients–Alessandro Bombaci, Antonella Iadarola, Elisa Fattori, Claudio Gojani, Umberto Manera, Andrea Calvo, Adriano Chio, Alessandro Cicolin

4:30 p.m. S6.006

Associations between cerebral small vessel disease and obstructive sleep apnea in patients with ischemic stroke and TIA– Ryan Thomas Muir, Laavanya Dharmakulaseelan, Sandra E. Black, Brian James Murray, Mark Boulos

4:42 p.m. S6.007

Post Ictal Generalized EEG suppression, Not Sleep State, is Associated with Peri-Ictal Respiratory Disturbances in Stereoelectroencephalography

Recorded Perisylvian Seizures– Laura Mora Munoz, Noah Andrews, Matheus Araujo, Loutfi S. Aboussouan, William Bingaman, Lu Wang, Madeleine M. GriggDamberger, Nancy R. Foldvary-Schaefer

4:54 p.m. S6.008

Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in isolated REM Sleep Behavior Disorder– Christopher Tan, Huma Nawaz, Sarah Kathryn Lageman, Leslie Cloud, Amy W. Amara, Jason Druzgal, Brian D. Berman, Nitai Das Mukhopadhyay, Matthew J. Barrett

5:06 p.m. S6.009

Efficacy of Lower-Sodium Oxybate in the Treatment of Idiopathic Hypersomnia: Evaluation of Treatment Response Based on the Epworth Sleepiness Scale and Idiopathic Hypersomnia Severity Scale Scores– Russell Rosenberg, Abby Chen, Teresa Steininger, Wayne Macfadden, Yves Dauvilliers

5:18 p.m. S6.010

Effect of Lemborexant on Early Morning Awakening in Elderly Subjects with Severe Problems with Waking Too Early– Christie Lundwall, Margaret Moline, Phyllis C. Zee, Dinesh Kumar, Elizabeth Pappadopulos

3:30 p.m. S7.001

Untangling the Signatures of Acquired Sporadic Late Onset Nemaline Myopathy (SLONM) and Inherited Nemaline Myopathy–Stefan Nicolau, Aneesha Dasgupta, Surendra Dasari, Cristine Charlesworth, Ken L. Johnson, Akhilesh Pandey, Jason Doles, Margherita Milone

3:42 p.m. S7.002

Symptomatic Myopathies in Sarcoidosis: Disease Spectrum and Myxovirus Resistance Protein A (MxA) Expression– Pitcha Chompoopong, Michael Paul Skolka, Floranne Ernste, Teerin Liewluck

3:54 p.m. S7.003

The Limb Girdle Muscular Dystrophy Health Index–Joy Anne Kerr Stouffer, Kameron Bates, Leroy R. Thacker, Chad R. Heatwole, Nicholas Elwood Johnson

4:06 p.m. S7.004

Motor Outcomes to Validate Evaluations in Facioscapulohumeral muscular dystrophy (MOVE FSHD): Preliminary Baseline Characteristics– Michaela Walker, Russell Butterfield, John W. Day, Katy Eichinger, Bakri Elsheikh, Seth Friedman, Angela L. Genge, Kiley Higgs, Nicholas Elwood Johnson, Peter Lawrence Jones, Doris G. Leung, Leann Lewis, Hanns Lochmuller, Erin K. O’Ferrall, William Martens, Dennis W. Shaw, Perry Shieh, S H. Subramony, Jaya Raghav

Trivedi, Leo Hong-Li Wang, Matthew P. Wicklund, Alrabi Tawil, Jeffrey Statland

4:18 p.m. S7.005

The FSHD Composite Outcome Measure (FSHD-COM) is Reliable, Valid, and Measures Disease Progression– Katy Eichinger, Michael McDermott, Kiley Higgs, Michaela Walker, Leann Lewis, William Martens, Doris G. Leung, Nikia Stinson, Megan McNerney Holzer, Sabrina Sacconi, Jeremy Garcia, Victor De Paz Benito, Karlien Mul, Valeria A. Sansone, Elena Carraro, Stefano Becchiati, Maria Chiara Frisoni, Leo Hong-Li Wang, Catherine Kieu, Perry Shieh, Christy Skura, Bakri Elsheikh, Kristina Marie Kelly, Andrea Jaworek, Samantha Jo LoRusso, Russell Butterfield, Amelia Wilson, Melissa McIntyre, Nicholas Elwood Johnson, Amanda Catherine Butler, Aileen S. Jones, Melissa Currence, Lindsay Baker, Sandhya Sasidharan, Alrabi Tawil, Jeffrey Statland

4:30 p.m. S7.006

Feasibility of Measuring Functional Performance of FSHD Patients Using Wearable Sensors to Quantify Physical Activity–Joost Kools, Nicol Voermans, Karlien Mul, John Jiang, Jennifer Shoskes, Kelly Marshall, Anil Tarachandani, Joanita Figueredo, Damien Eggenspieler

4:42 p.m. S7.007

Patient-Reported Outcomes in Myotonic Dystrophy Type 2: Correlations with Motor and Cognitive Endpoints– Nikita Jain, Carly Jo Olszewski, Laura Flashman, Carolina Burgos-Aguilar, Pamela W. Duncan, Peggy C. Nopoulos, Araya Puwanant

4:54 p.m. S7.008

Electrocardiographic characteristics of Duchenne muscular dystrophy young boys in pre-clinical stage–Ting Xu, Ke Xu, Xu Rong, Cai Xiaotang, Xu Huayan

5:06 p.m. S7.009

Natural History of TRPV4-Associated Neuromuscular Disease–Jack K. Donohue, Margo A. Peyton, Simone Thomas, Remi Ben-Davies, Charlotte J. Sumner, Brett Andrew McCray, Inherited Neuropathi Rare Disease Clinical Research

5:18 p.m. S7.010

Treatment characteristics in a cohort of patients with hereditary transthyretin amyloidosis–Taha Qarni, Nicolas Sarmiento Bustamante, Felipe Simoes Jones, Sami L. Khella, Brian Drachman, Janice Pieretti, Chafic Y. Karam

Sunday, April 23

3:30 p.m.–5:30 p.m. ET

3:30 p.m.

2023 Norman Geschwind Prize in Behavioral Neurology: This prize is awarded to an individual for outstanding research in the field of behavioral neurology.–Liliana A. Ramirez-Gomez, MD, Boston, MA

3:42 p.m. S8.002

Estimated Pulse Wave Velocity Inversely Associates with Cognition in the Northern Manhattan Study– Botagoz Aimagambetova, Taylor Ariko, Hannah Gardener, Bonnie E. Levin, Xiaoyan Sun, Carolina Gutierrez, Mitchell S. V. Elkind, Jose Gutierrez, Mitchell S. V. Elkind, Clinton B. Wright, Ralph L. Sacco, Digna Cabral, Tatjana Rundek

3:54 p.m. S8.003

Diminished autonomic nervous system responses to acoustic startle in progressive supranuclear palsy– Peter Pressman, Kuan-Hua Chen, Breanna M. Bullard, Katherine P. Rankin, Robert Levenson

4:06 p.m. S8.004

Clinico-radiologic and Pathological Evaluation of Corticobasal Syndrome– Dror Shir, Nha Trang Thu Pham, Hugo Botha, Shunsuke Koga, Naomi Kouri, Farwa Ali, David S. Knopman, Ronald C. Petersen, Bradley F. Boeve, Walter Kremers, Aivi Nguyen, Melissa Murray, Ross Reichard, Dennis W. Dickson, Neill R. GraffRadford, Keith A. Josephs, Jennifer Louise Whitwell, Jonathan Graff-Radford

4:18 p.m.

S8.005

Phase 1 Trial of Darigabat for the Reduction of Acute Psychological and Physiological Panic and Fear Symptoms Following CO2 Inhalation in Healthy Participants– Rachel Gurrell, Ih Chang, Ann Marie Dandurand, Sridhar Duvvuri, Amy Guigliano, Gina Pastino, Theresa Thien-Huong Pham, Stacey Versavel, Gabriel Jacobs, Asso Safai Pour, Rob Zuiker, Raymond Sanchez, John Renger

4:30 p.m.

S8.006

What’s changing from normal aging to pathological aging during semantic memory retrieval: insights from EEG oscillations– Hsueh-Sheng Chiang, Elizabeth Lydon, John Hart, Michael Kraut, Raksha Anand Mudar

4:42 p.m.

S8.007

Mapping Neural Activity with Optically-Pumped Magnetoencephalography–Abhishek Bhutada, Jeremy Myslowski, Jeff Scott Soldate, Jonathan Lisinski, Niall Holmes, Ryan Michael Hill, Rosalyn Moran, Read Montague, Mark Witcher, Stephen LaConte

4:54 p.m.

S8.008

Primary progressive apraxia of speech: Clinico-pathological associations of left-right hemispheric dominance– Carling Grace Robinson, Joseph Duffy, Heather Clark, Rene Utianski, Mary M. Machulda, Hugo Botha, Neha Atulkumar Singh, Nha Trang Thu Pham, Peter Martin, Nilufer Taner, Dennis W. Dickson, Val John Lowe, Jennifer Louise Whitwell, Keith A. Josephs

5:06 p.m. S8.009

Reliability of Unsupervised Digital Cognitive Assessment in a Large Adult Population Across the Aging Lifespan from INTUITION: A Brain Health Study– Michael G. Erkkinen, Monroe Butler, Roland Brown, Matt Hobbs, Audrey Gabelle, Andrew Becker, Paramita Saha-Chaudhuri, Jessica Ash, Sean Kenny, Hanson Lenyoun, Matt T. Bianchi, Shibeshih Belachew

5:18 p.m.

S8.010

An fMRI Investigation of Brain Reward Function in Patients with Schizophrenia and Comorbid Cannabis Use Disorder–Soo Hwan Park, Thomas A. Zeffiro, James C. Ford, Mary Frances Brunette

3:30 p.m. S9.001

Serum neurofilament light chain (NfL)and CSF glial fibrillary acidic protein (GFAP) together improve the prediction of long-term clinical outcomes in multiple sclerosis–Simon Thebault, Seyed-Mohammad Fereshtehnejad, Hailey Bergman, Gauruv Bose, Mark S. Freedman

3:42 p.m. S9.002

Telomere Length as a biomarker in Multiple Sclerosis– Maria Augustina Piedrabuena, Jorge D. Correale, Mauricio Franco Farez, Marcela Fiol, Mariano Marrodan, Celica Ysrraelit

3:54 p.m. S9.003

RNA profiles to distinguish multiple sclerosis (MS) and neuromyelitis optica (NMO) in peripheral whole blood– Lukasz Wylezinski, Guzel Shaginurova, Elena Grigorenko, Jay Wohlgemuth, Franklin Richard Cockerill, Michael K. Racke, Chase Floyd Spurlock

4:06 p.m. S9.004

Association between Serum Biomarker Profile and Real-World Evidence of Disability in Multiple Sclerosis–Wen Zhu, Chenyi Chen, Lili Zhang, Elizabeth Walker, Shruthi Venkatesh, Fujun Zhang, Ferhan Qureshi, Tamara Hoyt, John F. Foley, Zongqi Xia

4:18 p.m. S9.005

Serum neurofilament light chain association with progression independent of activity in people with early RRMS–Sammita Satyanarayan, Ilana B. Katz Sand, James F. Sumowski

4:30 p.m. S9.006

Genetic Variants in Iron Metabolism impact Disease Progression in MS through HIF1A–Antonino Giordano, Silvia Santoro, Melissa Sorosina, Elisabetta Mascia, Ferdinando Clarelli, Miryam Cannizzaro, Laura Ferrè, Thomas Moridi, Pernilla Stridh, Klementy Shchetynsky, Maria Needhamsen, Fredrik L. Piehl, Lars Alfredsson, Jan A. Hillert, Tomas Olsson, Ingrid Kockum, Maja Jagodic, Massimo Filippi, Federica Esposito

4:42 p.m. S9.007

Comparative Pharmacology of Ofatumumab vs Ocrelizumab in Humanized CD20 Transgenic Mice– Marc Bigaud, Daniel Anthony, Géraldine Zipfel, Tatjana Uffelmann, Helena Vostiarova, Volker Engelhardt, Barbara Nuesslein-Hildesheim, Bernd C. Kieseier

4:54 p.m. S9.008

Quantifying Retrograde Trans-Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis.–Sargis Manukyan, Gabriela Estefania Zabala, Laura Madeline Locke, Brooke Lauren Guerrero, Marwa Kaisey, Afshin Khodabakhsh, Nancy L. Sicotte, Pascal Sati, Omar Al-Louzi

5:06 p.m. S9.009

Accelerated Worsening in Serum Neurofilament Light Chain Levels and Multiple Sclerosis Functional Composite in Women with MS after Menopause– Hannah Silverman, Alan Bostrom, Ann A. Lazar, Refujia Gomez, Adam Santaniello, Adam Renschen, Meagan Michaela Harms, Tiffany Cooper, Robin R. Lincoln, Shane Poole, Roland G. Henry, Jorge Oksenberg, Stephen L. Hauser, Bruce A. C. Cree, Riley Bove

5:18 p.m. S9.010

In Vivo And Ex Vivo Characterization Of Meningeal Translocator Protein Expression In Multiple Sclerosis– Elena Herranz, Constantina Andrada Treaba, Valeria Teresa Barletta, Ambica Mehndiratta, Russell Alexander Ouellette, Eric Klawiter, Jacob Alexander Sloane, Carolina Ionete, Suma Babu, Marco Loggia, Jacob Hooker, Revere P. Kinkel, Roberta Magliozzi, Caterina Mainero

3:30 p.m.–5:30 p.m. ET

Sunday, April 23

S10 Utilizing Varied Modalities to Impact Learning and Make Curricular Changes

3:30 p.m. S10.001

Question of the Day: A Learning Success– Eric J. Seachrist, Lynne Shindoll, Gauri V. Pawar, Zachary N. London, Humaira Khan, Jeff Kraakevik, Jerome J. Graber, Felicia Gliksman

3:42 p.m. S10.002

Global Impact of a Virtual Neurology Morning Report– Maria Jimena Aleman, Valeria Roldan, Gabriela Figueiredo Pucci, John Penner, Saman Nematollahi, Aaron L. Berkowitz

3:54 p.m. S10.003

Investigating the Impact of Virtual Versus In-Person Small Group Discussion on Academic Performance in a First-Year Medical Neuroscience Course–Aimen

Vanood, Nikita Chhabra, Matthew T. Hoerth

4:06 p.m. S10.004

Evaluating Medical Student Learning Preference and its Relationship to Clerkship Satisfaction– Margo A. Peyton, Andrew Lea, Roy E. Strowd, Rachel Marie E. Salas, Charlene Gamaldo, Doris G. Leung

4:18 p.m. S10.005

Micro-learning and Micro-assessment Fulfill Teaching, Learning, and Patient Care Needs for Neurologists: Results of a qualitative study– Kara Stavros, Alexandra M. Miller, Jeremy Moeller, Kimberly Wiseman, Sydney-Evelyn Leonor Gibbs, Xiaoyu Sun, Lynne Shindoll, Robert A. Rook, Michaela Morris, Tessa Dahlgren, Zachary N. London, Roy E. Strowd

4:30 p.m. S10.006

Supercharging Memory Retention in Neurology Learning: A Faculty-Student Collaboration to Apply Cognitive Science Principles to Software-based Selfdirected Learning–Valerie DeLeon, Nabeel Ahmad, Luan Tran, Thomas Thesen

4:42 p.m. S10.007

Pilot Implementation and Evaluation of an Outpatient Teleneurology Curriculum for Medical Students– Melissa W. Ko, Heather Moss, Devin Dean Mackay, Paul Y. Ko, Katherine J. Chartier, Lindsey Jo Reese, Paul M. Wallach, Bradley Allen

4:54 p.m. S10.008

The Utility of a Novel Walk-Through/Talk-Through Stroke Simulation Model for Medical Student Education.–James David Dolbow, George Sadek, Faisal Al-Shaibi, Jessica Sponaugle, Wei Xiong

5:06 p.m. S10.009

Use of Simulation to Develop Telestroke Skills in Trainees– Kaitlyn Lillemoe, Arielle Marisa Kurzweil, Sakinah Sabadia, Perrin A. Pleninger, Ariane Lewis, Brandon Giglio, Sondra Zabar

5:18 p.m. S10.010

Remote Research Practices Enhance Acute Stroke Clinical Trial Enrollment–Abbey Staugaitis, Shayan Khan, Megan Tessmer, Denise Gaffney, Joseph P. Broderick, Pooja Khatri, Navdeep Sangha, Christopher Streib

SCIENTIFIC SESSIONS

Monday, April 24 11:15 a.m.–12:15 p.m. ET

11:15 a.m. S11.001

Multi-Centre Audit Of Myotonic Dystrophy In the UK: How Can We Improve Access to Care?– Channa Adithya Hewamadduma, James Brian Lilleker, Phillip Martin John Kelly, Isobel White, Douglas Whiter, Mahjabin Islam, Paul Robert Campbell, Sadaf Mehboob, Frederick Vonberg, Priya Devi Shanmugarajah, Helen Elizabeth Grote, Stuart Viegas, Sophie Olivia Turner

11:27 a.m. S11.002

Epilepsy Quality Performance Over Time: A National Veterans Health Administration Quality Improvement Study– Hamada Hamid Altalib, Margaret Gopaul, Sharyl R. Martini, Mary Jo Pugh

11:39 a.m. S11.003

Clinically Designed Improvisatory Music Interventions for Well-Being and Burnout Prevention for Neurology, Psychiatry, and Other Health Professionals: Preliminary Findings– Clara Takarabe, Raj Shah, Macy Walesa, Eileen Ngo, Brian Martin Wall, Logan Pause, Gaurava Agarwal, Borna Bonakdarpour

11:51 a.m. S11.004

Documentation of Thrombolytic Therapy Consent in Acute Ischemic Stroke–Alexis Nicole Kaiser, Stephanie Bartlett, Evan Templeton, Carl Pafford, Lynn D’Cruz, Veronica Kassab, Shelley E. Varner-Perez, Asia Madayag, Lindsay Marie Martinez, Amber Comer

12:03 p.m. S11.005

Ethically Translating Novel Neurotechnologies for Detecting Covert Consciousness: Clinician Perspectives from an Interim Analysis of the DECODE Study– Michael Young, India Anne Lissak, Yelena Bodien, Leigh R. Hochberg, Brian Edlow

11:15 a.m. S12.001

Classifying Papilledema Using Machine Learning – Modernizing Frisén Grading–Joseph Branco, Jui-Kai Wang, Tobias Elze, Mona Garvin, David Szanto, Randy Kardon, Louis Pasquale, Mark J. Kupersmith

11:27 a.m. S12.002

Nystagmus Response to Thiamine Replacement, a Predictor of WernickeKorsakoff (WE) Syndrome Outcome. A 21-patient Cohort Study–Jorge C. Kattah

11:39 a.m. S12.003

Benign Paroxysmal Positional Vertigo: The “SemontPLUS Maneuver” is more effective than the Epley Maneuver – a Prospective Tri-national Randomized Single-Blinded Trial in 195 Patients– Michael Strupp, Anne-Sophie Vinck, Otmar Bayer, Nicolina Goldschagg, Johannes Gerb, Vergil Mavrodiev, Marco Mandala

11:51 a.m. S12.004

Indirect Comparison of Lenadogene Nolparvovec Gene Therapy versus Natural History in m.11778G>A MT-ND4 Leber Hereditary Optic Neuropathy

Patients– Nancy J. Newman, Valerio Carelli, Patrick Yu-Wai-Man, Valerie Biousse, Mark L. Moster, Prem S. Subramanian, Catherine Vignal-Clermont, An-Guor Wang, Sean Donahue, Bart Peter Leroy, Robert C. Sergott, Thomas H. Klopstock, Alfredo Sadun, Gema Rebolleda, Bart Chwalisz, Rudrani Banik, Magali Taiel, Jose-Alain Sahel

12:03 p.m. S12.005

Long-term Follow-up of m.11778G>A MT-ND4-LHON Patients Treated with Lenadogene Nolparvovec Ocular Gene Therapy: the RESTORE Study–Valerie Biousse, Nancy J. Newman, Patrick Yu-Wai-Man, Valerio Carelli, Mark L. Moster, Catherine Vignal-Clermont, Thomas H. Klopstock, Alfredo Sadun, Robert C. Sergott, Magali Taiel, Jose-Alain Sahel

SCIENTIFIC SESSIONS

Monday, April 24

11:15 a.m.–12:15 p.m. ET

S13 Evaluating Diversity, Mitigating Bias, and Overcoming Challenges in Residency

11:15 a.m. S13.001

Using a Multidimensional Statistical Approach to Evaluate Diversity Trends Among U.S. Neurology Residents Between 2008–2020– Elijah Malik PersadPaisley, Saba S. Paracha, Selamawit Moges, Sanaya Daruvala, Ali Mahta, Neishay Ayub

11:27 a.m. S13.002

Facing the challenges of chief resident year: A standardized experiential simulation leadership curriculum– Elina Zakin, Nada Ghanime Abou Fayssal, Aaron S. Lord, Aaron Lane Nelson, Sara Kate Rostanski, Cen Zhang, Sondra Zabar, Steven Galetta, Arielle Marisa Kurzweil

11:39 a.m. S13.003

Correlation between USMLE Step scores, personal attributes and RITE exam performance among neurology residents at an academic center.– Haifa Al Issa, Disha Kohli, Chirantan Banerjee

11:51 a.m. S13.004

Barriers to Increasing Paid Parental Leave in U.S. Neurology Residencies: a Survey of Program Directors–Sarah Conway, Sashank Prasad

12:03 p.m. S13.005

“RVUS”: A Structured Framework for Residents to Approach Bias in Clinical Practice– Crystal Jing Yu, Aisha Elfasi, Lorena Maria Figueredo Rivas, Claudia Hernandez, Maria J. Bruzzone

1:00 p.m.–3:00 p.m. ET

S14 General Neurology: Emerging Therapies CME 2

1:00 p.m. S14.001

NfL Levels Significantly Decrease in Response to Treatment with Patisiran or Vutrisiran in hATTR Amyloidosis with Polyneuropathy– Michael J. Polydefkis, Emre Aldinc, Hans Nienhuis, Chafic Y. Karam, Senda Ajroud-Driss, Yoshiki Sekijima, Marcia Waddington Cruz, Jennifer Cramton Barnes, Paul Nioi, Simina Ticau

1:12 p.m. S14.002

Comparison of Therapeutic Efficacy of Gene Therapy for Tuberous Sclerosis Type 2 with Standard of Care Everolimus in Preclinical Model–Edwina Abou Haidar, Shilpa Prabhakar, Pike See Cheah, Sevda Lule, Roberta Beauchamp, Akiko Yoshinaga, Alexandra Geffrey, Anat Stemmer-Rachamimov, Vijaya Ramesh, Casey Maguire, Xandra O. Breakefield

1:24 p.m. S14.003

Comparison of Efficacy Outcomes with Vutrisiran vs. Patisiran in hATTR Amyloidosis with Polyneuropathy: Post-hoc Analysis of the HELIOS-A Study– Michael J. Polydefkis, Frank Birklein, Yoshiki Sekijima, Davide Pareyson, Marcia Waddington Cruz, David Danese, Kelley Elizabeth Capocelli, Madeline Merkel, Chongshu Chen, John Vest, David D. Adams

1:36 p.m. S14.004

A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Intravenous Dose Study of a novel TREM2 agonist (VGL101) in Healthy Volunteers (HVs)–Spyridon Papapetropoulos, Andreas Meier, Ryan O’Mara, Andrew James Marsh, Kelly Neelon, Rajasimhan Rajagovindan, Evan A. Thackaberry, David Stiles

1:48 p.m. S14.005

Effect of Patisiran on Polyneuropathy and Cardiomyopathy in Patients with hATTR Amyloidosis with V122I/T60A Variants: A Phase 4 Observational Study– Raymond L. Comenzo, Francy Y. Shu, Saurabh Malhotra, Yessar M. Hussain, Ronald Zolty, Urvi G. Desai, Joel Fernandez MD, Elena Yureneva, Lin-Na Chou, Kelley Elizabeth Capocelli

2:00 p.m. S14.006

Enabling Subcutaneous Dosing of Gantenerumab in Alzheimer’s Disease–Beate Bittner, Dietmar Schwab, Agnès Portron, Dominik Lott, Frank Boess, Remy Kohler, Jakub Wojtowicz, Carsten Hofmann

2:12 p.m. S14.007

Longer Milestone-Free Time in Patients With Amyotrophic Lateral Sclerosis

Treated With IV Edaravone vs Not Treated With IV Edaravone: Results From a US Administrative Claims Analysis– Malgorzata Ciepielewska, Jeffrey Zhang, Ying Liu, Melissa Hagan

2:24 p.m. S14.008

Therapeutic Potential of Fosgonimeton, a Small-Molecule Positive Modulator of the Neurotrophic HGF/MET Pathway, in Neurodegenerative Conditions–Sherif Reda, Robert Taylor, Jewel Johnston, Andree-Anne Berthiaume, Sharay E. Setti, Kevin Church

2:36 p.m. S14.009

Angubindin-1 opens the blood–brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system– Hiroya Kuwahara, Satoshi Zeniya, Tetsuya Nagata, Takanori Yokota

2:48 p.m. S14.010

Remote multimodal monitoring of motor neuron disease progression using wearable sensors and digital assessments–Andrew Geronimo, Jose Joaquin Casado, Ram Kinker Mishra, James Lim, Ashkan Vaziri, Zachary Simmons

1:00 p.m.–3:00 p.m. ET

SCIENTIFIC SESSIONS

Monday, April 24

1:00 p.m.–3:00 p.m.

1:00

S15.001

Ultrasound Imaging Markers of Carotid Atherosclerosis are Associated with Cognition Through Cerebral Small Vessel Disease on MRI–Taylor Ariko, Botagoz Aimagambetova, Hannah Gardener, Bonnie E. Levin, Xiaoyan Sun, Digna Cabral, Carolina Gutierrez, Weizhao Zhao, Noam Alperin, Consuelo MoraMcLaughlin, Mitchell S. V. Elkind, Jose Gutierrez, Clinton B. Wright, Ralph L. Sacco, Tatjana Rundek

1:12 p.m. S15.002

The Peruvian Alzheimer Disease Initiative (PeADI): An international effort model to increase diversity in AD research– Maryenela Illanes-Manrique, Pedro Mena, Karina Milla-Neyra, Larry D. Adams, Koni Mejia, Julia Rios Pinto, Rosario Isasi, Angel Cesar Medina, Gary W. Beecham, Ivan Cornejo-Herrera, Jeffery M. Vance, Edward Mario Ochoa, Sheila Castro Suarez, Michael L. Cuccaro, Elison Sarapura-Castro, Diana Cubas-Montecino, Mario R. Cornejo Olivas, Margaret A. Pericak-Vance

1:24 p.m. S15.003

Use of the Rowland Universal Dementia Scale (Rudas) for the diagnosis of cognitive impairment in illiterate individuals In Lima, Peru: An evaluation by domains– Nilton Custodio Capunay, Marco Moises Malaga, Diego ChambergoMichilot, Rosa Montesinos, Fiorella Alejandra Baca, Juan Carlos Carbajal, Jose Carlos Huilca, David Lira, Eder Herrera-Perez, Monica M. Diaz, Serggio Lanata

1:36 p.m. S15.004

Automated Drawing Process Metrics for Evaluating Cognitive Impairment from Human Drawing Behavior– Claudio Toro-Serey, Connor Patrick Higgins, Russell E. Banks, Ali Jannati, Joyce Rios Gomes-Osman, Alvaro Pascual-Leone, David James Bates, John W. Showalter, Sean Tobyne

1:48 p.m. S15.005

Cerebrospinal Fluid Biomarkers for the Early Detection of Alzheimer’s Disease Neuropathology– Michelle Jacqueline Safransky, Kaj Blennow, Henrik Zetterberg, Yorghos Tripodis, Brett Martin, Jason L. Weller, Breton Asken, Gil Dan Rabinovici, Wendy Qiu, Ann C. McKee, Thor D. Stein, Michael Alosco

2:00 p.m. S15.006

Analytical and Clinical Assessment of Plasma Phospho-Tau Isoforms in Alzheimer’s Disease (AD)–Ahmed Chenna, Andreas Jeromin, Brandon C. Yee, Youssouf Badal, Muriel Joy Mendes, Christos John Petropoulos, John Winslow

2:12 p.m. S15.007

Advancing knowledge and clinical development in frontotemporal dementia (FTD) using the American Academy of Neurology’s (AAN) Axon Registry®–Delaney Oliver, Esther Kane, Shana Dodge, Roisheen Doherty, Gabe Goldfeder, Oana Popescu, Sonya Li, Aracelis Torres, Heather Moss

2:24 p.m. S15.008

Real-world driving digital data reliably index MCI over time–Jun Ha Chang, Ruiqian Wu, Ying Zhang, Matthew Rizzo, Jennifer Merickel

2:36 p.m. S15.009

Diagnostic Value of the Boston criteria v2.0 for Cerebral Amyloid Angiopathy in Individuals Without Hemorrhage: An MRI-neuropathological Validation Study–Aaron Ross Switzer, Antreas Charidimou, Stuart McCarter, Scott Przybelski, Timothy Lesnick, Prashanthi Vemuri, Ross Reichard, Alejandro A. Rabinstein, David S. Knopman, Ronald C. Petersen, Jonathan Graff-Radford

2:48 p.m. S15.010

Expected vs Diagnosed Rates of Mild Cognitive Impairment and Dementia in the US Medicare Population–Soeren Mattke, Hankyung Jun, Emily Chen, Ying Liu, Andrew Becker, Chris Wallick

1:00 p.m.

2023 John Dystel Prize for Multiple Sclerosis Research: This prize recognizes outstanding contributions to research that have led to breakthroughs in the understanding, prevention, treatment, or cure of MS.– Roland Martin, MD, Zurich, Switzerland

1:24 p.m. S16.003

Immunological Signatures Associated With Ocrelizumab Treatment in Early RRMS: 12-Month Interim Analysis From the Ocrelizumab Phase IIIb (ENSEMBLE; NCT03085810) Immunological Substudy–Timo Wirth, Andreas Schulte-Mecklenbeck, Olga Vsevolodivna Steinberg, Catarina Raposo, Catharina Groß, Heinz Wiendl, Luisa Hildegard Klotz

1:36 p.m. S16.004

The Bruton’s Tyrosine Kinase Inhibitor Evobrutinib Demonstrates Superior Efficacy in Targeting Compartmentalized Neuroinflammation Compared to Anti-CD20 Treatment.– Hania Kebir, Cen Li, Michael May, Molly Church, Ursula Boschert Shafaatian, Jorge Alvarez

1:48 p.m. S16.005

Efficacy of Intrathecal Mesenchymal Stem Cell-Neural Progenitor Therapy in Progressive MS: Results from a Phase II Clinical Trial– Morgan C. Roche, Michaela L Malin, James Stark, Armistead Williams, Violaine K. Harris, Saud A.

Sadiq

2:00 p.m. S16.006

Blood Biomarker Dynamics in Highly Active Relapsing Multiple Sclerosis Patients Treated With Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study– Heinz Wiendl, Nicola De Stefano, Frederik Barkhof, Xavier Montalban, Anat Achiron, Tobias Derfuss, Andrew Chan, Suzanne J. Hodgkinson, Alexandre Prat, Letizia M. Leocani, Klaus Schmierer, Finn Sellebjerg, Patrick Vermersch, Hulin Jin, Elina Jarvinen, Anita Chudecka, Lidia Gardner

2:12 p.m. S16.007

Trial of Tauroursodeoxycholic Acid Supplementation in Patients with Progressive MS– Kimystian Harrison, Dimitrios Christos Ladakis, Soonmyung Hwang, Elias S. Sotirchos, Peter A. Calabresi, Pavan Bhargava

2:24 p.m. S16.008

Efficacy and Safety of the Bruton’s Tyrosine Kinase Inhibitor Evobrutinib for Relapsing Multiple Sclerosis Over 3.5 Years of Treatment: An Ongoing Phase II Open-Label Extension–Xavier Montalban, Jerry S. Wolinsky, Douglas L. Arnold, Martin Weber, Karolina Piasecka-Stryczynska, Davorka Tomic, Andrea Seitzinger, Hans Guehring

2:36 p.m. S16.009

Effect of Longer-term Ofatumumab Treatment on Disability Progression and Brain Volume Change–Jeffrey Alan Cohen, Stephen L. Hauser, Edward J. Fox, Ronald Zielman, Ayan Das Gupta, Amin Azmon, Jing Xi, Gina Mavrikis Cox, Derrick Robertson, Heinz Wiendl, Ludwig Kappos

2:48 p.m. S16.010

Safety and Clinical Efficacy Outcomes From the Long-term Extension Study of Tolebrutinib in Participants With Relapsing Multiple Sclerosis: 2.5-Year Results–Jiwon Oh, Sana Syed, Tong Li, Naji Salloum, Timothy J. Turner, Robert J. Fox

1:00 p.m.–3:00 p.m. ET

Monday, April 24

1:00 p.m.

2023 Neuro-oncology Investigator Award: This award recognizes junior investigators who have advanced the field of neuro-oncology.–Karisa C. Schreck, MD, PhD, Baltimore, MD

1:12 p.m.

2023 Neuro-oncology Scientific Award: This award recognizes an individual from any discipline and of any academic rank for a singular scientific achievement that has advanced the field of neuro-oncology.– Ingo K. Mellinghoff, MD, FACP, New York, NY

1:24 p.m. S17.003

Identification of the cuproptosis-related gene signature associated with the tumor environment and prognosis of patients with glioblastoma multiforme (GBM)– Ghayda’a Netham Al-Majali, Yaman Ahmed, Obada Ababneh, Zaid Mohammad Khalefa, Saja Alzghoul, Ayah Al-Bzour

1:36 p.m. S17.004

Pemigatinib For Previously Treated Central Nervous System Tumors With Activating FGFR Mutations or Translocations: Results From FIGHT-207– Iben Spanggaard, Marc Matrana, Caio Max Sao Pedro Rocha Lima, Amit Mahipal, Maria Vieito, Alice Hervieu, Myung-Ju Ahn, Lipika Goyal, Jordi Rodon, Luisa Veronese, Natalia Oliveira, Xin Li, Michael Schaffer, Santosh Kesari

1:48 p.m. S17.005

Safety of Direct Oral Anticoagulants as Compared to Low Molecular Weight Heparin in Treating Venous Thromboembolism in Patients with Primary Brain Tumors and Brain Metastases – A Review of Literature and Metaanalysis– Raphael Augusto Correa Bastianon Santiago, Nirja Shah, Asad Ali, Surabhi Ranjan

2:00 p.m. S17.006

Structured Early Advanced Care Planning Outcomes for Patients with High Grade Glioma– Meredith Pescatello, Nimish A. Mohile, Jennifer N. Serventi, Bethann Sayers, Jacqueline Marie Behr, Lauryn Hemminger, Sara Hardy

2:12 p.m. S17.007

The impact of hippocampal radiation dose on cognitive outcomes in older vs younger adults with brain tumors–Sara Hardy, Koren Holley, Lauryn Hemminger, Nimish A. Mohile, Michelle Janelsins, Michael T. Milano

2:24 p.m. S17.008

Soluble ST2 is associated with neurotoxicity following chimeric antigen receptor T-cell therapy– Elle Fietsam, Morgan McKeown, Caroline Booraem, Julia Cristina Jones, W. Taylor Kimberly, Caron Jacobson, Matthew Bradford Bevers

2:36 p.m. S17.009

Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival following Immunotherapy in Murine GBM.– Michal Nisnboym, Sarah Rose Vincze, Itay Raphael, Zujian Xiong, Chaim T. Sneiderman, Rebecca Raphael, Bo Li, Ambika Parmat Jaswal, ReidAnn Elizabeth Sever, Kathryn Elizabeth Day, Joe D. Latoche, Lesley May Foley, T Kevin Hitchenes, Sameer Agnihotri, Baoli Hu, Dhivyaa Rajasundaram, Carolyn J. Anderson, Deborah T. Blumenthal, Thomas Pearce, Shikhar Uttam, Jessie Nedrow, Ashok Panigrahy, Ian Pollack, Frank S. Lieberman, Jan Drappatz, Wilson Edwards, Gary Kohanbash

2:48 p.m. S17.010

Comparison of a STIR- and T1-based radiomics model to differentiate between plexiform neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 (NF1)– Ina Ly, Tianyu Liu, Wenli Cai, Olivia Michaels, Maya Viera, Daniel Junhyuk Kwon, Miriam Bredella, Justin T. Jordan, Dana Borcherding, Demetrius Devin Boswell, Crystal Burgess, Ping Chi, Peter De Blank, Eva Dombi, Angela C. Hirbe, Bruce R. Korf, Shernine Lee, Victor Mautner, Mairim Melecio-Vazquez, Zachary Mulder, Kai Pollard, Christine Pratilas, Johannes Martin Salamon, Divya Srihari, Matt Steensma, Brigitte Widemann, Jaishri Blakeley, Scott R. Plotkin

3:30 p.m.–4:20 p.m. ET

SCIENTIFIC SESSIONS

Monday, April 24

3:30

3:30 p.m.

2023 Lawrence C. McHenry: An Award for the History of Neurology: This award recognizes excellence in research in the history of neurology.–Kelsey Smith, MD, Rochester, MN

3:54 p.m. S18.003

History of the First Women Neurologists and Scientists who Participated in the Development of the American Academy of Neurology– Negin Badihian, Alison L. Christy, Christopher J. Boes, Elizabeth A. Coon

4:06 p.m. S18.004

MS Times Machine: The Story of Multiple Sclerosis in the 19th and 20th Century Through the Eyes of the Times Reader– Lakshman Narain Arcot Arcot Jayagopal

3:30 p.m.

2023 Bruce S. Schoenberg International Award in Neuroepidemiology: The award salutes those who are in their early and mid-career, who have a strong background and future promise as a leader in neuroepidemiological research.–Jitendra Sahu, DM, Chandigarh, India

3:54 p.m. S19.003

PM2.5 and Parkinson Disease Risk in Medicare Beneficiaries– Brittany Krzyzanowski, Susan Searles Nielsen, Brad A. Racette

4:06 p.m. S19.004

Incidence of syndromes associated with Frontotemporal Lobar Degeneration–Giancarlo Logroscino, Marco Piccininni, Caroline Graff, Orla Hardiman, Albert C. Ludolph, Fermin Moreno, Markus Otto, Anne Remes, James Rowe, Harro Seelaar, Eino Solje, Elka Stefanova, Latchezar D. Traykov, Vesna Jelic, Melissa Thaeri Rydell, Niall Pender, Sarah Anderl-Straub, Mirian Barandiaran Amillano, Alazne Gabilondo Lopez, Suvi-Johanna Kruger, Alexander G. Murley, Timothy Rittman, Emma L. Van Der Ende, John Van Swieten, Paivi Hartikainen, Gorana Mandic-Stojmenovic, Shima Meherabian, Luisa Benussi, Antonella Alberici, Maria Teresa Dell’Abate, Chiara Zecca, Barbara Borroni

4:18 p.m. S19.005

Shared genetics of migraine with irritable bowel syndrome, peptic ulcer, gastric reflux, diverticular disease, and autoimmune GI disorders– Daniel Chasman, Yanjun Guo, Andrew Chan, Kyle Staller, Pamela M. Rist

4:30 p.m. S19.006

The influence of arable crops on ALS risk and age at onset: a population-based study–Andrea Calvo, Stefano Callegaro, Rosario Vasta, Maurizio Grassano, Antonio Canosa, Sara Cabras, Francesca Di Pede, Enrico Matteoni, Fabiola De Marchi, Letizia Mazzini, Cristina Moglia, Adriano Chio, Umberto Manera

4:42 p.m. S19.007

Incidence and Prevalence of Myasthenia Gravis in the United States: A Claims-Based Analysis– Ema Rodrigues, Emeka Umeh, Aishwarya Uday, Nizanth Navaratnarajah, Kristin Moy

4:54 p.m. S19.008

Effect of Treatments on All-Cause of Mortality in Chronic Inflammatory Demyelinating Polyneuropathy–Anam Khalid Shaikh, Hassaam Shafiq Choudhry, Hannaan S. Choudhry, Kazim Jaffry, Ronak Trivedi, Kranthi Kiran Mandava, Mustafa Jaffry, Muhammed Ors, Iqra Faiz, Nizar Souayah

5:06 p.m. S19.009

Trends in the prevalence of stroke among community-dwelling individuals in the U.S.: 1999-2018–Wells Andres, Aaron Rothstein, Holly Elser, Kelly Sloane, Scott E. Kasner, Rebecca F. Gottesman, Andrea Lauren Christman Schneider

5:18 p.m. S19.010

Association of Cognitive and Structural Correlates of Brain Aging and Incident Epilepsy. The Framingham Heart Study.– Maria Stefanidou, Jayandra J. Himali, Claudia L. Satizabal, Alexa Beiser, Orrin Devinsky, Sudha Seshadri, Daniel Friedman

3:30 p.m.–5:30 p.m. ET

SCIENTIFIC SESSIONS

Monday, April 24

S20 Cerebrovascular Disease and Interventional Neurology: Clinical Trials and Outcomes Studies

3:30 p.m. S20.001

An Effectiveness Analysis of Walk-in Stroke Centres in Northern Alberta–Kaylynn Purdy, Thomas J. Jeerakathil, Douglas Oweens, Eran Bendavid

3:42 p.m. S20.002

CME 2

Infarct Topography and Reperfusion Injury After Endovascular Thrombectomy for Large Vessel Occlusion Stroke– Robert W. Regenhardt, Anna Katharina Bonkhoff, Markus D. Schirmer, Alvin Das, Adam A. Dmytriw, Justin E. Vranic, Rajiv Gupta, James D. Rabinov, Christopher Stapleton, Thabele M. Leslie-Mazwi, Aman Patel, Natalia S. Rost

3:54 p.m. S20.003

Robot-assisted transcranial Doppler versus transthoracic echocardiography for right to left shunt detection: “Real World” First-Look– Mark N. Rubin, Ira Chang, Michael F. Waters, Ruchir Shah, Thomas G. Devlin, Andrei V. Alexandrov

4:06 p.m. S20.004

Maraviroc pharmacotherapy in post-stroke depression: A proof of concept clinical trial– Einor Ben Assayag, Oren Tene, Jeremy Molad, Estelle Seyman, Ofer Rotchild, Hen Hallevi

4:18 p.m. S20.005

Physician Approaches to the Initial Management of an Intraluminal Thrombus in Recently Symptomatic Carotid Artery Stenosis: Results from the Hot Carotid Study– Davis Maclean, Benjamin Frank Beland, Gordon Jewett, Luca Bartolini, David JT Campbell, Malavika Varma, Ravinder Jeet Singh, Abdulaziz Sulaiman Al Sultan, John Wong, Bijoy Menon, Aravind Ganesh

4:30 p.m. S20.006

Dual anti-platelet aggregation Versus Aspirin alone in acute minor ischemic stroke and high-risk TIA : A Tunisian Study–Yasmine Saad, Mariem Mhiri, Yasmine Saad, Amal Abbes, Narjes Gouta, Mouna Aissi, Yasmine Saad

4:42 p.m. S20.007

Association Between Self And Caregiver Reported Sleep Problems And Polysomnographic Findings In Post-stroke Patients: A Cross Sectional Study.– Kamalesh Sukdev Tayade, Deepti Vibha, Manjari Tripathi, Rajesh Kumar Singh, Arunmozhimaran Elavarasi

4:54 p.m. S20.008

Patient-reported outcomes in the Telehealth After Stroke Care feasibility randomized clinical trial: home blood pressure telemonitoring-enhanced versus usual post-acute stroke care in an underserved setting– Hanlin Li, Kevin Strobino, Kevin Schmitt, Yuliya Baratt, Carmen Elisabeth Castillo, Adriana Arcia, Ian Kronish, Mitchell S. V. Elkind, Imama Ali Naqvi

5:06 p.m. S20.009

Association of Global Cortical Atrophy Score with Clinical Outcomes after Large Middle Cerebral Artery Stroke– Rebecca Stafford, Stefanos Chatzidakis, Ivy So Yeon Kim, Benjamin Brush, Asim Zia Mian, David M. Greer, Stelios M. Smirnakis, Steven K. Feske, Charlene Jennifer Ong

5:18 p.m. S20.010

Reaching Accuracy Assessment in Cerebellar Stroke using Virtual Reality–Khai Du, Leonardo Roberto Benavides, Emily Isenstein, Duje Tadin, Ania Busza

3:30 p.m.–5:30 p.m. ET

S21 Acute and Post-Acute Sequelae of COVID-19 CME 2

3:30 p.m. S21.001

Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy–Antonia De Oliveira, Joyce Lei, Jiayuan Liu, Morgan C. Roche, Jerry Lin, Roberto Alfonso, Saud A. Sadiq

3:42 p.m. S21.002

Machine Learning Models to Predict Severity and Mortality of COVID-19 Using Neurological Symptoms– Mona Salehi, Amir Garakani, Manouchehr Amanat

3:54 p.m. S21.003

Cognitive Concerns are a Risk Factor for Mortality in People with Human Immunodeficiency Virus and COVID-19– Emily Anne Rudmann, Douglas Robert Wilcox, Elissa Ye, Ayush Noori, Colin Magdamo, Aayushee Jain, Haitham Alabsi, Virginia Triant, Gregory Robbins, M. Brandon Westover, Sudeshna Das, Shibani

Sharon Mukerji

4:06 p.m. S21.004

The MRI Analysis of 300 Subjects Revealed Grey Matter Atrophy of the Frontal Lobe and Limbic System in Four SARS-CoV-2 Strains– Lucas Scárdua Silva, Beatriz Costa, Vítor Guimaraes Correa, Rafael Joao, Mateus Nogueira, Italo Karmann Aventurato, Marina Koutsodontis Alvim, Mariana Rabelo De Brito, Fernando Cendes, Clarissa L. Yasuda

4:18 p.m. S21.005

Coronavirus 2019: Clinicopathological Update– David S. Younger

4:30 p.m. S21.006

Serum And Cerebrospinal Fluid Antibody Signatures Track With Outcome Of Neurologic Post-Acute Sequelae Of SARS-Cov-2 Infection (NeuroPASC)–Marianna Spatola, Alessandro Dinoto, Silvia Bozzetti, Vanessa Chiodega, Sergio Ferrari, Sara Mariotto, Galit Alter

4:42 p.m. S21.007

Anxiety And Depression Are Associated With Limbic Atrophy And Severe Disruption Of Brain Functional Connectivity After Mild COVID-19 Infection–Beatriz Costa, Lucas Scárdua Silva, Maria Mendes, Italo Karmann Aventurato, Brunno de Campos, Mateus Nogueira, Rafael Joao, Fernando Cendes, Clarissa

L. Yasuda

4:54 p.m. S21.008

Changes In Cognitive Functioning In Patients Seeking Treatment For “Brain Fog” Through A Post-Covid Treatment Clinic–Shruti Prabodh Agnihotri, Jamie Hansel Robinson, Richard Kennedy, David E. Vance, Kristine Lokken

5:06 p.m. S21.009

Effect of Human Immunodeficiency Virus Infection on the Incidence and Severity of Neurological Post-Acute Sequelae of COVID-19– Mustafa Jaffry, Kranthi Kiran Mandava, Kazim Jaffry, Muhammed Ors, Anam Khalid Shaikh, Ronak Trivedi, Iqra Faiz, Firas Gerges, Michel Boufadel, Nizar Souayah

5:18 p.m. S21.010

Long-COVID-19 cognitive disfunction: strain-specific effects on 452 subjects– Italo Karmann Aventurato, Mateus Nogueira, Lucas Scárdua Silva, Rafael Joao, Jose Flavio Becchelli, Alan Ferreira dos Santos, Leila Camila Santos Silva, Mariana Rabelo De Brito, Fernando Cendes, Clarissa L. Yasuda

3:30 p.m.–5:30 p.m. ET

Monday, April 24

S22 Autoimmune Neurology: Autoimmune Encephalitis and Other Antibody-associated Syndromes

3:30 p.m.

2023 Alliance Award Founders: This award is designed to encourage clinical and translational research in neuroscience by physicians in clinical neurology training programs.–Alexander Sandweiss, MD, PhD, Houston, TX

3:42 p.m.

2023 Alliance Award S. Weir Mitchell: This award is designed to encourage basic research in neuroscience by physicians in clinical neurology training programs.–John Pluvinage, MD, PhD, San Francisco, CA

3:54 p.m. S22.003

MRI Features and their Association with Outcomes in Children with AntiNMDA Receptor Encephalitis– Grace Gombolay, James Nick Brenton, Jennifer H. Yang, Coral Marie Stredny, Ryan Kammeyer, Catherine E. Otten, NgocHanh H. Vu, Jonathan Santoro, Karla Robles Lopez, Andrew Christiana, Claude Steriade, Morgan E. Morris, Mark Gorman, Manikum Moodley, Duriel Isaiah Hardy, Alexandra Behar Kornbluh, Ilana L. Kahn, Leigh Nicole Sepeta, Anusha Yeshokumar

4:06 p.m. S22.004

Frontal cognitive-behavioural deficits in patients with anti-leucine-rich gliomainactivated protein 1 antibody encephalitis–Sydney Lee, Seth Andrew Climans, Gregory S. Day, Julien Hebert, Sarah Lapointe, Ronald Cepe Ramos, Claude Steriade, Richard Wennberg, Alexandra Muccilli, David F. Tang-Wai

4:18 p.m. S22.005

Monoclonal Humanized One-Armed Antibody Blocking Therapy for AntiNMDAR Encephalitis– Mitsuyuki Matsumoto, Shanni Tsuyako Yamaki, Roghiye Kazimi, Atsuo Kanno, Masashi Maeda, Satoshi Kubo, Mathew Mitchell, Jay Lichter

4:30 p.m. S22.006

Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders– Mar Guasp, Mireia Rosa Justicia, Amaia Muñoz-Lopetegi, Eugenia Martinez-Hernandez, Thais Armangue, Gisela Sugranyes, Heike Stein, Laia Prades, Helena Arino, Jesús Planagumà, Elena De la Serna, Domingo Escudero, Sara Llufriu, Raquel Sanchez Del Valle Diaz, Joan Santamaria, Albert Compte, Josefina Castro-Fornieles, Josep O. Dalmau

4:42 p.m. S22.007

Cognitive Impairment is Associated with Longitudinal Disability in LGI-1IgG Encephalitis–Albert Aboseif, Yadi Li, Moein Amin, Brittany Lapin, Justin Abbatemarco, Alexander D. Rae-Grant, Vineet Punia, Rachel Galioto, Amy Kunchok

4:54 p.m. S22.008

Animal model of HSV-induced-NMDAR Autoimmune Encephalitis affects predominantly female mice–Alexander Sandweiss, Yike Jiang, Kristy Murray, Shannon Elizabeth Ronca

5:06 p.m. S22.009

Long Term Outcomes in Patients with Anti-DPPX Autoimmunity– Lisette Dominguez, Andrew McKeon, Alfonso Sebastian Lopez

5:18 p.m. S22.010

Frequency of anti-IgLON5 disease in patients who meet the clinical diagnostic criteria for progressive supranuclear palsy/corticobasal syndrome–Yoya Ono, Akira Takekoshi, Nobuaki Yoshikura, Hiroshi Takigawa, Ikuko Aiba, Ritsuko Hanajima, Hisanori Kowa, Masato Kanazawa, Takahiko Tokuda, Aya Tokumaru, Mitsuya Morita, Kazuko Hasegawa, Kenji Nakashima, Takeshi Ikeuchi, Akio Kimura, Takayoshi Shimohata

1:00 p.m.–1:45 p.m. ET

SCIENTIFIC SESSIONS

Tuesday, April 25

1:00 p.m.–3:00 p.m. ET

1:00 p.m. S23.001

Peripheral myeloid cells control resolution of painful Chemotherapy-Induced Peripheral Neuropathy (CIPN)– George Naratadam, Armen Akopian

1:12 p.m. S23.002

Novel Variants and Phenotypic Heterogeneity in Congenital Insensitivity to Pain–Sinem Seleme Ovunc, Aysel Kalayci Yigin, Betul Kesriklioglu, Gizem Izgi, Fitnat Ulug, Sema Saltik, Mehmet Seven, Deniz Agirbaslo

1:24 p.m. S23.003

Cilnidipine, a Novel N-Type Specific Calcium Channel Antagonist, Has Potent Activity at the Nav1.7 Sodium Channel, Which May Have Implications for Treatment of Certain Neuropathic Pain Conditions–Andrew Sternlicht

S24 Cerebrovascular Disease and Interventional Neurology: Endovascular Thrombectomy and Large Vessel Occlusions

1:00 p.m. S24.001

Endovascular Thrombectomy Beyond 24 Hours from Stroke Onset: A Systematic Review and Meta-Analysis–Aaron Eduardo Rodriguez-Calienes, Juan A. Vivanco-Suarez, Milagros Galecio-Castillo, Cynthia Zevallos, Marco Moises Malaga, Mudassir Farooqui, Santiago Ortega Gutierrez

1:12 p.m. S24.002

Acute Basilar Artery Occlusion Thrombectomy Performed in Early (6 hours) from the PC-SEARCH Registry– Nameer Aladamat, Adam T. Mierzwa, Syed F. Zaidi, Khaled Gharaibeh, Ehad Afreen, Sami Alkasab, Ashley Nelson, Mudassir Farooqui, Juan A. Vivanco-Suarez, Ashutosh P. Jadhav, Shashvat Desai, Gabor

Toth, Anas Mohammed Alrohimi, Thanh Ngoc Nguyen, Piers Klein, Mohamad Abdalkader, Aditya S. Pandey, Sravanthi Koduri, Nirav Vora, Shivangi Vora, Mouhammad A. Jumaa, Santiago Ortega Gutierrez

1:24 p.m. S24.003

Mechanical Thrombectomy Versus Combined Thrombectomy and Intravenous Thrombolysis in Tandem Lesions–Aaron Eduardo Rodriguez-Calienes, Milagros Galecio-Castillo, Mudassir Farooqui, Sunil Sheth, Albert J. Yoo, Afshin A. Divani, Nils Petersen, Michael George Abraham, Johanna Therese Fifi, Waldo Guerrero, Amer Malik, James E. Siegler, Thanh Ngoc Nguyen, Guillermo Linares, Nazli

A. Janjua, Darko Ernesto Quispe Orozco, Syed F. Zaidi, Jessica Kobsa, Ayush Prasad, Asad Ikram, Cynthia Zevallos, Manuel Requena, Marta Olive Gadea, Abid Qureshi, Tiffany Barkley, Stavros Matsoukas, Mohamad Abdalkader, Sergio Arturo Salazar Marioni, Jazba Soomro, Juan A. Vivanco-Suarez, Randall Edgell, Maxim Mokin, Dileep R. Yavagal, Mouhammad A. Jumaa, Ameer Hassan, Santiago Ortega Gutierrez

1:36 p.m. S24.004

Failed Mechanical Thrombectomy: prevalence, etiology and predictors– Hamid Ali, Orgest Lajthia, Eyad Almallouhi, Muhammed Amir Essibayi, Eric Bass, Ron Neyens, Mohammad Anadani, Reda Mohamad Chalhoub, Kimberly Kicielinski, Jonathan Lena, Guilherme Porto, Mithun G. Sattur, Alejandro Spiotta, Sami Alkasab

1:48 p.m. S24.005

Predictors of good outcome in Acute stroke due to basilar artery occlusion from the PC-SEARCH Registry–Adam T. Mierzwa, Syed F. Zaidi, Nameer Aladamat, Khaled Gharaibeh, Ehad Afreen, Sami Alkasab, Ashley Nelson, Santiago Ortega Gutierrez, Juan A. Vivanco-Suarez, Mudassir Farooqui, Ashutosh P. Jadhav, Shashvat Desai, Gabor Toth, Anas Mohammed Alrohimi, Thanh Ngoc Nguyen, Piers Klein, Mohamad Abdalkader, Hisham Raza Alim Salahuddin, Aditya S. Pandey, Sravanthi Koduri, Nirav Vora, Mouhammad A. Jumaa

2:00 p.m. S24.006

Investigating the Relationship Between Oximetry Trends During Endovascular Therapy and Neurological Worsening for Patients with Acute Ischemic Stroke– Madelynne Olexa, Yelyzaveta Begunova, David Bartolome, Teng Jiao Peng, Charles Matouk, Kevin N. Sheth, Nils Petersen

2:12 p.m. S24.007

SCIENTIFIC SESSIONS

2:24 p.m. S24.008

Endovascular Thrombectomy Versus Medical Management for Large Vessel Occlusion Stroke Patients with Severe Baseline Disability–Amine Mohamed Marc Awad, Michael Young, Alexander Andreev, Adam A. Dmytriw, Justin E. Vranic, James D. Rabinov, Christopher Stapleton, Alvin Das, Aneesh B. Singhal, Natalia S. Rost, Aman Patel, Robert W. Regenhardt

2:36 p.m. S24.009

Analysis of Advanced Imaging Utilization in Low National Institutes of Health Stroke Scale Score and Rate of Large Vessel Occlusion Detection in Large Telestroke Database–Theresa Beth Sevilis, Mariecken V. Fowler, Amanda Avila, Caitlyn Boyd, Oleg William Collins, Lan Gao, Gregory Wayne Heath, Thomas G. Devlin

2:48 p.m. S24.010

Intravenous Thrombolysis (IV tPA) Prior to Basilar Artery Thrombectomy, Analysis of the PC-SEARCH Registry– Ehad Afreen, Adam T. Mierzwa, Syed F. Zaidi, Khaled Gharaibeh, Nameer Aladamat, Sami Alkasab, Ashley Nelson, Santiago Ortega Gutierrez, Mudassir Farooqui, Juan A. Vivanco-Suarez, Ashutosh P. Jadhav, Shashvat Desai, Gabor Toth, Anas Mohammed Alrohimi, Thanh Ngoc Nguyen, Piers Klein, Mohamad Abdalkader, Aditya S. Pandey, Sravanthi Koduri, Shivangi Vora, Nirav Vora, Mouhammad A. Jumaa, Hisham Raza Alim Salahuddin

1:00 p.m.

2023 AAN Neuro-infectious Disease Award: This award recognizes individuals who have made a contribution to neuro-infectious disease research.–Mashina Chomba, MBChB, MMed, Lusaka, Zambia

1:12 p.m. S25.002

Dramatic Improvement of MRI Abnormalities of HIV Dementia after Suppressive Antiretroviral Therapy– Devon Kathleen Dietrich, Elizabeth Laidlaw, Dima Hammoud, Alice K. Pau, Bryan Smith

1:24 p.m. S25.003

Safety and tolerability of adjunctive linezolid with high or standard dose rifampin for the treatment of adults with HIV-associated tuberculous meningitis in Uganda: preliminary findings from the ALTER trial– Freddie Mukasa Kibengo, Anita Kabarambi, Paddy Kafeero, Muhumuza Patrick, Maria Assumpta Nakimbugwe, Anthony Ssemaganda, Colman Tayebwa, Payam Nahid, Fiona Cresswell, Felicia Chow

1:36 p.m. S25.004

Linezolid As An Add On Treatment In The Intensive Phase Of Tubercular Meningitis. A Randomized Controlled Pilot Trial.–Akhil Sahib, Rohit Bhatia, M.V.Padma Srivastava, Mamta Singh Bhushan, Vishnu VY, Roopa Rajan, Anu Gupta, Achal K. Srivastava

1:48 p.m. S25.005

Role of Thalidomide in the management of complicated Tuberculous Meningitis– Manish Modi, Ritu Shree, Ashish Kumar Kakkar, Manoj Goyal, Kusum Sharma

2:00 p.m. S25.006

Clinical Factors Associated with Poor Outcomes in Patients with Central Nervous System Tuberculosis Treated in San Francisco, CA from 2011 to 2021– Carlos Hernandez Castillo, Felicia Chow, Janice Louie, Laura Romo

2:12 p.m. S25.007

Drug Resistance Patterns in Tubercular Meningitis patients from North India–Tanish Modi, Kusum Sharma, Neeraj Singla, Tina Sood

2:24 p.m. S25.008

Subcortical Gray Matter Loss and Ventricular Enlargement Define Specific HIV Biotypes– Devon Kathleen Dietrich, Cynthia Chen McMahan, Tianxia Wu, Govind Bhagavatheeshwaran, Daniel Reich, Joseph Snow, Anuradha Ganesan, Catherine M. Berjohn, Brian K. Agan, Avindra Nath, Bryan Smith

2:36 p.m. S25.009

Immunocompromise and herpes simplex virus type 1 encephalitis (HSVE): a nationwide cohort and case-control study–Alice Ruo Wei Tang, Shamik Bhattacharyya, Edison K. Miyawaki, Kazuki Yoshida, Douglas Robert Wilcox, Karen Costenbader, Daniel Solomon, Hongshu Guan, Hannah Lahey

2:48 p.m. S25.010

Infectious Encephalitis in Adults: Characteristics, Outcome and Clinical Clues–Gadi Maayan Eshed, Tal Levinson, Yair Mina, Adi Ashkenazi, Michal Dekel, Ronit Cohen-Poradosu, Yifat Alcalay, Orna Aizenstein Lehavi, Yael Paran, Avi Gadoth

SCIENTIFIC SESSIONS

Tuesday, April 25

1:00 p.m.–3:00 p.m. ET

S26 Experimental Therapeutics in Dementia

1:00 p.m.

2023 Potamkin Prize for Research in Pick’s, Alzheimer’s, and Related Diseases: This award recognizes major contributions to the understanding of the causes, prevention, treatment, and cure for Pick’s, Alzheimer’s, and related diseases.–Maria Gorno Tempini, MD, PhD, San Francisco, CA

1:24 p.m. S26.003

Plasma biomarkers predict pre-clinical amyloid- and tau-PET in a cognitively healthy cohort: The Framingham Heart Study– Martin David Mulligan, Qiong Yang, Ruiqi Wang, Alexa Beiser, Saptaparni Ghosh, Claudia L. Satizabal, Russell Tracy, Sudha Seshadri, Emer McGrath

1:36 p.m. S26.004

Rational design of a vaccine for Alzheimer’s disease using computationallyderived conformational B cell epitopes to selectively target toxic amyloid-beta oligomers– Johanne M. Kaplan, Scott Napper, Erin Scruten, Ebrima Gibbs, Juliane Ashleigh Coutts, Neil R. Cashman

1:48 p.m. S26.005

Using Predictive Models to Reduce Heterogeneity in Alzheimer’s Disease Clinical Trials–Ali Ezzati, Kellen Petersen, Bhargav Nallapu, Richard B. Lipton

2:00 p.m. S26.006

ALUMNI AD Study Design: Evaluation of Subcutaneous Gantenerumab in Historically Underrepresented US Populations With Early Symptomatic Alzheimer’s Disease–Sheila Seleri, Sharon A. Brangman, Joseph Neil Henderson, Monica Lauren Parker, Stephanie Monroe, Jacobo E. Mintzer, Alexandria Wise-Brown, Michael Grundman, Janice W. Smith, Rachelle S. Doody, Helen C. Lin, Beverly Assman, Gregory A. Rippon

2:12 p.m. S26.007

Effects of ALZ-801, an Oral Amyloid Oligomer Inhibitor, on Biomarkers of Alzheimer’s Disease (AD): 12-Month Results of Phase 2 Biomarker Study in Early AD–John A. Hey, Sawsan (Susan) R. Abushakra, Kaj Blennow, Philip Scheltens, Jakub Hort, Katerina Sheardova, Niels D. Prins, Sterre Malou Rutgers, Paul L. Dautzenberg, Ladislav Pazdera, Patrick Kesslak, Rosalind Mandelbaum, Aidan Power, Martin Tolar

2:24 p.m. S26.008

Fosgonimeton Provides Congruent Improvements on Neurodegeneration Biomarkers, Significantly Correlating With Composite Clinical Score of Cognition and Function in Alzheimer’s Disease– Hans J. Moebius, Kai-Bin Ceres Ooi, Michael Don Hale, Sharay E. Setti, Kayla Nicole Kleist, Charles Bernick

2:36 p.m. S26.009

TRAILBLAZER-ALZ 4: Topline study results directly comparing donanemab to aducanumab on amyloid lowering in early, symptomatic Alzheimer’s disease–Stephen P. Salloway, Elly Lee, Michelle Papka, Andrew John Kinsman Pain, Ena Oru, Margaret Ferguson, Hong Wang, Michael G. Case, Ming Lu, Emily Catherine Collins, Dawn A. Brooks, John R. Sims

2:48 p.m. S26.010

GRADUATE I AND II: Findings of Two Phase III Randomized Placebo-controlled Studies Assessing the Efficacy and Safety of Subcutaneous Gantenerumab in Early Alzheimer’s Disease–Janice Smith, Michael Donohue, Elisabeth Gruendl, Timo Grimmer, Richard Perry, Sandra Black, Stephen Salloway, Marco Lyons, Loes Rutten-Jacobs, Tobias Bittner, Kaj Blennow, Chris Pelentrides, Frederik Barkhof, Matteo Tonietto, Monika Baudler, Paulo Fontoura, Rachelle Doody

1:00 p.m. S27.001

A 2-Stage Model of Heterogenous Treatment Effects for Brain Atrophy in MS Utilizing the MS PATHS Research Network– Carrie Michelle Hersh, Zhaonan Sun, Cynthia Grossman, Changyu Shen, Fabio Pellegrini, Nolan Campbell

1:12 p.m. S27.002

CSF-In Gradient of Thalamic and Cortical Damage in Multiple Sclerosis: A 3T Magnetization Transfer Ratio Study– Martina Rubin, Elisabetta Pagani, Loredana Storelli, Alessandro Meani, Paolo Preziosa, Monica Margoni, Maria Assunta Rocca, Massimo Filippi

1:24 p.m. S27.003

Paramagnetic rim lesions predict the development of clinical MS in radiologically isolated syndrome: results from a prospective cohort study–Jiwon Oh, Timothy R. Lim, Suradech Suthiphosuwan, Adrian Isidoro Espiritu, Melanie Guenette, Aditya Bharatha, Pascal Sati, Martina Absinta, Daniel Reich

1:36 p.m. S27.004

Clinical Relevance of Spatial Correspondence Between Regional Gene Expression and Gray Matter Atrophy in Multiple Sclerosis– Paolo Preziosa, Loredana Storelli, Nicolò Tedone, Monica Margoni, Carmen Vizzino, Damiano Mistri, Mor Gueye, Massimo Filippi, Maria Assunta Rocca

1:48 p.m. S27.005

Using Myelin Water Imaging to Investigate Myelin Damage and its Association with Clinical Outcomes in Radiologically Isolated Syndrome–Connor Keane, Poljanka Johnson, Joshua D. Lee, Roger Tam, Jiwon Oh, Anthony Traboulsee, Shannon Kolind

2:00 p.m. S27.006

Dynamic MRI Lesion Evolution in Pediatric Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)– Omar Abdel-Mannan, Dimitrios Champsas, Sharmila Manivannan, Kshitij Mankad, Rachel Kneen, Vivek Chitre, Sukhvir Wright, Evangeline Wassmer, Cheryl Hemingway, Thomas Rossor, Ming Lim, Olga Ciccarelli, Yael Hacohen

2:12 p.m. S27.007

Influence of Cardiorespiratory Fitness and MRI Measures of Neuroinflammation on Hippocampal Volume in Multiple Sclerosis Patients–Tetsu Morozumi, Paolo Preziosa, Matteo Albergoni, Monica Margoni, Elisabetta Pagani, Alessandro Meani, Massimo Filippi, Maria Assunta Rocca

2:24 p.m. S27.008

The Positive Effects of Aerobic Capacity on Fatigue are Mediated by Thalamic Nuclei in People With Multiple Sclerosis– Matteo Albergoni, Elisabetta Pagani, Paolo Preziosa, Monica Margoni, Massimo Filippi, Maria Assunta Rocca

2:36 p.m. S27.009

Association of Daily Physical Activity with Cervical Spinal Cord Areas in Multiple Sclerosis–Valerie A J Block, Shuiting Cheng, Jeremy Juwono, Richard A. Cuneo, Gina Kirkish, Amber M. Alexander, Mahir Hossain Khan, Amit Vijay Akula, Eduardo Caverzasi, Nico Papinutto, William Stern, Refujia Gomez, Mark Pletcher, Gregory Marcus, Jeffrey Olgin, Stephen L. Hauser, Jeffrey Marc Gelfand, Riley Bove, Bruce A. C. Cree, Roland G. Henry

2:48 p.m. S27.010

Is Fatigue Response to tDCS Mediated by Change in Affect? An Open-label tDCS-MRI Study– Giuseppina Pilloni, Lillian Walton Masters, Marco Muccio, Claire Choi, Abhishek Datta, Marom Bikson, Lauren B. Krupp, Yulin Ge, Leigh Elkins Charvet

SCIENTIFIC SESSIONS

Tuesday, April 25

3:30 p.m. S28.001

Macromolecular Dexamethasone Prodrug Ameliorates Neuroinflammation and Prevents Bone Loss Associated with Traumatic Brain Injury–Xin Wei, Gang Zhao, Jia Zhenshan, Zhao Zhifeng, Ningrong Chen, Yuanyuan Sun, Matthew Kelso, Geetanjali Singh Rathore, Dong Wang

3:42 p.m. S28.002

Failure to Receive Specialty Concussion Care in Pediatric Patients–Jonathan Davidow, Anmol Singh, Henry Neri, Paige Buddenhagen, Kate M. Essad

3:54 p.m. S28.003

Salt diet Induces Neuroinflammatory Response, Microbiome Dysregulation and Associated with Long-term Anxiety Following Repetitive Closed Head Injury.–Saef Izzy, Taha Yahya, Tian Cao, Omar Albastaki, Mokalad Waed, Kusha Chopra, Millicent Nkiruka Ekwudo, Ugne Kurdeikaite, Isabelly Moraes Verissimo, Laura M. Cox, Ross Zafonte, Michael Whalen

4:06 p.m. S28.004

Prevalence of White Matter Hyperintensities in Young Adults With and Without Mild Traumatic Brain Injury–Teena Shetty, Jonathan Westafer, Joseph T Nguyen, Luella Coffey

4:18 p.m. S28.005

Differences in Satisfaction with Life Among Individuals Diagnosed with TBI Before and During the COVID-19 Pandemic– Lauren Dugan, Mihran Hovhannesyan, Saewon Chun, Sthefon Tran, Patrick Mariani, Hani Atamna

3:30 p.m. S29.001

Black Patients with Movement Disorders Less Likely to Receive Treatment with Deep Brain Stimulation–Andrew Dorritie, Mohammad Faysel, Angelika C. Gruessner, Daphne Robakis

3:42 p.m. S29.002

Neighborhood Disadvantage and Outcomes Following Intracerebral Hemorrhage–Jisoo Kim, Eva Gordon Kitlen, Victor Manuel Torres-Lopez, Cyprien Rivier, Daniela Brenda Renedo, Maia Schlechter, Leah Macht Kleinberg, Melissa Pish, Michael Conrad Kampp, Sara Jasak, Lauren Hachmann Sansing, Kevin N. Sheth, Guido Jose Falcone

3:54 p.m. S29.003

Minorities, Socioeconomic Disadvantaged, and Older Patients have Decreased Utilization of Telehealth for Neurological Conditions– Marisa P. McGinley, Tucker Harvey, Allison L. Weathers, Daniel Ontaneda

4:06 p.m. S29.004

Does the Area Deprivation Index (ADI) influence dementia evaluation and diagnosis in Virginia?–Anelyssa D’Abreu, Pavel Chernyavskiy

4:18 p.m. S29.005

Free Neurology Community Health Clinic: Insights on Patient Population and Resident Experience– Dan Tong Jia, Juan Ramon Deliz Gonzalez, Hrayr P. Attarian, Yvonne M. Curran, Neena Cherayil, Katherine Carroll

sponsored no-charge NGS (Next-generation sequencing) panel can help to reach a diagnosis. This can help to reduce diagnostic delays, aid in family planning, and create a better path forward for disease management.

Tuesday, April 25

3:30 p.m.–5:30 p.m. ET

S30 Epilepsy/Clinical Neurophysiology (EEG): Technology

3:30 p.m.

2023 Dreifuss-Penry Epilepsy Award: This award recognizes physicians in the early stages of their careers who have made an independent contribution to epilepsy research.–Jonathan Kleen, MD, PhD, San Francisco, CA

3:42 p.m. S30.002

Predicting Seizure Freedom through Computational Processing of Routine EEG– Emile Lemoine, Denahin Hinnoutondji Toffa, Frédéric Lesage, Dang Khoa Nguyen, Elie Bou Assi

3:54 p.m. S30.003

Prediction of post-surgical neuropsychological outcomes from high-gamma modulation language mapping and cortical resections– Christina Vera Kargol, Brian Ervin, Clayton James Frink, Craig William Scholle, Jason Buroker, Anna Byars, Ravindra Arya

4:06 p.m. S30.004

The Presence or Absence of Hippocampal Atrophy Differently Disrupts Graph Theory Properties of Cerebral Functional Connectivity in Temporal Lobe Epilepsy.– Lucas Scárdua Silva, Italo Karmann Aventurato, Raphael F. Casseb, Brunno de Campos, Fernando Cendes, Clarissa L. Yasuda

4:18 p.m. S30.005

Machine-learning Assisted Differentiation Between Physiological Oscillation Epochs and Muscle or Epileptiform activity in EEGs–Vikram Jakkamsetti, Gauri Anil Kathote, Adrian Avila, Sharon Primeaux, Aksharkumar Dobariya, Ignacio Malaga Dieguez, Juan Pascual

4:30 p.m. S30.006

An online competency-based examination of routine EEG interpretation accurately differentiates novices and experienced EEG readers– Fabio Nascimento, Hong Gao, Roohi Katyal, Rebecca E. Matthews, Stefan Rampp, William O. Tatum, Roy E. Strowd, Sandor Beniczky

4:42 p.m. S30.007

Machine Learning Prediction of Seizures after Ischemic Strokes.–Alain Zingraff Lekoubou Looti, Justin Petucci, Avnish Katoch, Vasant G. Honavar

4:54 p.m. S30.008

Inter-Rater Reliability of EEG-Based Encephalopathy Grading–Anika Zahoor, Jayme C. Banks, Ryan A. Tesh, Christine Ann Eckhardt, Haoqi Sun, Adam Seth Greenblatt, Aline Herlopian, Ioannis Karakis, Roohi Katyal, Chetan Nayak, Marcus Ng, Jonathan Williams, Irfan Sahail Sheikh, Fabio Nascimento, M. Brandon Westover

5:06 p.m. S30.009

Evaluation of Automated Seizure Detection Measurements in Cardiac Arrest Patients Undergoing Ceribell Rapid-EEG– Mauricio Fernando Villamar, Neishay Ayub, Seth Jason Koenig

5:18 p.m. S30.010

Comparison of Machine Learning Algorithms for Somatosensory Functional Mapping– Iktimal Alwan, Dennis Spencer, Rafeed Alkawadri

3:30 p.m. S31.001

Evaluation of B-cell Abnormalities in Infants of Breastfeeding Mothers on anti-CD20 Therapies for Multiple Sclerosis–Anna Shah, Enrique Alvarez

3:42 p.m. S31.002

Race Disparities in Pregnancy Care and Clinical Outcomes in Women with MS: a Diverse, Multicenter Cohort–Anne Marie Radzik, Annika Anderson, Lilyana M. Amezcua, Sophie Ahmad, Rachel Brandstadter, Michelle Fabian, Edith Graham, Sophia Eugenia Hodgkinson, Lindsay A. Horton, Dina Jacobs, Ilana B. Katz Sand, Amit Kohli, Annette Okai, Monica R. McLemore, Jasmin Patel, Shane Poole, Sammita Satyanarayan, Claire Riley, Lauren Tardo, Elizabeth Verter, Veronica Villacorta, Mitzi Joi Williams, Vanessa Zimmerman, Leah Zuroff, Maria K. Houtchens, Riley Bove

3:54 p.m. S31.003

Latinx with multiple sclerosis have greater disability and loss of deep and cortical gray matter– Daniel Ontaneda, Marisa P. McGinley, Tucker Harvey, Kathryn Fitzgerald, Ellen M. Mowry, Jeffrey Alan Cohen, Farren Briggs

4:06 p.m. S31.004

Final Analysis of Pregnancy Outcomes Following Exposure to Dimethyl Fumarate in a Prospective International Registry– Kerstin Hellwig, David Rog, Christopher McGuigan, Maria K. Houtchens, Denise Bruen, Oksana Mokliatchouk, Filipe Branco, Seth Nathatn Levin, Xiaochen Lin

4:18 p.m. S31.005

Impact of Assisted Reproductive Technologies (ART) on Relapse Risk in Women with Multiple Sclerosis– Nele Rosa Range, Sandra Thiel, Kerstin Hellwig, Ralf Gold

4:30 p.m. S31.006

An Interim Analysis of Efficacy and Safety Data in Black and Hispanic Patients With Multiple Sclerosis Receiving Ocrelizumab Treatment in the CHIMES

Trial– Evanthia Bernitsas, Anthony Reder, Angel R. Chinea, Craig E. Herrman, Barbara Cape O’Brien, Richard A. Sater, Lilyana M. Amezcua, Mitzi Joi Williams, Gregory F. Wu, Timothy K. Vartanian, Jinglan Pei, Juan A. Acosta, Nancy Monson

4:42 p.m. S31.007

Real-World Effectiveness of Ocrelizumab in a Multi-Centre Pediatric-Onset Multiple Sclerosis (POMS) Cohort in the United Kingdom– Omar AbdelMannan, Arman Eshaghi, Dimitrios Champsas, Kshitij Mankad, Wallace Brownlee, Thomas Rossor, Sukhvir Wright, Evangeline Wassmer, Cheryl Hemingway, Ming Lim, Olga Ciccarelli, Yael Hacohen

4:54 p.m. S31.008

Longitudinal Cognitive Screening Findings in Pediatric MS vs. Pediatric Controls and Adult MS in a Multi-center Cohort– Kimberly O’Neill, Leigh Elkins Charvet, Michael Waltz, Theron Charles Casper, Allan George, Leslie A. Benson, Mark Gorman, Manu S. Goyal, Soe Soe Mar, Jayne Ness, Teri Schreiner, Emmanuelle Waubant, Bianca Weinstock-Guttman, Yolanda Wheeler, Gregory S. Aaen, Aaron Wachtenheim Abrams, Tanuja Chitnis, Timothy E. Lotze, Mary R. Rensel, Moses Rodriguez, John W. Rose, Nikita Shukla, Jan-Mendelt Tillema, Lauren B. Krupp

5:06 p.m. S31.009

Comparative Analysis of Diagnostic Criteria for Radiologically Isolated Syndrome–Tuncay Gunduz, Irem Ciftci, Bilge Piri Cinar, Cavid Baba, Meral Seferoglu, Ali Ozhan Sivaci, Vedat Cilingir, Ozlem Ethemoglu, Levent Ocek, Mehmet Barburoglu, Serkan Ozakbas, Mefkure Eraksoy, Murat Kurtuncu

5:18 p.m. S31.010

Efficacy of tixagevimab/cilgavimab as pre-exposure prophylaxis to prevent symptomatic COVID-19 infection in Multiple Sclerosis and Related Disorders: a real-world observational study– Christina Tan, Laura Madeline Locke, Pascal Sati, Brooke Lauren Guerrero, Nancy L. Sicotte, Omar Al-Louzi

3:30 p.m.–5:30 p.m. ET

Tuesday, April 25

3:30 p.m.

2023 Jon Stolk Award in Movement Disorders for Young Investigators: This award recognizes junior investigators who have made significant contributions to movement disorders research.– Farwa Ali, MBBS, Rochester, MN

3:42 p.m. S32.002

Small Molecule Inhibitors for Precise Inhibition of Alpha-Synuclein Oligomer Generation in Parkinson’s Disease–John Thomson, Andrew Cridland, Sarah Ball, Roxine Staats, Samata Pandey, Marta Castellana Cruz, Katarina Pisani, Georg Meisl, Isaac Kitchen-Smith, Xiaoting Yang, Benedetta Mannini, Scott Jeffrey Pollack, Luke Rajah, Suzanne Clare Brewerton, Johnny Habchi, Alleyn Plowright

3:54 p.m. S32.003

Efficacy on Non-motor and Motor symptoms and Quality of Life using a multidisciplinary telemedicine program in high-risk fall patients with Parkinson´s disease.– Esther Cubo Delgado, Alvaro Garcia Bustillo, Alvar ArnaizGonzalez, Florita Valiñas, Marta Allende Del Río, José Miguel Ramírez Sanz, Jose Luis Garrido-Labrador, Alicia Olivares Gil, José Francisco Diez Pastor, Jose M. Trejo, Jeronimo Gonzalez-Bernal, Josefa Gonzalez-Santos

4:06 p.m. S32.004

Safety of Foslevodopa/Foscarbidopa During Optimization and Maintenance

Treatment: Post Hoc Analysis of a Phase 3 Trial– Drew S. Kern, Khashayar Dashtipour, Jason Lamar Aldred, Thomas Edmund Kimber, Robert Iansek, Pavnit Kukreja, Lars Bergmann, Nahome Fisseha, Resmi Gupta, Saritha Talapala, Anna Jeong, Victor Fung, Vincent Lepetit

4:18 p.m. S32.005

Exploratory Delayed-Start Analysis Of PASADENA Part 3 52-Week OLE Evaluating Prasinezumab Efficacy On Motor Progression And Complications In Early-Stage PD– Gennaro Pagano, Stefano Zanigni, Annabelle Monnet, Kirsten I. Taylor, Andrea Hahn, Tanya Simuni, Kenneth L. Marek, Ronald Postuma, Nicola Pavese, Fabrizio Stocchi, Hanno Svoboda, Paulo Pacheco Fontoura, Rachelle S. Doody, Geoffrey A. Kerchner, Azad Bonni, Tania Nikolcheva

4:30 p.m. S32.006

Long-term Safety and Efficacy of IPX203 in Parkinson’s Disease Patients with Motor Fluctuations: A 9-Month Open-label Extension Trial–Alberto J. Espay, Robert A. Hauser, Rohit Dhall, Sandeep Thakkar, Leslie Cloud, Ghazal Banisadr, Stanley Fisher, Hester Visser

4:42 p.m. S32.007

Patients Reported Improvement in Quality of “OFF” time, Severity of NonMotor Fluctuations, and Medication Satisfaction in the OPTI-ON Study– Peter A. LeWitt, Olga Klepitskaya, Michael Serbin, Eric Jen, Stacy Rattana, Jeffrey Trotter, Grace Lin Liang

4:54 p.m. S32.008

Continuous, Subcutaneous Apomorphine Infusion for Persistent Motor Fluctuations in Parkinson’s Disease: Full results of the AP2-3000 open-label study–Stuart H. Isaacson, Gianpiera Ceresoli-Borroni, Alberto J. Espay, Rajesh Pahwa, Pinky Agarwal, Holly A. Shill, Jennifer S. Hui, Khashayar Dashtipour, Mark F. Lew, Peibing Qin, Azmi Nasser, Peter A. LeWitt

5:06 p.m. S32.009

A Phase 2 Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous ANX005 in Patients with, or at Risk of, Manifest Huntington’s Disease (HD)– Rajeev Kumar, Daniel O. Claassen, Ann Mongan, Benjamin Hoehn, Ping Lin, Ellen Cahir McFarland, Chenying Guo, Vladislav Volman, Lori Kell Taylor, Priya Chandra, Ted Yednock, Henk-Andre Kroon

5:18 p.m. S32.010

P2B001 (low dose combination of extended-release pramipexole and rasagiline) versus titrated extended-release pramipexole in the management of early Parkinson’s disease: Exploratory findings from a randomized, controlled trial– Lawrence W. Elmer, Pninit Litman, Hadas Friedman, Cheryl FitzerAttas, Sheila Oren

1:00 p.m.–3:00 p.m. ET

SCIENTIFIC SESSIONS

Wednesday, April 26

1:00

2023 Sheila Essey Award: An Award for ALS Research: This award recognizes an individual who has made significant research contributions in the search for the cause, prevention of, and cure for amyotrophic lateral sclerosis (ALS).–Virginia Lee, PhD, MBA, Philadelphia, PA

1:24 p.m. S33.003

Masitinib Shows Prolonged Survival in Amyotrophic Lateral Sclerosis (ALS) Patients with Mild or Moderate Disease Severity at Baseline–Albert C. Ludolph, Olivier Hermine

1:36 p.m. S33.004

Genetic modifiers have an additive effect on ALS prognosis: a populationbased study–Adriano Chio, Cristina Moglia, Antonio Canosa, Umberto Manera, Maurizio Grassano, Rosario Vasta, Francesca Palumbo, Maura Brunetti, Fabiola De Marchi, Ruth Chia, Gabriele Mora, Barbara Iazzolino, Laura Peotta, Bryan Traynor, Lucia Corrado, Sandra D’Alfonso, Letizia Mazzini, Andrea Calvo

1:48 p.m. S33.005

Evaluating the Effect of Sodium Phenylbutyrate and Taurursodiol on Survival Outcomes in Amyotrophic Lateral Sclerosis Using a Propensity Score–Matched Cohort From the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database–Sabrina Paganoni, Melanie Quintana, Wu Yuehui, Jamie Timmons, Merit E. Cudkowicz

2:00 p.m. S33.006

Structural and functional connectome alterations across King’s stages in amyotrophic lateral sclerosis– Edoardo G. Spinelli, Alma Ghirelli, Silvia Basaia, Camilla Cividini, Nilo Riva, Tommaso Russo, Elisa Canu, Veronica Castelnovo, Massimo Filippi, Federica Agosta

2:12 p.m. S33.007

Patient Reported Impact of Symptoms in Spinal Bulbar Muscular Atrophy (PRISM-SBMA)–Abdullah Zahi Alqahtani, Angela Kokkinis, Nuran Dilek, Kenneth H. Fischbeck, Chad R. Heatwole, Christopher Grunseich

2:24 p.m. S33.008

Cervical Spinal Cord Gray Matter Area is Associated with Motor Unit Number Index in Spinal Muscular Atrophy– Maria Janina Wendebourg, Eva Maria Kesenheimer, Claudia Weidensteiner, Laura Sander, Matthias Weigel, Tanja Haas, Dirk Fischer, Christoph Neuwirth, Nathalie Braun, Markus Weber, Cristina Granziera, Michael Sinnreich, Oliver Bieri, Regina Schlaeger

2:36 p.m. S33.009

Hepatic Steatosis in Spinal Muscular Atrophy: Evidence for a Primary Hepatic Defect and Implications– Crystal Jing Jing Yeo, Damien Meng Kiat Kiat, Yang Kai Ng, Wei-Yi Ong, Basil T. Darras

2:48 p.m. S33.010

Spinraza in Adults with Spinal Muscular Atrophy (SAS) – 14 month results–Craig M. Zaidman, Crystal M Proud, Jason Robert Thonhoff, Nassim Rad, Doreen Ho, MaryLynn Chu, Shafeeq Ladha, Thomas O. Crawford, Shakti Nayar, Angela L. Genge, Margaret R. Frey, Chad R. Heatwole, Daphne Lew

1:00 p.m. S34.001

The Natural History of Motor, Cognitive Development and Mood in Early Onset Hereditary Spastic Paraplegias– Michelle Rose Christie, Brooke Marie Marvel

1:12 p.m. S34.002

Intravenous and Intrathecal Onasemnogene Abeparvovec Gene Therapy in Symptomatic and Presymptomatic Spinal Muscular Atrophy: Long-Term Follow-Up Study– Basil T. Darras, Eugenio Mercuri, Kevin Strauss, John W. Day, Yin-Hsiu Chien, Ricardo Masson, Melissa Wigderson, Iulian Alecu, Nicolas Marcelo Ballarini, Lesa Mehl, Jonathan D. Marra, Anne M. Connolly

1:24 p.m. S34.003

Immunotherapy Responsiveness and Risk of Relapse in Down Syndrome Regression Disorder– Jonathan Santoro, Noemi A. Spinazzi, Robyn Ann Filipink, Panteha Hayati Rezvan, Ryan Kammeyer, Lina Patel, Elise Michelle Sannar, Luke Dwyer, Abhik Banerjee, Mellad Khoshnood, Saba Jafarpour, Natalie K. Boyd, Rebecca Partridge, Grace Gombolay, Alison L. Christy, Maria Del Carmen Ortega Bernardo, Melanie Manning, Heather Van Mater, Gordon Worley, Catherine Susan Franklin, Maria A. Stanley, Ruth C. Brown, George Capone, Eileen A. Quinn, Michael S. Rafii

1:36 p.m. S34.004

Eladocagene Exuparvovec Gene Therapy Improves Motor Development in Patients With Aromatic L-Amino Acid Decarboxylase Deficiency–Alexis Russell, Agathe Roubertie, Yin-Hsiu Chien, Ni-Chung Lee, Rafael Sierra, Jasmine Turna, Antonia Wang, Chun-Hwei Tai, Paul Wuh-Liang Hwu

1:48 p.m. S34.005

Skin-dependent morphological and molecular maturation of specialized mechanosensory neurons– Charalampia Koutsioumpa, Celine Santiago, Kiani Jacobs, Brendan Lehnert, David Ginty

2:00 p.m. S34.006

Pediatric Neuroinflammatory Disease in the Era of COVID-19: Single Center Survey of the Medical and Social Impact of COVID-19 and COVID-19 Vaccines–Lauren Hurst, Robin Alexander, Melissa Hutchinson

2:12 p.m. S34.007

PRAX-562 is a Well-Tolerated, Novel Persistent Sodium Channel Blocker with Broad Anticonvulsant Activity in Multiple DEE Mouse Models– Lyndsey Anderson Anderson, Nikola Jancovski, William A. Eckert, Erin Marie Baker, Pravin Wagley, Snezana Maljevic, Christopher Reid, Manoj Patel, Jennifer Kearney, Kris Kahlig, Steven Petrou

2:24 p.m. S34.008

Ataluren Preserves Upper Limb Function in nmDMD Patients from Study 041, a Phase 3 Placebo-Controlled Trial, and the STRIDE Registry– Craig McDonald, Eugenio Mercuri, Francesco Muntoni, Heather Gordish-Dressman, Lauren Morgenroth, Maria Bernadete Resende, Shuizhen Zhou, Mathukumalli Lakshmi Neeharika, Kazuhiro Haginoya, Leigh Ramos-Platt, Paula Williams, Vinay Penematsa, Connie Chou, Min Lin, Shelley Yvonne Johnson, Karyn Koladicz, Nick Mastrandrea, Christian Werner, Panayiota Trifillis

2:36 p.m. S34.009

SUNFISH Parts 1 and 2: 4-year Efficacy and Safety Data of Risdiplam in Types 2 and 3 Spinal Muscular Atrophy (SMA)– Maryam Oskoui, John W. Day, Nicholas Deconinck, Elena Mazzone, Andrés Nascimento, Kyoko Saito, Carole Vuillerot, Giovanni Baranello, Odile Boespflug-Tanguy, Nathalie M. Goemans, Janbernd Kirschner, Anna Kostera-Pruszczyk, Laurent Servais, Jessica Braid, Gergely Zoltan Papp, Ksenija Gorni, Carmen Martin, Renata Scalco, Wai Yin Yeung, Eugenio Mercuri

SCIENTIFIC SESSIONS

Wednesday, April 26

1:00

2:48 p.m. S34.010

Evaluation of the Biodistribution, Efficacy, and Side-Effect Profile of Deflazacort, Prednisolone and Vamorolone in a DMD Mouse Model– Grace Liu, Philip Lipari, Anna Mollin, Stephen Patrick Jung, Irina Teplova, Chia Ma, Wencheng Li, Lanqing Ying, Shirley Yeh, Jana Narasimhan, Panayiota Trifillis, Efthimia Leonardi, Ellen Welch, Greg Voronin, Elaine Dong, Nick Mastrandrea, Jonathan Blaize, Marla Weetall

1:00 p.m. S35.001

Single-Cell RNA and TCR Sequencing Reveals Novel Immune Cell Networks in Poorly Controlled Epilepsy– Rani A. Sarkis, Hanien Amer, Jason Mares, Ryan Hobson, Vilas Menon, Page B. Pennell, Wassim Elyaman

1:12 p.m. S35.002

Overproduction of Pro-inflammatory Cytokines in New-Onset Refractory Status Epilepticus (NORSE)–Aurelie Hanin, Jorge Arturo Cespedes, Karim Dorgham, Margaret Gopaul, David A. Hafler, Vincent Navarro, Nicolas Gaspard, Lawrence J. Hirsch

1:24 p.m. S35.003

Verbal-memory impairment is associated with widespread white-matter tract involvement in patients with temporal lobe epilepsy and hippocampal sclerosis– Joao Vitor Mahler Ferreira Oliveira, Marina Solti, Carla Adda, Carmen Lisa Jorge, Rosa Valerio, Katarina Lyra, Bruno Pastorello, Claudia Leite, Maria Otaduy, Luiz H. Castro

1:36 p.m. S35.004

T-wave Heterogeneity is Superior to QTc in 12-Lead ECG in Detection of Cardiac Electrical Instability at EMU Admission–Trudy Pang, Wan Yee Kong, Anthony Phan Tran, Calvin Yu, Yvo Andres Rodriguez-Linares, Bruce Nearing, Steven C. Schachter, Richard Verrier

1:48 p.m. S35.005

Care priorities of patients with drug-resistant epilepsy– Nishad Shaheid, Darin Zahuranec, Lesli Skolarus, Chloe Electra Hill

2:00 p.m. S35.006

Pathophysiology of Epilepsy in Inherited Metabolic Disorders of GABA Metabolism– Itay Tokatly Latzer, Melissa DiBacco, Thomas Opladen, Kathrin Jeltsch, Angels Garcia-Cazorla, Deniz Aygun, Alexander Rotenberg, JeanBaptiste Roullett, Mike Gibson, Phillip L. Pearl

2:12 p.m. S35.007

“Epileptoconomics”, The futurist cost to live in space: Economics of Epilepsy Hospitalizations in the United States during the past three decades– Carlos Garcia Rodriguez, Shwetha Menon, Maggie Moran, Ashley Young, Ali Seifi

2:24 p.m. S35.008

Online Information Gaps in Access to Community Health Literacy about Epilepsy Surgery: A Preliminary Content Analysis of Online Health Education Materials in the United States–Sophey Ho, Namal Seneviratne, Daniel Jose Correa

2:36 p.m. S35.009

Focal epilepsy: EEG interictal patterns and etiology correlation–Abdalhamid Lagnf, Hassan Souidan, Abdelrahman Alsherbini, Rene Andrade Machado, Mona Elsayed

2:48 p.m. S35.010

Development of De novo Functional Seizures after Epilepsy Surgery– Merlin Mary Manoj, Mahinda Yogarajah, Shehroz Huda, Jane De Tisi, John S. Duncan

SCIENTIFIC SESSIONS

Wednesday, April 26

1:00 p.m.–3:00 p.m. ET

S36 Cerebrovascular Disease and Interventional Neurology: Basic and Translational

1:00 p.m.

Science

CME 2

2023 Michael S. Pessin Stroke Leadership Prize: This award recognizes emerging neurologists who have a strong interest in and have demonstrated a passion for learning and expanding the field of stroke research.– Neal S. Parikh, MD, MS, New York, NY

1:12 p.m. S36.002

Distinct imaging features of cerebral small vessel disease are related to rare NOTCH3 variants–Zi-Yue Liu, Feifei Zhai, Jingyi Liu, Yijun Zhou, Mei-jun Shu, Xiaohong Huang, Fei Han, Ming-Li Li, Lixin Zhou, Jun Ni, Ming Yao, Shuyang Zhang, Liying Cui, Zheng-Yu Jin, Yi-Cheng Zhu

1:24 p.m. S36.003

Patients with NOTCH2NLC GGC Repeat Expansion Presenting with Vascular Leukoencephalopathy–Yi-Chu Liao, Chih-Ping Chung, Yi-Chung Lee

1:36 p.m. S36.004

Association of serum glucose/potassium ratio with the prognosis of aneurysmal subarachnoid hemorrhage: a systematic review with metaanalysis– Claudia Cruzalegui Bazán, Milenka Del Rosario Del Rosario Cierto Torre, Renzo Gabriel Vallejos, Anaiz Daniela Ticona Flores, José Luis Acha Sanchez, Miguel Francisco Cabanillas Lazo

1:48 p.m. S36.005

Abnormal Left Ventricular Geometry is Associated with Cerebral White Matter Disease–Amr Mostafa Abdall Salem, Nihas Raja Mateti, Mutlu Demirer, Bhrugun Anisetti, Hossam Youssef, Ahamed Mamoun Elkhair, Demilade Adedinsewo, James F. Meschia, Michelle P. Lin

2:00 p.m. S36.006

Influence of Cortical Superficial Siderosis in Patients with Mixed Location Cerebral Microbleeds and Intracerebral Hemorrhage–Alvin Das, Elif Gokcal, Alessandro Biffi, Robert W. Regenhardt, Avia Abramovitz, Anand Viswanathan, W. Taylor Kimberly, Joshua Goldstein, Lee H. Schwamm, Jonathan Rosand, Steven M. Greenberg, Edip M. Gurol

2:12 p.m. S36.007

The relationship between thrombotic genetics markers and recurrent arterial ischemic stroke in young– Lamia M’barek, Khadija Sonda Moalla, Nadia Bouattour, Sawsan Daoud, Nouha Farhat, Mariem Damak, Salma Sakka, Chokri Abdellaziz Mhiri

2:24 p.m. S36.008

A comprehensive framework for cerebral amyloid angiopathy diagnosis: Diagnostic accuracy meta-analyses of different biomarkers–Antreas Charidimou, Gregoire Boulouis

2:36 p.m. S36.009

Clinical Characteristics of Cerebral Amyloid Angiopathy and Risk Factors of Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage–Juanjuan Wu, Zi-Yue Liu, Ming Yao, Yi-Cheng Zhu, Bin Peng, Jun Ni

2:48 p.m. S36.010

Protective Effect of APOE-e2 on Cortical Thickness and Volume in a Cerebrovascular Registry– Hossam Youssef, Nihas Raja Mateti, Erik Middlebrooks, Nilufer Taner, James F. Meschia, Michelle P. Lin

1:00 p.m.

2023 Movement Disorders Research Award: This award recognizes an individual for outstanding work in the field of Parkinson’s disease or other movement disorders.–Jill L. Ostrem, MD, FAAN, San Francisco, CA

1:24 p.m. S37.003

Composite Measures of Prodromal Parkinson’s Disease and the Probability of Phenoconversion at 3 Years– Mario H. Torres, Katherine C. Hughes, Kjetil Bjornevik, Marianna Cortese, Albert Hung, Michael Schwarzschild, Alberto Ascherio

1:36 p.m. S37.004

The Synuclein-One Study: Skin Biopsy Detection of Phosphorylated alphasynuclein for Diagnosis of the Synucleinopathies– Christopher H. Gibbons, Bailey Bellaire, Ningshan Wang, Roy L. Freeman, Charles H. Adler, Mitchell G. Miglis, Stuart H. Isaacson, Virgilio Gerald H. Evidente, Michael Soileau, Mark Gudesblatt, Guillaume Lamotte, Rajeev Kumar, Melita Talene Petrossian, Maria Alejandra Gonzalez Duarte, Pravin Khemani, Marie-Helene Saint-Hilaire, Nikolaus McFarland, Hemant Kumar Pandey, Oleg Yerokhin Yerstein, Alexandru C. Barboi, Andrew Liu, Todd D. Levine

1:48 p.m. S37.005

Toward a Biomarker Panel measured in CNS-originating Extracellular Vesicles for Differential Diagnosis of Parkinson’s Disease and Multiple System

Atrophy– Hash Brown Taha, Leony Fenwick, Simon Hornung, Suman Dutta, Kathryn Howe, Nour Elabed, Irish Pearl Del Rosario, Darice Wong, Aline Duarte Folle, Daniela Markovic, Jose-Alberto Palma, Un Jung Kang, Roy Alcalay, Miriam M. Sklerov, Horacio C. Kaufmann, Brent L. Fogel, Jeff M. Bronstein, Beate Ritz, Gal Bitan

2:00 p.m. S37.006

Blood microRNA-7 as a Progression Biomarker in men with Parkinson’s disease– Mya C. Schiess, Jessika Suescun, Kelly Lauren Block, Emily Tharp, Timothy Michael Ellmore, Mohammad Shahnawaz, Christopher Adams

2:12 p.m. S37.007

Tear Fluid as a Biomarker for Parkinson’s Disease: Downregulation of DNA Repair Genes/Pathways via RNA-Seq Analysis– Mark F. Lew, Audrey Omidsalar, Shruti Singh Kakan, Daniel Gerke, Maryam Tanveer, Danielle Feigenbaum, Emily Tamadonfar, Sarah Hamm-Alvarez, Brooke Erika Hjelm

2:24 p.m. S37.008

Fusing the Virtual and Physical Worlds to Identify Declines in Instrumental Activities of Daily Living Associated with Parkinson’s Disease– Morgan McGrath, Anson Rosenfeldt, Colin Waltz, Mandy Koop, Hubert H. Fernandez, Jay L Alberts

2:36 p.m. S37.009

DaT-uptake z-scores for Caudate and Striatum Predict Levodopa Requirement in Early Parkinson’s Disease– Katarina Rukavina, Nicola Mulholland, Ben Corcoran, Juliet Staunton, Magdalena Krbot Skoric, SIlvia Rota, Alexandra Rizos, K Ray Chaudhuri

2:48 p.m. S37.010

Automated Audio Analysis of Dysarthria in Huntington’s disease (AudioHD)– Luis Alberto Sierra, Karen Hildebrand, Clementina Julia Ullman, Magdaline Mwangi, Henry J. O’Connell, Samuel A. Frank, Simon Laganiere

3:30 p.m.–4:20 p.m. ET

SCIENTIFIC SESSIONS

Wednesday, April 26

3:30 p.m. S38.001

Endovascular Brain-Computer Interface to Restore Motor Control for the Command of Digital Devices in Patients with Severe Quadriparesis–Shahram Majidi, Noam Y. Harel, Miguel Xavier Escalon, Abbey Sawyer, Marta Lapinska, Aidan Rogers, Raul G. Nogueira, Douglas Weber, David Putrino

3:42 p.m. S38.002

CPAP Therapy for 4 Months Improves Sleep Quality, Daytime Alertness, Fatigue, and Mental Health in People with Chronic Spinal Cord Injury and Moderate-to-Severe Sleep-Related Breathing Disorder: The Preliminary Results of an Ongoing Prospective Study.–Julio C. Furlan, Sander Hitzig, Mark Boulos

3:54 p.m. S38.003

Vigilance Improves in People with Multiple Sclerosis (MS) and Fatigue following Repeated Dorsolateral Prefrontal Cortex Transcranial Direct Current Stimulation (tDCS) Sessions Paired with Cognitive Training Delivered at Home– Leigh Elkins Charvet, Lillian Walton Masters, Claire Choi, Marco Muccio, Yulin Ge, Lauren B. Krupp, Giuseppina Pilloni

4:06 p.m. S38.004

Individualized Real-Time fMRI Neuromodulation for the Alleviation of Cranial Nerve IX and XII Neuropathy–Anthony Kaspa Allam, Emmanouil Froudarakis, T. Dorina Papageorgiou

3:30 p.m. S39.001

Diagnosis of Alzheimer’s Disease and Tauopathies on Whole Slide Images using Deep Learning Algorithm–Shunsuke Koga, Minji Kim, Hiroaki Sekiya, Nicholas Martin, Monica Castanedes-Casey, Gary Yao, Dennis W. Dickson, Tae Hyun Hwang

3:42 p.m. S39.002

Prediction of Regional Tau Spread Using Individualized Tau Epicenters and Structural Connectomes– Christopher A. Brown, Sandhitsu Das, Ilya Nasrallah, John A. Detre, Paul Yushkevich, Corey McMillan, David A. Wolk

3:54 p.m. S39.003

Mitochondrial complex I abnormalities is associated with tau and cognitive decline in Alzheimer’s disease–Tatsuhiro Terada, William Joseph Therriault, Min Su Kang, Tharick Ali Pascoal, Takashi Matsudaira, Tomoyasu Bunai, Tomokazu Obi, Hideo Tsukada, Pedro Rosa Neto, Yasuomi Ouchi

4:06 p.m. S39.004

Effects of APOE4 and education on the clinical onset of autosomal dominant Alzheimer’s disease due to the PSEN1 E280A mutation– Nicholas Gilbert Barksdale, Stephanie Langella, Daniel Vasquez, David Fernando Aguillon, Yinghua Chen, Yi Su, Natalia Acosta-Baena, Juliana Acosta Uribe, Ana Baena, Gloria Garcia-Ospina, Margarita Giraldo, Victoria Tirado, Claudia Cecilia Munoz, Claudia Maria Guzman Martinez, Silvia J. Rios Romenets, Gabriel Maiate

Oliveira, Hyun-Sik Yang, Clara Vila-Castelar, Jeremy J. Pruzin, Valentina Ghisays, Joseph Arboleda-Velasquez, Kenneth S. Kosik, Eric M. Reiman, Francisco T. Lopera, Yakeel Quiroz

4:18 p.m. S39.005

Amygdala Atrophy as an Early Manifestation of Alzheimer’s Disease– Lina Al-Ani, Alice Tao, Jonathan Dyke, Gloria Chiang, Makoto Ishii

4:30 p.m. S39.006

Characterization of the Monoamine Oxidase-B (MAO-B) Expression in Postmortem Normal and Alzheimer’s Disease Brains– Methasit Jaisa-aad, Tessa General Connors, Bradley T. Hyman, Alberto Serrano-Pozo

4:42 p.m. S39.007

Clinical and genetic characteristics of patients with very early onset frontotemporal dementia–Adit Friedberg, Eliana Marisa Ramos, Luke Bonham, Marguerite Knudtson, Alexis Oddi, Patricia Alejandra Castruita, Lucia Lopez, Yi Li, Daniel H. Geschwind, William Seeley, Jennifer Sachiko Yokoyama, Bruce L. Miller

4:54 p.m. S39.008

Associations between neuropsychiatric symptoms, pathology, and survival in an autopsy-confirmed cohorts of Alzheimer’s disease, Alzheimer’s disease with Lewy bodies and Dementia with Lewy bodies– Neha Shakir, Cecilia Tremblay, Nan Zhang, Charles H. Adler, Christine Belden, Alireza Atri, Thomas Beach, Geidy Serrano, Parichita Choudhury

5:06 p.m. S39.009

Association of Traumatic Brain Injury, Mild Cognitive Impairment and Dementia in the Framingham Heart Study’s Original Cohort–Shruti Subhash Durape, Prajakta Joshi, Rebecca Burton, Kurtis Chien-Young, Eden Price, Kristin Shanabrook, Eukyung Yhang, Yulin Liu, Ting Fang Alvin Ang, Sherral Devine, Ashita Gurnani, Douglas I. Katz, Yorghos Tripodis, Michael Alosco, Kristen DamsO’Connor, Rhoda Au, Jesse B. Mez

5:18 p.m. S39.010

MCI patients with COVID-19 Have Increased Progression to Dementia at 18 months–Angelia Kirkpatrick, Claire Emmanuelle Delpirou Nouh, Farhat Husain, Chao Xu, Andrea Vincent, Andriy Yabluchanskiy, Anna Csiszar, Zoltan Ungvari, Jim Scott, Calin I. Prodan

3:30 p.m.–5:30 p.m. ET

SCIENTIFIC

Wednesday, April 26

S40 Autoimmune Neurology: Stiff Person Syndrome/ GAD65 Neurological Autoimmunity, CIDP, and MOGAD

3:30 p.m. S40.001

Early Predictors of Future Disability in Stiff Person Syndrome Spectrum Disorders–Yujie Wang, Chen Hu, Loulwah Mukharesh, Salman Aljarallah, Maria I. Reyes-Mantilla, Michael Comisac, Alexandra Rose Balshi, Danielle Obando, Sarah Snoops, Kathryn Fitzgerald, Scott Douglas Newsome

3:42 p.m. S40.002

Rituximab is Associated with Limiting Progression in Individuals with Stiff Person Syndrome Spectrum Disorders– Kimystian Harrison, Chen Hu, Salman Aljarallah, Yujie Wang, Kathryn Fitzgerald, Scott Douglas Newsome

3:54 p.m. S40.003

A Familial Analysis of Stiff-Person Spectrum Disorder utilizing the Utah Population Database– Justin Abbatemarco, Paul Daniel Crane, Jonathan Ross Galli, Stefanie Jordan Rodenbeck, Zhe Yu, Ankita Date, Jennifer West, Alison Fraser, Michael Joseph Madsen, Ka-Ho Wong, John E. Greenlee, Stacey Clardy

4:06 p.m. S40.004

Outcomes of Surgical Resection and VNS in Patients with Medically Refractory Epilepsy and GAD65 Antibody Positivity– Hannah Zhao-Fleming, Jeffrey W. Britton, Divyanshu Dubey, Kelsey Marie Smith

4:18 p.m. S40.005

Early B cell tolerance defects in anti-neurofascin 155 mediated chronic inflammatory demyelinating polyneuropathy– Bhaskar Roy, Abeer Obaid, Sarah N. Ohashi, Carmina Coppola, Sameeran Das, Amanda Hernandez, Gianvito Masi, Lorena Martín-Aguilar, Cinta Lleixa, Richard J. Nowak, Luis Querol, Kevin O’Connor

4:30 p.m. S40.006

Cognitive impairment in MOGAD is associated with ADEM-like episodes and deep grey matter atrophy– Ilya Ayzenberg, Theodoros Ladopoulos, Carolin Schwake, Bianca Teegen, Ingo Kleiter, Nadine Siems, Christian Prehn, Marius Ringelstein, Orhan Aktas, Refik Pul, Britta Matusche, Carsten Lukas, Iris Katharina Penner, Ralf Gold, Ruth Schneider, Ann-Kathrin Kogel

4:42 p.m. S40.007

Cerebral Attacks in MOG Antibody-Associated Disease: Clinical Spectrum and Fulfillment of ADEM criteria–Sara J. Hooshmand, Xiaoyang Li, John J. Chen, Vyanka Redenbaugh, Samantha Banks, Laura Cacciaguerra, Cristina Valencia Sanchez, Alfonso Sebastian Lopez, Elia Sechi, Jan-Mendelt Tillema, Sean J. Pittock, Eoin P. Flanagan

4:54 p.m. S40.008

Long-term Outcomes of MOGAD without Chronic Steroid-sparing

Immunotherapy: a Multicenter Retrospective Cohort– Nanthaya Tisavipat, Adi Wilf-Yarkoni, Eoin P. Flanagan, Vyanka Redenbaugh, Yoel Schwartzmann, Mark Andrew Hellmann, Assaf Tolkovsky, Hadas Kalisch, Itay Lotan, Michael Levy, Rebecca Salky, Adi Vaknin-Dembinsky, Esther Ganelin-Cohen, Alfonso Sebastian Lopez, Sean J. Pittock, John J. Chen

5:06 p.m. S40.009

Treatment at Onset Predicts a Longer Time-to-Relapse After Index Event in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)– Negar Molazadeh, Philippe-Antoine Bilodeau, Rebecca Salky, Gauruv Bose, Tanuja Chitnis, Michael Levy

5:18 p.m. S40.010

Investigating in vitro NF-K B and STAT3 activation in MOGAD– Osman Corbali, Shrishti Saxena, Rohit Patel, Tanuja Chitnis

3:30 p.m. S41.001

Simultaneous Comparisons of 25 Acute Migraine Medications: A Big Data Analysis of 10 Million Patient Self-Reported Treatment Records From A Migraine Smartphone Application– Chia-Chun Chiang, Xuemin Fang, Zsolt Horvath, Francois Cadiou, Alexandre Urani, Weijie Poh, Hiroto Narimatsu, Yu Cheng, David W. Dodick

3:42 p.m. S41.002

Disability in Migraine: Multicountry Results From the CaMEO-International Study–Zaza Katsarava, Dawn C. Buse, Elizabeth Leroux, Michel Lanteri-Minet, Fumihiko Sakai, Manjit S. Matharu, Katherine Sommer, Michael Seminerio, Kristina Fanning, Richard B. Lipton

3:54 p.m. S41.003

Burden of Migraine and Migraine-Associated Symptoms in People with Differing Ethnic and Racial Backgrounds: Results of the OVERCOME (US) Study– Dawn C. Buse, Betzaida Martinez, Eva Jolanda Muenzel, Robert A. Nicholson, Anthony J Zagar, Fred Cohen, Susan Hutchinson, Sait Ashina, Robert E. Shapiro, Eric M. Pearlman, Richard B. Lipton

4:06 p.m. S41.004

Lifestyle factors, substance use, and frequent recurrent headaches in youth: Data from a Canadian population-based observational study–Serena Orr, Christelle Nilles, Scott Patten, Jeanne Williams, Tamara M. Pringsheim

4:18 p.m. S41.005

Pre-cluster symptoms and treatment response in cluster headache: A large cohort in Taiwanese patients–ShuTing Chen, Yu-Ching Lin, Hsin Yi Tseng, Jr-Wei Wu

4:30 p.m. S41.006

Disparities in Pediatric Headache and Migraine Diagnosis and Treatment in the Emergency Department– Danielle Joy Kellier, Marissa Anto, Matt Hall, Christina Szperka, Kendall Nash, Melissa Hutchinson, Elizabeth Molloy Wells, Mahendranath Moharir, Nicholas Scott Abend, Ricka Messer, Jamie L. Palaganas, Juan Piantino, Craig A. Press

4:42 p.m. S41.007

Whole Exome/Genome Sequencing in Cyclic Vomiting Syndrome, a Migraine Variant, Reveals Multiple Candidate Genes, Especially in Cation Channels, Suggesting a Mechanism of Cellular Overexcitation– Omri Bar, Laurie Ebenau, Kellee Weiner, Mark Mintz, Richard Gregory Boles

4:54 p.m. S41.008

Clinical Correlates of Longitudinal Hypothalamic-Pontine Functional Changes in Migraine Patients– Roberta Messina, Paola Valsasina, Laura Zanandrea, Ilaria Cetta, Bruno Colombo, Maria Assunta Rocca, Massimo Filippi

5:06 p.m. S41.009

Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening Period–Todd J. Schwedt, Richard B. Lipton, Peter Goadsby, Chia-Chun Chiang, Brad C. Klein, Chengcheng Liu, Sung Yun Yu, Lawrence Severt, Michelle Finnegan, Joel M. Trugman

5:18 p.m. S41.010

Ultrasound And Magnetic Resonance Imaging Guided Assessment Of The Optic Nerve Sheath Diameter In Idiopathic Intracranial Hypertension– Nada Abdelhameed Elsaid, Tamer M. Belal, Ahmed Gamal Azab

p.m. ET

SCIENTIFIC SESSIONS

Wednesday, April 26

4:30

3:30

S42.001

Identification of candidate Parkinson’s disease predisposition genes in high-risk pedigrees– Paolo M. Moretti, Karla Patricia Figueroa, Stefan M. Pulst, Alessandro Dotti, Jeff Stevens, Kristina Allen-Brady, Lisa A. Cannon-Albright

3:42 p.m. S42.002

Frequency of Known Genetic Variants for Parkinson’s Disease in the PD GENEration Study Cohort–James Beck, Kamalini Ghosh Galvelis, Martha A. Nance, Anna Naito, Niccolo Emanuele Mencacci, Ignacio Mata, Anne Hall, Jeanine Schulze, Rayza Priscila Delgado Hodges, Anne Marie A. Wills, Michael Schwarzschild, Karen S. Marder, Tanya Simuni, Amanda Miller, Jennifer Verbrugge, Lola Shukla, Laura EA Heathers, Michelle Totten, Tatiana Foroud, Roy Alcalay

3:54 p.m. S42.003

Understanding how GBA mutations influence Parkinson’s disease progression–Arnav Khera, Sarah L. Fish, Raja Elizabeth Estes, Selina Yu, Leo Pallanck, Jessica Young, Marie Ynez Davis

4:06 p.m. S42.004

Expanding the genotype-phenotype landscape of PDE10A- associated movement disorders–Saeed A. Bohlega, Zina Ali Alqahtani, Francisco J. Guzmán-Vega, Reshmi Ramakrishnan, Ali Hussain Abusrair, Haya Aldosari, Amaal AlDakheel, Salma Misfer AlQahtani, Dorota Monies, Stefan T. Arold

4:18 p.m. S42.005

Correlation Between Motor Progression and Structural Connectivity in GBA, LRRK2, and sporadic Parkinson’s Disease– Cherry Yu, Sandra Wilson, Federico J. Rodriguez-Porcel, Christine Cooper

4:30 p.m. S42.006

Proteomic Signatures Associated with Genetic and Clinical Subtypes of Parkinson’s Disease– Mei-Yu Lai, Divya Palanisamy, Bruno Benitez

4:42 p.m. S42.007

Treatment of High Blood Pressure is associated with a Reduced Incidence of Parkinson’s disease–Trond Riise, Magne Solheim, Kjetil Bjornevik, Jannicke Igland, Julia Axiina Tuominen, Asieh Abolpour Mofrad, Marianna Cortese, Clemens R. Scherzer, Julia Romanowska

4:54 p.m. S42.008

Low Dose Carbon Monoxide Is Neuroprotective in Models of Parkinson’s Disease–Stephen Neil Gomperts, Kenneth Rose, Musab Zorlu, Xiaofan Xue, Waijiao Cai, Sonia Lin, Han K. Lee, Edward Gomperts, Michael Schwarzschild, Xiqun Chen

5:06 p.m. S42.009

Assessing Sex Differences in Individuals with Tourette Syndrome and Persistent Motor or Vocal Tic Disorder– Marisela E. Dy-Hollins, Lori B. Chibnik, Lisa Osiecki, Nutan Sharma, Carol Mathews, Jeremiah M. Scharf

5:18 p.m.

S42.010

Conversion Rate of Essential Tremor to Essential Tremor-Parkinson’s Disease: Data from a Prospective, Longitudinal Study– Elan D. Louis, Diane Berry, Ali Ghanem, Stephanie Cosentino

4:30 p.m.

2023 Irwin Schatz Award for Autonomic Disorders: This award recognizes junior investigators who have advanced the field of autonomic disorders, or senior investigators who have made major contributions to the field.–Paola Sandroni, MD, PhD, FAAN, Rochester, MN

4:42 p.m. S43.002

Psychometric Validation of a Modified United Multiple System Atrophy Rating Scale– Michele Potashman, Lila Channing Brady, Susan Durham, Victoria Wirtz, Gilbert J. L’Italien, Vladimir Coric, Günter Hoglinger, Horacio C. Kaufmann, Phillip A. Low, Nikolaus McFarland, Wassilios Meissner, Patricio Millar Vernetti, Huw R. Morris, Werner Poewe, Klaus Seppi, Wolfgang Singer, Steven Vernino, Irfan

Qureshi

4:54 p.m. S43.003

Hypocapnic Orthostatic Intolerance with (POTS) and without (HYCH)

Tachycardia Represent a Spectrum of the Same Disorder– Peter Novak, Sadie Patricia Marciano

5:06 p.m. S43.004

Minimal Objective Autonomic Dysfunction in Long-COVID– Meredith Anne Bryarly, Juan Andres Cabrera, Surendra Barshikar, Steven Vernino

1:00 p.m.–3:00 p.m. ET

SCIENTIFIC SESSIONS

Thursday, April 27

S44 Epilepsy/Clinical Neurophysiology (EEG): Epilepsy Outcomes

1:00 p.m. S44.001

CME 2

Preclinical Proof-of-concept of a Novel AAV9-microRNA based Targeting of GRIK2 for the Treatment of Temporal Lobe Epilepsy– Nick Pearson, Stephane Baudouin, Morgane Wartel, Sonay Keskin, Olivier Danos, Christophe Mulle, Nicolas Partouche, Valerie Crepel, Andreas Borta, Richard Hugh Porter

1:12 p.m. S44.002

Impact of Fenfluramine on Drop Seizure Frequency in Adults or Dose-Capped Patients With Lennox-Gastaut Syndrome: Comparative Analysis of Clinical Trial Data– Kelly G. Knupp, Ingrid E. Scheffer, Berten Ceulemans, Joseph Sullivan, Katherine C. Nickels, Lieven G. Lagae, Renzo Guerrini, Sameer M Zuberi, Rima Nabbout, Catherine Riney, Shikha Polega, Amelie Lothe, Ronald G. Davis, Antonio Gil-Nagel

1:24 p.m. S44.003

Microburst Vagus Nerve Stimulation: Safety and Efficacy Outcomes– Cornelia

Drees, Mesha Gay Brown, Danielle S. McDermott, Lesley Kaye, Rebecca O’Dwyer, Michael P. Macken, Muhammad Shahzad Zafar, William O. Tatum, Zeenat Jaisani, Kristl Vonck, Pegah Afra, Blake Newman, Ryan Verner, Amy Keith, Mei Jiang, Selim R. Benbadis

1:36 p.m. S44.004

Long-Term Treatment Effects of Soticlestat in Patients with Dravet Syndrome or Lennox–Gastaut Syndrome: Interim Data from the ENDYMION 1 Trial–Yuan Yao, Dennis J. Dlugos, Mahnaz Asgharnejad, Pranab K. Mitra, Naga Venkatesha Murthy Pathi Jagannatham

1:48 p.m.

S44.005

Corpus Callosotomy for Drug Resistant Epilepsy. Long Term Outcome in Adult Population.– Krista Proteasa, Simona Vasilica Proteasa

2:00 p.m.

S44.006

Predictors of Achievement of Response With Cenobamate: Post-hoc Subset Analysis From a Phase 3, Open-Label Safety Study– Robert T. Wechsler, David G. Vossler, Wesley Kerr, Sean Stern, Clarence Wade, William E. Rosenfeld

2:12 p.m. S44.007

Pre-Treatment Seizure Intervals in a Large Prospective Observational Cohort– Manisha Gupte Holmes, Annie Yang, Sarah Barnard, Jacqueline French

2:24 p.m. S44.008

XEN1101, a Novel Potassium Channel Modulator: Interim Data From an Ongoing, Long-Term, Open-Label Extension of a Phase 2b study (X-TOLE) in Adults with Focal Epilepsy–Jacqueline French, Roger J. Porter, Emilio Perucca, Martin Brodie, Michael A. Rogawski, Cynthia L. Harden, Jenny Qian, Constanza Luzon, Christopher Kenney, Gregory N. Beatch

2:36 p.m. S44.009

Long-term Remission in Juvenile Myoclonic Epilepsy–Shashank Jaiswal, Sita Jayalakshmi Sattaluri, Anuja R. Patil

2:48 p.m. S44.010

A Randomised Controlled Trial on the Effect of Viewing the Event in Psychogenic non epileptic Events– Lakshmi Priya, Ashalatha Radhakrishnan

1:00 p.m.–3:00 p.m. ET

S45 Cerebrovascular Disease and Interventional Neurology: Meta-analyses and Outcomes Research

1:00 p.m. S45.001

Differential Effect of Stroke Types on Cerebral White Matter Disease

Progression–Ahamed Mamoun Elkhair, Hossam Youssef, Bhrugun Anisetti, Amr Mostafa Abdall Salem, Nihas Raja Mateti, Michelle P. Lin

1:12 p.m. S45.002

Comparative Efficacy and Safety of Tenecteplase and Alteplase in Acute Ischemic Stroke: A Pairwise and Network Meta-analysis of Randomized Controlled Trials–Aqeeb Ur Rehman, Muhammad Aemaz Ur Rehman, Aleenah Mohsin, Huzaifa Ahmad Cheema, Afra Zahid, Muhammad Ebaad Ur Rehman, Muhammad Zain Ameer, Muhammad Ayyan, Muhammad Ehsan, Abia Shahid, Ayaz M. Khawaja

1:24 p.m. S45.003

Tenecteplase versus alteplase safety and efficacy in acute ischemic stroke: a systematic review and meta-analysis of 3706 patients.– Mohamed Zaazouee, Zainab Ahmed Ayoob, Abdelrahman H. Hafez, Ahmed Mahmoud Mostafa, Abdelazeem Salah Rajeh, Mo’men Mohamed Roshdy, Joslin AlDadah, Salmah Alrshedi, Ahmed Bostamy Elsnhory, Mhd Firas Safadi, Abdlerahman Kh Hammad, Marwa Hamdy Saif, Sohaib Mowafaq Orssan, Marwa Zeid Zeid, Alaa Elshanbary

1:36 p.m. S45.004

Stroke Risk with Warfarin vs. NOACs in Artificial Heart Valves: a MetaAnalysis–Yeju Srivastava, Diana Almader-Douglas, Salil Deo, Umesh Sharma

1:48 p.m. S45.005

Higher Degree of Carotid Artery Stenosis is Associated with Worse Cognition– Michelle P. Lin, Nihas Raja Mateti, Young Erben, Kevin M. Barrett, Nilufer Taner, Thomas G. Brott, James F. Meschia

2:00 p.m. S45.006

Mortality and functional outcomes in patients with post-stroke epileptic seizures: a systematic review and meta-analysis–Shubham Misra, Juan Pablo Vazquez, Ece Eldem, Lucas Scárdua Silva, Saba Sari Mohidat, Leonard Brian Hickman, Erum Khan, Melissa Funaro, Clarissa L. Yasuda, David S. Liebeskind, Scott E. Kasner, Nishant Kumar Mishra

2:12 p.m. S45.007

Correlation Analysis of Middle Cerebral Artery Stenosis and Enlarged Perivascular Space in Patients with Moyamoya Disease– Guangsong Han, Yuehui Hong, Ding-Ding Zhang, Xiaoyuan Fan, Ming Yao, Jun Ni

2:24 p.m. S45.008

Factors Affecting The Fate Of Raymond-Roy Grade 2–Ahmed Saied, Nada Abdelhameed Elsaid

2:36 p.m. S45.009

Creating the Global Moyamoya Patient Registry - A Patient Engagement Effort and Preliminary Findings– Roxanne Houle, Sophia Kocher, Dean Houle, Samantha Houle, Catherine Stratton

2:48 p.m. S45.010

Thrombolytic Therapy for Non-arteritic Central Retinal Artery Occlusion in an Academic Multi-site Stroke Center– Nour Sami Ahmad Alhayek, Jacob Matthew Sobczak, Emilie Weinberg, Bart M. Demaerschalk, Oana Maria Dumitrascu

1:00 p.m.–3:00 p.m. ET

SCIENTIFIC SESSIONS

Thursday, April 27

S46 MS Therapeutics and Clinical Decision Making

1:00 p.m. S46.001

Patient-reported outcomes and clinical disability outcomes in Multiple Sclerosis (MS) demonstrate the same rates of worsening when performed in, neurology clinic, patient registry and a clinical trial.– Richard St. John Nicholas, Rod Middleton, MS-SMART Investigators, Jeremy S. Chataway, Jeff Rodgers

1:12 p.m. S46.002

Long-Term Treatment With First-Line Ocrelizumab in Patients With Early RMS: 9-Year OPERA Subgroup Analysis – Joao J. Cerqueira, Achim Berthele, Bruce A. C. Cree, Massimo Filippi, Gabriel Pardo, Owen R. Pearson, Anthony Traboulsee, Tjalf Ziemssen, Timothy L. Vollmer, Corrado Bernasconi, Corey Mandel, Inessa Kulyk, Cathy Chognot, Hans-Martin Schneble, Kalpesh Prajapati, Eva Havrdova

1:24 p.m. S46.003

Delayed Signs of Early Disability Progression After 8.5 Years of Ocrelizumab Treatment in Patients With Relapsing Multiple Sclerosis– Martin Weber, Ludwig Kappos, Stephen L. Hauser, Hans-Martin Schneble, Qing Wang, Gavin Giovannoni

1:36 p.m. S46.004

Low Disease Activity Over 4 Years of Ocrelizumab Therapy in Treatment-Naive Patients With Early-Stage Relapsing-Remitting Multiple Sclerosis; the Phase IIIb ENSEMBLE Study

Robert A. Bermel, Hans-Peter Hartung, Bruno Brochet, Ralph H. B. Benedict, Thomas Alois Berger, William M. Carroll, Timothy L. Vollmer, Trygve Holmoy, Rana Karabudak, Joep Killestein, Carlos Nos, Francesco Patti, Amy Perrin Ross, Ludo J. Vanopdenbosch, Jens Wuerfel, Thomas Kuenzel, Karen Kadner, Inessa Kulyk, Mark S. Freedman

1:48 p.m. S46.005

First-in-Human Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAR443820, a Central Nervous System Penetrant RIPK1 Inhibitor in Healthy Participants –Agnes Hincelin-Mery, Pascale Lewanczyk, Cathy Cantalloube, Xavier Nicolas, Myriam Benamor, Robert Pomponio, Emmanuel Krupka, Dimitry Ofengeim, Amy Eastenson, Li Xiong, Nazem Atassi

2:00 p.m. S46.006

How much of the increased infection risk from higher rituximab doses is mediated by hypogammaglobulinemia in patients with multiple sclerosis?–Annette M. Langer-Gould, Bonnie Li, Jessica Betty Smith, Edlin Gonzales, Stanley Xu

2:12 p.m. S46.007

Comparative CNS Pharmacology of Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating MS –Timothy J. Turner, Olivier Nicolas, Priscilla Brun, Dimitry Ofengeim

2:24 p.m. S46.008

Association of Specific “Critical” Demyelinating Lesions and Motor Impairment in Progressive Multiple Sclerosis: A Prospective Study– Rowaid Ahmad, Caitlin Tarlton, Eoin P. Flanagan, Steven Anthony Messina, Dustin Duffy, W. Oliver Tobin, Michel Toledano, Sean J. Pittock, Claudia F. Lucchinetti, Brian G. Weinshenker, Orhun H. Kantarci, Mark Keegan

2:36 p.m.

S46.009

Addition of optic nerve involvement to dissemination in space criteria for multiple sclerosis – the value of optical coherence tomography – Gabriel Bsteh, Harald Hegen, Patrick Altmann, Michael Auer, Klaus Berek, Franziska Di Pauli, Barbara Kornek, Nik Krajnc, Fritz Leutmezer, Stefan Macher, Paulus Stefan Rommer, Karin Zebenholzer, Gudrun Zulehner, Tobias Zrzavy, Florian Deisenhammer, Berthold Pemp, Thomas Alois Berger

2:48 p.m.

S46.010

Mediterranean Diet is Associated with Cognition in Multiple Sclerosis– Ilana

B. Katz Sand, Kathryn Fitzgerald, James F. Sumowski

1:00 p.m. S47.001

Ubrogepant for the Acute Treatment of Migraine When Administered During the Prodrome (Premonitory Phase): Results From a Phase 3, Randomized, Double-blind, Placebo-Controlled, Crossover Study– David W. Dodick, Peter Goadsby, Todd J. Schwedt, Richard B. Lipton, Chengcheng Liu, Kaifeng Lu, Sung Yun Yu, Lawrence Severt, Michelle Finnegan, Joel M. Trugman

1:12 p.m. S47.002

Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial– Peter Goadsby, Jessica Ailani, David W. Dodick, Amaal J. Starling, Chengcheng Liu, Sung Yun Yu, Elimor Brand-Schieber, Michelle Finnegan, Joel M. Trugman

1:24 p.m. S47.003

Zavegepant 10 mg Nasal Spray is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials–Jelena M. Pavlovic, Timothy R. Smith, Kathleen B. Mullin, Shivang Joshi, Robert Croop, Jennifer Madonia, Linda Mosher, Meghan Lovegren, Micaela Forshaw, Richard B. Lipton

1:36 p.m. S47.004

Zavegepant Nasal Spray for the Acute Treatment of Migraine With Aura and Without Aura: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials–Timothy R. Smith, Jelena M. Pavlovic, Kathleen B. Mullin, Shivang Joshi, Robert Croop, Jennifer Madonia, Linda Mosher, Meghan Lovegren, Micaela Forshaw, Richard B. Lipton

1:48 p.m. S47.005

Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial– Patricia Pozo-Rosich, Jessica Ailani, Messoud Ashina, Peter Goadsby, Richard B. Lipton, Uwe Reuter, Hua Guo, Brittany Schwefel, Ramesh Boinpally, Emily McCusker, Sung Yun Yu, Michelle Finnegan, Joel M. Trugman

2:00 p.m. S47.006

Preventive Treatment With Eptinezumab in Patients With a Dual Diagnosis of Chronic Migraine and Medication-Overuse Headache: Subgroup Analysis of PROMISE-2– Michael J. Marmura, H. Christoph Diener, Robert Cowan, Amaal J. Starling, Joe Hirman, Thomas Brevig, Roger Cady

2:12 p.m. S47.007

Responder Rates With Eptinezumab Over 24 Weeks in Patients With Prior Migraine Preventive Treatment Failures– Messoud Ashina, Richard B. Lipton, Jessica Ailani, Jan Versijpt, Simona Sacco, Dimos Dimitrios D. Mitsikostas, Cecilie Laurberg Christoffersen, Bjoern Sperling, Anders Ettrup

2:24 p.m. S47.008

Pre-Treatment Cephalic Interictal Allodynia Predicts Outcome of Prophylactic Treatment of Chronic and Episodic Migraine Patients with Galcanezumab: A Prospective Quantitative Sensory Testing Study–Sait Ashina, Agustin Melo Carrillo, Edina Szabo, David Borsook, Rami Burstein

2:36 p.m. S47.009

Investigating the Risk of Hypertension After Initiation of Erenumab in the PostMarket Setting– Nikita Chhabra, Carolyn Mead-Harvey, Courtney Iser, Hallie K. Taylor, Hira S. Chaudhary, Aimen Vanood, David W. Dodick

2:48 p.m. S47.010

Significant reduction in migraine days with Remote Electrical Neuromodulation (REN) for migraine prevention: A double-blind randomized sham-controlled clinical trial–Stewart J. Tepper, Liron Rabany, Robert Cowan, Timothy R. Smith, Brian Grosberg, Brad Torphy, Dagan Harris, Maya Vizel, Alon Ironi, Alit Stark-Inbar, Sandy Yacoub Garas, Andrew M. Blumenfeld

Thursday, April 27

p.m.–5:30 p.m. ET

3:30 p.m. S48.001

PGN-EDODM1: Preclinical Data Supporting the Development of an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Myotonic Dystrophy Type 1 (DM1)–Ashling Holland, Arnaud F. Klein, Caroline Godfrey, Niels Svenstrup, Jane Larkindale, Sonia Bracegirdle, Denis Furling, Jaya Goyal

3:42 p.m. S48.002

Preliminary Assessment of the Phase 1/2 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Patients with Myotonic Dystrophy Type 1 (DM1) (MARINA)– Nicholas Elwood Johnson, John W. Day, Johanna Hamel, Charles A. Thornton, S H. Subramony, Payam Soltanzadeh, Jeffrey Statland, William D. Arnold, Matthew P. Wicklund, Kelly Ditrapani, Carrie Heusner, ChaoYin Chen, Bradley W. McEvoy, Yiming Zhu, Li-Jung Tai, Elizabeth Jane Ackermann

3:54 p.m. S48.003

One-year Data from ENDEAVOR, a Phase 1b Trial of Delandistrogene Moxeparvovec (SRP-9001) in Patients with Duchenne Muscular Dystrophy (DMD)– Craig M. Zaidman, Crystal M Proud, Craig McDonald, Stefanie Mason, Maitea Guridi, Shufang Wang, Carol Reid, Eddie Darton, Christoph Wandel, Sarah Lewis, Jyoti Malhotra, Danielle A. Griffin, Rachael Potter, Louise R. RodinoKlapac, Jerry R. Mendell

4:06 p.m. S48.004

A Phase 2 Clinical Trial Evaluating the Safety and Efficacy of Delandistrogene

Moxeparvovec (SRP-9001) in Patients with Duchenne Muscular Dystrophy (DMD)–Jerry R. Mendell, Perry Shieh, Zarife Sahenk, Kelly Lehman, Linda Pax Lowes, Natalie F. Reash, Megan Iammarino, Lindsay N. Alfano, Brenna Rose Sabo, Jeremy Woods, Christy Skura, Howard Mao, Loretta Staudt, Rachael Potter, Danielle A. Griffin, Sarah Lewis, Shufang Wang, Tejdip Singh, Louise R. Rodino-Klapac

4:18 p.m. S48.005

PK/PD Modeling to Inform Clinical Development of an Adeno-associated Virus Gene Transfer Therapy for Duchenne Muscular Dystrophy– Lilly East, Rachael Potter, John Snedeker, Alemayehu Girma Haile, Christopher Wier, Louise R. Rodino-Klapac

4:30 p.m. S48.006

Integrated Analyses of Data from Clinical Trials of Delandistrogene

Moxeparvovec (SRP-9001) in Duchenne Muscular Dystrophy (DMD)– Crystal M Proud, Craig M. Zaidman, Perry Shieh, Craig McDonald, John W. Day, Stefanie Mason, Maitea Guridi, Lixin Han, Lixi Yu, Carol Reid, Eddie Darton, Christoph Wandel, James Antony Richardson, Jyoti Malhotra, Tejdip Singh, Louise R. Rodino-Klapac, Jerry R. Mendell

4:42 p.m. S48.007

Long-term Follow-up of Cipaglucosidase Alfa/Miglustat in Ambulatory Patients with Pompe Disease: An Open-label Phase I/II Study (ATB20002)–Tahseen Mozaffar, Benedikt Schoser, Priya Kishnani, Drago Bratkovic, Paula R. Clemens, Ozlem Goker-Alpan, Xue Ming, Mark Roberts, Kumaraswamy Sivakumar, Ans Van Der Ploeg, Mitchell Goldman, Jacquelyn Wright, Frederick Holdbrook, Vipul Jain, Sheela Sitaraman, Yasmine Wasfi, Barry Byrne

4:54 p.m. S48.008

Results from 96 Weeks Open-Label Extension of a Phase 2 Trial of Losmapimod in Subjects with FSHD: ReDUX4– Leo Hong-Li Wang, Jay Han, Jennifer Shoskes, John Jiang, Alrabi Tawil

5:06 p.m. S48.009

Results from a 36-Week Open-Label Study of Recombinant Human Growth Hormone and Testosterone in Facioscapulohumeral Muscular Dystrophy (FSHD)– Chad R. Heatwole, Elizabeth Luebbe, Johanna Hamel, Phillip C. Mongiovi, Emma Ciafaloni, Nuran Dilek, William Martens, David Ryan Weber, Hani Rashid, Jamie Allen, Claire Helene Smith, Samantha Howell, Spencer Zachary Rosero, Katy Eichinger, Lindsay Baker, Jeanne Dekdebrun, James E. Hilbert, Anika Varma, Michael McDermott, Charles A. Thornton, Richard T. Moxley

5:18 p.m. S48.010

Annualized Rates of Change from A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 48-Week Study of Losmapimod in Subjects with FSHD: ReDUX4–Alrabi Tawil

3:30 p.m.–5:30 p.m. ET

SCIENTIFIC SESSIONS

Thursday, April 27

3:30 p.m.–5:30 p.m. ET

3:30 p.m. S49.001

Genetic Analyses of Oral Health and Neuroimaging Markers of Brain Health in Persons without Stroke– Cyprien Rivier, Daniela Brenda Renedo, Adam De Havenon, Sam Payabvash, Victor Manuel Torres-Lopez, Thomas Gill, Kevin N. Sheth, Guido Jose Falcone

3:42 p.m. S49.002

Implementation of a Point of Care MRI Program to Improve Hospital Outcomes in the Inpatient Neurology Setting– Christopher Medina, Edmond Knopp, Amy Wen, Christopher Willey, Paul Wright

3:54 p.m. S49.003

The Association between Pulmonary Function and Cerebral Small Vessel Diseases– Jin Park, Kyungha Min

4:06 p.m. S49.004

Abnormalities of lipid metabolism in neuronal models of CoQ10 deficiency–Alba Pesini Martin, Giacomo Monzio-Compagnoni, Eliana Barriocanal, Agustin Hidalgo Gutierrez, Giulio Kleiner, Giussepe A. Yanez, Mohammed Bakkali, Edoardo Monfrini, Yashpal S. Chhonker, Saba Tadesse, Delfina Larrea, DJ Murry, Caterina Mariotti, Barbara Castellotti, Luis Lopez, Alesio Di Fonzo, Estela Area, Catarina Quinzii Hirano

4:18 p.m. S49.005

Telemedicine Use Before and During the COVID-19 Pandemic Among People With Neurological Disorders: A Cross-Sectional Study Using US Commercial Claims Data–Anisha Patel, Robert Francis Schuldt, Denise Boudreau, Nikki Win, Bryan Cobb, Marisa P. McGinley

4:30 p.m. S49.006

Assessing sensory complaints in the outpatient clinic: predicting neurologic disease versus idiopathic sensory phenomena– Leah Zuroff, Maya Alexis, David Do

4:42 p.m. S49.007

Neighborhood Deprivation and Polygenic Contribution to Acute Ischemic Stroke: Results from the All of Us Research Program– Cyprien Rivier, Julian Acosta, Daniela Brenda Renedo, Thomas Gill, Kevin N. Sheth, Guido Jose Falcone

4:54 p.m. S49.008

A Prospective Natural History Study of Patients with Adult-Onset

Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)–Rajasimhan Rajagovindan, Benjamin Matys, Elizabeth Finger, Jeffrey Marc Gelfand, , Wolfgang Koehler, Rajeev Kumar, David S. Lynch, Jennifer Lauren Orthmann Murphy, Ludger Schols, Nicole Wolf, Andreas Meier, Spyridon Papapetropoulos, Zbigniew K. Wszolek

5:06 p.m. S49.009

One year follow-up of neurologic symptoms in non-hospitalized neurology outpatients with post-acute sequelae of COVID-19 (PASC)–Sujata P. Thawani, Sherry Fung, Rachel Kenney, Sara Wesley Hyman, Samarah Ahmed, Azizi Seixas, Girardin Jean-Louis, Jennifer A. Frontera, Steven Galetta, Laura J. Balcer

5:18 p.m. S49.010

Refining the phenotype of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a commonly misdiagnosed autosomal dominant neurodegenerative disease–Spyridon Papapetropoulos, Andrew James Marsh, Andreas Meier, Rajasimhan Rajagovindan, Leslie Leahy, Ryan O’Mara, Zbigniew K. Wszolek

3:30 p.m. S50.001

Dried Blood Spot Collection for AQP4-IgG testing provides opportunity for improving global health NMOSD diagnostics–Yahya Jamal Abdulrahman, James Fryer, Vyanka Redenbaugh, Eoin P. Flanagan, Jessica Ann Sagen, Holly Morrison, John J. Chen, Anastasia Zekeridou, Andrew McKeon, John R. Mills, Sean J. Pittock

3:42 p.m. S50.002

NMOSDCopilot: Feasibility of Smartphone-Based Digital Biomarkers for the Self-Assessment of Vision, Motor and Cognitive Functions in Neuromyelitis Optica Spectrum Disorder– Michael Levy, Elias S. Sotirchos, Helene Zephir, Julie Pique, Loic Carment, Clarissa Gorin, Sonia Kapche Kamga, Dellini Ravindra, Emma Touré Cuq, Sami Fam, Adrian Kielhorn, Emrah Aras, Jerome De Seze

3:54 p.m. S50.003

Upregulated complement receptors correlate with Fc gamma receptor

3A-positive natural killer cells (NK) and natural killer-T cells (NKT) in neuromyelitis optica spectrum disorder.–Shuhei Nishiyama, Amy Wright, Itay Lotan, Friedemann Paul, Michael Levy

4:06 p.m. S50.004

Spatial Association Between Gene Expression and Brain Damage in Neuromyelitis Optica Spectrum Disorders– Laura Cacciaguerra, Loredana Storelli, Elisabetta Pagani, Vittorio Martinelli, Lucia Moiola, Massimo Filippi, Maria Assunta Rocca

4:18 p.m. S50.005

Presymptomatic Aquaporin-4 (AQP4) Autoantibody Seropositivity in NMOSD: Analysis of the Department of Defense Serum Repository (DoDSR)–Tammy L. Smith, Ka-Ho Wong, Lisa Kay Peterson, Noel Carlson, John W. Rose, David Edward Horvat, Keith Groshans, Sithembile Mabila, Sean J. Pittock, Nathan Tagg, Stacey Clardy

4:30 p.m. S50.006

Effectiveness of Lower Rituximab Doses in Neuromyelitis Optica Spectrum Disorder: A Population-based Cohort Study– Radostina Iordanova, Jessica Betty Smith, Edlin Gonzales, Angus Lee, Bonnie Li, Annette M. Langer-Gould

4:42 p.m. S50.007

Contribution of clinical attacks to the irreversible disability in NMOSD– Bo Chen, Anna Francis, Jacqueline Palace

4:54 p.m. S50.008

High-Efficacy Therapies Reduce Clinical and Radiological Events More Effectively than Traditional Treatments in Neuromyelitis Optica Spectrum Disorder–Tatum Moog, Alexander Smith, Morgan C. McCreary, Katy Burgess, Darin T. Okuda

5:06 p.m. S50.009

Profile of serum biomarkers in seronegative NMOSD–Sara Carta, Alessandro Dinoto, Marco Alfonso Narduc Capobianco, Paola Valentino, Marianna Lo Re, Vanessa Chiodega, Pierre Branger, Bertrand Audoin, Jennifer Aboab, Caroline Papeix, Nicolas Collongues, Philippe Kerschen, Helene Zephir, Alain Creange, Bertrand Bourre, Eoin P. Flanagan, Vyanka Redenbaugh, Javier VillacierosÁlvarez, Georgina Arrambide, Alvaro Cobo Calvo, Sergio Ferrari, Romain Marignier, Sara Mariotto

5:18 p.m. S50.010

Radiologic Disease Activity Independent of Relapses in Aquaporin4-IgGSeropositive Neuromyelitis Optica Spectrum Disorder (AQP4-IgG+ NMOSD), Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), and Multiple Sclerosis (MS): A Retrospective Comparative Study– Negar Molazadeh, Gauruv Bose, Tanuja Chitnis, Michael Levy

3:30 p.m.–5:30 p.m. ET

Thursday, April 27

S51 Movement Disorders: Tremor, Parkinsonism, and Non-motor Symptoms CME 2

3:30 p.m. S51.001

Low Clinical Sensitivity and Unexpectedly High Incidence for Neuropathologically Diagnosed Progressive Supranuclear Palsy (PSP)– Erika Driver-Dunckley, Nathaniel Dunckley, Nan Zhang, Geidy Serrano, Lucia Sue, Holly A. Shill, Shyamal Mehta, Christine Belden, Cecilia Tremblay, Alireza Atri, Charles H. Adler, Thomas Beach

3:42 p.m. S51.002

Longitudinal study of Progressive Supranuclear Palsy (PSP) using remote athome multi-modal digital assessments and wearable devices– Mansi Sharma, AJ Jane Hall, Rylee Cole, Jose Joaquin Casado, Ram Kinker Mishra, Ashkan Vaziri, Alexander Pantelyat, Anne Marie A. Wills

3:54 p.m. S51.003

Diagnosed and Drug-Treated Prevalence of Essential Tremor in Pediatric Patients: Retrospective Analyses of Two US Healthcare Claims Databases–Ragy Saad, Michael Markowitz, Liza Gibbs, Douglas S. Fuller, Weiyi Ni, Rajesh Pahwa, Kelly E. Lyons, Michelle Baladi, Junji Lin

4:06 p.m. S51.004

Diagnosed and Drug-Treated Prevalence of Essential Tremor in Adult Patients: Retrospective Analyses of Two US Healthcare Claims Databases– Ragy Saad, Michael Markowitz, Liza Gibbs, Douglas S. Fuller, Weiyi Ni, Rajesh Pahwa, Kelly E. Lyons, Michelle Baladi, Junji Lin

4:18 p.m. S51.005

Characterizing Lewy Pathology in 231 Essential Tremor Brains from the Essential Tremor Centralized Brain Repository– Elan D. Louis, Sheng-Han Kuo, Phyllis Faust

4:30 p.m. S51.006

Speech pauses in production of action language in Parkinson’s disease: A potential marker of mild cognitive impairment– Eduardo Inacio Nascimento Andrade, Kara M. Smith, Christina Manxhari

4:42 p.m. S51.007

Evidence of Improved Verbal Fluency Following Unilateral Right Hemisphere Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease–Victor A. Del Bene, Roy C Martin, Sarah Brinkerhoff, Joseph Olson, Matthew Nelson, Dario Marotta, Christopher L. Gonzalez, Kelly A. Mills, Vidyulata Kamath, Nicole Bentley, Harrison Carroll Walker

4:54 p.m. S51.008

Electrophysiological Signatures of Anxiety in Parkinson’s Disease–Sahar Yassine, Sourour Almarouk, Ute Gschwandtner, Manon Auffret, Mahmoud Hassan, Peter Fuhr, Marc Verin

5:06 p.m. S51.009

Direct Electrophysiological Imaging, Analyzing Brain-induced Magnetic Stimulation Response, for the Diagnosis and Indication of Ventriculoperitoneal Shunting in Patients with Normal Pressure Hydrocephalus–Tal Davidy, Saar Anis, Alexandra Suminski, Yakov Zauberman, Tsvia Fay-Karmon, Sharon HassinBaer

5:18 p.m. S51.010

Biopsychological trait markers supporting the stress-diathesis model in functional neurological disorders.–Samantha Weber, Janine Bühler, Serafeim Loukas, Selma Aybek

Cleveland Clinic Brain Study

› Comprehensively monitoring up to 200,000 older adults without neurological disease for up to 20 years.

› Looking for biomarkers of neurological disease before symptoms start.

› Pursuing precision medicine to prevent and cure neurodegenerative disorders.

Come hear details about this first-of-kind longitudinal investigation from co-principal investigator Imad Najm, MD.

Monday, April 24 | 12:30 p.m.

Emerging Neurologic Care Presentation Stage in the Exhibit Hall

Studies like this don’t get launched every day. Visit

throughout the week to learn about the study and other initiatives of Cleveland Clinic’s Neurological Institute.

The Poster Hall features all digital displays with presentations with authors scheduled for multiple times per day In between each scheduled presentation with authors, you can visit the hall to revisit any previously presented posters .

Posters on related topics are grouped together in “neighborhoods” for easy navigation . There are 14 total poster standby times when authors will be available to present their research and answer questions Poster session standby times will occur Sunday, April 23-Wednesday, April 26 from 8:00 a m –9:00 a m ET, 11:45 a m –12:45 p m ET, and 5:30 p .m .–6:30 p .m . ET and on Thursday, April 27 from 8:00 a .m .–9:00 a .m . ET and 11:45 a .m .–12:45 p .m . ET .

POSTER SESSION 1

1Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): Neuropsychiatry

P1.1-001

Assessing Neuropsychology Testing Variation at Level IV Epilepsy Centers – Patrick Landazuri, Jennifer Gess, David Denney, Bradley Folley, Christian LoBue, Melissa Sutcliffe, Taylor Abel, James Baumgartner, Joseph S Neimat, Viktoras

Palys, Caleb Pearson

P1.1-002

Short versus Long video-EEG in Diagnosis of Psychogenic Non-Epileptic Spells (PNES): Yield and Cost-Effectiveness – Haneen Faisal

Al Refa’i, Ahmed Moh’d Yassin, Maram Shati AL Anbar, Alameen Ahmed Alsabbah, Salma Yahya

Bashayreh, Khalid El-Salim

P1.1-003

EEG abnormalities in patients with PNES – Shazia

Mirza, Mark A. Agostini, Kan Ding, Alexander G. Doyle, Sasha Alick-Lindstrom, Irina Podkorytova, Ryan Hays, Rodrigo Zepeda Garcia, Ghazala

Perven, Marisara Dieppa, Rohit Das

P1.1-004

Feasibility and Insights from Automated Depression and Anxiety Screening for People with Epilepsy – Lilian Coelho, Maria Andrea Donahue, Yashmi Shirish Sevak, Poojith Nuthalapati, Jeffrey R. Buchhalter, Brandy Fureman, Susan T. Herman, Lidia Maria Veras Rocha Moura

P1.1-005

Correlation Between Depressive And Anxious Symptoms And White Matter Changes In Relatives Of People With Epilepsy – Gabriel Ferri Baltazar, Ricardo Brioschi, Rafael Joao, Clarissa L. Yasuda, Mateus Nogueira, Fernando Cendes, Marina Koutsodontis Alvim, Leticia Franceschet Ribeiro, Lucas Scárdua Silva

P1.1-006

Association of interictal EEG findings in those with concomitant epileptic seizures and PNES –Gabriela Alejo, Olivia Iheme, Brendan J. Kelley

Sunday, April 23 | 8:00 a.m.–9:00 a.m. ET

P1.1-007

A Study On The Quality Of Life And Psychiatric Comorbidities In Patients Of Juvenile Myoclonic Epilepsy In A Tertiary Care Center In North India – Cankatika Choudhury, Neera Chaudhry, Sanghamitra Laskar

P1.1-008

Improving Post-Operative Psychiatric Outcomes in Surgical Epilepsy Patients – Tandees Najimi

P1.1-009

Epileptiform Discharges in Patients with Psychogenic Non-Epileptic Attacks: A Case Series – Mohamed Afify, Benjamin David Tolchin, Hamada Hamid Altalib, Lawrence J. Hirsch, Aline Herlopian

P1.1-010

Emergency Department Treatment of Psychogenic Non-epileptic Seizures: A Retrospective Chart Review – Nicole Sukkarieh, Adel Hijazi, Manik Tetarbe, Niveta Aravind, Maysaa Merhi Basha, Deepti Zutshi

P1.1-011

Investigation of anxiety, depression, and adjustment disorder in mothers of children with a seizure disorder in the Georgian population –Mariam Alavidze, Marilyn Victoria Ann Dias, Tinatin Tkemaladze, Sofia Vakhtang Kasradze

P1.1-012

Assessing Biases in the Diagnosis of Psychogenic Non-Epileptic Spells (PNES) – Ramsha Ali Bhutta, Ashley Bailey, Marco M. Wolmarans, Chindo Bala Mallum, Paul Grunsted, Sarah R. Durica, Denise K. Sebasigari

2Education, Research, and Methodology

Education, Research, and Methodology: Resident Education 1

P1.2-001

Assessing a Novel Asynchronous EEG-Learning Curriculum via Quantitative and Qualitative Methods – Christopher Bentley Traner

P1.2-002

A Longitudinal Experience and Annual “CheckIns” to Increase Resident EEG and EMG Milestone Attainment and Improve Milestone Rating Accuracy – Harry William Sutherland, Aaron Stephen Bower, Kathryn Zuchowski, Jeffrey Dewey, Jeremy Moeller

P1.2-003

Neuropalliative Curriculum in Neurology Residency Program – Gitanjali Das, Abby Bossart, Eric Stulberg, Jonathan Ross Galli

P1.2-004

Teaching Neurology Trainees to Provide a Terminal Diagnosis Using Objective Structured Clinical Examinations (OSCE) – Mordechai Z. Smith, Ariane Lewis, Perrin A. Pleninger, Kaitlyn Lillemoe, Sakinah Sabadia, Brandon Giglio, Sondra Zabar, Elina Zakin, Arielle Marisa Kurzweil

P1.2-005

Assessing the Impact of a Multi-Modal NeuroOphthalmology Educational Workshop on Resident Confidence in the Neuro-Ophthalmology

Examination – Jieun Kang, Alexis Flowers, Christopher David Lee, Patrick J. Lavin, Shailee Samir Shah

P1.2-006

An Interactive Approach to Teaching Neurology Residents about Intellectual and Developmental Disabilities (IDD): Effects of In-Person Versus Virtual Noon Conferences – Julia Sophie Frueh, Stefan Sillau, Rita Elias, Alexandra Raquel Santana Almansa, Rebecca MacRae, Hannah Shapiro, Madeline Chiujdea, Jessica Sanders

3 MS and Inflammatory Disease

MS Biomarkers

P1.3-001

Cerebrospinal Fluid Biomarkers Associated with Intrathecal Cell Therapy in Patients with Progressive Multiple Sclerosis – Cara Kizilbash, Alyssa Carlson, Violaine K. Harris, Saud A. Sadiq

P1.3-002

Serum Natalizumab and Anti-Natalizumab Antibody Concentrations May Be Useful in Patient Management – Jane Yang, Kelly Chun

P1.3-003

Plasma glial fibrillary acidic protein levels correlate with unfavourable imaging measures in Radiologically Isolated Syndrome – Raphael Schneider, Koroboshka Brand-Arzamendi, Timothy R. Lim, Lisa Eunyoung Lee, Melanie Guenette, Suradech Suthiphosuwan, Aditya Bharatha, Jiwon Oh

P1.3-004

Inflammatory Cytokines as a correlate for MRI regional activity in Multiple Sclerosis – Rajesh K. Gupta, Rohini D. Samudralwar, John William Lindsey, Bharti Manwani

P1.3-005

Establishing Demographic and Comorbidity Based Reference Ranges for NfL and GFAP in Healthy Controls – Tyler Lee Borko, Britney Barrera, Alanna Marie Ritchie, Sean Selva, Stefan Sillau, Eric Engebretson, Rebecca Seale, Brooke L. Valdez, Enrique Alvarez, John Corboy, Anna Shah, Robert H. Gross, Diego Silva, Gregory Owens, Amanda Lee Piquet, Jeffrey L. Bennett, Timothy L. Vollmer, Salim Chahin, Kavita Nair

P1.3-006

Serum NfL in MS Patients Treated with Cladribine: Course and Predictive Value – Tobias Moser, Michael Seiberl

P1.3-007

A Systematic Review of Epstein-Barr Virus Antibodies as Clinical Biomarkers in Multiple Sclerosis – Abigail Suprova Bose, Farnaz Khalighinejad, Christopher Hemond

P1.3-008

Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories – Catharina Groß, Andreas SchulteMecklenbeck, Olga Vsevolodivna Steinberg, Timo Wirth, Sarah Lauks, Sergio Baranzini, Stefan Bittner, Judith Bellmann-Strobl, Nora Buenger, Eva Eilers, Maria Eveslage, Vinzenz Fleischer, Barbara Gisevius, Sergiu Groppa, Juergen Haas, Martin Kerschensteiner, Lucienne Kirstein, Catharina Korsukewitz, Lisa Lohmann, Jan Lünemann, Felix Lüssi, Gerd Meyer Zu Horste, Jeremias Motte, Tobias Ruck, Nicholas Schwab, Sven G. Meuth, Friedemann Paul, Brigitte Wildemann, Tania Kuempfel, Ralf Gold, Frauke Zipp, Luisa Hildegard Klotz, Heinz Wiendl

P1.3-009

Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity and Treatment Response in Patients with Progressive and Relapsing Multiple Sclerosis – Marzena Pedrini, Belinda Kaskow, Stephanie Trend, William Carroll, Susan Walters, Aleksandra Maleska Maceski, Jens Kuhle, Allan G. Kermode

P1.3-010

Using Plasma NfL and GFAP to Monitor Response to Anti-CD20 Treatment in MS – Robert H. Gross, Stefan Sillau, Sean Selva, Alanna Marie Ritchie

P1.3-011

Neurofilament Light Chain Levels and Disease Activity During Long-Term Treatment of Relapsing Multiple Sclerosis with the Bruton’s Tyrosine Kinase Inhibitor Evobrutinib – Jens Kuhle, Ludwig Kappos, Xavier Montalban, Pascal Benkert, Ying Li, Karthinathan Thangavelu, Yann Hyvert, Davorka Tomic

P1.3-012

NfL as a Predictor of GdE Lesions in Patients With Relapsing Multiple Sclerosis Treated With Ozanimod in the Phase 2 RADIANCE Trial – Sarah Harris, Patrick Vermersch, Xavier Montalban, HansPeter Hartung, Ludwig Kappos, Harry Southworth, James K. Sheffield, Diego Silva, Jeffrey Alan Cohen

P1.3-013

Relevance of Bright Spotty Lesions (BSLs) in Neuromyelitis Optica Spectrum Disorders (NMOSD): A Case Series – Katherine Elizabeth Beard, Shreya Reddy P, Kanika Sharma, Shruti K. Jaiswal, Shitiz K. Sriwastava

P1.3-014

Role Of Antimüllerian Hormone Levels and Neurofilament Light Chains In Family Planning In MS – Juan Pablo Cuello, Ariana Meldaña Rivera, Jose Manuel Garcia Dominguez, Alexander Rodero Romero, Haydee Goicochea Briceño, Elda María Maria Alba Suarez, Enric Monreal Laguillo, Susana Sainz de la Maza, Lucienne Costa Costa-Frossard Franca, Juan de-León Luis, Carmen Martinez Asensio, Lourdes Fatima Yllana Pérez, Yolanda Higueras, Maria Luisa Martinez Gines, Luisa M. Villar

4 General Neurology

General Neurology: Telemedicine

P1.4-001

Patient Experience with Video Telemedicine Neurology Follow-up Visits at Community Clinics –Karen A. Truitt, Kogul Arumaithurai, Nathan P. Young

P1.4-002

Teleneurology Satisfaction during the COVID-19 Pandemic – Sheffield Sharp, Dylan Makani, P. David Charles, Kelly Harper

P1.4-003

Patient Satisfaction with Teleneurology across Neurologic Conditions – Courtney Seigel, Holly Martin, Grace Kathryn Bastin, Laura Myers, Stanley Taylor, Francis Pike, Jayne R. Wilkinson, Linda S. Williams

P1.4-004

The Lacune of Teleneurology: Autochromatic Correction of Jaundice – Reshma Bano Shahzadi, Sunjeet Brar, Alan R. Hirsch

4 General Neurology

General Neurology: Vascular

P1.4-005

Bilateral Subdural Hematoma, The Cause or Consequence – Narmada Mannem, Nicholas Yelverton

P1.4-006

Intravenous tPA administration in patients with negative diffusion-weighted imaging (DWI) study on the MRI brain – Pradeepthi Badugu, Amrita Pandey, Maithreyi Chappidi, Roger E. Kelley

P1.4-007

Correlation analysis of parameters of cardiointervalography and immune status in patients with ischemic stroke depending on the affected area – Nargiza Chekeeva

5

Autoimmune Neurology

Autoimmune Neurology: Myasthenia Gravis

P1.5-001

Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-Mediated Autoimmune Diseases – Kelly G. Gwathmey, Catherine Broome, Matthias Goebeler, Hiroyuki Murai, Zsuzsanna Bata-Csorgo, Adrian Charles Newland, Peter Ulrichts, Rene Kerstens, Jeff Guptill, Sofiane Agha, Ming Jiang, James F. Howard

P1.5-002

Change in Concomitant Therapies for Generalized Myasthenia Gravis in Patients Receiving Eculizumab: a Retrospective Analysis of Registry Data – Michael T. Pulley, Samir Philip Macwan, Richard J. Nowak, Tahseen Mozaffar, Ema Rodrigues, Houari Korideck, Brian Werneburg, Pushpa Narayanaswami

P1.5-003

Comorbidities in patients with myasthenia gravis in the USA: a retrospective claims database analysis – Daniel Basoff, Anju Parthan, Raj Bandaru, Anusorn Thanataveerat, Matthew Kent, Michael K. Hehir, Ali A. Habib

P1.5-004

Ravulizumab for the Treatment of Generalized Myasthenia Gravis: Timing of Response – Ali A. Habib, Michael G. Benatar, Tuan Hoang Vu, Andreas Meisel, Shahram Attarian, Masahisa Katsuno, Serena Liao, Kathleen Beasley, James F. Howard

P1.5-005

Investigating Autoantibody Profiles in Seronegative Myasthenia Gravis – Gianvito Masi, Minh Cong Pham, Yile Dai, Yingkai Li, Tabitha Karatz, Seneca Oxendine, Vern C. Juel, Aaron M. Ring, Richard J. Nowak, Jeff Guptill, Kevin O’Connor

P1.5-006

Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis – Michael D. Weiss, Saskia Bresch, Miriam L. Freimer, Channa Adithya

Hewamadduma, Raul Juntas-Morales, Maria Isabel Leite, Angelina H. Maniaol, Masayuki Masuda, Kumaraswamy Sivakumar, Malgorzata Zajda, Babak Boroojerdi, Petra W. Duda, Guillemette De La Borderie, James F. Howard

P1.5-007

RAISE-XT: An interim analysis of safety and efficacy in an open-label extension study of zilucoplan in patients with myasthenia gravis – Miriam L. Freimer, Maria Isabel Leite, Angela L. Genge, Yessar M. Hussain, Henry J. Kaminski, Renato Mantegazza, Kimiaki Utsugisawa, Tuan Hoang Vu, Petra W. Duda, Babak Boroojerdi, Mark Louis Vanderkelen, Romana Lowcock, James F. Howard

P1.5-008

Study design and methodology of the PREVAIL trial: a phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of subcutaneous ALXN1720 in adults with generalized myasthenia gravis – James F. Howard, Sanjay N. Rakhade, Joachim Scholz, Stephan Ortiz, Shulian Shang, Tuan Hoang Vu

P1.5-009

A Rare Case of Thymoma-Associated Idiopathic Inflammatory Myopathy and Myasthenia Gravis –Chelsea Schmoll, Stefanie Jordan Rodenbeck

P1.5-010

Mortality in Mechanically Ventilated Myasthenia Gravis Adult Patients: Comparing Intravenous Immunoglobulin vs Steroids – Kranthi Kiran Mandava, Kazim Jaffry, Mustafa Jaffry, Anam Khalid Shaikh, Ronak Trivedi, Muhammed Ors, Iqra Faiz, Reza Mohammed Ali, GM Fahad Bin Mostafa, Hafiz Khan, Nizar Souayah

P1.5-011

Use of Efgartigimod in Treatment of Myasthenia Gravis Relapse after Possible Recurrence of Invasive Thymoma: A Case Report – Fatai Momodu Akemokwe, Elif Pinar Coskun, Shari Meyerson, Ima M. Ebong

P1.5-012

Long-term Efficacy and Safety of Symptom-driven Cyclic Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis: A Pooled Analysis of a Phase 3 Study and Two Open-label Extension Studies – Vera Bril, Artur Druzdz, Julian Grosskreutz, Ali A. Habib, Renato Mantegazza, Kimiaki Utsugisawa, John Vissing, Tuan Hoang Vu, Marion Boehnlein, Maryam Gayfieva, Bernhard Greve, Franz Woltering, Henry J. Kaminski

P1.5-013

Ravulizumab in Adults with Generalized Myasthenia Gravis: A Sub-Analysis of the Phase 3 CHAMPION MG Study According to Chronic IVIg Use at Study Entry – Vera Bril, Jin-Hong Shin, Nicholas Joseph Silvestri, James M. Winkley, Andrew J. Gordon, Yasushi Suzuki, Rasha Aguzzi, Glen Frick

P1.5-014

Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study – James F. Howard, George Li, Tuan Hoang Vu, Denis Korobko, Marek Smilowski, Li Liu, Sophie Steeland, Jan Noukens, Benjamin Van Hoorick, Jana Podhorna, Yuebing Li, Kimiaki Utsugisawa, Francesco Sacca, Heinz Wiendl, Jan L. De Bleecker, Renato Mantegazza, In Collaboration With ADAPT-SC Investigator Study Group

P1.5-015

Efgartigimod Demonstrates Consistent Improvements in Generalized Myasthenia Gravis

Patients of Shorter Disease Duration – Vera Bril, Tuan Hoang Vu, Edward Brauer, Rene Kerstens, James F. Howard, In Collaboration With ADAPT-SC Investigator Study Group

P1.5-016

Safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of subcutaneous and intravenous ALXN1720 in healthy volunteers: a phase 1, randomized, double-blind, placebo-controlled, single and multiple ascending dose study – Stephan Ortiz, Alanna McEneny, Praveen Kumar Amancha, Kara Rice, Joachim Scholz, Sanjay N. Rakhade, Min Yee

P1.5-017

Dose Selection and Clinical Development of Efgartigimod PH20 Subcutaneous in Patients with Generalized Myasthenia Gravis – George Li, Yuebing Li, Tuan Hoang Vu, Denis Korobko, Marek Smilowski, Li Liu, Sophie Steeland, Benjamin Van Hoorick, Jana Podhorna, Jenna Casey, Jan Noukens, Tonke Van Bragt, Kimiaki Utsugisawa, Heinz Wiendl, Jan L. De Bleecker, Renato Mantegazza, James F. Howard, In Collaboration With ADAPT-SC Investigator Study Group

P1.5-018

Nipocalimab Dose Selection for A Phase 3 Study in Adult Patients with Generalized Myasthenia Gravis – Juan Jose Pérez Ruixo, Yaowei Zhu, Martine Neyens, Marie-Helene Jouvin, Sindhu Ramchandren, Yan Xu, Jocelyn Leu, Anne-Gaelle Dosne, Yuan Xiong, Belen Valenzuela, Leona Ling, Partha Nandy, Hong Sun

P1.5-019

Post COVID-19 Myasthenia Gravis – Nathaniel Rogers, Elizabeth Crabtree-Hartman

P1.5-020

Myasthenia Gravis Activities of Daily Living (MG-ADL) Response to Eculizumab Treatment in Patients from the Generalized Myasthenia Gravis Registry – Ericka P. Greene, Gary Raymond Cutter, Srikanth Muppidi, Vern C. Juel, Ema Rodrigues, Houari Korideck, James F. Howard

5 General Neurology Neuroepidemiology 1

P1.5-021

Insomnia Symptoms Trajectories and increased risk of Stroke: A Prospective Cohort Study –Wendemi Sawadogo, Tilahun Adera

P1.5-022

Impact of Insurance on Acute Stroke Care Cost: A mediation analysis – Chad Aldridge, Peter Victoria, Matthew Gusler, Cheyenne Batton, Adam De Havenon, Andrew Mebane Southerland

P1.5-023

Effect of SARS-CoV-2 Pandemic on Trends in Stroke Hospitalizations and Associated Risk Factors in Non-SARS-CoV-2 Infection Patients

– Mohsen Ahmed, Umair Azhar, Afaaq Ahmed, Nabeel Ahmed, Sania Azhar, Nizar Souayah

P1.5-024

Data in brief: Factors associated with in-patient admission among stroke patients – Jared Craig Wolfe, Karan Patel, Kamil Taneja, Solomon Oak, Christopher George Favilla, Jesse Thon, James E. Siegler

P1.5-025

Emerging Trends in Stroke Epidemiology in Indian Women Over the Last Decade – Rajinder Kumar Dhamija, Abhishek Aggarwal, Alvee Saluja, Jasmine Parihar

P1.5-026

Substance Use, Demographics, and Other Medical Diagnoses That Increase Readmission Rates After Stroke – Christina Istrate, Mary Safaeipour, Natasha Thomas, Jonathan Borg Thomas, Laura Elena Paul

P1.5-027

Association Between TBI Exposure and Multiple Sclerosis Among Post-9/11 Era Veterans – Mary Jo Pugh, Megan Amuan, Krista Ocier, Glenn D. Graham, Ace Adamson

P1.5-028

Addressing The Traumatic Brain Injury Crisis

In Thailand: Analysis Of National Access To Neurosurgical Facilities Utilizing Geospatial Mapping – Arnav Mahajan, Wuttipong Tirakotai

P1.5-029

Sex Differences in Characteristics and Outcomes of Patients with Todd’s Paralysis; An Analysis

From 11,175 Cases in the United States – Shaheen Sombans, Sailaja Sanikommu, Kamleshun Ramphul, Renuka Verma, Yogeshwaree Ramphul, Nomesh Kumar, Indu Meena, Stephanie Gonzalez Mejias, Komal Kumari, Petras Jairam Das Lohana, Fnu Arti

P1.5-030

Survival Analysis Methods in Natural History Studies – Alex Berger, David Walk, Matteo Locatelli, Alexander Sherman

P1.5-031

Regional Epidemiology of Status Epilepticus: Determinants for Healthcare Cost and Outcome in Central New York – Yung-Tian Anjolie Gau, Elena M. Kleinhenz, Carolina Cuello-Oderiz, Shahram Izadyar

P1.5-032

Predictors of No-show in Neurology clinics –Thirumalaivasan Dhasakeerthi, Hisham Gibriel Bakhiet Elkhider, Rohan Sharma, Abhilash Thatikala, Krishna Nalleballe, Sanjeeva Reddy Onteddu

6 Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Basic Science

P1.6-001

Cdk5 inhibition in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis suppresses neurodegeneration and extends survival . – Ahwon Kim, Do-Yeon Lee, Jung-Joon

Sung

P1.6-002

Hexanucleotide repeat expansions in C9orf72 alter microglial responses and prevent a coordinated glial reaction in ALS – Pegah Masrori, Baukje Bijnens, Kristofer Davie, Suresh Kumar Poovathingal, Annet Storm, Nicole Hersmus, Laura Fumagalli, Ludo Van Den Bosch, Mark Fiers, Dietmar Thal, Renzo Mancuso, Philip Van Damme

P1.6-003

RACK1 Knockdown is a Potential Therapeutic Target in ALS and FTLD-TDP – Neil R. Cashman, Beibei Zhao, Catherine M. Cowan, Ananya Saraph, Darren David Christy, Juliane Ashleigh Coutts, Johanne M. Kaplan

P1.6-004

Aqueously diffusible RNA-bound amyloid-ß aggregates in Alzheimer disease brain – Andrew Stern, Angela Lynn Meunier, Wen Liu, Dennis J. Selkoe

P1.6-005

Single-cell RNA analysis reveals cell-specific increases in SUR1-related pathway activity with age in murine brain – Zujian Xiong, Chaim T. Sneiderman, Dhivyaa Rajasundaram, Dennis William Simon, Lance Lim, Lance Lim, Lance Lim, Lance Lim, Lance Lim, Lance Lim, Lance Lim, Keri Feldman, Ria Trivedi, Vincent Vagni, Patrick M. Kochanek, Ruchira M. Jha, Gary Kohanbash

P1.6-006

Protection against toxic amyloid-beta oligomers by PMN310, a monoclonal antibody rationally designed for greater therapeutic potency in Alzheimer’s disease – Johanne M. Kaplan, Ebrima Gibbs, Judith Silverman, Beibei Zhao, Juliane Ashleigh Coutts, Xubiao Peng, Steven S. Plotkin, Neil R. Cashman

P1.6-007

A Lipopolysaccharide Mouse Model Mirrors

Neuroinflammatory Transcriptional Signatures of Human AD, and the Glucagon-Like Peptide-1 Receptor Agonist Semaglutide Attenuates

Neuroinflammation in this Model – Mette Ludwig, Dylan Rausch, Anna Secher, Marie Aare Bentsen, Stine Normann Hansen, Anne-Mette Bjerregaard, Kristoffer Niss, Kristoffer L. Egerod, Charlotte Thim Hansen, Kevin Dalgaard, Myrte Merkestein, Dorte Holst, Charles Pyke, Franziska Wichern, Joseph Polex-Wolf, Tune H. Pers, Lotte B. Knudsen

P1.6-008

Microbiota-derived SCFAs Promote Chronic Neurogenesis and Anti-inflammatory Gene Expression after Traumatic Brain Injury – Zujian Xiong, Brittany Paige Nelson, Chaim T. Sneiderman, Keri Feldman, Patrick M. Kochanek, Dhivyaa Rajasundaram, Ruchira M. Jha, Gary Kohanbash, Dennis William Simon

P1.6-009

Optogenetic activation of basal forebrain cholinergic neurons improves interval timing performance in rodents – Qiang Johnson Zhang, Braedon Kirkpatrick, Nandakumar Narayanan

P1.6-010

Assessing the Co-Chaperone and Synaptic Protein DNAJC5 as a Therapeutic Target in Alzheimer’s Disease – Matthew James Rosene, Niko Nykanen, Kevin O’Dell, Marie Sutherland Nunez, Oscar Harari, John Cirrito, Mark Sands, Bruno Benitez

7 Neuro Trauma and Critical Care

Neurocritical Care: Cardiac Arrest and Brain Death

P1.7-001

Neuroprognostication After Out of Hospital

Asystole Cardiac Arrest – Trilok Stead, Anjali Banerjee, Latha Ganti, Paul Banerjee

P1.7-002

Predictors of Good Neurologic Outcome After Pulseless Electrical Activity – Anjali Banerjee, Trilok Stead, Latha Ganti, Paul Banerjee

P1.7-003

The Financial Impact of Coma on the Healthcare System in the United States During 2016-2019, a Cross-Sectional Study – Maggie Moran, Ashley Young, Shwetha Menon, Ali Seifi

P1.7-004

Isolated Brainstem Death is Rare and is Associated with Infratentorial Stroke Among Patients Suspected of Death by Neurologic Criteria – Joel Neves Briard, Dean Fergusson, Shane English, Sonny Dhanani, Alexis Turgeon, Francois Lauzier, Ian Ball, Jai Jai Shankar, Michael Chasse

P1.7-005

Efficacy of the Implementation of Brain Herniation Codes at a Tertiary Medical Center – Eunice

Jiyoung Lee, Lucy Elizabeth Gee, Malissa Pynes, Courtney Curran, Rebecca T. Hsu, Julian Gal, Jennifer Hannah Newman, Elizabeth Woods

Fletman, Pooja Gupta, Emma Yellin, Alexander Buslov, Henry Millard Lee, Kasun Indika Navarathna, Matthew Vibbert, Syed Omar Shah

P1.7-006

Eye Movement and Coma Recovery after Cardiac Arrest – Michael Francis Maimon Cronin, Laura Hwang, Audrey Serena Wack, Brian Pugsley, Mary Russo, David M. Greer, Charlene Jennifer Ong

8

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Neuromuscular Junction Disorders 1

P1.8-001

A case report of resolving an uncertain variant in CHRN1B as pathogenic leading to Congenital Myasthenic Syndrome type 2C – Zurisadai

Gonzalez Castillo, Simon Kayyal, Neda Zadeh, Julian Thomas

P1.8-002

Triple M Syndrome with Triple Seronegative Myasthenia Gravis presenting as a Non-ST Elevation Myocardial Infarction – Octavio

Carranza-Renteria, Olivia Mattner, Nadia Sial, Denis Babici, Roxana Maria Dragomir, Adrian RodriguezHernandez, Thomas C. Hammond

P1.8-003

Congenital Myasthenic Syndrome due to DOK-7 Mutation in a Quinquagenarian Responding to Salbutamol – Saranya B. Gomathy, Animesh Das, Divya M. Radhakrishnan, Ayush Agarwal, Awadh K. Pandit, Achal K. Srivastava

P1.8-004

Clinical Experience With Efgartigimod For Treatment Of Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis – Nakul Katyal, Karen Halldorsdottir, Neelam Goyal, Raghav Govindarajan, Srikanth Muppidi, Ali A. Habib

P1.8-005

Malignant Ectopic Cervical Thymoma in Myasthenia Gravis: A Case Report – Maryam Hosseini, Shima Zargar

P1.8-006

Efgartigimod for Pembrolizumab-induced Myasthenia Gravis Refractory to Standard Therapy – Maryellen Campbell, Adrian RodriguezHernandez, Zufe Rizvi, Marc A. Swerdloff, Elina Zakin, Svetlana Faktorovich

P1.8-007

The impact of Myasthenia Gravis antibody status on pregnancy and neonatal outcomes – Mariam Al Hussona, Aaron E. Izenberg, Carolina Barnett Tapia, Anne Berndl

P1.8-008

Acquired Rippling Muscle Disease with Acetylcholine Receptor Antibodies – Thapat Wannarong, Karissa Gable, Vern C. Juel

P1.8-009

Characterization of Early Adopters of Efgartigimod for gMG – Georgiana Kuhlmann, Emma McFadden

P1.8-010

Iron Metabolism Patterns in Non-anemic Myasthenia Gravis Patients: A Cross-sectional and Follow-up Study – Ke Li, Li’an Hou, Ying Tan, Yangyu Huang, Jiayu Shi, Jianhua Han, Jing Yang, Yuzhou Guan

8

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Imaging, Genetics, and Outcome Measures

P1.8-011

Benefit of Neuromuscular Ultrasound on Patient Management and Outcomes – Raed Gasemaltayeb, Thapat Wannarong, Hemani Ticku, David C. Preston

P1.8-012

Utility of Diagnostic Neuromuscular Ultrasound in Unrevealing Electrodiagnostic Studies: Case Series – Eonjung Kim, Shanna Patterson, Rory Abrams

P1.8-013

Four Looks to a Gene – Narges Rahimi, Pooneh Memar Ardestani, Aparna M. Prabhu, Anishee Shah Undavia

P1.8-014

Genetic panel testing’s diagnostic accuracy for hereditary neuromuscular diseases in Hospital

Universitário Antônio Pedro – Lorena Adolphsson, Helen Azevedo, Camila Pupe, Renata Cavalcanti Eiras, Thiago Pinheiro, Osvaldo J M Nascimento, Helen Azevedo

P1.8-015

Validation of the Toronto Cramp Impact Index (TCII) for Assessment of Muscle Cramps – Hans D. Katzberg, Sara Abdullah Alnajjar, Nouf Salem AlFaidi, Meg Mendoza, Lorne H. Zinman, Agessandro Abrahao, Hemant Shah, David Cherney, Vera Bril, Carolina Barnett Tapia

9

Neuro-ophthalmology/Neurootology

Neuro-ophthalmology/Neuro-otology: Case Reports

P1.9-001

Orbital Myositis Presenting as a Late ImmuneRelated Adverse Event Four Months After Stopping Immune Checkpoint Inhibitor – Mohammad Dibs, Ventaka Bendi, Joseph Nahas, Sahara Cathcart, Yu-Ting Chen

P1.9-002

When Two is More Than Too Much: Carotid Stenosis and Giant Cell Arteritis – Jose Ronel N.

Santos

P1.9-003

Diffuse Leptomeningeal Glioneuronal Tumor (DLGNT) with Direct Cystic Infiltration of the Optic Chiasm and Tracts – John E. Paddock, Marc Dinkin

P1.9-004

A Case of Neural Integrator Failure in Vitamin B1 Deficiency – Hongying Chen, Niall Warfield, Ciaran Nannery, Zara Abigail Togher, Yaseen Yacoob

P1.9-005

“Convergence” Esotropia – as A Rare presentation of Hypothalamic hamartoma with Supra-sellar and Pre pontine Arachnoid cyst – Venkata Sriram Chintha, Bhaswar Bhattacharya, Debarup Das, Kuntal Biswas, Adreesh Mukherjee, Goutam Gangopadhyay

P1.9-006

Horner’s Syndrome as an Atypical Presentation of Neuroborreliosis: A Case Report and Review of Literature – Sarah Bou Reslan, George Park, Sakinah Sabadia, Scott Grossman, Elina Zakin

P1.9-007

A Rare Case of Bilateral Optic Perineuritis, Scleritis and Uveitis in a Pediatric Patient Following Influenza Vaccination – Nathaniel Gray Wooten, Irena Dujmovic Basuroski, Aliese Sarkissian, Maja Kostic, Bushra Javed, Jordan Broman-Fulks

P1.9-008

Bilateral Ischemic Optic Neuropathy as the First Manifestation of Severe Anemia – Sayyeda Zahra, Negar Moheb, Christopher Melinosky

P1.9-009

Diplopia After Baerveldt Shunt Placement – Robert Flinn, Aileen Antonio, Alex Dombrowski

P1.9-010

When vision loss is beyond cataract: a case of fatal neurodegenerative disease – Khawla M. Abusamra, Tarek Emran Ali, Padmaja Sudhakar

P1.9-011

Visual hallucinations More than just a psychiatric problem – Muhammad Sulman Bhatti

P1.9-012

Curious Cases of Painful Ophthalmoplegia –Keshav Jayeshbhai Shah

10

Infectious Disease

Infectious Disease: Cryptococcal Infections

P1.10-001

Pitfalls in the diagnosis of Cryptococcal Meningoencephalitis – Yash Nene, Rahul Mahapatra, Anuradha Duleep

P1.10-002

Bruton Tyrosine Kinase Inhibitor Associated Cryptococcal Meningitis Manifesting as Stroke –Michael A Perez, Andrew Morrison, Kelly Sloane

P1.10-003

A Case of Brainstem Cryptococcoma Causing Pontine Stroke in an Immunocompetent Male –Iffat Jabeen, Armin Maghsoudlou

P1.10-004

Cryptococcal Cerebellitis In the Setting of Fingolimod Use for Multiple Sclerosis: Atypical Clinical Presentation of Dystonia and Imaging Finding Mimicking Subacute Ischemic Stroke –Raman Singh, Hamza Mohiuddin Ahmed, Soroush Kakawand, Ahmer Asif, Ahmad Al-Awwad

P1.10-005

Cryptococcal Meningoencephalitis and Immune Reconstitution Inflammatory Syndrome in a patient on Tocilizumab Therapy: A Case Report – Nina Navalkar, Vanessa Sui, Khurram Bashir

Infectious Disease

Infectious Disease: Bacterial Infections 1

P1.10-006

Atypical Presentation of Nocardia Brainstem

Abscess: A Case Report – Sathvik S Shastry, Brian Sacks, Cleo Zarina Alejo Reyes, Ye Su, Gary W. Clauser, Alex Benjamin

P1.10-007

Bacterial Meningitis, Streptococcus Suis Isolate: A Case Series – Wilgee Eila Sun Abbot, Arlene Ng, Samantha Anne Gutierrez

11 Movement Disorders

Movement Disorders: Clinical Trials in Parkinson’s Disease 1

P1.11-001

A Double-Blind, Sham Controlled Study of Transcranial Photobiomodulation (PBM) in Parkinsons Disease – Ann Liebert, Geoffrey Kenneth Herkes, Claire McGee, Brian Bicknell, Hosen Kiat, Craig McLachlan

P1.11-002

Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease: ADAPT-PD clinical trial methodology and early data – Helen BronteStewart, Martijn Beudel, Jill L. Ostrem, Alfonso Fasano, Leonardo B. Almeida, Travis J.W. Hassell, Elena Moro, Michal T. Gostkowski, Kyle T. Mitchell, Elodie Hainque, Nagaraja Sarangmat, Scott Stanslaski, Lisa Tonder, Rebekah Summers, Robert S. Raike, Todd Herrington

P1.11-003

Foslevodopa/foscarbidopa Subcutaneous Infusion Maintains Similar Levodopa Exposure to Levodopa-Carbidopa Intestinal Gel Delivered to the Jejunum when Infused for 24-hours – Matthew Rosebraugh, Maurizio F. Facheris

P1.11-004

Design and Baseline characteristic of Phase II clinical trial of allogeneic bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for idiopathic Parkinson’s disease – Mya C. Schiess, Timothy Michael Ellmore, Mohammad Shahnawaz, Marie-Francoise Doursout, Christopher Adams, Emily Tharp, Jessika Suescun

P1.11-005

Randomized, waitlist-controlled trial of KICK OUT PD: Parkinson’s Disease-specific karate yields high adherence and improved quality of life – Jori Fleisher, Katheryn Woo, Brianna Jean Sennott, Joan O’Keefe, Chandler Gill, Sharlet Anderson, Nicollette Purcell, Bichum Ouyang, Joshua Chodosh

P1.11-006

Integrated safety summary from Phase 3 clinical trials of IPX203, an extended-release carbidopalevodopa formulation, in Parkinson disease –Hubert H. Fernandez, Robert A. Hauser, Vanessa K. Hinson, Nirav Pavasia, Eric Molho, Leonid Zeitlin, Hester Visser, Richard D’Souza

P1.11-007

Reducing a-Synuclein in Human CSF; An Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEDI1341, an a-Synuclein-specific antibody, in Healthy Volunteers and Parkinson’s Disease Patients –Craig Shering, Michael Pomfret, Robert J. Kubiak, Isabelle Pouliquen, Wei Yin, Arthur Simen, Elena Ratti, Michael Shields Perkinton, Keith Tan, Iain Chessell, Thor Ostenfeld

P1.11-008

P1.11-012

The Risk of Depression in a Large Huntington Disease Population Compared With Controls: Analysis of the Enroll-HD Registry Data –Shoshana Reshef, Gerald Smith, Ofir Harari, Mark Forrest Gordon, Rinat Ribalov, Tamar Lengil, Sam Leo, Rosa Willock, Jose Antonio Robles-Zurita, Erin Furr-Stimming, Victor W. Sung

P1.11-013

Melatonin for Huntington Disease (HD) Gene Carriers with HD-Related Sleep Disturbance - a Pilot Study – Jorge Eduardo Patino Murillas, Shayan Abdollah Zadegan, Natalia Pessoa Rocha, Nicholas Karagas, Will Keizo Tanigaki, Brittany Jay Duncan, Erin Furr-Stimming

P1.11-014

Prevalence of Neurocognitive Disorder in a Pre-manifest Huntington’s disease Cohort – Luis Alberto Sierra, Clementina Julia Ullman, Clara Baselga-Garriga, Karen Hildebrand, Samuel A. Frank, Simon Laganiere

P1.11-015

Molecular Gene Expression Analysis of Medium Spiny Neurons in Huntington’s Disease – Evan El-Halawani, Alysia Martins, Rahul A. Bharadwaj, Ran Tao, Qiang Chen, Joel E. Kleinman, Daniel R. Weinberger, Thomas M. Hyde

P1.11-016

Investigating the Effects of Brain Cholesterol Metabolism Using CYP46A1 Gene Therapy in Subjects with Huntington’s Disease – Meredith Schultz, Alexandra Durr, Carine Karachi, Michael O’Callaghan, Sandro Paiva Fernande Alves, Alain Lamontagne, Hortense Hurmic, Nathalie Cartier

Movement Disorders

Safety, Tolerability, And Efficacy Of NE3107 From A Phase 2, Double-Blind, Placebo-Controlled Study In Levodopa/Carbidopa-Treated Patients With Parkinson’s Disease – Clarence Ahlem, Christopher Reading, Joseph Djan, Joseph Michael Palumbo 11

Movement Disorders: Huntington’s Disease and Chorea 1

P1.11-009

Racial and Ethnic Disparities in Access to Huntington’s Disease (HD) care in North America: Analysis using the ENROLL-HD dataset – Adys Mendizabal, Susan L. Perlman, Yvette Bordelon

P1.11-010

Chorea Severity Change Over Time in Huntington Disease and by Huntington Disease Stage – Erin Furr-Stimming, Victor W. Sung, Shoshana Reshef, Rosa Willock, Rinat Ribalov, Sarah Brighton, Sam Leo

P1.11-011

Randomized Trial of Telegenetic Counseling for Gene Testing in Huntington’s Disease – Deborah Hall, Marc Rosenbaum, Jacob Hawkins, Bichum Ouyang, Christa Suzanne Cooper, Neepa J. Patel

Aging, Dementia, Cognitive, and Behavioral Neurology

Behavioral and Cognitive Neurology: Cognitive Sequelae of COVID-19 and Neuropsychiatry 1

P1.12-001

“Klüver-Bucy syndrome as a complication of COVID-19” – Nigar Dargah-Zada

P1.12-002

Promoting Participation in an Exercise Program for Individuals with Neurodegenerative Disease: Post-pandemic Adjustments – Sarah Ingersoll, Kris Mendenhall, Kenneth Hayashida

P1.12-003

Cerebral amyloid angiopathy-related inflammation (CAARI) and HHV-6 positivity: A case report of a treatment dilemma and a possible relationship

– Anas Alshawa, Muhammad Makkieh, Hanan Alsakka, Myrka Raquel Torres-Melendez

P1.12-004

A Scoping Review of Functional Neurological Disorder in Sexual and Gender Minority People – Z

Paige L’Erario, Mark Fusunyan, Christopher Stave, Jeffrey Waugh, Alison Wilkinson-Smith, Valeria

Roldan, Alex Keuroghlian, Jack Turban, David L. Perez, Tina Marie Maschi, Nicole Rosendale

P1.12-005

Establishing the relationship between ADHD and emotional facial expression recognition deficit: a systematic review – Maria Daniela Olaya Galindo, Oscar Alberto Vargas Cifuentes, Alberto Velez Van Meerbeke, Claudia Talero-Gutierrez

Aging, Dementia, Cognitive, and Behavioral Neurology

Behavioral and Cognitive Neurology: Genetics and Clinical Translational Studies in Cognition 1

P1.12-006

A Survey of Virtual Reality Interventions for Autistic Spectrum Disorder Therapy: A Neuroscience Perspective – Dana Allison, Patricia Prelock

P1.12-007

Identifying Key Patterns of Social and Structural Determinants of Health and Their Association with Dementia Risk in a Population-Based Study of Cognitive Aging – Maria Vassilaki, Jeremiah Aakre, Anna Castillo, Timothy Lesnick, Jonathan GraffRadford, David S. Knopman, Clifford R. Jack, Ronald C. Petersen, Prashanthi Vemuri

P1.12-008

CD5 knockout modulates effects of alcohol consumption in mouse models – Alfred Biagio Amendolara, Andrew Payne, J Daniel Obray, Benjamin Williams, Christina Small, Jordan Yorgason, Jeff Edwards, Scott Weber, Scott C. Steffensen

P1.12-009

Norepinephrine Regulates Spatial Memory Consolidation Using Barnes Maze in Male, but Not Female Rats – Serena Simpson, Ali Gheidi, Cameron J. Davidson, Majd Ahmad Yahya, Alixandria Trombley, Nareen Sadik, Shane Perrine

P1.12-010

Prevalence, demographics and etiologies of earlyonset dementia in Brazil: a retrospective cohort

– Joao Vitor Mahler Ferreira Oliveira, Marina Solti, Leonel Takada, Sonia Brucki

13 Sleep

Sleep and Neurology 1

P1.13-001

Evaluation of Sleep Parameters with Polysomnography and Multiple Sleep Latency Test in Cirrhotic Patients with Daytime Sleepiness

– Humay Ismayilzada, Gulin Sunter, Kadriye Agan, Feyza Gunduz

P1.13-002

Untreated Moderate-to-Severe Sleep-Related Breathing Disorders Are Associated with Increased Frequency of Episodes of Autonomic Dysreflexia during Sleep in Individuals with Subacute or Chronic Spinal Cord Injury: A Prospective CrossSectional Study – Julio C. Furlan, Eldon Loh, Mark Boulos

P1.13-003

Brain Age Prediction based on Sleep EEG in Shift Workers – Su Jung Choi, Soonhyun Yook, Hea Ree Park, Hosung Kim, Eun-Yeon Joo

P1.13-004

Sleep Duration is Associated with Clinically Silent Brain Injury in Middle-Aged Persons without Stroke – Santiago Clocchiatti-Tuozzo, Cyprien Rivier, Daniela Brenda Renedo, Victor Manuel TorresLopez, Sam Payabvash, Kevin N. Sheth, Thomas Gill, Guido Jose Falcone

P1.13-005

Insomnia and Post Acute Sequelae of COVID-19 in an outpatient neurology cohort – Sherry Fung, Rachel Kenney, Sara Wesley Hyman, Azizi Seixas, Girardin Jean-Louis, Laura J. Balcer, Sujata P. Thawani

Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): Intracranial EEG, Seizure Localization, and Epilepsy Surgery

P2.1-001

Long-term Remission and Resolution of Epilepsy following Surgery for Drug Resistant Lesional

Temporal Lobe Epilepsy – Sita Jayalakshmi

Sattaluri, Anuja R. Patil, Akanksha Choudhary, Sudhindra Vooturi

P2.1-002

Outcome after laser interstitial thermal therapy (LITT) in patients with drug-resistant epilepsy

– Emily In, Mohamed El Refaey, James Francis Castellano, Mark Richardson, Anto Bagic, Niravkumar Barot

P2.1-003

Lesion-related epilepsy maps to a common brain network – Frederic Schaper, Janne Nordberg, Alexander Li Cohen, Christopher Lin, Joey Hsu, Andreas Horn, Michael Ferguson, Shan Siddiqi, William Drew, Louis Soussand, Anderson M. Winkler, Marta Simó, Jordi Bruna, Sylvain Rheims, Marc Guenot, Marco Bucci, Lauri Nummenmaa, Julie E. Staals, Albert Colon, Linda Ackermans, Ellen Bubrick, Jurriaan Peters, Ona Wu, Natalia S. Rost, Jordan Grafman, Hal Blumenfeld, Yasin Temel, Rob Rouhl, Juho Joutsa, Michael D. Fox

P2.1-004

Network metrics to localize the Seizure Onset Zone: A Directed Functional Connectivity Study Using MEG Data – Natascha Cardoso Da Fonseca, Pegah Askari, Amy L. Proskovec, Sasha AlickLindstrom, Andrea R. Lowden, Afsaneh Talai, Joseph Maldjian, Elizabeth Moody Davenport

P2.1-005

Initial Clinical Experience with Thin-Film Polyimide Subdural Electrodes for Seizure Monitoring –Brigitte Reina, Yinchen Song, George Wesley Culler, Joshua Paul Aronson

P2.1-006

External Validation of Novel Method of Seizure Onset Zone Localization Based on Neural Resonance – Derrick Barnagian, Rachel June Smith, Joon Yi Kang, Mark Hays, Jorge Gonzalez, Sridevi Sarma, Niravkumar Barot

P2.1-007

Characteristics and Surgical Outcomes in a Cohort of Patients with Epilepsy and encephaloceles –Daniel Esteban Mafla Delgado, Maryam Matloub, Zihan Masood, Bryan Schatmeyer, Lauren Holland, Patrick Landazuri

P2.1-008

Two Distinct Networks are Affected by Mesial Temporal Lobe Epilepsy – Jonathan Michael Towne, Vahid Eslami, Peter Fox, Jose E. Cavazos, Peter T. Fox

P2.1-009

Yield of Stereotactic Electroencephalography for evaluation of Drug Resistant Focal Epilepsy: Single-Center Experience – Cindy Luan, Jaysingh Singh

P2.1-010

Ipsilateral Arm Movement related to Extratemporal Premotor Cortex Seizures with Secondary Spread to the Limbic Network seen on Pre-Surgical Stereotactic Electroencephalogram – Gaurav Kathuria, Tarek Zakaria

P2.1-011

Survival Analysis of Accidents Confirms Reduction After Surgery in a Group of 439 Individuals with Temporal Lobe Epilepsy and Hippocampal Atrophy – Aline Fatima Dias, Leticia Franceschet Ribeiro, Lucas Scárdua Silva, Rafael Joao, Marina Koutsodontis Alvim, Fernando Cendes, Clarissa L. Yasuda

P2.1-012

Ictal Single Photon Emission Computed Tomography (SPECT) In Patients with Focal Aware Seizure without Ictal Electroencephalographic Changes: A Single Center Experience – Saniya Pervin, Subhan Ahmed Khan, Jordan Lee Clay, Riham El Khouli, Farhan Mirza, Sally Valentina Mathias

2Education, Research, and Methodology

Education, Research, and Methodology: Resident Education 2

P2.2-001

The Completion of a PGY-1 Neurology Bootcamp Leads to Increased Trainee Knowledge and Confidence in Neurologic Emergencies Management and Procedural Skills – Carol Swetlik, A. Blake Buletko, Robert J. Marquardt, Erin Higgins, Catherine Hassett

P2.2-002

Neurology 101 for Medicine Residents: A Straightforward and Effective Lecture – Erafat Rehim, Cleo Zarina Alejo Reyes, Harry Zobel

P2.2-003

Near-Peer Learning in Neurology Residency Training on Cerebrovascular Disease in A Teaching Hospital in China – Yuehui Hong, Ning Su, Hanhui Fu, Yuze Cao, Ming Yao, Lixin Zhou, Jun Ni, Yi-Cheng Zhu

P2.2-004

Child Neurology Residency Survey of Psychogenic Nonepileptic Seizure Education – Dara V. Albert, Daniel Freedman, Afsaneh Talai

P2.2-005

Developing a Curriculum for Functional Neurological Disorder in Neurology Training – Sara A. Finkelstein, Mary Angela O’Neal, Gaston Baslet, Barbara A. Dworetzky, Ellen Godena, Julie Maggio, Daniel Millstein, Tracey A. Milligan, David L. Perez

P2.2-006

Improving Residents’ Knowledge and Interest in Outpatient Neurology through an Interactive, Discussion-Based, Patient-Centered Didactic Series – Galina Gheihman, Tracey Cho, Tracey A. Milligan, Christopher T. Doughty

3 MS and Inflammatory Disease

MS Immunology and Basic Science

P2.3-001

Regulation of the PD-1/PD-L1 axis in relapsingremitting Multiple Sclerosis – Thanos Tsaktanis, Mathias Linnerbauer, Lena Loesslein, Bernhard Hemmer, Mark Mühlau, Francisco J. Quintana, Veit Rothhammer

P2.3-002

Long-term Culture of Cerebral Organoid Reveals Disruption of Glial Cell Differentiation and Glutamate Excitotoxicity in Multiple Sclerosis

– Tanmay Mehta, Annie Elle McDermott, Nicolas Daviaud, Saud A. Sadiq

P2.3-003

A Potential Protective Role of Nurr1 in Multiple Sclerosis Motor Cortex – Jonathan Pansieri, Marco Pisa, Richard L. Yates, Sydney Yee, Margaret Esiri, Gabriele C. De Luca

P2.3-004

Effects of ocrelizumab on NK cell activation in Relapsing Multiple Sclerosis – Gianmarco Abbadessa, Sara Bruzzaniti, Giuseppina Miele, Erica Piemonte, Maria Teresa Lepore, Elisabetta Signoriello, Giacomo Lus, Giuseppe Matarese, Mario Galgani, Simona Bonavita

P2.3-005

Biological roles of myeloid cell subsets during CNS inflammation – Navid Manouchehri, Victor Hernan Salinas, Rehana Hussain, Olaf Stuve

P2.3-006

Astrocyte-derived HB-EGF promotes recovery from autoimmune CNS inflammation and is a potential target in progressive disease – Mathias Linnerbauer, Lena Loesslein, Thanos Tsaktanis, Maja Jagodic, Francisco J. Quintana, Veit Rothhammer

P2.3-007

Aldh1l1-cre/ERT2 promoter drives flox-mediated recombination in peripheral immune cells in addition to astrocytes – Mario Amatruda, Jorge Uriel Villavicencio, Graham John Britton, Sam H. Horng

P2.3-008

Gut microbiota composition in untreated people with relapsing-remitting and secondaryprogressive Multiple Sclerosis – Radu Tanasescu, Alba Cortés Carbonell, David Pritchard, Cinzia Cantacessi, Cris S. Constantinescu

P2.3-009

Single Cell Transcriptomics of Myeloid Cells in Black Americans with Multiple Sclerosis – Jeremy Michael Bingen, Lindsay Virginia Clark, Chris L. Wright, Fangxiu Xu, Michael D. Carrithers

P2.3-010

Metabolomic Profiling of Multiple Sclerosis Lesions and Periplaque White Matter Demonstrates Extensive Changes in Lipid Metabolism – Dimitrios Christos Ladakis, Martina Absinta, Maria I. Reyes-Mantilla, Carlos A. Pardo-Villamizar, Pavan Bhargava

P2.3-011

Conserved Transcriptional Signatures of Microglia in Health and Disease – Victor Hernan Salinas, Navid Manouchehri, Rehana Hussain, Olaf Stuve

P2.3-012

Evaluating the Effect of a Bruton’s Tyrosine Kinase Inhibitor in a Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis –Ross C. Gruber, Anna Blazier, Lan Lee, Sean Ryan, Agnes Cheong, Evis Havari, Timothy J. Turner, Dimitry Ofengeim

P2.3-013

Remibrutinib Inhibits Neuroinflammation Driven by B Cells and Myeloid Cells in Preclinical Models of Multiple Sclerosis – Bruno Cenni, Barbara Nuesslein-Hildesheim, Enrico Ferrero, Catherine Huck, Denis Eichlisberger, Marina Ollervides Ziehn

P2.3-014

Pharmacological inhibition of FGFR by infigratinib reduces lipids associated with neurodegeneration in MOG35-55-induced EAE – Martin Berghoff, Natascha Wallendszus, Vinothkumar Rajendran, Gerhard Liebisch, Srikanth Karnati, Ranjithkumar

Rajendran

P2.3-015

Interferome perturbation of human brain organoids induces progenitor and neuronal dysfunction seen in multiple sclerosis and autism –Ethan Hollingsworth, Dominic Louis Julian, Fumihiro Watanabe, Trevor Reutershan, Katherine Ann Julian, Ivette Martorell Serra, Sofia Lizarraga, Mark Hester, Jaime Imitola

P2.3-016

Tracking the immune response to SARS-CoV-2 mRNA booster vaccination in an open-label multicenter study in participants with relapsing multiple sclerosis treated with ofatumumab s c (KYRIOS clinical trial) – Tobias Bopp, Marie Groth, Veronika Eva Winkelmann, Tjalf Ziemssen

P2.3-017

Immune Response Following COVID-19 Vaccination (mRNA or Non-mRNA) in Patients with Relapsing Multiple Sclerosis Treated with the Bruton’s Tyrosine Kinase Inhibitor Evobrutinib: An Update – Amit Bar-Or, Anne H. Cross, Anthony Cunningham, Yann Hyvert, Andrea Seitzinger, Elise Drouin, Nektaria Alexandri, Davorka Tomic, Xavier Montalban

P2.3-018

Serologic Response and Clinical Outcomes of SARS-CoV-2 Infection and Vaccination in Ozanimod-Treated Participants With Relapsing Multiple Sclerosis – Bruce A. C. Cree, Rachel Maddux, Amit Bar-Or, Hans-Peter Hartung, Amandeep Kaur, Elizabeth Brown, Sarah Hu, James K. Sheffield, Diego Silva, Sarah Harris

4 General Neurology

General Neurology: Neuroinfections and Neuroinflammation

P2.4-001

MRI negative Varicella zoster virus (VZV) plexopathy in a young man with history of malignancy – Sedat Gul, Adeenah Ahmed, Corey A. McGraw, Ruham Alshiekh Nasany

P2.4-002

A Rare Case of Dengue Encephalitis with Extensive Brain Lesions from Pakistan – Taimoor Hussain, Zaraq Rashid Khan, Jasvindar Kumar, Daneet Kumar

P2.4-003

Eyes as a Gateway to the Brain: Spontaneous Horizontal Nystagmus as Primary Neurologic Manifestation of West Nile Encephalitis – Claire Simon, Micah Etter

4 General Neurology

Medical Student Essay Award Recipients

P2.4-004

Neurology: The Cerebral and Corporeal Specialty – Sumita Madhok Strander

P2.4-005

The Neurologist’s Dragon – Trenley Anderson

P2.4-006

Sclerose en Plaques: A Tribute to the History of Multiple Sclerosis and Charcot’s Role in Precision Medicine Today – Zabrina Gail Reyes

P2.4-007

Rolling With The Punches – Alexandra Miner

5 Cerebrovascular Disease and Interventional Neurology

Cerebrovascular Disease and Interventional Neurology: Interesting Cases 1

P2.5-001

Ischemic Stroke due to Intracerebral Steal from Calvarial Metastasis: a Case Report – Anjali Murthy, Prateek Kumar, Fernando Testai, Edward Michals

P2.5-002

A Rare Mutation Associated with Cerebral Arteriopathy with Subcortical Infarct and Leukoencephalopathy (CADASIL) – Claire Emmanuelle Delpirou Nouh, Noor Mahmoud, Juliane Chainakul, Robert Hamilton, Evgeny Sidorov

P2.5-003

Transient Perivascular Inflammation of the Carotid Artery (TIPIC) Syndrome after Breast Implant Surgery – Lekshmi Peringassery Sateesh, Adrian Marchidann

P2.5-004

A Case Report of Pituitary Apoplexy and Acute Ischemic Stroke – Sukhmani Sandhu, Harneel Singh Saini, Ye V. Liang

P2.5-005

Lemierre syndrome associated Cavernous Sinus Thrombosis and Development of Internal Carotid Artery Narrowing: A Case Report and Review of Literature – Jiping Zhou, Sabeena Iqbal Malik

P2.5-006

Non-traumatic Cerebral Fat Emboli Syndrome in a patient with Sickle Cell Crisis – Yoram Ebrahimi, Anvesh Balabhadra, Sanjay Mittal

P2.5-007

Embolic Stroke Following Intravenous Ozone Therapy – Atef Kokash, Sayyeda Zahra, Satinderpal Singh, Hussam A. Yacoub, Megan Caroll Leary

P2.5-008

Heart-Shaped infarct: Devastating Bilateral Medial Medullary Strokes Due to Amphetamine abuse –Muhammad Ismail Khalid Yousaf, Talita D’Aguiar Rosa, Marwa A. Elnazeir, Michael Haboubi, Saad Hasan, Mohammad Ravi Ghani

P2.5-009

Spontaneous Paradoxical Improvement of Motor Function after a Second Stroke – Shuojohn Li, Matthew Bloch, Yookyeong Baek, Shruthi

Sree Sivakumar, James Christian Hiana, Adrian Marchidann

P2.5-010

Asystole, A Rare Cardiac Complication of Lateral Medullary Infarction: Case report and Literature Review – Laura Gutierrez Quiceno, Ram Chandra Gowda, Bhavika Kakadia

P2.5-011

Testosterone Therapy in a Transgender Male Patient as a cause of Acute Ischemic Stroke –Christina Tan, Lauren Kim Sing, Ron Josef Danziger, Alex Chap Wee Aw, Chae Yoon Kim, Stephen Daniel Avila, Vilakshan Alambyan, Angud Mehdi, Michael M. Gezalian, Maranatha Ayodele, Shahed Toossi

P2.5-012

Posterior Reversible Encephalopathy Syndrome (PRES), Hypoxic Injury and Stroke: A Sequelae of Bath Salt Inhalation? – Zarmina Mufti, Ping Shi, Harris Idris Mufti, Saad Hasan

P2.5-013

A challenging case of an occult Multiple Myeloma presenting as an embolic stroke due to combined coagulopathy in the setting of Atrial fibrillation and cerebral cavernous malformations, a diagnostic and therapeutic conundrum – Vinay Bhushan Reddy Lakki, Ram Mohan R. Sankaraneni, Amanda Furtmann

P2.5-014

Persistent Hiccups Following Thalamic Hemorrhage – Dipali P. Nemade, Vikram Shivkumar, Neelu Dhingra

P2.5-015

Transient Cortical Blindness Following Cerebral Angiography: A Case Report – Roberto Gomez, Jennifer Harris

P2.5-016

Intravascular CNS Lymphoma: An elusive diagnosis

– Hemani Ticku, Alessandro Serra

P2.5-017

CHANTER Syndrome: A Rare Cause of Encephalopathy and Ischemic Lesions – James Christian Hiana, James Soh, Adrian Marchidann

P2.5-018

Concomitant occurrence of Cerebral Hyperperfusion Syndrome (CHS) and Reversible Cerebral Vasoconstriction Syndrome (RCVS) after right Carotid Endarterectomy (CEA) – Muhammad

Waseem Anjum, Erik Von Burton, Vijayakumar Javalkar, Oleg Y. Chernyshev

P2.5-019

Cardiac Papillary fibroelastoma (CPF): a rare underrecognized etiology of cardioembolic stroke

– Mohamed Mahmoud Eldokmak, Yohannes

Simeneh Mulatu, Biniyam Simeneh Mulatu, Weijun

Jin

P2.5-020

A rare presentation of a longitudinally extensive spinal cord lesion: a S5 Sacral Dural Venous Fistula

– Isabelle Hunt, Orlaith O Connell, Mahmoud Kamel, Gerald Wyse, Orna O’Toole, Michael Amoo

5 Cerebrovascular Disease and Interventional Neurology

Cerebrovascular Disease and Interventional Neurology: Clinical Science 1

P2.5-021

Centenarians with Cerebrovascular Disease: 38 Patients from a Single Center How much do we know? What can we improve? – Roxana Maria Dragomir, Octavio Carranza-Renteria, Denis Babici, Roberta Lesli Miles-Kiple, Kendra Kent, Diana M. Barratt

P2.5-022

Case Series of Ischemic Stroke occurring in Maleto- Female Transgender population on Gender - Affirming Hormonal Therapy and Review of the Literature – Marina Giovannini, Cristina S. Ivan, Jon Alexander Karel

5 General Neurology

Neuroepidemiology 2

P2.5-023

The Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis: A Systematic Review – Christina Wolfson, Danielle Elizabeth Gauvin, Foluso Ishola, Maryam Oskoui

P2.5-024

Greater Blood Heavy Metal Levels in the Participants of National ALS Biorepository Compared to the Participants of National Health And Nutrition Examination Survey – Moon Han, Theodore Larson, Maureen Orr, Jaime Raymond, Laurie Wagner, Wendy Eileen Kaye, Paul Mehta, D. Kevin Horton

P2.5-025

Environmental Risk Factors for Amyotrophic Lateral Sclerosis: A Case–Control Study in Canada and France – Marie Beaudin, Francois Salachas, Pierre-Francois Pradat, Nicolas Dupre

P2.5-026

Real-World Data on the Incidence and Risk of Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination; A Prospective Surveillance Study – Jongmok Ha, Hyunwook Kang, Taeeun Kyung, Namoh Kim, Dong Kyu Kim, Hyeonjoon Kim, Kihoon Bae, Min Cheol Song, Kwang June Lee, Euiho Lee, Suyeon Park, Beom Seuk Hwang, Kunhee Park, Jin Myoung Seok, Jinyoung Youn

P2.5-027

Epidemiology of Antibody-positive Myasthenia Gravis in Sardinia, Italy – Pietro Zara, Giovanni Andrea Deiana, Giovanni Sotgiu, Enzo Ortu, Stefano Sotgiu, Gregorio Spagni, Valentina Damato, Paolo Solla, Elia Sechi

P2.5-028

Age and Sex Distributions of MOG-IgG and AQP4IgG Positive Sera from a Large Neuroimmunology Laboratory Database – Nisa Vorasoot, Amy Kunchok, Matthew C. Edmond, Jennifer McCombe, Vyanka Redenbaugh, Laura Cacciaguerra, Smathorn Thakolwiboon, Nanthaya Tisavipat, Yahya Jamal Abdulrahman, John J. Chen, Sean J. Pittock, Eoin P. Flanagan

P2.5-029

Modifiable Risk Factors of COVID-19 in Patients with Multiple Sclerosis: A Single-Centre CaseControl Study – Federico Montini, Agostino Nozzolillo, Paola MV Rancoita, Chiara Zanetta, Lucia Moiola, Federica Esposito, Federica Cugnata, Maria Assunta Rocca, Massimo Filippi, Vittorio Martinelli

P2.5-030

Life’s Simple 7 and the Risk of Dementia among Women – Pamela M. Rist, Melinda Power, I-Min Lee, Julie E. Buring

P2.5-031

Prevalence of Peripheral Nervous System Involvement in Adult Leukodystrophies – Al-alya Alsabah, Zehra Isik Hasiloglu, Rami Massie, Bernard Brais, Jennifer Lauren Orthmann Murphy, Roberta

La Piana

P2.5-032

Change In Fall Risk-Increasing Drug Use Among Individuals with Parkinson Disease Before and After a Serious Injury – Thanh Phuong Pham Nguyen, Shelly Gray, Craig Newcomb, Qing Liu, Ali G. Hamedani, Sean Hennessy, Allison Wright Willis

6

Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Challenges in Dementia Clinical Practice

P2.6-001

Clinical Outcomes of Older Persons and Persons

With Dementia Admitted for Coronavirus Disease

2019: Findings From the Philippine CORONA Study

– Michelle Anlacan, Bernadeth Lyn Cal Piamonte, Marie Charmaine Cootauco Sy, Emilio Villanueva III, Roland Dominic Jamora, Adrian Isidoro Espiritu

P2.6-002

Precision Neurology for Dementia – Joshua M. Shulman, Nora Vanegas-Arroyave, Jamie Fong, Sarah Elsea, Chi-Ying Lin, Hiba Saade, Fatima Chavez, Kimberly Walker, Bo Yuan, Eric Venner, Jianhong Hu, Ariel Levchenko, Hadley Stevens Smith, Jill Oliver Robinson, Belen Pascual, Donna Muzny, Richard Gibbs, Amy McGuire, Joseph C. Masdeu

P2.6-003

What Comes First: The Diagnosis or the Pill? Evidence from Alzheimer’s Disease Population –Helen Trenz, Kimberly R. Glenn, Michael Johnson, Jeffrey McPheeters

P2.6-004

Epileptic Amnesia as an Alzheimer’s Disease Mimic

– Karan Philip, Tinatin Chabrashvili

P2.6-005

Practice Implications of Patterns of Healthcare Utilization before and after Alzheimer’s Disease diagnosis – Lauren R. Moo, Heather Davila, Guneet Jasuja, Madhuri Palnati, Qing Shao, Deepika Dinesh, Natalia Palacios, Sarah E. McDannold, Weiming Xia, Quan Zhang, Amir Tahami, Donald R. Miller

P2.6-006

Creation of a Memory Disorders Clinic Biorepository to Characterize a Clinic Population and Accurately Refer to Research Studies – Kim Graham Johnson, Cody I. Perry, Daniel Christopher Parker, Andrew Liu, Cynthia Lynn Beam, Michelle Sanfilippo, Michael Lutz, Richard J. O’Brien

P2.6-007

Population Attributable Fraction of Hypertension for Dementia: Global, Regional, and National Estimates for 186 countries – Martin David Mulligan, Robert Murphy, John Ferguson, Conor Judge, Catriona Reddin, Emer McGrath, Martin O’Donnell

P2.6-008

Depression and Dementia Risk: A PopulationBased Cohort Study in Denmark – Holly Elser, Erzsebet Horvath-Puho, Jaimie Gradus, Meghan L. Smith, Timothy L. Lash, M. Maria Glymour, Henrik Toft Soerensen, Victor W. Henderson

P2.6-009

Causes of Rapidly Progressive Dementia in a Prospectively Accrued Cohort – Gregory S. Day, Philip W. Tipton, Evelyn Lazar, Nihal Satyadev, Yuka Atagi Martens, Steven Richard Dunham, Michael D. Geschwind, John C. Morris, Neill R. Graff-Radford

P2.6-010

Unusual Presentations Accentuating the Diagnostic Confusion of CJD – Katie Weeks, Chandra Sekhar Mannyam, Muhammad Qasim Bhatti, Manasa Gunturu

7

Neuro Trauma and Critical Care

Neurocritical Care: COVID and Other Infectious Complications

P2.7-001

Critically-Elevated Interleukin-6 (IL-6): A Prognostic Biomarker for Post-Acute Sequelae of COVID-19 (PASC)? – Ronak Trivedi, Mustafa Jaffry, Iqra Faiz, Muhammed Ors, Kranthi Kiran Mandava, Kazim Jaffry, Anam Khalid Shaikh, Pratibha Surathi, Toluwalase Oluwakemi Tofade, Evan Huff, Sviatoslav Redko, Nizar Souayah

P2.7-002

Edema to Hematoma Ratio is Elevated in COVID-19 ICH Patients – Justin Lee Sim, Caleb Pang, Ivan Da Silva

P2.7-003

A Survey of Burnout among Neurocritical Care Practitioners – Pakinam Aboutaleb, Deborah M. Green-LaRoche

P2.7-004

Reversible Cerebral Vasoconstriction Syndrome (RCVS) After COVID-19 Vaccination: An Analysis of VAERS – Bahadar Singh Srichawla

P2.7-005

Mechanical Angioplasty with Comaneci for the Treatment Refractory Vasospasm Secondary to Coccidioidal Meningits – Hisham Raza Alim Salahuddin, Hanah Ayesha Imam

P2.7-006

Wernicke’s Encephalopathy Preceded by COVID-19 Infection: A Case Report – Anna Volski, Satabdi Chakrabarti Pulakanti, Amandeep Dolla

8

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Neuromuscular Junction Disorders 2

P2.8-001

Burden of Myasthenia Gravis Based on Sentiment Analysis of Patients’ Digital Conversations –Caroline Brethenoux, Jacqueline Pesa, Zia Ulhaq Chaudhry, Tiina Drissen, Patrick Furey, Liliana Gil Valletta, Laura Gonzalez Quijano, Alex Lorenzo

P2.8-002

The clinical and genetic characteristics of 17 cases with Congenital Myasthenic Syndrome: Data from a single center – Gulshan Yunisova, Ayfer Arduc Akcay, Sahin Avci, Serpil Eraslan, Hulya Kayserili, Piraye Oflazer

P2.8-003

VAMP-1 associated congenital myasthenic syndrome: a demonstrative case with response to low-dose pyridostigmine – Eleni Drakou, Leslie D. Delfiner

P2.8-004

Iron Metabolism in Non-anemic Myasthenia Gravis

Patients: A Cohort Study – Ke Li, Li’an Hou, Ying Tan, Yangyu Huang, Jiayu Shi, Jianhua Han, Jing Yang, Yuzhou Guan

P2.8-005

Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-MuscleSpecific Kinase Positive Myasthenia Gravis

Patients: A Prospective Study – Ying Tan, Jiayu Shi, Yangyu Huang, Ke Li, Jing Yang, Yuzhou Guan, Liying Cui

P2.8-006

Effect of COVID-19 on Myasthenia Gravis –Sukhmani Sandhu, Timothy Quezada, Sandeep S. Rana, George A. Small

P2.8-007

Associations Between Clinical Severity, Serological Testing, and Electrophysiological Profiles in Patients with Myasthenia Gravis – Ladan Bigdeli, William D. Arnold, Kristina Marie Kelly, Bakri Elsheikh, Jordan Tyler Mizell, Samuel Paul

P2.8-008

Risk of Infection in Patients with Myasthenia Gravis With and Without Thymoma – Katherine Michelle Clifford, Will McKeen, Ye Yuan, Srikanth Muppidi

8 Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: ALS, SMA, and Other Motor Neuron Disorders 1

P2.8-009

Weight Loss and Disease Progression in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis – Ikjae Lee, Hiroshi Mitsumoto, Pam Factor-Litvak, Jeri Wanzor Nieves

P2.8-010

Treatment Effects Among Patients with Type II and Type III SMA Directly Reported by Patients and Caregivers from the TOPAZ Clinical Trial – Robin Pokrzywinski, Katelyn Cutts, Hemal Shah, Nathalie Kertesz, Amy Place, Sabrina Grace Lesh, Mara E Sadanowicz, Guochen Song, Janet ONeil, Doreen Barrett, Erin Collins Barnobi, Georgios Nomikos

P2.8-011

Assessment of Transition Plan Implementation and Provider Engagement Amongst Adults Affected by Spinal Muscular Atrophy (SMA) – Lauren Elizabeth Eisenman, Mary Curry, Lisa Belter, Jill Jarecki, Mary K. Schroth

P2.8-012

Comparing Spinal Muscular Atrophy (SMA) outcomes between a patient-reported membership database and a clinical data registry – Lisa Belter, Sarah Michelle Whitmire, Mary Curry, Mary K. Schroth

P2.8-013

The Use of Onasemnogene-abeparvovec at 33 weeks’ gestation in Spinal Muscular Atrophy with One Copy of SMN2 – Katherine D. Mathews, Divya Ramachandra

P2.8-014

Cervical Spinal Cord Gray Matter Atrophy as an Emerging Imaging Marker in Spinal Muscular Atrophy – Eva Maria Kesenheimer, Maria Janina Wendebourg, Claudia Weidensteiner, Laura Sander, Matthias Weigel, Tanja Haas, Dirk Fischer, Christoph Neuwirth, Nathalie Braun, Markus Weber, Cristina Granziera, Michael Sinnreich, Oliver Bieri, Regina Schlaeger

P2.8-015

Single Center Experience of Nusinersen and Risdiplam in Adult SMA patients – Akhil Shivaprasad, Sara Eunice Benitez, Niloofar Yari, Ashley E. Anderson, Sheetal Shroff

9

Neuro-ophthalmology/Neurootology

Neuro-ophthalmology/Neuro-otology: Clinical Research of the Afferent Visual System

P2.9-001

Seizures as the initial manifestation of Idiopathic Intracranial Hypertension – Walid Bouthour, Nisreen Nasser Al-Balushi, Michael Dattilo, Nancy J. Newman, Valerie Biousse

P2.9-002

No Association Between Non-arteritic Anterior Ischemic Optic Neuropathy and COVID-19 Vaccination – Nicholas John Bellacicco, Mustafa Jaffry, John Benalcazar, Kranthi Kiran Mandava, GM Fahad Bin Mostafa, Hafiz Khan, Nizar Souayah

P2.9-003

Association Between Hospital-Ascertained Atrial Fibrillation And Central Retinal Artery Occlusion: A Study Of 12 Million Patients – Jay B. Lusk, Ailin Song, Shakthi Unnithan, Hussein Al-Khalidi, Jonathan Piccini, Ying Xian, Emily O’Brien, Brian Mac Grory

P2.9-004

Optic nerve T2-hyperintensity: a nonspecific marker of optic nerve damage – Fernando Labella Alvarez, Rasha Mosleh, Walid Bouthour, Amit Saindane, Michael Dattilo, Nancy J. Newman, Valerie Biousse

P2.9-005

MICK (Mobile Integrated Cognitive Kit) App: Feasibility of an Accessible Tablet-Based Rapid Picture and Number Naming Task for Concussion Assessment in a Youth Ice Hockey League – Sara Wesley Hyman, Mason M. Blacker, Carter Alden Bell, Marc Balcer, Binu Joseph, Steven Galetta, Laura J. Balcer, Scott Grossman

P2.9-006

Multi-registry Analysis of Patients with Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) to Improve Capture of Demographic Data and Compare Visual Outcomes – Heather Moss, Lauren Wiener, Caitlin Rizy, Shrujal Baxi, Manan Kocher, Aracelis Torres, Michael Mbagwu

P2.9-007

Retina and optic nerve diffusion restriction in acute central retinal artery occlusion – Daniel Gomez Ramos, Ehab Yaser Khaled Harahsheh, Nan Zhang, Parth Pranav Parikh, Omer Elshaigi, Tanya Rath, Joseph Michael Hoxworth, Oana Maria Dumitrascu

P2.9-008

Corneal Confocal Microscopy Demonstrates No Evidence of Small Nerve Fiber Pathology in Obese Children and Adolescents – Farah Wahbeh, Hoda Gad, Einas Elgassim, Ioannis Petropoulos, Georgios Ponirakis, Khalid Hussain, Rayaz Ahmed Malik

P2.9-009

Select Patients with High-Risk IIH May Be Managed with Medical Therapy Alone – Jeffrey Gluckstein, Joseph F. Rizzo, Amalie Chen

P2.9-010

The Unmet Challenge of Diagnosing and Treating Photophobia in Children – Sarah Shapiro, Kenzie Isaacson Keeney, Eric Caskey, Jantz Jay Arbon, Meagan Dawn Seay, Judith E A Warner, Kathleen B. Digre, Bradley J. Katz

P2.9-011

Smell the Rainbow: Olfactory Intensity Changes Color, not Luminescence in a Synesthete – Sunjeet Brar, Alan R. Hirsch

P2.9-012

Clues on Optical Coherence Tomography Leading to Diagnosis of Primary CNS Lymphoma – Negar Moheb, Timothy W. Olsen, W. Oliver Tobin, John J. Chen

Infectious Disease

Infectious Disease: Bacterial Infections 2

P2.10-001

Acute Cerebellar Stroke of Unclear Etiology Complicated by Lemierre’s Disease and Papillary Thyroid Carcinoma – Stacey Nu Ngoc Ho, Nina Maithi Long, Kassi Kronfeld

P2.10-002

Neurological manifestations of scrub typhus: Encephalitis and Acute Inflammatory Demyelinating Polyneuropathy (AIDP) – Tina Sood, Tanish Modi, Navneet Arora, Sandeep Moudgil

P2.10-003

From (Cat) Scratch: A Unique Presentation of CNS Bartonella Infection – Wilson Eduardo Rodriguez, Margarita Fedorova, Lokesh A. Rukmangadachar

P2.10-004

Sensorineural Hearing Loss From Capnocytophaga canimorsus Meningitis in an Immunocompetent Patient – Manny Villar, Cleo Zarina Alejo Reyes, Ajay Menon, Erafat Rehim, Gary W. Clauser

P2.10-005

First Case Report of Bacteroides Thetaiotaomicron Cerebral Abscess after Cholesteatoma Resection

– Stephanie McGovern, Carlos Garcia Rodriguez, Firas Kaddouh

P2.10-006

Postpartum Listeria Meningitis: A Case Report

– Rui Tang, Naila Kausar, Janice Michelle Rivera, Salvador Cruz-Flores, Sushma Reddy Yerram

P2.10-007

A Case of Oral Flora Related Carotid Vasculitis –Cory P. Hackmyer, Nora Ko, Brian James Hanrahan

11 Movement Disorders

Movement Disorders: Clinical Trials in Parkinson’s Disease 2

P2.11-001

P2B001 significantly reduced risk of daytime sleepiness: results from a randomized controlled phase 3 trial with active pramipexole arm in early Parkinson’s disease (PD) – David Kreitzman, Pninit Litman, Hadas Friedman, Sheila Oren, Cheryl Fitzer-Attas

P2.11-002

Clinical trial protocol: TRANSCEND 1 – an observational study of patients with moderate Parkinson’s disease – Paul-Visse Gesine, Hakan Widner, Regine Bergholdt, Helle Frimer-Larsen, Ida Stenfeldt Mathiasen, Anne Moeller Nielsen, Roger Barker

P2.11-003

A Phase 2, Randomized, Double-Blind, ParallelGroup, Placebo-Controlled Study Evaluating Efficacy, Safety and Tolerability of PRAX-944 in Adults with Parkinson’s Disease and Motor Fluctuations – Monique Giroux, Marcio Souza, Alex La Croix, Mark Versavel, Henry Jacotin

P2.11-004

Relative bioavailability of levodopa administered as a subcutaneous infusion with ND0612 versus oral immediate-release levodopa/carbidopa tablets – Liat Adar, Natalia Vostokova

P2.11-005

The Phase 2, Randomized, Placebo-controlled PRECEDENT Trial of SAGE-718 in Patients With Parkinson’s Disease Cognitive Impairment: Clinical Trial in Progress – Amy E. Bullock, Aaron Koenig, Katrina Paumier, Emily Freitag, Jeffrey Wald, Sola Park, Michael Quirk, Jennifer Petrillo Billet, James Doherty

P2.11-006

Characterizing a Parkinson’s Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa – Per Odin, Rajesh Pahwa, Jill M. Farmer, Thomas Edmund Kimber, Bruno Bergmans, Eric Freire Alvarez, K Ray Chaudhuri, Resmi Gupta, Connie H. Yan, Lars Bergmann, Pavnit Kukreja, Angelo Antonini

P2.11-007

Phase Ib Study Design Evaluating The Safety, Pharmacokinetics And Pharmacodynamics Of Selnoflast, A Novel NLRP3 Inflammasome Inhibitor In Early-Stage PD – Giulia D’Urso, Alessandra Thomann, Judith Anzures-Cabrera, Bastian Zinnhardt, Benedicte Ricci, Lorna Bailey, Krzysztof Smigorski, Venissa Machado, Eva Zszuzsanna Mracsko, Nicola Pavese, Kenneth L. Marek, Kathrin Brockmann, Tanya Simuni, Nicoletta Milani Muelhardt, Gennaro Pagano

P2.11-008

Optimizing Augmented Reality Cueing Strategies for Freezing of Gait in Parkinson Disease: Interim Results of the ELIMINATE FoG Study – Brendan Baugher, Ryan Kaya, Kathryn Scelina, Debolina Ghosh, Alexa Margaret Amato, Ken Baker, Hubert H. Fernandez, Jay L Alberts, Nathaniel Szewczyk, James Liao

P2.11-009

BCR-ABL Tyrosine Kinase Inhibitors in Parkinson’s Disease and Lewy Body Dementia: A Systematic Review – Giovanni Gosch Berton, Amanda Cyntia Lima Fonseca Rodrigues, Rafael Dos Santos Borges, Nicole Rodrigues Cardoso, Marcos Vinicius Oliveira Marques, Thiago Abrahao Oliveira

11 Movement Disorders

Movement Disorders: Huntington’s Disease and Chorea 2

P2.11-010

Real-World Effectiveness and Safety of Deutetrabenazine in Combination with Antipsychotic Drugs in Patients With Chorea

Associated With Huntington Disease – Daniel O. Claassen, Hela Romdhani, Rajeev Ayyagari, Debbie Goldschmidt, Sarah Z. Moroz, Adreanna Hernandez, Nayla Chaijale, Sam Leo

P2.11-011

Baseline Characteristics and Treatment Patterns of a Global Huntington Disease Population Stratified by Chorea Severity – Victor W. Sung, Erin FurrStimming, Shoshana Reshef, Rosa Willock, Rinat Ribalov, Sarah Brighton, Sam Leo

P2.11-012

Valbenazine Decreases Disease Burden in Patients with Chorea Associated with Huntington Disease: Patient-Reported Huntington Disease Health Index (HD-HI) Results From the KINECT-HD Trial

– Chad R. Heatwole, Erin Furr-Stimming, Daniel O. Claassen, Elise Paulin Kayson, Jody Goldstein, Olga Klepitskaya, Grace Lin Liang, Dietrich Haubenberger

P2.11-013

Therapeutic Challenges of Huntington’s Disease in Guinea: Study of HD Confirmed Cases in a Country with Limited Resources – Guelngar Carlos Othon, Mendi Muthinja, Mie Rizig, Fode Abass Cisse, Cisse Amara

P2.11-014

Chorea Associated with Lamotrigine Use: A case report, retrospective chart review, and literature summary – Sofia Hanson, Negin Badihian, Kelsey Marie Smith, Elizabeth A. Coon

P2.11-015

A Bioequivalence Comparison at Steady State between the Newly Developed Once-Daily Extended Release Tablet Formulation and the Approved Twice-Daily Tablet Formulation of Deutetrabenazine – Maria Sunzel, Laura Rabinovich-Guilatt, Malini Iyengar, Debra Ruffo, Maria Josefa Gutierrez, Mark Forrest Gordon, Giulia Ghibellini

P2.11-016

Assessment of Dose Proportionality of Three Dose Strengths (6 mg, 12 mg and 24 mg) over the Clinical Dose Range (6-48 mg) of the Newly Developed Once-Daily Extended Release Tablet Formulation of Deutetrabenazine – Maria Sunzel, Giulia Ghibellini, Malini Iyengar, Maria Josefa Gutierrez, Debra Ruffo, Mark Forrest Gordon, Laura Rabinovich-Guilatt

12 Aging, Dementia, Cognitive, and Behavioral Neurology

Behavioral and Cognitive Neurology: Genetics and Clinical Translational Studies in Cognition 2

P2.12-001

Association of a ≥2 point decrease of MoCA 1 year after noncardiac surgery with patientimportant outcomes: a secondary analysis of the NeuroVISION cohort study – Maura Marcucci, Parthasarathy Thirumala, Marko Mrkobrada, PJ Devereaux

P2.12-002

Transcutaneous Cervical Vagus Nerve Stimulation Enhances Second-Language Vocabulary Acquisition While Simultaneously Mitigating Fatigue and Promoting Focus – Toshiya Miyatsu, Vanessa Oviedo, Jajaira Lira Reynaga, Valerie Karuzis, David Martinez, Melissa Key, Lindsey McIntire, William Aue, Peter Pirolli, Polly O’Rourke, Andy McKinley, Timothy Broderick

P2.12-003

Selective NKCC1 Inhibitors for the Treatment of Neurodevelopmental and Neurological Disorders with Defective NKCC1/KCC2 expression-ratio –Annalisa Savardi, Marco Borgogno, Marco De Vivo, Laura Cancedda

P2.12-004

Higher Initial Platelet Procoagulant Potential is Associated with Lower Cognitive Scores at 14 Months after COVID-19 – Claire Emmanuelle Delpirou Nouh, Calin I. Prodan, Chao Xu, Andrea Vincent, Eleanor Mathews, Leslie Guthery, Jason Sharps, Jim Scott, George Dale, Angelia Kirkpatrick

P2.12-005

A Novel Mutation in PDGFRB in a Patient with Primary Familial Brain Calcification: Case Report –Jamal Al Ali, Jessica Yang, Matthew Phillips, Joseph Fink, James A. Mastrianni, Kaitlin Seibert

P2.12-006

Proximity to Green and Blue Spaces and Serious Psychological Distress in Urban-Dwelling Older Adults: Analysis of Washington State BRFSS data –Adithya Vegaraju, Solmaz Amiri

12

Aging, Dementia, Cognitive, and Behavioral Neurology

Behavioral and Cognitive Neurology: Cognitive Sequelae of COVID-19 and Neuropsychiatry 2

P2.12-007

Description of cognitive and imaging function in a cohort of COVID-19 survivors in a tertiary hospital in Mexico City – Raul Anwar Garcia Santos, Monica Saray Rodriguez Rodríguez, Antonio Arauz, Alonso Gutierrez Romero, Francisco Javier Soto Moreno, Diana Sarai Lopez Gonzalez, Yaneth Rodriguez, Francisco Paz Rodriguez, Mireya Chávez Oliveros, Susana Lozano Tovar Susana, Manuel Alejandro Del Rio Quiñones, Karina González Alonso, Roger Carrillo-Mezo, Oscar Marrufo Meléndez

P2.12-008

Neuropsychiatric Presentations in Late-onset Inborn Errors of the Metabolism: A Systematic Review of the Literature – Mattia Rosso, Federico J. Rodriguez-Porcel

P2.12-009

Functional Pseudo-Stroke Presentations in the Emergency Department at a Comprehensive Stroke Center; a 6-year Retrospective Chart

Review – Mohammad Ali Shahab, Winston Whiting Oliver, Rashid Ali Ahmed, Mohammed Alwahaidy, Hesham Masoud

13

Neuro-oncology

Neuro-oncology: Lymphoma in the CNS

P2.13-001

Peripheral T-Cell Lymphoma Manifesting as Multifocal Central Nervous System Disease with Prominent Spinal Cord Involvement – Eesha Singh, Richard Carozza, Karl E. Misulis, Shailee Samir Shah

P2.13-002

Treatment of Central Nervous System PostTransplant Lymphoproliferative Disorder in Immunocompromised Patients with Pancreas Transplant– Between the Rock and a Hard Place

– Maira Iqbal Haque, Giuseppe Orlando, Glenn Lesser, Roy E. Strowd

P2.13-003

Cranial Neurolymphomatosis: An Analysis of Seven Cases – Abigail Suprova Bose, Bahadar Singh Srichawla

13 Sleep

Sleep and Neurology 2

P2.13-004

Prevalence of Insomnia and Associated Factors Among Medical Students Who Recovered From Acute COVID-19 Infection – Presley Martin Gruezo, Arianna Chango, Mónica Jaramillo Castro, Israel Fernando Rosero Basurto, Linker Elias Viñan Paucar, Efrain Ignacio Paredes, José Andrés Andres Jara Escobar, Luis Bejar, Joyce Antonella Jimenez Zambrano

P2.13-005

A longitudinal study identifies progressive alterations in brain white matter microstructure and networks in male adults with obstructive sleep apnea and their recovery after sleep surgery

– Hea Ree Park, Yaqiong Chai, Eun-Yeon Joo, Hosung Kim

P2.13-006

Characteristics and Disease Burden of Patients With Idiopathic Hypersomnia With and Without Long Sleep Time: The Real-World Idiopathic Hypersomnia Outcomes Study (ARISE) – Logan D. Schneider, Joanne Stevens, Aatif M. Husain, Diane Ito, Douglas S. Fuller, Wayne Macfadden

1

Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): Epilepsy Syndromes

P3.1-001

Seizures in Dementia are Associated with Worse Clinical Outcomes, Higher Mortality and Shorter

Lifespans – Ifrah Zawar, Mark S. Quigg, Carol A. Manning, Jaideep Kapur

P3.1-002

Clinical characteristics associated with the development of preoperative and postoperative seizures in patients with glioblastoma – Sofía

Stefanie Sánchez Boluarte, Diogo Garcia, Charlene

Leona Gunasekera, William O. Tatum, Joseph I. Sirven, Brin Freund, Anthony L. Ritaccio, Kaisorn Chaichana, Alfredo Quinones-Hinojosa, Anteneh

Mekonnen Feyissa

P3.1-003

Copy Number Variant Associated with Familial Epilepsy with Wide Phenotypic Spectrum: A Case Series – Shashwat Pokharel, Thomas Sequeira Przybycien, Karen Krajewski, Xue Yang, Deepti Zutshi, Maysaa Merhi Basha

P3.1-004

Post-stroke Epilepsy and its Association with Stroke Location - Meta-analysis – Sihyeong Park, Yasar Taylan Esengul, Ajaz Sheikh, Khaled Gharaibeh

P3.1-005

S for Seizure? A Case of SMART syndrome – Cleo Zarina Alejo Reyes, Erafat Rehim, Tsneem Mbydeen, Gary W. Clauser, Steven L. Lewis

P3.1-006

Tuberous Sclerosis Complex in Adulthood: A Descriptive Cohort Retrospective Review

– Jacqueline Elizabeth Summers Stromberg, Scheherazade Le

P3.1-007

Raising Clinical Suspicion for Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS): Recurrent Seizures, Stroke-like Episodes, and Cortical Atrophy in Young Patients

– Srikar Tallavajhala, Krzysztof M. Bochenek, Aanini Dwivedi, Alexa Caitlen Caffio-Learner, Suha Suliman, Sairah Bashir, Mohankumar Kurukumbi

P3.1-008

Mowat-Wilson Syndrome; 3 Cases with Characteristic EEG Findings – Mohammad Ali Shahab, Arayamparambil Anilkumar

P3.1-009

Novel ictal manifestations in Leucine rich Glioma Inactivated 1 Encephalitis - Transient, Alternating Hemi-body Paresthesias – Susmit Tripathi, Tahsin Tazwar Khan, Seyhmus Aydemir, Pegah Afra

P3.1-010

A novel CACNA1A variant causing Developmental and Epileptic Encephalopathy 42: Report of the first case in Colombia – Maria Daniela Orellana Zambrano, Estephania Candelo, Lorena Diaz, Rafael Adrian Pacheco, Sebastian Giraldo-Ocampo, Eidith Gomez-Pineda, Harry Pachajoa

P3.1-011

Characteristics of Patients With Lennox-Gastaut Syndrome and Predictors for a Longer Stay Following Hospitalization – Shaheen Sombans, Sailaja Sanikommu, Kamleshun Ramphul, Renuka Verma, Yogeshwaree Ramphul, Nomesh Kumar, Indu Meena, Komal Kumari, Stephanie Gonzalez Mejias, Petras Jairam Das Lohana, Fnu Arti

P3.1-012

Clinical and Electrographic Features in BetaLactam Antibiotic Induced Neurotoxicity – Gloria Isabel Ortiz Guerrero, Vishal Shah, Utku Uysal 2

Education, Research, and Methodology

Education, Research, and Methodology: Medical Student Education 1

P3.2-001

Use of a Standardized Communication Card Facilitated Patient-as-Teacher Training on Communication Skills and Improved Patient Care in the Neurology Clerkship – Carmen Priego, Punthitra Arpornsuksant, Rajaa Alhamd, Monica E. Lemmon, Roy E. Strowd, Charlene Gamaldo, Doris G. Leung, Rachel Marie E. Salas

P3.2-002

A Night at the Neurocinema: Evaluating the Educational Impact of a Neurology-Centric Film Series on a Medical Student Cohort – Phil Joseph Schmitt, Anne Bryden, Saurav Das, Arpita Lakhotia

P3.2-003

The Neurology Rotation: Evaluation of the Medical Student Experience – Jenifer Nicole Moceri, Azima Shaji, Adriana Carola Mendez, Naaima Mufti, Catherine Rachel Craven, Rebecca Mayeda, Brian James Hanrahan

P3.2-004

Midclerkship Feedback Quality Improvement via Introduction of Simple Form – Robert Fekete

2 Education, Research, and Methodology

Education, Research, and Methodology: Resident Education 3

P3.2-005

Development and implementation of a telephone triage curriculum for neurology residents – Midori Eckenstein, Jana Wold

P3.2-006

Impacting the Culture of Neurologic Care: Piloting a Structural Competency Training into Neurology Core Competencies – Kendra M. Anderson, Sonia Kaur Singh, Thy Nguyen

3 MS and Inflammatory Disease

MS Technology, Digital Tools, and Artificial Intelligence

P3.3-001

Identifying Multiple Sclerosis Relapses from Clinical Notes Using Combined Rule-based and Deep Learning Methodologies – Iris Chin, Heather Moss, Kathryn Anne Sands, Manan Kocher, Oguz Akkas, Aracelis Torres

P3.3-002

Quality of online materials in MS – Quessi Albacha, Mahmoud Elkhooly, Evanthia Bernitsas

P3.3-003

ILLUMINATE: Design of a Real-World, NonInterventional Study Evaluating the Usability and Value of Integrated Digital Solutions for Routine Care of Patients with Multiple Sclerosis – Tjalf Ziemssen, Vera Zingler, Petra Dirks, Boris Addow, Jelle Praet, Annemie Ribbens, Dirk Smeets, Stephen Krieger

P3.3-004

Subtypes of Relapsing-Remitting Multiple Sclerosis Identified by Network Analysis – Quentin HowlettPrieto, Chelsea Oommen, Michael D. Carrithers, Daniel B. Hier

P3.3-005

Telehealth Utilization in a Comprehensive Multiple Sclerosis Clinic During the COVID-19 Pandemic: Single Center Experience – Trieste Francis, Sama Noroozi Gilandehi, Sarah Shapiro, Yiran Sun, Melissa Ann Wright, Sarah Germaine, Jonathan Ross Galli, Robert Kadish, Julia Klein, L Dana DeWitt, Tammy L. Smith, M. Mateo Paz Soldan, Stacey Clardy, Ka-Ho Wong, John W. Rose

P3.3-006

In a Digital Version of the 9-Hole Peg Test, IntraTask Speed, Accounting for Variance in Distance Traveled, May be a Better Measure of MS-Related Upper-Limb Disability Than Completion Time

– Xiaotong Jiang, Marisa P. McGinley, Joshua Johnston, Jay L Alberts, Robert A. Bermel, Daniel Ontaneda, Nicholas Levitt, Johan Van Beek, Nolan Campbell

P3.3-007

Financial Burden of Multiple Sclerosis Hospitalizations; A National Study during 20092019 in the United States – Sepideh Yadollahi, Radbod J. Movassagh, Ali Seifi

P3.3-008

Working your CoRe : Further Development of a Mobile Cognitive Assessment Application – Rod Middleton, Moesha Lamptey, Jeff Rodgers, Elaine Craig, Katherine Tuite-Dalton, Richard St. John Nicholas

P3.3-009

Wearing-Off Effect Toward the End of Treatment Cycles in Patients With MS Receiving High-Efficacy Disease-Modifying Therapies: Data From Social Media Listening – Ivan John Clement, Joanne Fielding, Marie Serceau, Janine Robinson, Chinmay Deshpande

P3.3-010

Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) – Francesco Sacca, Teresa Costabile, Elisabetta Signoriello, Lauro Francesca, Manuela Altieri, Antonio Rosario Ziello, Alessandro d’Ambrosio, Alvino Bisecco, Giorgia Teresa Maniscalco, Simona Bonavita, Antonio Gallo, Vincenzo Brescia Morra, Giacomo Lus, Cinzia Valeria Russo

P3.3-011

Diurnal Step Count Patterns in Progressive Multiple Sclerosis – Dev Navani, Valerie A J Block, Bruce A. C. Cree, Reza Abbasi-Asl

P3.3-012

Using Natural Language Processing to identify patients with Multiple Sclerosis – Dhruv Jimulia, Chiraag Lala, Richard St. John Nicholas, Rod Middleton

P3.3-013

Exploring the Utility of ActiGraph in Measuring Gait Impairment and Physical Activity in Patients with MS Using Digital Biomarkers – Elias Abou Zeid, Xiaoyu Jiang, Atuyota Larry Orogun, Hillol Sarker, Sana Syed

P3.3-014

Motor threshold to predict responsiveness to neurorehabilitation combined with repetitive transcranial magnetic stimulation in people with multiple sclerosis: real-world evidence – Letizia M. Leocani, Michelangelo Dini, Mariaemma Rodegher, Luca Chiveri, Carmen Dumitru, Ranieri Marika, Angela Boschetti, Gloria Dalla Costa, Paolo Della Vecchia, Giulia Gamberini, Giancarlo Comi

P3.3-015

Data-driven deep phenotyping of multiple sclerosis patients using patient-reported outcome measures – Farren Briggs, Doug Gunzler, Daniel Ontaneda, Deborah M. Miller, Ryan Zamora, Alessandro De Nadai

P3.3-016

Educational Research: Multiple Sclerosis (MS) and Neuroimmunology Education in Neurology Residency Training in the United States – Ian Limuel Dimaandal, Juan Pablo Cabrera Pulla, Sarah Germaine, Jaime Imitola

P3.3-017

Disease Modifying Therapy in Newly Diagnosed People with Multiple Sclerosis – A Real-World Administrative Claims Study – Kesshi Marin Jordan, Heather Hua, Ati Ghoreyshi, Michael L. Edgeworth

P3.3-018

AI-based characterization of multiple sclerosis clinical symptomatology using lesion parenchymal fraction: empirical support for the topographical model of MS – Stephen Krieger, Thibo Billiet, Celine Maes, Nuno Pedrosa De Barros, Wim Van Hecke, Annemie Ribbens, Chenyu Wang, Kain Kyle, Linda Ly, Justin Yehuda Garber, Michael Barnett

4 General Neurology

General Neurology: Case Reports 1

P3.4-001

An unusual case of a Puerto Rican patient with involuntary pelvic movements, behavioral changes and mutism associated to VSP13A gene – Yesenia Enriquez-Gonzalez, Carmen Serrano

P3.4-002

Parkinsonism in a Zambian Man with an unusual occupational exposure – Dickson Munkombwe, Melody Tunsubilege Asukile, Peter J. Schwab, Deanna Saylor

P3.4-003

Subarachnoid Fat Globules Following Spinal Surgery: A Case Report – Kehan Zhao, Eric Nicholas Beck, Ferhat Erol, Sedat Gul, Robert Beach

P3.4-004

Rare Cortical and Intraparenchymal Epidermoid Cyst within the Right Occipital Lobe – Lauren Michelle Webb, Terry C. Burns, Pingchuan Zhang, Ugur Sener

4

General Neurology

Neuroscience Research Prize Recipients

P3.4-005

Investigating the use of focused ultrasound to induce blood-brain barrier opening and increase drug delivery into a murine model of primary high grade glioma tumors – Samantha Schaevitz

P3.4-006

Modulation of Memory Processes in Alzheimer’s Cell Models by Recently Discovered Mu-Opioids: Endomorphin-1 and Endomorphin-2 – Maxx Yung

P3.4-007

ParkinSense: Contactless Parkinson’s Disease diagnosis, telemonitoring, and severity analysis via Machine Learning and Multimodal Digital Biomarkers – Pulkith Paruchuri

5

Cerebrovascular Disease and Interventional Neurology

Cerebrovascular Disease and Interventional Neurology: Basic and Translational Research

P3.5-001

Widespread Aneurysms Secondary to Myosin Light-Chain Kinase Gene Mutation Leading to Multifocal Right Hemispheric Stroke – Haroutiun Hamzoian, Michel Abdelmasih, Mekdes Ditamo, Roua Kahila

P3.5-002

All Trans Retinoic Acid: A Cerebral Friend or Foe? – Ryan Pinosky, Ezekiel Gonzalez-Fernandez, Chandra Sekhar Mannyam, Maryam Zulfiqar, Oriana Sanchez, Shreyas Gangadhara

P3.5-003

Inflammatory Markers in Patients with Acute Ischemic Stroke – Mudassir Farooqui, Sayid Suriya, Asad Ikram, Dania Qaryouti, Syed A. Quadri, Surojit Paul, Atif Zafar

P3.5-004

Post-stroke Depression is Alleviated by Apelin-13 via Regulating BDNF Mediated Phosphorylation of Forkhead box O 3A Protein in Rat Model of Ischemic Stroke – Aishika Datta, Deepaneeta Sarmah, Shubhrakanta Sahu, Bijoyani Ghosh, Nikita Sanjay Rana, Pallab Bhattacharya

P3.5-005

Treatment with rhFGF18 Analog Results in Cerebroprotection and Recovery of Motor and Memory Function in a Rat Model of Acute Ischemic Stroke – Alexei Goraltchouk, Francesco Luppino, Alexey Seregin

P3.5-006

Glucosamine and Tau protein phosphorylation in a brain permanent-ischemia animal model: a paradoxical effect? – Valentina Quintana, Carlos Fernando Cardozo, Cesar Augusto Arango, Juliana Rengifo

P3.5-007

High Immature Platelet Fraction is Associated with Early Neurological Deterioration in Acute Ischemic Stroke – Bang-Hoon Cho, Sung-Wook Yu

P3.5-008

Altered angiogenic and neuroinflammatory markers in peripartum individuals with and without severe preeclampsia compared to non-pregnant adults – Noora Camile Haghighi, Mary Claire Tuohy, Natalie Bello, Whitney Alexandra Booker, Andrea Miltiades, Ronald Wapner, Randolph S. Marshall, Eliza Cushman Miller

P3.5-009

Association of gamma-glutamyl transferase variability with risk of venous thrombosis: A nationwide cohort study – Sumin Kim, Hyunji Kim, Tae-Jin Song, Kee Duk Park, Yoonkyung Chang

P3.5-010

Maximum Euclidean Deflection: A Novel Metric For Safety Of Neurovascular Devices In An In-vitro Stroke Model – Shashvat Desai, Joshua Catapano, Neil Majmundar, Angelina N. Cooper, Roxanne Flynn, Loren Jones, Andrew Ducruet, Ashutosh P. Jadhav

P3.5-011

Inosine administration following ischemic stroke regulates inflammasome mediated microglial polarization – Pallab Bhattacharya, Deepaneeta Sarmah, Aishika Datta

P3.5-012

Lower Omega-3 Levels Were Found In Post Stroke Post Traumatic Stress Disorder – Swetha Renati, Marla Hairston, Weiliang Cen, Henian Chen, Andrea Bozeman, William Scott Burgin

P3.5-013

Aldosterone Level Predicts Hypertension After ICH in the REDUCE Trial – Julia Zabinska, Teng Jiao Peng, Rachel Forman, Anna Schwartz, Audrey Leasure, Maia Schlechter, Guido Jose Falcone, Adam De Havenon, Lauren Hachmann Sansing, Dheeraj Devkrishin Lalwani, Nethra Parasuram, Vineetha Yadlapalli, Cheryl Bushnell, Michael T. Mullen, Jordana Cohen, Debbie Cohen, Steven R. Messe, Kevin N. Sheth

P3.5-014

Synergistic effect of MTHFR polymorphisms in arterial ischemic stroke in young adult – Lamia M’barek, Khadija Sonda Moalla, Nadia Bouattour, Sawsan Daoud, Nouha Farhat, Mariem Damak, Salma Sakka, Chokri Abdellaziz Mhiri

P3.5-015

Diabetes-Related Polygenic Risk Is Associated with Poor Glycemic Control and Higher Risk of Acute Cardiovascular Events in Stroke Survivors –Zachariah Demarais, Carolyn Conlon, Shufan Huo, Cyprien Rivier, Daniela Brenda Renedo, Kevin N. Sheth, Guido Jose Falcone

P3.5-016

Impaired Kidney Function Small Vessel Disease Markers and Its Association with Periventricular White Matter Hyperintensities – Ricardo Murguia Fuentes, Farid Khasiyev, Kursat Gurel, Antonio Spagnolo-Allende, Salwa Rahman, Pedro Gabriel Bueno, Jose Murguia Fuentes, Randolph S. Marshall, Mitchell S. V. Elkind, Jose Gutierrez

P3.5-017

Biomarkers as prognostic determinants of epilepsy after post-acute central nervous system insults: a systematic review and meta-analysis – Shubham Misra, Erum Khan, TuKiet Lam, Rajarshi Mazumder, Ece Eldem, Kapil Gururangan, Leonard Brian Hickman, Vaibhav Goswami, Melissa Funaro, Joan Montaner, Terry Quinn, David S. Liebeskind, Nishant Kumar Mishra

5Cerebrovascular Disease and Interventional Neurology

Cerebrovascular Disease and Interventional Neurology: Interesting Cases 2

P3.5-018

Thyroid hormone decreasing after mechanical thrombectomy for cerebral infarction – Yuya

Kobayashi

P3.5-019

Nitinol in Medical Devices: Not so Innocuous –Rana K. Zabad, Krystian Solis, Courtney Venegas, Erin Dennis, Ezequiel A. Piccione, Brian Westerhuis, Lakshman Narain Arcot Arcot Jayagopal

P3.5-020

Persistent Trigeminal Artery causing anterior and posterior circulation ischemic stroke – Saketh Annam, Nitin Ramanujam Chakravarthula, Christopher Streib, Allison Michelle Ho

P3.5-021

CT Perfusion Imaging Guides Clinical Decision Making in a Case of Thalamic Stroke – Kasim Qureshi, Alisha Qaiser, Daniela Lozano, Muhammad Farooq

P3.5-022

Linear Scleroderma en Coup de Sabre Presenting with Stroke and Seizure – Tatiana Greige, Steven K. Feske

P3.5-023

Transient Perivascular Inflammation of the Carotid Artery (TIPIC): A rare cause of Horner’s Syndrome

– Elizabeth Celente, Mary Coughlin, Cole Phillips Denkensohn

P3.5-024

A rare case of Carotid Dissection seen in Vascular Eagle Syndrome – Collette Kokikian, Ann Nguyen Ly, Lama M. Al-Khoury

P3.5-025

Stroke syndrome Z: Bilateral Symmetrical Corona Radiata strokes causing facial diplegia, anarthria, and quadriparesis mimicking an acute neuromuscular syndrome – Azka Shaikh, Aya A. Ouf, Russell James Van Coevering, Amit Kandel

P3.5-026

Cardiac Calcified Amorphous Tumor: An Unusual Etiology for Recurrent Cardioembolic Strokes

– Rishi Sharma, Saketh Annam, Mehmet Guler, Haitham Hussein

P3.5-027

Sudden Bilateral Sensorineural Hearing Loss due to Basilar Artery Occlusion – Marina Buciuc, Paulo Gonzalez, Hamid Ali, Cassie Lee Nankee, Christine Holmstedt

P3.5-028

Periprocedural Cerebral Air Embolism; A Rare and Potentially Fatal Complication of Watchman Device

– Krithika Umesh Peshwe, Badria Munir, Mandy Hatfield, Amelia Karen Adcock

P3.5-029

Uncommon Presentation of an Uncommon Disease: Stroke-like Migraine Attacks after Radiation Therapy in a Patient with Sudden Onset Expressive Aphasia and Cryptogenic Fevers

– Sukhraj Gill, Sandeep Gill, J. David Avila, Gino Mongelluzzo

P3.5-030

A Unique Case of Vestibular Symptoms in Parietal Stroke – Rawan Albadareen, Corbin Stephens

P3.5-031

Unique Patterns of Ischemic Stroke from Combined Cocaine and Heroin Use: A Case Series

– Zachariah Hasan, Pranusha Pinna, John K. Lynch, Yongwoo Kim

P3.5-032

Bow Hunter Syndrome Involving Rare PICA Variant

– Alexis Nicole Trujillo, RayLee Otero-Bell, Tarun Girotra

6 Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Clinicopathological Correlations

P3.6-001

The Mechanism of Disease of Alzheimer’s and Parkinson Disease – Piet C De Groen

P3.6-002

Digital Histological Measurements Show a Range of Values Within Traditional Pathological Metrics of AD-related Tau Pathology – David Gerhard Coughlin, Yongya Kim, Sanaz Arezoumandan, Claire Shan Peterson, Anne Elizabeth Hiniker, Larry Hansen, Robert A. Rissman, Donald Pizzo, Edward Lee, David Irwin

P3.6-003

Development of a MATLAB-based Toolkit to Quantify Neurodegenerative Histopathology

Markers Applied to the Evaluation of a CRISPRbased Therapeutic for Alzheimer’s Disease – Nihal Satyadev, Brent Aulston, Kristen Mary Branes, Nidhi Checka, Subhojit Roy

P3.6-004

Association of Younger Age and APOE e4 Carrier Status with Cerebral Amyloid Angiopathy in Pure and Mixed Alzheimers Disease Neuropathology –Jagan Pillai, James Bena, James B. Leverenz

P3.6-005

Seizure Rates Across Pathologically-Confirmed Dementia Subtypes – Lauren R. Moo, Steven D. Shirk, Lauren Baumann, Sara Sullivan

P3.6-006

Comparison of Structural MRI Profiles Between Autopsy-Confirmed Chronic Traumatic Encephalopathy and Alzheimer’s Disease – Sydney

Mosaheb, Asim Zia Mian, Chad W. Farris, Karen Buch, Breton Asken, Gil Dan Rabinovici, Madeline Uretsky, Yorghos Tripodis, Brett Martin, Joseph N. Palmisano, Neil W. Kowall, Bertrand Huber, Robert Stern, Ronald J. Killiany, Thor D. Stein, Ann C. McKee, Jesse B. Mez, Michael Alosco

P3.6-007

Histopathological Analysis of Cerebral Microvasculature Pathology with Alzheimer’s Disease Neuropathological Changes: An Autopsy Study – Yuan Cao, Mei-Ying Huang, Chenhui Mao, Xue Wang, Yuan-Yuan Xu, Xiao-Jing Qian, Chao Ma, Wen-Ying Qiu, Yi-Cheng Zhu

P3.6-008

Histopathologic Brain Age Estimation via Deep Multiple Instance Learning – Gabriel A. Marx, Andrew McKenzie, Justin Kauffman, Daniel Gordon Koenigsberg, Kurt Farrell, John Crary

P3.6-009

Prevalence of Autoantibody Positivity and Associated Neuropathologies in the Oldest-old –Anne-Marie Leiby, Aanan Ramanathan, Chuching Ho, Sean Siguenza, Ghazaleh Ahmadi Jazi, S. Ahmad Sajjadi

P3.6-010

Arteriolosclerosis Differs from Venular Collagenosis in Relation to Cerebrovascular Parenchymal Damages: An Autopsy-based Study

– Yuan Cao, Mei-Ying Huang, Chenhui Mao, Xue Wang, Yuan-Yuan Xu, Xiao-Jing Qian, Chao Ma, Wen-Ying Qiu, Yi-Cheng Zhu

7 Practice, Policy, and Ethics

Practice, Policy, and Ethics: Improving Patient Care and Research 1

P3.7-001

Major Drivers of Increased Cost of Inpatient Stroke Care in the Wake of the COVID-19 Pandemic –Cathy A. Sila, Colin Beilman, Michael Ross Vincent, Michael A. De Georgia, Amrou Sarraj

P3.7-002

NF1 Recommendation-Based Care Delivery: A Survey of Patients and Caregivers – Justin T. Jordan, Vanessa Merker, Lori B. Chibnik, Yidan Ma, Nicole Ullrich, Kaleb H. Yohay, Pamela Knight, Heather Radtke, Scott R. Plotkin

P3.7-003

Minimal acceptable functional outcomes according to surrogates and professionals caring for unconscious patients – Gregory Heinonen, Jerina Carmona, Kevin Doyle, Lauren Grobois, Lucie Summer Kruger, Angela M. Velazquez, Athina Vrosgou, Qi Shen, Lizbeth Cespedes, Mariam Catherine Yazdi, Shivani Ghoshal, David J. Roh, Sachin Agarwal, Soojin Park, Lydia Dugdale, Jan Claassen

P3.7-004

Improving Consistency in Audits with Human Research Participants: Determining the Optimal Percent of Research Records to Review – Matthew Gooden, Gina Norato, Sandra Martin, Avindra Nath, Lauren B. Reoma

P3.7-005

Impact of Medication Optimization and Recommendations by Clinical Pharmacists

Embedded in a Memory Disorder Clinic – Anna Mattle, Katherine Coli, Monica Lee, Traci Aladeen, Bela Ajtai, Michelle Rainka

P3.7-006

Inpatient Neurology Huddle Quality Improvement

Project – Maryam Matloub, Carley Ann Carter, Yunxia Wang

8

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Inherited Muscle Disorders 1

P3.8-001

Safety and Tolerability of Losmapimod for the Treatment of FSHD – Vivekananda Ramana, Jennifer Shoskes

P3.8-002

PGN-EDO51: Preclinical Data Supporting the Development of an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD) – Ashling Holland, Caroline Godfrey, Pallavi Lonkar, Niels Svenstrup, Jane Larkindale, James McArthur, Sonia Bracegirdle, Jaya Goyal

P3.8-003

WITHDRAWN

P3.8-004

PGN-EDO51, an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD): Results of a Phase 1 Study in Healthy Volunteers – Michelle L. Mellion, Jane Larkindale, Pallavi Lonkar, Jaya Goyal, Ashling Holland, Jeffrey Foy, Brijesh Garg, Shaoxia Yu, Anthony Frank, Christopher Abbott, Niels Svenstrup, Jennifer Cormier, Sarah Vacca, James McArthur

P3.8-005

EIM Phase Angle as a Candidate Biomarker of Muscle Function in DM1 Patients – Edwin Parker Conquest, Brigham McKee, Elizabeth Cornforth, Jeffrey Alexander Sizemore, Elise Townsend, Seward B. Rutkove, Thurman M. Wheeler

P3.8-006

Long-term Safety and Sustained Functional Benefit in Patients with Duchenne Muscular Dystrophy (DMD) 4 Years Post-Treatment with Delandistrogene Moxeparvovec (SRP-9001) in a Phase 1/2a Study – Jerry R. Mendell, Zarife Sahenk, Kelly Lehman, Linda Pax Lowes, Natalie F. Reash, Megan Iammarino, Lindsay N. Alfano, Sarah Lewis, Kathleen Church, Richard Shell, Rachael Potter, Danielle A. Griffin, Mark Hogan, Shufang Wang, Stefanie Mason, Eddie Darton, Louise R. RodinoKlapac

P3.8-007

Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of AOC 1020 Administered Intravenously to Adult Patients with Facioscapulohumeral Muscular Dystrophy (FORTITUDE) Trial Design – Amy Halseth, Elizabeth Jane Ackermann, Teresa Brandt, Chao-Yin Chen, Mark Stahl, Kelly Ditrapani, Steve Hughes, Alrabi Tawil, Jeffrey Statland

P3.8-008

Evaluating Pharmacology and Efficacy of Delandistrogene Moxeparvovec in Young and Aged DMDmdx Rats – Rachael Potter, Christopher Wier, Grace Cooper-Olson, Esther Wheeler, Emily Anderbery, Amber Kempton, Leah Michelle Clements, Kaitlin Adegboye, Alemayehu Girma Haile, Ellyn L. Peterson, Louise R. Rodino-Klapac

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: ALS, SMA, and Other Motor Neuron Disorders 2

P3.8-009

Outstripping of Motor Unit Compensation with Disease Severity in Adults with Spinal Muscular Atrophy – Adam S. Deardorff, Felix Santiago Guerra Castanon, Songzhu Zhao, Kristina Marie Kelly, Marco Tellez, Sarah Heintzman, Stephen J. Kolb, William D. Arnold, Bakri Elsheikh

P3.8-010

Impact of Nusinersen treatment on quality of life in adult patients with Spinal Muscular Atrophy – Felix Santiago Guerra Castanon, Adam S. Deardorff, Songzhu Zhao, Steven Severyn, Kristina Marie Kelly, Marco Tellez, Sarah Heintzman, Gary Sterling, Stephen J. Kolb, William D. Arnold, Bakri Elsheikh

P3.8-011

VRK1 mutation associated with adult-onset spinal muscular atrophy and persistently elevated creatine kinase – Adrian Rodriguez-Hernandez, Octavio Carranza-Renteria, Svetlana Faktorovich

P3.8-012

Mills’ Disease Variant – Rasha Moussallem, Omar Jawdat, Duaa Jabari, Mamatha Pasnoor, Mazen M. Dimachkie, Jeffrey Statland

P3.8-013

A Rare Case of Hereditary Spastic Paraplegia 46 With Novel Compound Heterozygous GBA2 gene variants – Sandeep Gill, Sukhraj Gill, Madeline Williamson, J. David Avila

P3.8-014

Paraneoplastic pure motor neuropathy in a 48-year-old male with recently diagnosed DLBCL – Avinash Simhachala Kolli, Anooshah Ata, Rebecca L. Hurst

P3.8-015

A Review of Economic Studies of Amyotrophic Lateral Sclerosis (ALS) in the United States –Anudeeta Gautam, Ilene Hollin, Terry D. HeimanPatterson

9 Neuro-ophthalmology/Neurootology

Neuro-ophthalmology/Neuro-otology: Clinical Research of the Efferent Visual System

P3.9-001

Phase 1/2 Clinical Study of VRDN-001, A Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients with Thyroid Eye Disease (TED) – Mark L. Moster, Raymond Douglas, Kimberly P. Cockerham, Roger Turbin, Nav Nijhawan, Jade S. Schiffman, Shoaib Ugradar, Denis Oshaughnessy, Rochelle Marie Summerfelt, Angela She, Barrett Katz

P3.9-002

Worldwide Survey on the Treatment of Peripheral Vestibular Disorders – Michael Strupp, Nils Lucca Kern, Goran Frans Emanuel Laurell, Eva Grill, Ralf Strobl

P3.9-003

Stimulated Corneal Blink Reflex Response changes with Age in Healthy Adults – Dena Garner, Benjamin E. Keenan, Fahed Ali, Mohammad Nadir Haider

P3.9-004

Ocular counter-roll during a Ménière’s attack: evidence of ictal utricle pathway imbalance using fundus photography – Elizabeth A. Fracica, Daniel R. Gold

P3.9-005

Ping-pong gaze with “staircase” saccades in coma: An oculographic analysis using EEG – Neel Fotedar

P3.9-006

Optokinetic Nystagmus: Five Reasons Why Every Neurologist Should Evaluate It – David Edward Hale, Stephen G. Reich, Daniel R. Gold

P3.9-007

Phase 1 Safety and Pharmacodynamic Results of VRDN-001, a Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF1R) in Development for Thyroid Eye Disease (TED) – Angela She, Barrett Katz, Rochelle Marie Summerfelt, Denis Oshaughnessy, Brent Allen Dickinson, Kelly Foster, Vahe Bedian 9

Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Seizures 1

P3.9-008

A Novel Approach to Assess the Impact of Disease in Patients with SCN8A-Related Developmental and Epileptic Encephalopathy – Kelley Dalby, Ted Snyder, Lillian G Matthews, Michael Stefan Oldham

P3.9-009

Functional Investigation of Somatic Variants in Pediatric Epilepsy Using Single-Cell DNA/RNA Assays from Patient Derived Single Cells – Drew Cheng, Michael Zhu Chen, Yue Huang, Junseok Park, Heidi E. Kirsch, Christopher Walsh, Diane Donghui Shao

P3.9-010

Effect of Fenfluramine on Generalized Tonic-Clonic Seizures in Rare Epilepsy Syndromes: A Review of Published Studies – J. Helen Cross, Orrin Devinsky, Antonio Gil-Nagel, Berten Ceulemans, Lieven G. Lagae, Kelly G. Knupp, An-Sofie Schoonjans, Philippe Ryvlin, Elizabeth Thiele, Rima Nabbout, Amelie Lothe, Shikha Polega

P3.9-011

A Retrospective Textual Analysis of Sexual and Reproductive Health Counseling for Adolescent and Young Adult Women with Epilepsy – Elizabeth Ivy Harrison, Laura Anne Kirkpatrick, Harry Hochheiser, Yoshimi Sogawa, Traci Kazmerski

P3.9-012

Racial disparities in genetic testing in children with pediatric epilepsy – Kunal Bonde, Joshua Ray Tanzer, Lauren Massingham, Rachit Patil

10 Infectious Disease

Infectious Disease: Atypical Bacterial Infections

P3.10-001

Intracranial Aneurysm In a Case of Tubercular Meningoencephalitis, a Rare Presentation – Kuntal Biswas, Debarup Das, Venkata Sriram Chintha, Bhaswar Bhattacharya, Atanu Biswas, Uddalak Chakraborty

P3.10-002

Tuberculous Meningitis: Is the Fixed Dose Anti-TB treatment strategy effective? Case report from Sri Lanka – Shanindra Revanka De Alwis, Arjuna Hirantha Fernando

P3.10-003

Cerebral Sparganosis Presenting with Status

Epilepticus in a Young Male Patient Not Having Brain Lesions on MRI – Dong Jin Shin

P3.10-004

Neuropathy as the Initial Manifestation of Leprosy in an Older Patient – Kush Sharma, Elizabeth Monohan, Yaacov Anziska, Nuri Jacoby

P3.10-005

Neurobrucellosis Presenting With Isolated Intracranial Hypertension – Nesrine Charfi, Sawsan Daoud, Nadia Bouattour, Salma Sakka, Khadija Sonda Moalla, Mariem Damak, Chokri Abdellaziz Mhiri

P3.10-006

Tissue is Still the Issue: A Unique Case of CulturePositive CNS MAC Infection and Biopsy-Proven Large B-Cell Lymphoma – Sojung Kara Park, Andrew Jameson

P3.10-007

Neurocysticercosis in Non-Endemic Areas: The Experience in Qatar – Areej Nauman, Farah Wahbeh, Yanal Ramzi Shaheen, Mohammed Elrasheed Abunaib, Gayane Robert Melikyan, Boulenouar Mesraoua, Dirk T. Deleu, Hassan Jassim Al Hail, Ahmed El Sotouhy, Ziyad Mahfoud, Naim I. Haddad

11 Movement Disorders

Movement Disorders: Biomarkers and Genetics of Parkinson’s Disease 1

P3.11-001

Clinical Utility of Skin Biopsy Compared to DaTscan in Diagnosing Synucleinopathies – Nikita Urval, Leon Meytin, Benjamin John Dorfman, Jeffrey Philip Lahrmann, Elena Bortan, Michelle M. Dagostine, James D. Duffy, Maria L. Moro-de-Casillas, Duarte G. Machado, Sulada Kanchana, Joy Antonelle DeMarcaida

P3.11-002

a-Synuclein membrane-binding in the central and enteric nervous system in Parkinson’s disease –Virginia Gao, Juan Antonio Briano, Lauren Komer, Carl Crawford, Claire Henchcliffe, Andrea P. Lee, Jacqueline Burré

P3.11-003

Retinal age gap as a predictive biomarker of future risk of Parkinson’s disease – Lisa Zhuoting Zhu

P3.11-004

Transferrin as a Possible CSF Biomarker in Neurodegenerative Proteinopathies – Katerina Mensikova, Katerina Klicova, Dorota Konickova, Sandra Kurcova, Pavel Otruba, Zuzana Grambalova, Michaela Kaiserova, Petr Kanovsky

P3.11-005

Updated Parkinson’s disease motor subtypes classification and correlation to CSF HVA and 5-HIAA levels – Jessika Suescun, Christopher Adams, Kelly Lauren Block, Emily Tharp, Timothy Michael Ellmore, Mya C. Schiess

P3.11-006

The Serum Metabolome as a Potential Biochemical Indicator of Parkinson’s Disease – Bianca Palushaj, Meenakshi Chakraborty

P3.11-007

Peripheral Sphingolipids as Potential Biomarkers of Parkinson disease Including Sex-Related Differences – Roberto P. Ortega, Lena F. Burbulla, Izolda Mileva, Graeme Taylor, Miroslava CuperlovicCulf, Amanda Glickman, Mariel Yvonne Pullman, Clemens R. Scherzer, Deborah Raymond, Gabriel Miltenyi-Miltenberger, Andrea Sujung Yoo, William C. Nichols, Dimitri Krainc, Susan B. Bressman, Lina Obeid, Yusuf Hannun, Steffany Bennett, Rachel J. Saunders-Pullman

P3.11-008

The assessment of inflammation markers IL-1beta and IL-6 before and after FMT in patients with Parkinson’s disease – Karol Sadowski, Monika Figura, Lukasz Milanowski, Dariusz Koziorowski, Stanislaw Szlufik, Aleksandra Antoniak, Julia Maya Nowak, Mateusz Henryk Kopczynski, Marta Grzyb

P3.11-009

Blepharoclonus as a Potential Novel Clinical Marker in Parkinson’s Disease – Nestor Guarionex Beltre, Matthew Feldman, Sarah Marmol, Danielle Spengler Shpiner, Corneliu C. Luca, Henry Paul Moore, Carlos Singer, Joanne Wuu, Michael G. Benatar, Ihtsham Haq, Jason H. Margolesky

P3.11-010

In-lab Assessment of a Sternum-Worn Accelerometer to Measure Gait Speed in Healthy Individuals – Nunzio Camerlingo, Miles Alexander Welbourn, Dimitrios Psaltos, Andrew Messere, Hao Zhang, Charmaine Demanuele, Mar Santamaria Serra, Lukas Adamowicz, Fikret Isik Karahanoglu, Xuemei Cai

P3.11-011

Metabolomic Profiling of Plasma Samples from PPMI Identifies Molecular Signatures of Parkinson’s Disease and Genetic Parkinson’s Disease Susceptibility – Sarah HuntworkRodriguez, Jung Suh, Grace Crotty, Romeo Maciuca, Eric A. Macklin, Sonnet Davis, Jamal Alkabsh, Rachit Bakshi, Xiqun Chen, Samantha Molsberry, Alberto Ascherio, Michael Schwarzschild

P3.11-012

Genotype-Phenotype correlation in ParkinParkinson’s disease – Poornima Jayadev Menon, Sara Sambin, Baptiste Criniere-Boizet, Thomas Courtin, Fanny Casse, Christelle Tesson, Mélanie Ferrien, Emmanuel Roze, Francois Xavier Lejeune, Aymeric Lanore, Graziella Mangone, Louise-Laure Mariani, Jan O. Aasly, Ziv Gan-Or, Eric Yu, Yves Dauvilliers, Alexander Zimprich, Ignacio Alvarez, Pau Pastor, Alesio Di Fonzo, Kailash P. Bhatia, Francesca Magrinelli, Henry Houlden, Raquel Real, Derek Narendra, Hsin-Pin Lin, Carna Janovick, Sulev Koks, Timothy Lynch, Amy Gallagher, Wim Vandenberghe, Thomas Gasser, Huw R. Morris, Christine Klein, Kathrin Brockmann, Olga Corti, Alexis Brice, Suzanne Lesage, Jean Christophe Corvol

P3.11-013

Rare TMEM230 Variants are Potentially Associated With Early Onset Parkinson’s Disease – Konstantin Senkevich, Eric Yu, Uladzislau Rudakou, Jamil Ahmad, Jennifer Ruskey, Farnaz Asayesh, Dan Spiegelman, Stanley Fahn, Cheryl H. Waters, Oury Monchi, Yves Dauvilliers, Nicolas Dupre, Irina Miliukhina, Alla Timofeeva, Daria Kulabukhova, Anton Emelyanov, Sofya Pchelina, Lior Greenbaum, Sharon Hassin, Roy Alcalay, Ziv Gan-Or

P3.11-014

Impact of PINK1 knockout on expression and phosphorylation of mitochondrial proteins and dopamine regulation: insight into early-stage Parkinson’s Disease in the rat model . – Joshia John, Michael Salvatore

P3.11-015

Caudal Mediates a Glial Alpha-synuclein Induced Increase in Proteolysis-Related Genes – Ming Shen, Abby Lauren Olsen

12 Headache

Headache: Clinical Investigations in Headache 1

P3.12-001

Longitudinal follow-up of headaches in the context of Post-Acute Sequelae of COVID-19 (PASC) in an outpatient neurology cohort – Sara Wesley Hyman, Rachel Kenney, Samarah Ahmed, Sherry Fung, Azizi Seixas, Girardin Jean-Louis, Steven Galetta, Laura J. Balcer, Sujata P. Thawani

P3.12-002

Quality of Life in Patients with Confirmed and Suspected Spontaneous Intracranial Hypotension – Victor Liaw, Deborah I. Friedman, Morgan C. McCreary

P3.12-003

Neurologic Deficits and cerebrospinal fluid (CSF) lymphocytosis (HaNDL): a comprehensive systematic review of 93 patients from 57 studies – Fahham Asghar, Mohammad Mahmoud Samara, Prajwal Hegde, Nicholas Robert Delcimmuto, Khaled Gharaibeh, Nameer Aladamat, Yasar Taylan

Esengul, Mohammad Mahmoud Samara, Ajaz

Sheikh

P3.12-004

Exploring the Experience of Neck Pain in Individuals With Episodic Migraine – Andrew M. Blumenfeld, Margaret Mordin, Katherine M. Kosa, Colleen Volz Castro, Jonathan Stokes, Darshini Shah, Dawn C. Buse

P3.12-005

Co-relation of Venous Sinus Changes to Intracranial Pressure in IIH – Tonse Ashwini Kini, Padmaja Sudhakar, Shivani Pahwa

P3.12-006

Clinical and Imaging Analysis of Headaches in Neurological Post-acute Sequelae of SARS-CoV-2 Infection – Tyler Kuhns, Jaime Imitola, Shivam Patel

P3.12-007

Headache in acute ischemic stroke as a good prognostic factor – Alejandro R. Marfil-Rivera, Jennifer Riojas, Juan Fernando Gongora Rivera

P3.12-008

Ketamine Induced RCVS – Naaima Mufti, Bryan Paulo Lopez Canlas, Michel A. Ritenuti

P3.12-009

Cerebral Venous Sinus Pressure and Head Pain: A Case of Cough Headache Secondary to Superior Sagittal Sinus Stenosis – Taylor Haddad, Victor Wang, Simy K. Parikh

P3.12-010

Migraine Presented as Harlequin Syndrome –Anand Kumar, Deepika Joshi, Varun Kumar Singh, Vijaya Nath Mishra, Abhishek Pathak, Rameshwar Nath Chaurasia

1 Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): Real-World Use of ASMs

P4.1-001

Beneficial effects of Inhalant Cannabidiol in the prophylactic treatment of drug resistant epilepsy

– Hesamoldin Khodadadi Chamgordani, Sahar Emami Naeini, Bidhan Bhandari, Evila Salles, Kathryn Gayoung Ko, Krishnan M. Dhandapani, Jack C. Yu, Fernando L. Vale, Debra Moore-Hill, Lei Wang, Babak Baban

P4.1-002

Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients –Rebecca O’Dwyer, Sean Stern, Clarence Wade, Anuradha Guggilam, William E. Rosenfeld

P4.1-003

Comparing Mutability of Clinically Significant Voltage-Gated Sodium Channel Subunits –Gustavo A. Patino, Ian N. Armstrong

P4.1-004

Concomitant Antiseizure Medication Dose Reduction and Discontinuation After Starting Cenobamate: a Retrospective Review – Danielle Becker, Sarah Demko

P4.1-005

Retention of Cenobamate in the Real World –Mindl M. Weingarten, Clarence Wade, Sudhakar Mandapati, Vernon Francis Schabert, Sean Stern

P4.1-006

Long-term Cenobamate for Uncontrolled Focal Seizures in Patients Living in a Group Home or With Developmental Disability – Gregory S. Connor

P4.1-007

Characterization of lacosamide pharmacokinetics in older adults with epilepsy – Charul Avachat, Stephanie Reeder, Yuhan Long, Ilo E. Leppik, Sima I. Patel, Angela K. Birnbaum

P4.1-008

Use of Non-Medical Cannabis in Epilepsy: A Scoping Review – Jimmy Li, Cassandra Charbonneau-Areal, Denahin Hinnoutondji Toffa, Daphne Citherlet, Didier Jutras-Aswad, Charles Deacon, Mark Robert Keezer, Dang Khoa Nguyen

P4.1-009

The Pharmacokinetics of Cenobamate When Used as Monotherapy – Vijaykumar Vashi, William E. Rosenfeld, Louis Ferrari, Marc Kamin

P4.1-010

Real-World Evaluation of Serum Sodium Levels in Patients With Focal Seizures Treated With Eslicarbazepine Acetate – Guy Rayford Mitchell, David Cantu, Darshan Mehta, Todd Grinnell, David Smith

P4.1-011

Determinants for the Initiation of Anti-seizure Medication in a Canadian Tertiary Emergency Department – Angela Young, Marcus Ng

P4.1-012

Anti-seizure medication use in hospitalized patients undergoing continuous EEG monitoring: A multicenter validation study – Natalie Karina ErlichMalona, Neishay Ayub, Hunter Rice, Fernando H. Ibanhes, Mohammad Nadir Haider, Clio A. Rubinos, Adithya Sivaraju, Vineet Punia, Sahar Fatima Zafar, Monica B. Dhakar 2

Education, Research, and Methodology

Education, Research, and Methodology: Medical Student Education 2

P4.2-001

PREP- A Medical Student Led Initiative to Enhance Learning and Facilitate Assessment Preparation

– Adam Quick, Samuel Paul, William Schwartzman, Vamsee Krishna Vemulapalli, Galo Bustamante, Chloe Amsterdam, Christopher R. Pierson

P4.2-002

Neurology Clerkship Shelf Score Analysis Pre- and Post-Satisfactory/Unsatisfactory Grading System –Jordan Mayberry, Vern C. Juel, Karissa Gable

P4.2-003

Acute Neurological Emergencies: Using Neurology-Trained Standardized Patients To Promote Active Learning in a Case-Based Simulation Curriculum for Neurology Clerkship Students – Galina Gheihman, George Kyle Harrold, Danielle Marie Howard, Casey S.W. Albin, Tamara

B. Kaplan

P4.2-004

Assessing Best Practices in a Simulated Lumbar Puncture Workshop with Medical Students –Lauren Dugan, Kyle Matthew Rei, Arisa Ueno, Joshua Mahutga Joel Mahutga, Timothy Daniel Hantz, Madhu Varma

P4.2-005

Enhancing medical student neuroscience training with a team-based learning curriculum –Christopher Tarolli, Ralph F. Jozefowicz

P4.2-006

Localizing Weaknesses in Pre-Clinical Neurology Education – Shari Mitzi Duarte, Joanne Baltazar Vakil, Adam Quick

3 History of Neurology

History of Neurology

P4.3-001

A History of the Women’s Auxiliary to the American Academy of Neurology – Negin Badihian, Alison L. Christy, Christopher J. Boes, Elizabeth A. Coon

P4.3-002

A Unique Collection of Wax Models Showing Neurosurgical Technique – Christopher J. Boes

P4.3-003

Stroke, Seizures, and State of the Union: How Neurologic Ailments of FLOTUS Changed the Course of World Affairs – Sara Kate Heide, Mill Etienne

P4.3-004

The Gomez-Lopez-Hernandez Syndrome: the contribution of two Hispanic giants of Pediatric Neurology – Bao Xin Liang, Jason Viereck, Kore K. Liow, Enrique Carrazana

P4.3-005

The Advent of the Automated Pupillometer in Neurocritical Care – Jorge Luis Rodriguez Lee, Nick Bellacicco, Nicholas John Bellacicco

P4.3-006

The American story of apomorphine : between mistrust and remarkable discoveries – Manon Auffret, Andrew John Lees, Marc Verin

P4.3-007

A History of Headache Medicine Training in the United States – Noah Rosen

P4.3-008

Derek Denny-Brown: His Life in New Zealand and England 1901-1941 – Neil Anderson, Sid Gilman

P4.3-009

Dejerine and Klumpke: An Homage to Relationship and Partnership in Neurology – Tyler Crissinger, Jennifer Lauren Dobson

P4.3-010

Wilhelm Uhthoff and his contributions – Roopa Sharma, Maria Andreina Hernandez

P4.3-011

How great was the influence of his origins and descendants on Charcot’s behaviors? – Leo Coutinho, Carlos Henrique Ferreira Camargo, Gustavo Leite Franklin, Emanuel Cassou, Helio Afonso Ghizoni Teive, Olivier Walusinski

P4.3-012

Das Narrenhaus and the Faces of Mental Illness –Russell Reed, Robert M. Pascuzzi

4 General Neurology

General Neurology: Encephalopathy

P4.4-001

Recurrent Transient Global Amnesia with Contralateral Hippocampal Restricted Diffusion MRI Changes: A Case Report – Laura Mora Munoz, Zachary McKee, A. Blake Buletko, Maryann Mays

P4.4-002

Posterior Reversible Encephalopathy Syndrome Causing Takotsubo Cardiomyopathy or Vise a Versa: How to Differentiate – Pavitra Suhani Srinivasan, Lydia Kauffman, Bhavan U. Shah, Hakim Uqdah, Francois Philippe Kaleta

P4.4-003

A Rare Case of Bilateral Globus Pallidus Enhancement in a Patient with Clinical Wernicke Encephalopathy – Choongwon Jin, Tasneem Karim, Ranjit Bagga, Mehyar Mehrizi

P4.4-004

Atypical Clinical Presentations and Neuroimaging Findings of Wernicke Encephalopathy – Shubham Biyani, Khushboo Verma, Naren Raj Arulprakash, Vishank Arun Shah, Kelly-Ann Patrice

P4.4-005

Wernicke-Korsakoff Syndrome in pregnancy: a preventable complication – Brian Morris, Ketevan Amirkhanashvili, Runjhun Bhatia, Alexandra Fields, Pranayjit Adsule, Sheryl R. Haut

P4.4-006

Cognitive Impairment in Liver Transplant Recipients ≥3 Months After Transplant – Ketura Berry, Fawzy Barry, Amy Shui, Randi J. Wong, Srilakshmi Seetharaman, Dorothea Stark Kent, Jessica Moore Ruck, Lawren VandeVrede, Jennifer Lai

P4.4-007

Pathologically- confirmed Osmotic Demyelination in the Case of Clinically and Radiographically Progressive Encephalopathy due to Liver Disease and Malnutrition – Ryan E. Hanson, Yuri Bronstein, Caroline L. Fong, Nazely Ashikian

5 Autoimmune Neurology

Autoimmune Neurology: Autoimmune Encephalitis / Paraneoplastic / StiffPerson Syndrome / Immunotherapy (IrAe)

P4.5-001

Building Paraneoplastic and Disease-Specific Autoimmune Neurology Testing for a National Reference Laboratory – Ajay Grover, Stanley J. Naides, Andre Valcour, Vincent Ricchiuti, Melinda Nye, Joseph Volpe

P4.5-002

GABA-A Receptor Meningoencephalitis presenting with New Onset Refractory Status Epilepticus and Reversible Vasculopathy – Carolina Garcia, Cole Crowson, Dhanalakshmi Angappan, Vicky Chen, Vijayshree Yadav

P4.5-003

A retrospective survival analysis of relapse rate in pediatric and adult autoimmune encephalitis – Jennifer H. Yang, Emilie Liu, Linda Nguyen, Anastasie M. Dunn-Pirio, Jennifer Graves

P4.5-004

Clinical characterisation of encephalitis of unknown cause and ‘mimics’ of encephalitis –Bernard Liem, Joseph Donnelly, Neil Anderson

P4.5-005

Pseudo-bulbar affect and Tremors in GFAP

Astrocytopathy: A Case Report – Anza Zahid, Beatriz Helena Thames, Osman Ozel, Mohammad Obadah Nakawah, Sheetal Shroff

P4.5-006

A Case of Dancing Eyes and Feet – Shubhdeep Ahden, Benjamin P. George, Lawrence M. Samkoff

P4.5-007

Rare Case of DPPX Encephalitis – Veena Pawate, Sukhmani Sandhu, Eric Weisman, George A. Small

P4.5-008

Clinical significance and limitations of Commercial Rat Brain Immunohistochemistry as a Screening Test for Neuronal Surface Antibodies – Takahiro Iizuka, Naomi Nagata, Naomi Kanazawa, Masaki Iizuka, Makoto Nagashima, Masaaki Nakamura, Juntaro Kaneko, Eiji Kitamura, Kazutoshi Nishiyama

P4.5-009

Associations of Serum Neurofilament Light Chain with Outcomes in Children with Autoimmune Encephalitis – Susana Da Silva, Carmen Yea, Jihan Madani Madani AlYanbuaawy, Matt W. Wagner, Giulia Longoni, Helen Branson, Logi Vidarsson, Birgit Betina Ertl-Wagner, E. Ann Yeh

P4.5-010

A Case of Seropositive Autoimmune Glial Fibrillary Acidic Protein Encephalitis with Renal Cell Carcinoma – Krithika Arrabothu, Srinivas Govindan, Wilson Eduardo Rodriguez, Sophie Xie, Christopher Tapia

P4.5-011

Characterization of the Common Symptomology and Great Mimickers of Autoimmune Encephalitis

– Riya Amit Soneji, Sarah Shapiro, Melissa Ann Wright, Sama Noroozi Gilandehi, Trieste Francis, Tammy L. Smith, Ka-Ho Wong, Stacey Clardy

P4.5-012

Recurrent GRAF1 Antibody Encephalitis in Woman with History of Cancer and Powassan Encephalitis

– Jennifer Lauren Dobson, Tyler Crissinger

P4.5-013

Late-Onset Cerebellar Ataxia Associated with Anti-GAD Autoantibodies: A Rare and Puzzling Disease – Meghana Nyapati Rao, Katy Anne Helms, Araya Puwanant

P4.5-014

Anti-Purkinje Cell Antibody Autoimmune Cerebellar Ataxia: A pediatric case report –Zachary Cox, Naeem Mahfooz

P4.5-015

Cerebellar Degeneration Causing Saccadic Dysmetria and Ocular Flutter: A Seronegative Paraneoplastic Syndrome – Anthony Peter Zampino, Mark Phillips Figgie, Aasef Shaikh, Alessandro Serra

P4.5-016

Case Series of Patients with Brainstem Inflammation Causing Paroxysmal Movement Disorders – Evan Luxenberg, Yujie Wang, Annette Wundes, Gloria Von Geldern

P4.5-017

Late-onset Stiff Person Syndrome (SPS): Challenges in Diagnosis and Management –Jessica Yi, Marinos C. Dalakas

P4.5-018

Identifying Key Components for Diagnosing Stiff Person Syndrome Spectrum Disorders: A Sensitivity and Specificity Study – Shuvro Roy, Chen Hu, Yujie Wang, Kathryn Fitzgerald, Scott Douglas Newsome

P4.5-019

Successful Autologous Hematopoietic Stem Cell Transplant in a Case of Stiff Person Spectrum Disorder with a positive Glycine Receptor antibody – Sofia Io I Celli, Richard Nash, Constance McMenamin, Madeline Garza, Gloria Von Geldern, George Georges, Amanda Lee Piquet

P4.5-020

Use of Immunotherapy and Symptomatic Therapy

Differs Between Clinical Phenotypes of Stiff Person Syndrome Spectrum Disorders – Alexandra Christina Simpson, Alexandra Rose Balshi, Danielle Obando, Ashley Miles, Elena Rose Taylor, Sarah Snoops, Yujie Wang, Scott Douglas Newsome

Monday, April 24 | 8:00 a.m.–9:00

P4.5-021

Longitudinal brain and skeletal muscle FDG-PET changes in people with stiff person syndrome spectrum disorders – Samantha Roman, Yujie Wang, Mohammad Sadaghiani, Scott Douglas Newsome

P4.5-022

Misdiagnosis of Stiff Person Syndrome Spectrum Disorders: Identifying the Most Common Culprits –Shuvro Roy, Yujie Wang, Scott Douglas Newsome

P4.5-023

A Case of Stiff Person Syndrome with Response to Methotrexate Therapy for Lymphoma – Zeinab Birjandian, Jerome J. Graber

P4.5-024

Challenges in the Diagnosis of EBV Encephalitis vs CNS CLL: A Case Report – Maria Alejandra GarciaDominguez, Margaret A. Owegi, Wissam Georges Deeb, David Cachia, Carolina Ionete

P4.5-025

Evaluation of a self-questionnaire to screen for neurological complications associated with immunological checkpoint inhibitors : are we missing something ? – Bruno Lemarchant, Julien Lannoy, Sylvain Dubucquoi, Helene Zephir

P4.5-026

Clinical characterization and outcome of 47 patients with neurologic adverse events of immune-checkpoint inhibitors – Elianet Perez Fonseca, Jose Maria Cabrera Maqueda, Raquel Ruiz-Garcia, Laura Naranjo Rondan, Yolanda Blanco Morgado, Josep O. Dalmau, Francesc R. Graus, Eugenia Martinez-Hernandez

P4.5-027

Anti-Yo autoimmunity in patients with postimmune checkpoint inhibitors neurological syndromes – Antonio Farina, Veronique Rogemond, Elise Peter, Valentin Wucher, Macarena Villagran Garcia, Le Duy Do, Géraldine Picard, Bastien Joubert, Jerome Honnorat, Virginie Desestret

P4.5-028

Immune Checkpoint Inhibitors Related New Onset Myasthenia Gravis: Case Series – Sara Habib, Hamza Mohiuddin Ahmed, Ahmad Al-Awwad, Sarah Sung

P4.5-029

Pre-existing Lambert-Eaton Myasthenic Syndrome and Scleroderma in a Patient with Neuroendocrine Tumor undergoing Immune Checkpoint Inhibitor Cancer Immunotherapy – Nisa Vorasoot, Thorvardur Ragnar Halfdanarson, Nicolas N. Madigan, Uma Thanarajasingam, Anastasia Zekeridou

P4.5-030

Pembrolizumab-Induced CNS Vasculitis: A Likely Underdiagnosed Cause of Primary Angiitis of the CNS – Tyler Kendrick Simons, Veronica Astrid Moreno Gomez, Gillian L. Gordon-Perue, Negar Asdaghi

P4.5-031

Rare development of anti-CRMP5 Parkinsonism and worsening ataxia while on Atezolizumab for SCLC: A case report – Jennifer L Purks, Lawrence

M. Samkoff

P4.5-032

Adult-onset CLIPPERS with systemic Hemophagocytic Lymphohistiocytosis related to PRFN1 mutation: A case report – Bruno Lemarchant, Geneviève De Saint Basile-Chazelas, Helene Zephir, Julie Boucher, Guillaume Taieb

Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Emerging Topics

P4.6-001

Adaptive Recruitment Strategies for Decentralized Trials: Learnings from INTUITION: A Brain Health Study – Jessica Ash, Sean Kenny, Matt Hobbs, Andrew Becker, Roland Brown, Paramita SahaChaudhuri, Hanson Lenyoun, Matt T. Bianchi, Monroe Butler, Shibeshih Belachew

P4.6-002

Methylation status and sulfur amino-acids as risk factors for cognitive decline over 12 years: A longitudinal population based study – Babak Hooshmand

P4.6-003

RNAseq transcriptome profiling reveals activation of immune responses and disrupted circadian patterns in the cerebral white matter of aged mice

– Hidehiro Ishikawa, Gen Hamanaka, Emiri Tejima Mandeville, Shuzhen Guo, Wenlu Li, Akihiro Shindo, Eng Lo, Ken Arai

P4.6-004

Investigation into the Difference of Cognitive Decline between the Centenarians and Alzheimer’s Disease – Yoshinori Nishimoto, Takashi Sasaki, Yukiko Abe, Mika Konishi, Daisuke Ito, Shogyoku Bun, Yuri Otaki, Norikazu Hara, Akinori Miyashita, Takeshi Ikeuchi, Yasumichi Arai

P4.6-005

Study of the relationships between quantitative measurements of cerebral vascularization obtained by artificial intelligence, cognitive functions, and biomarkers of Alzheimer’s disease

– Vivian Ni, Felix Janelle, Felix Dumais, Christian Bocti, Kevin Whittingstall

P4.6-006

EMPOWER AD: A Novel, Patient-Centric, Longitudinal, Clinical Dataset in the United States

– Michael Grundman, Elizabeth Mearns, Karina Raimundo, Chris Wallick, Katherine Belendiuk, Katherine Glockner, Seth Colbert-Pollack, Jiayin Xue, Hinal Patel, Sheila Seleri

P4.6-007

Impact of Omega-3 fatty acid Supplementation on Global Cognitive Function among Healthy and Althahimer’s disease Elders: A Systematic Review and Meta-analysis – Mahmoud Tarek Hefnawy, Rehab Adel Diab, Maged Elsayed, Ahmed Abdelaziz, Adel Mouffokes, Toka Samy Elboraay, Qasi Mustafa Mohamm Najah, Ahmed Aljabali, Ahmed Said Abdou Negida

7 Practice, Policy, and Ethics

Practice, Policy, and Ethics: Improving Patient Care and Research 2

P4.7-001

Neurology Clinic for Marginalized Populations –Victoria Reedman, Alexandra Muccilli

P4.7-002

A Survey of EMG Productivity Benchmarks – Thy Nguyen, Kristin Angelica Brown, Suur Biliciler

P4.7-003

The Veterans Affairs Healthcare System (VA)

National Neurology Community Care Dashboard: Development and Evaluation – Mirza M. Baig, Margaret Gopaul, Sharyl R. Martini, Hamada Hamid Altalib

P4.7-004

Aircraft pilot healthcare avoidance due to fear for aeromedical certificate loss and implications for neurology care of the pilot patient – William Hoffman

P4.7-005

Ethical implications of detecting cognitive motor dissociation early after brain injury – Gregory Heinonen, Jerina Carmona, Kevin Doyle, Lauren Grobois, Lucie Summer Kruger, Angela M. Velazquez, Athina Vrosgou, Qi Shen, Lizbeth Cespedes, Mariam Catherine Yazdi, Shivani Ghoshal, David J. Roh, Sachin Agarwal, Soojin Park, Lydia Dugdale, Jan Claassen

P4.7-006

Healthcare Disparity in East African Island Hospital, A Neurological Perspective – Soroush Kakawand

8 Global Health Global Health

P4.8-001

Evaluation of Three Cohorts of the First Neurology Postgraduate Training Program in Zambia –Rebecca DiBiase, Edford Sinkala, Sitali Ikachana Jonathan, Sean Tackett, Deanna Saylor

P4.8-002

Pathways and Patients: building an innovative collaborative medical education curriculum between Valparaiso and Boston – Christina BriscoeAbath, Hanalise Huff, Ingrid Gutierrez, Francisca Aguilera, David K. Urion, Juan Francisco Cabello

P4.8-003

Neurocognitive Impairment for Persons Living with HIV in Peru: A National Physician Survey –Rebecca Margalete Wasserman Slotkin, Hanalise Huff, Camila Granda, Diego Cabrera, Monica M. Diaz, Carlos Benites Benites, Evelyn Hsieh, Patricia Jannet Garcia

P4.8-004

Cryptococcal Meningitis and Spatial Distribution of Pigeons (Columba livia) in Colombia – Gabriel D. Pinilla Monsalve, Norma Forero

P4.8-005

Inflammatory and Immunologic Biomarkers

Associated with Cognitive Impairment in Pediatric and Adolescent Patients with HIV in Lusaka, Zambia: A Sub-Study of the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ)

– Mina Grace Shah, Caroline Kabwe, Maria Elise Molinaro, Allyson Metro, Esau G. Mbewe, Pelekelo Kabundula, Milimo Mweemba, Sylvia MwanzaKabaghe, Heather Adams, Gretchen L. Birbeck, David Bearden

P4.8-006

Impact of the COVID-19 Pandemic on Patients with Dementia or Parkinson’s Disease and their Caregivers in Lima, Peru – Monica M. Diaz, Morgan Beauchamp, Maisie Ann Bailey, Ximena Carolina Rosas, Danilo Americo Sanchez Coronel

P4.8-007

Evaluating the Experience of Visiting International Providers on Local Neurology Trainees in a Resource-Limited Setting – Vanessa Salasky, Rebecca DiBiase, Deanna Saylor

P4.8-008

Prevalence and associated factors of psychological distress of patients with stroke attending the Neurology Clinics of the National Hospital of Sri Lanka, Colombo – Pumudu Chandira Weerasekara

P4.8-009

Impact of Delayed Diagnosis on Zambians Living With Multiple Sclerosis – Mashina Chomba, Dominique Mortel, Deanna Saylor

P4.8-010

Development of a structured process for the Spanish translation of the 2021 ACNS standardized critical care EEG terminology – Maria J. Bruzzone, Clio A. Rubinos, Andrea R. Lowden, Juan Appendino, Jorge A. Vidaurre, Daniel San JuanOrta, Naiara Garcia Losarcos, Mauricio Fernando Villamar, Jorge G. Burneo, Luis Carlos Mayor, Andres Rodriguez-Ruiz, Camilo A. Gutierrez, Andres Fernandez

P4.8-011

The Prevalence and Etiologies of Transverse Myelitis in Latin America: A Systematic Review

– Faris Almubaslat, Matthew Underwood, Stacy Torian, Justina Luz Salvatierra, Rocio Aponte Castro, Carrie Baldwin-SoRelle, Rebecca Carlson, Monica M. Diaz

P4.8-012

Patient Feedback for a Neurology Specialty Clinic with a “Provider Continuity” Model in Lusaka, Zambia – Rebecca DiBiase, Ndonji Chiwaya, Thomas Giauque, Deanna Saylor

P4.8-013

Neurologists Unite for Ukraine: Grassroots Movement Transformed into Lasting Collaboration – Christina BriscoeAbath, Olha Tychkivska, Aristides Hadjinicolaou, Anna Minster, Irina A. Anselm, Danielle Friedman, Alina Ivaniuk, Elaine C. Wirrell, Alina Sharinn, Alexander Paciorkowski, Yuliya Snyder, Mike Corcoran, Todd Stone, Ozzy Samad, Agnieszka Kielian, Svetlana Faktorovich

P4.8-014

Access to health care in patients with epilepsy in Latin America – Ana Claudia Villegas, Hernan Nicolas Lemus Esquivel, Luis Carlos Mayor, Paula Martinez

P4.8-015

More Than Meets the Eye: A Closer Look At Demyelinating Diseases In Zambia – Dominique Mortel, Sarah Braun, Lorraine Chishimba, Mashina Chomba, Frighton Brighton Mutete, Naluca Mwendaweli, Coolwe Namangala, Stanley Zimba, Deanna Saylor

9

Health Care Disparities

Health Care Disparities: Dementia, Movement, Neuromuscular, MS

P4.9-001

Racial Disparities in High- and Low-Value Healthcare Services Received in the Final Year of Life for Medicare Beneficiaries with Neurodegenerative Diseases – Jay B. Lusk, Catherine Barasch Ford, Melissa Greiner, Amy Clark, Kim Graham Johnson, Brystana Kaufman, Sneha Mantri, Ying Xian, Richard J. O’Brien, Emily O’Brien, Margarethe Goetz

P4.9-002

Variability in newborn screening across Canada: spinal muscular atrophy and beyond

– Emilie Groulx-Boivin, Homira Osman, Pranesh Chakraborty, Stacey Lintern, Maryam Oskoui, Kathy Selby, Paul Van Caeseele, Alexandra Wyatt, Hugh John McMillan

P4.9-003

Health Disparities in Medication Use for the Treatment of Dementia in the Outpatient Setting

– Alice Hawkins, Estevana Isaac, Parul Agarwal, Nathalie Jette, Georges Naasan

P4.9-004

A Patient Registry to Identify Barriers to Health Care in an Underserved Parkinson’s Disease Population – Stephanie L. Bissonnette, Rosemary Owen, Ashley Martin, Katelyn Cecilia Klee Bird, Michael Stevenson, Raymond James, Rebekah Lee, Abigail Desrosier, Terry Ellis, Nicholas Wendel, Helen Bresler, Bertha Lee, Cathi Ann Thomas, MarieHelene Saint-Hilaire, Ludy Chen Shih

P4.9-005

Discordant Race and Ethnicity Documentation in the Georgetown Multiple Sclerosis and Neuroimmunology Center – Luis Guillermo Manrique, Leanne Marie Peres Da Silva, Benjamin Joseph Osborne, Carlo S. Tornatore, Robert K. Shin

P4.9-006

Patient Support Program Enhancements In Patients Diagnosed With Generalized Myasthenia Gravis Facing Social Determinants of Health Challenges – Tom Hughes, Cecilia Zvosec, Ashley E. Anderson, Ali A. Habib, Sharon Suchotliff, Kathy Perez, Cathleen Bergin, Glenn A. Phillips

P4.9-007

Traumatic Brain Injury, Cognition and Structural Racism in Persons Newly Diagnosed with Multiple Sclerosis – Jemima Akinsanya, Jessica Betty Smith, Edlin Gonzales, Annette M. Langer-Gould

9 Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Seizures 2

P4.9-008

Application Of Plan-Do-Study-Act Method In Seizure Rescue Medication Practices: A Single Pediatric Neurology Clinic Quality Improvement Study – Lekshmi Peringassery Sateesh, Fatemeh Mohammadpour Touserkani, Theodora Andriotis, Tooba Shafiq, Geetha Chari

P4.9-009

Efficacy of Vigabatrin as Treatment for Seizures in Children Without Infantile Spasms – Malcolm Alan Alan Rosario, Alexander Bolufer, Vikram Prakash

P4.9-010

Decreasing Duration of Anti-Seizure Medication Use in Neonatal Acute Symptomatic Seizures –Kayla

P4.9-011

PRAX-562-102: A Phase 1 Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRAX-562 in Healthy Volunteers – Rajeshwari Mahalingam, Michael Stefan Oldham, Prashant Bansal, Balaji Sriram, Dharit Patel, Henry Claude Jacotin, Marjie Hard, Million Arefayene, Bernard M. Ravina

P4.9-012

PRAX-628 is a Novel, Well-Tolerated, Activity Dependent Sodium Channel Blocker with Potent Anticonvulsant Activity – William A. Eckert, Kris Kahlig, Lyndsey Anderson Anderson, Steven Petrou

Infectious Disease

Infectious Disease: COVID and CNS Manifestations

P4.10-001

Intracranial extension in COVID-19 associated mucormycosis cases – Poorvi Tangri, Awadh K. Pandit, Shubham Misra, Achal K. Srivastava, Vishnu VY, Rajesh Kumar Singh, Divya M. MR

P4.10-002

Cerebral White Matter Injury in a Neonate with COVID-19 Infection – Fazila Aseem, Melissa Martinez Johnson, Zachary Willis, Afsaneh Pirzadeh, Yueh Lee, Casey Olm-Shipman

P4.10-003

Myelitis and Myelopathies in the Era of COVID-19 – Samantha Hao, Susana Carolina Dominguez Penuela, Maria I. Reyes-Mantilla, Paula Barreras, Carlos A. Pardo-Villamizar

P4.10-004

Acute Transverse Myelitis (ATM) as a rare neurological complication of COVID-19 infection – Michel Abdelmasih, Haroutiun Hamzoian, Roua Kahila, Amparo Gutierrez

P4.10-005

Metabolic Kinetics: A Predictor for Encephalopathy, Seizure, and Stroke in Patients Hospitalized with SARS-CoV-19? – Mohsen Ahmed, Umair Azhar, Afaaq Ahmed, Nabeel Ahmed, Sania Azhar, Nizar Souayah

P4.10-006

Unusual Presentation of COVID-19 Associated Acute Myelitis with Predominant Corticospinal Tract Involvement: A Case Report – Arsenio Luis Reyes Rivera, Francine L. Tait, Carmen Serrano

P4.10-007

Focal Cerebral CNS Vasculitis due to SARS-CoV-2 Infection – Manny Villar, Cleo Zarina Alejo Reyes, Negar Moheb, Kathryn E. Ess, Hussam A. Yacoub

11 Movement Disorders

Movement Disorders: Surgical Therapies for Parkinson’s Disease 1

P4.11-001

Single Trajectory Dual Targeting of Subthalamic Nucleus and Ventral Intermedius Thalamic Nucleus in Patients with Severe Tremor-Predominant Parkinson’s Disease – Virgilio Gerald H. Evidente, Francisco Ponce, Danica Luz Evidente, Robin Garrett, Maris Evidente

P4.11-002

Efficacy and Safety of Unilateral MRgFUS Thalamotomy for Tremor-Predominant Parkinson’s Disease – Ka Loong Kelvin Au, Kelly E. Lyons, Lauren O’Brien, Vibhash D. Sharma, Jennifer Cheng, Michael Kinsman, Rajesh Pahwa

P4.11-003

Influence of Body Mass Index (BMI) and Blood Pressure (BP) on Deep Brain Stimulation (DBS) Outcomes in Parkinson’s disease (PD) Patients – Julia See, Scott Harcourt, Annelly Buré-Reyes, Dayana Rodriguez, Corneliu C. Luca, Jonathan Jagid, Bonnie E. Levin, Hannah Margaret Bullock, Ihtsham Haq, Marina Sarno

P4.11-004

Combined effects of GBA mutations and STNDBS negatively impact executive function in Parkinson’s disease – Ahmad Muhammad Awd Almelegy, Srujanesh Gunda, Steven Buyske, Marc Rosenbaum, Sepehr Sani, Mitra Afshari, Leonard Verhagen Metman, Christopher Goetz, Deborah Hall, M. Maral Mouradian, Gian D. Pal

P4.11-005

A Single-Center Experience with Local Field Potential-Guided Initial Deep Brain Stimulation Programming in Parkinson’s Disease – Osama Mahmoud Abu-hadid, Joohi Jimenez Shahed

P4.11-006

Parkinson’s Disease Local Field Potential (LFP) Prevalence Tracking in GPi-DBS Via BrainsenseTM Survey – Omolara Lawal, Zahir Sheikh, Anna Tarren, Marisa Ann Kovach, James McInerney, Elana Farace, Sol T. De Jesus

P4.11-007

Image-Guided Programing is Useful in DBS for Parkinson’s Disease – Joshua Moll, Hannah Margaret Bullock, Sarah Marmol, Jennifer Hislop, Jonathan Jagid, Ihtsham Haq, Corneliu C. Luca

P4.11-008

Clinical and Physiological Effects of Single Day Accelerated Theta Burst Transcranial Focused Ultrasound in Parkinson’s Disease – Yi Rong Ding, Nardin Samuel, Talyta Grippe, Can Sarica, Andres M. Lozano, Robert E. Chen

P4.11-009

Motor Function and Quality of Life Improvement following Asleep versus Awake Deep Brain Stimulation (DBS) Procedures – Jan Vesper, Guenther Deuschl, Lilly Chen, Roshini Jain

P4.11-010

Improvement in Quality of Life and Motor Function during Daily Clinical Practice using Directional DBS Systems – Guenther Deuschl, Roshini Jain, Heleen Scholtes, Lilly Chen, Michael Barbe, Steffen Paschen, Andrea Kuehn, Chong S. Lee, Jan Vesper

P4.11-011

Real-World Local Field Potential Recordings in Patients with Parkinson’s Disease: Peak Detection and Influence of Patient Related Factors – Nathan Morelli, Alexa Singer, Claudia Sannelli, Hideo Mure, Kenneth P. Martinez, Genko Oyama, Steven Falowski, Sarah Bick, Mya C. Schiess, Farrokh Farrokhi, Thomas Witt

P4.11-012

Image-Guided Programming Tool for DBS Programming Used with a Multiple-Source, Constant-Current System Reduces Initial Programming Time – Jason Lamar Aldred, Theresa A. Zesiewicz, Michael S. Okun, Juan Ramirez Castaneda, Leonard Verhagen Metman, Corneliu C. Luca, Ritesh Ramdhani, Jennifer Lyn Durphy, Yarema B Bezchlibnyk, Jonathan Carlson, Kelly D. Foote, Sepehr Sani, Alexander M. Papanastassiou, Jonathan Jagid, David Weintraub, Julie Pilitsis, Lilly Chen, Roshini Jain

11 Movement Disorders

Movement Disorders: Biomarkers and Genetics of Parkinson’s Disease 2

P4.11-013

Cortical activation during fine motor movement of Parkinson’s disease patients using fNIRS –Francisco Javier Rivas, Edgar Guevara, Ildefonso Rodriguez-Leyva

P4.11-014

Neurophysiological and Clinical Effects of Lowintensity Transcranial Ultrasound of the Motor Cortex in Parkinson’s Disease – Talyta Grippe, Yazan Shamli Oghli, Can Sarica, Cricia Rinchon, Jean-Francois Nankoo, Robert E. Chen

P4.11-015

A Caveat in Identifying a Suitable Reference for Quantitative Susceptibility Mapping in Parkinson’s Disease – Timothy Michael Ellmore, Jessika Suescun, Mohammad Shahnawaz, Mya C. Schiess

P4.11-016

Basal ganglia and brainstem located cerebral microbleeds contribute to gait impairment – Hejiao Mao, Ning Su, Jiangxia Zhang, Wencheng Zhu, Hao Zhang, Xiangmin Fan, Fei Han, Jun Ni, Lixin Zhou, Ming Yao, Feng Tian, Yi-Cheng Zhu

Aging, Dementia, Cognitive, and Behavioral Neurology

Behavioral and Cognitive Neurology: Language Disorders, Multiple Sclerosis, and Case Reports in Behavioral and Cognitive Neurology

P4.12-001

Visual and Motor Anosognosia: shared Modalityspecific Damage and convergent Disconnections in Temporo-parietal Cortex – Elena Monai, Federica Palacino, Marta Bisio, Lorenzo Pini, Alessandro Salvalaggio, Maurizio Corbetta

P4.12-002

A Case of Acquired Speech-to-Color Synesthesia following Traumatic Brain Injury – Vasundhra Mahendra, Alexandra Parashos, Mark T. Wagner, Ezequiel Gleichgerrcht

P4.12-003

Perceptual Visual Inversion Secondary to Inhalation of Fumes of Sulfuryl Chloride –Vilayanur Ramachandran, Soroush Kakawand, Paul McGeoch, Jonathan Ray Ahern, Manuel D. Tobias

P4.12-004

An Endless Relay of Words: Syndrome of Frontallike Disinhibition and Logorrhea following a Thalamic Hemorrhagic Stroke – Jose Pedro Falero Pomales, Audrey Wadood, Micah Etter

P4.12-005

Impact of Bilingualism on the Cognitive Outcomes in Stroke Survivors: A Systematic Review – Ece Eldem, Shubham Misra, Terry Quinn, Lucas Driskell, Alice Perez, Carmen I. Carrión, Todd Constable, Joseph Schindler, Yize Zhao, Jason J. Sico, Jason D. Hinman, Heather Allore, Swathi Kiran, Jubin Abutalebi, Jean Marie Annoni, Nishant Kumar

Mishra

P4.12-006

Metronidazole Induced Encephalopathy

Responsive to High Dose Thiamine – Sofia Matta, Mohona Reza, Bridget A. Bagert

P4.12-007

Acute Anterograde Amnesia with Bilateral Hippocampal and Globus Pallidus Lesions –Aleksandra Safonova, Alicia Ines Arbaje

P4.12-008

Distinguishing Peduncular Hallucinosis From Charles Bonnet Syndrome: A Case Report – Amaris Alayon, Caleene R. Goodis, Elizabeth Wirkowski

P4.12-009

Quality of life of caregivers of people with multiple sclerosis: Correlations between cognition, clinical variables, and functional dependency – Lara Bardoneschi, Maria Sol Román, Flavia Ferrandina, Johana Bauer, Roberto Rosalino Rosa, Maria Laura Saladino, Fernando J. Caceres, Sandra Vanotti

P4.12-010

AARS2-related Leukodystrophy Without Ovarian Failure Mimicking Multiple Sclerosis in a Female: A Case Report With a Novel Pathogenic Variant

– Manouchehr Amanat, Julie Cohen, Seyed Ali Fatemi, Amena Smith Fine

P4.12-011

Dementia Modulates the Distributed Representations of Cognitive Functions –Khushboo Verma, Satwant Kumar

13 Sleep Sleep Therapeutics 1

P4.13-001

Effect of Lemborexant on Sleep Onset and Maintenance in Patients with Comorbid Insomnia Disorder and Mild Obstructive Sleep Apnea –Margaret Moline, Jocelyn Y. Cheng, Dinesh Kumar, Barbara Ramos, Alan David Lowe

P4.13-002

Relationship Between Daytime Functioning and Fatigue Over 6 Months in Lemborexant-Treated Subjects with Insomnia Disorder – Craig Chepke, Jane Yardley, Kate Pinner, Christie Lundwall, Margaret Moline

P4.13-003

Effect of Lemborexant Treatment on Polysomnographic Sleep Measures in Older Adults with Insomnia and Objective Short Sleep Duration

– Andrew Krystal, Jack Edinger, Dinesh Kumar, Elizabeth Pappadopulos, Margaret Moline

P4.13-004

Effects of Solriamfetol on Cognitive Function in Participants with Cognitive Impairment Associated with Excessive Daytime Sleepiness in Obstructive Sleep Apnea: Results of the SHARP Study – Hans P A Van Dongen, Eileen Leary, Christopher Lawrence Drake, Richard K. Bogan, Judith Jaeger, Russell Rosenberg, Caroline Streicher, Hannah Kwak, Jay Bates, Herriot Tabuteau

P4.13-005

Preclinical Pharmacology of Solriamfetol: Potential Mechanisms for Wake Promotion – Hema Gursahani, Thierry Jolas, Maryse Martin, Sandrine Cotier, Sandrine Hugues, Wayne Macfadden, Gregory S. Parks, Craig Chepke

P4.13-006

Solriamfetol Real World Experience Study: Initiation, Titration, Safety, Effectiveness, and Experience During Follow-Up for Patients with Narcolepsy from Germany – PD Dr Yaroslav Winter, Geert K. Mayer, Sylvia Kotterba, Heike Benes, Lothar Burghaus, Gregory S. Parks, Andreas Koch, Daniela Girfoglio, Melinda Setanoians, Ulf Kallweit

1

Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): Neuromodulation

P5.1-001

Is Thalamic DBS Synergistic With VNS in Drug Resistant Genetic Generalized Epilepsy? – Aafreen Khan, Erik Middlebrooks, Brin Freund, Sanjeet S. Grewal, William O. Tatum

P5.1-002

Efficacy and Quality of Life Outcome of Combined Epilepsy Surgery with RNS Placement – Jie Pan, Shazia Mirza, Mark A. Agostini, Sasha AlickLindstrom, Rohit Das, Kan Ding, Alexander G. Doyle, Marisara Dieppa, Ryan Hays, J. H. Harvey, Bradley Lega, Irina Podkorytova, Rodrigo Zepeda Garcia, Ghazala Perven

P5.1-003

Thalamic neuromodulation outcomes in drugresistant refractory epilepsy with Deep Brain Stimulation and Responsive Neurostimulation –Rohit Das, Irina Podkorytova, Chijindu Iheanacho, Sasha Alick-Lindstrom, Mark A. Agostini, Alexander G. Doyle, Kan Ding, Ryan Hays, Ghazala Perven, Marisara Dieppa, Rodrigo Zepeda Garcia

P5.1-004

Clinical Outcomes in Combined Epilepsy Surgery and Responsive Neurostimulation – Anna Zolyan, Lilit Mnatsakanyan

P5.1-005

Responsive neurostimulation device use in patients with epilepsy and psychogenic nonepileptic events Case report and Healthcare expenditure analysis related to neuromodulation therapy in Epilepsy patients – Ahmad Sawalha, Christopher Anderson, Chad Carlson

P5.1-006

Scheduled Programming Reduces Time-To-Dose and Office Visits in the COVID-19 Pandemic –Maxine Dibue-Adjei, Roshani Patel, Michal Tzadok, Firas Fahoum, Charles Gordon, Riem El Tahry

P5.1-007

High Frequency Stimulation of the Centromedian Thalamic Nucleus to Abort Seizures and Interictal Discharges During Stereoelectroencephalography

Evaluation – Cody Louis Nathan, Scott K. Adney, Joshua M. Rosenow, Stephan Schuele, Elizabeth Gerard

P5.1-008

Ictal Thalamic Recordings in Patients with Deep Brain Stimulation Targeting Thalamic NucleiIdentify whether ictal thalamic EEG signals could be derived from ambulatory recordings in patients with pharmacoresistant epilepsy treated with deep brain stimulation (DBS) targeting either bilateral anterior thalamic nuclei (ATN) or centromedian nuclei (CMN) – Lea Saab, Jasmine W. Jiang, Imran H. Quraishi, Aline Herlopian

P5.1-009

Is there a difference in reduction of seizure frequency between transcutaneous and traditional VNS? – Caio Pluvier Duarte Costa, Jonadab Dos Santos Silva, Henrique Jannuzzelli Prado, Isabella D’Andrea Meira

P5.1-010

Deep Brain Stimulation in Hemimegalencephaly with Medically Intractable Epilepsy: A Case Report – Delini Sivakumar, Nada Ahmed, Andrea S. Hakimi

P5.1-011

A Single-Center Evaluation of Responsive Neurostimulation as Treatment for Drug-resistant Epilepsy – Sean Thomas Beattie, Gloria Isabel Ortiz Guerrero, Utku Uysal

P5.1-012

An educational intervention to improve the efficacy of responsive neurostimulation scans: a single-center study – Mohammad Abughanam, Roohi Katyal, Camilo A. Gutierrez, Stephanie Hsinyun Chen

2

Education, Research, and Methodology

Education, Research, and Methodology: Diversity, Equity, and Inclusion Pertaining to Faculty and an Academic Career

P5.2-001

Impact of Gender and Race on Academic Achievements for Neurology Faculty – Sima I. Patel, Parneet Kaur Grewal, Christa O’hana San Luis Nobleza, Neishay Ayub, Doris Kung, Suma Shah, Myriam Abdennadher, Halley Alexander, Natasha Frost, Seema Nagpal, Sarah R. Durica, June Yoshii-Contreras, Katherine A. Zarroli, Padmaja Sudhakar, Chen Zhao, Sol T. De Jesus, Deborah Young Bradshaw, Nicole Brescia, Nancy R. FoldvarySchaefer, Laura Marie Tormoehlen, Sneha Mantri, Laurie Gutmann, Ailing Eileen Yang, Annie Ziyi He, Cynthia Zheng, Virginia J. Howard, Julie K. Silver, Alyssa Westring, Sasha Alick-Lindstrom, Jane B. Allendorfer

P5.2-002

A Student-Faculty Collaboration for Authentic Teaching of the Effects of Discrimination on Brain Health – Breanna Chachere, Jalyce Taylor, Ashlynn Mills, Kennedi Wilson, LeChauncy Woodard, Thomas Thesen

P5.2-003

Creation of a Faculty Development Curriculum to Reduce the Impact of Racial/Ethnic Bias on Medical Students – Robert Ian Thompson-Stone, Catherine R. Jay, Ramya Sampath, Racquel Whyte, Melanie Braun

P5.2-004

Feasibility of an Interactive Zoom-based Antiracism Course for Academic Neurology Faculty

– Neishay Ayub, Joshua Ray Tanzer, Ryan Lantini, Rochelle Rosen, Debasree Banerjee

P5.2-005

Academic Vascular Neurology - Lingering Effect of Gender Inequity on Compensation, Career and Burnout – Annie Ziyi He, Christa O’hana San Luis Nobleza, Cynthia Zheng, Sima I. Patel, Sasha AlickLindstrom, Neishay Ayub, Parneet Kaur Grewal

P5.2-006

Parental Leave Experience for Academic Neurology Faculty at 19 Academic Centers –Annie Ziyi He, Parneet Kaur Grewal, Kamala Marie Rodrigues, Suma Shah, Halley Alexander, Ailing Eileen Yang, Neishay Ayub, Christa O’hana San Luis Nobleza, Doris Kung, Natasha Frost, Seema Nagpal, Sarah R. Durica, Julie K. Silver, Sima I. Patel, Jane B. Allendorfer, Sasha Alick-Lindstrom

3 MS and Inflammatory Disease

MS Prognosis/Epidemiology

P5.3-001

The Risk of Secondary Progressive Multiple Sclerosis is Geographically Determined but Modifiable – Sifat Sharmin, Izanne Roos, Steve Simpson-Yap, Charles Malpas, Marina Martinez Sanchez, Tomas Kalincik, and Named Authors of The MSBase Study Group

P5.3-002

Multiple Sclerosis Research Across the African Continent: A Systematic Review – Soonmyung Hwang, Ilena George, Maria Alejandra GarciaDominguez, Vanessa Salasky, Anastasia Vishnevetsky, Dhanashri P. Miskin, Andy Tran, Brian Chiluba, Deanna Saylor

P5.3-003

Most Opticospinal Demyelination is NMOSD, not MS- A 17-year UK Longitudinal Cohort Study –Mirasol Forcadela, Chiara Rocchi, Jay Panicker, Kerry Mutch, Saif Huda, Anu Jacob, Shahd Hassan Mahmoud Hamid

P5.3-004

Effect of endocrine disrupting chemicals on early disease course in Multiple sclerosis – Tzu-ying Chuang, Talia Brianna Feldman, Brian Curran Healy, Shrishti Saxena, Eunnindy Dells Sanon, Taylor Jane Saraceno, Tanuja Chitnis

P5.3-005

Idiosyncrasy in a Spanish-speaking developing country and Employment: study of general population and Multiple Sclerosis – Sandra Vanotti, Maria Sol Román, Lara Bardoneschi, Michael Jaworski III, Loana De Los Santos, Florencia Micaela Daniele, Maria Laura Saladino, Ralph H. B. Benedict, Fernando J. Caceres

P5.3-006

Characteristics of Multiple Sclerosis Patients by Phenotype: A Cross-Sectional Analysis Using the CLIMB Study – Gauruv Bose, Nupur Greene, Brian Curran Healy, Howard L. Weiner, Lisa E. Farnett, Keiko Higuchi, Tanuja Chitnis

P5.3-007

Oral health-related quality of life in multiple sclerosis and neuromyelitis optica spectrum disorder patients from Argentina – Veronica A. Tkachuk, Alberto Rafael Aguirre, Juan Ignacio Cao, Debora Nadur, Santiago Isa, Maria Eugenia Balbuena, María Del Pilar Perachino, Edgar Carnero Contentti

P5.3-008

Investigating the Prevalence of Psychiatric Disorders in Multiple Sclerosis with Autoimmune Comorbidities – Shin Chang, Plyfaa SuwanamalikMurphy, Jenna Okazaki, Donovan Roy, Masako Matsunaga, Connor Goo, Enrique Carrazana, Jason Viereck, Kore K. Liow

P5.3-009

Symptom Severity in Early-stage Relapsing Remitting Multiple Sclerosis – Susana Sainz de la Maza, Rocío Gómez, Mónica Borges Guerra, Jesus Manuel Martin Martinez, Javier Sotoca Fernandez, Ana María Alonso Torres, Ana Belen Caminero Rodriguez, Laura Borrega Canelo, Jose Luis Sanchez Menoyo, Francisco Barrero-Hernandez, Carmen Calles, Luis Brieva Ruiz, Rosario Blasco Quilez, Julio Dotor Garcia-Soto, Maria Campo Amigo, Laura Navarro, Eduardo Aguera Morales, Moises Garces Redondo, Olga Carmona, Gabaldon Torres Laura, Lucía Forero, Mariona Hervas Pujol, Jorge Maurino, Tamara Castillo-Trivino

P5.3-010

Correlations Between Early MRI Parameters and Long-term Clinical Outcomes in Phase 3 and Open-label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis – Douglas L. Arnold, Leorah Aude Emmanuelle Freeman, Hans-Peter Hartung, Xavier Montalban, Jeffrey Alan Cohen, Amit Bar-Or, Lawrence Steinman, John DeLuca, Chun-Yen Cheng, Jon V. Riolo, Diego Silva, Chahin Pachai, Bruce A. C. Cree

P5.3-011

Long-term Survival in Multiple Sclerosis is Improving – Stig Wergeland, Janne Mannseth, Sari Atula, Lars Forsberg, Anna Glaser, Hanna Joensen, Melinda Magyari, Merja Soilu-Hanninen, Matias Viitala, Jan A. Hillert, Nina Grytten

P5.3-012

Use of individual measure and Z-scores to monitor disease course in Relapsing Multiple Sclerosis: A 1-year Prospective Study in a Single Center –Luis Rafael Solís-Tarazona, Salma Reddam, Sara Gil-Perotin

P5.3-013

Serum metabolic profile in early multiple sclerosis as predictor of long-term disease progression in BENEFIT – Marianna Cortese, Xiaojing Peng, Kjetil Bjornevik, Clary B. Clish, Gilles Edan, Mark S. Freedman, Hans-Peter Hartung, Xavier Montalban, Rupert Sandbrink, Ernst-Wilhelm Radue, Frederik Barkhof, Eva-Maria Wicklein, Ludwig Kappos, Kassandra L. Munger, Alberto Ascherio

P5.3-014

Cognitive Processing Speed Predicts Disability Milestones in Multiple Sclerosis – Danielle Marie Howard, Hrishikesh A. Lokhande, Brian Curran Healy, Virginia De Las Heras Revilla, Sophie Arnould, Bonnie Glanz, Jonathan D. Zurawski, Mariann Polgar-Turcsanyi, Taylor Jane Saraceno, Howard L. Weiner, Tanuja Chitnis

P5.3-015

Baseline predictors of disability worsening among patients wth a Clinically Isolated Syndrome – Enric Monreal Laguillo, José Ignacio Fernández Velasco, Susana Sainz de la Maza, Noelia Villarrubia, Mercedes Espiño, Fernando Rodriguez Jorge, Juan Luis Chico-Garcia, Jaime Masjuanvallejo, Lucienne Costa Costa-Frossard Franca, Luisa M. Villar

P5.3-016

Serum Glial Fibrillary Acidic Protein compared with Neurofilament Light Chain as Biomarker for Multiple Sclerosis Disease Progression – Stephanie Victoria Meier, Pascal Benkert, Aleksandra Maleska Maceski, Sabine Schaedelin, Johanna Oechtering, Lester Melie-Garcia, Alessandro Cagol, Muhamed Barakovic, Riccardo Galbusera, Lutz Achtnichts, Patrice LaLive, Claire Bridel, Stefanie MuellerSchunk, Caroline Pot, Anke Salmen, Giulio Disanto, Chiara Zecca, Ahmed Mohamed Taha Abdelhak, Christian Barro, Simon Thebault, Marcus D’Souza, Tobias Derfuss, Annette Orleth, Michael Khalil, Oezguer Yaldizli, Marco Hermesdorf, Heinz Wiendl, Fredrik L. Piehl, Urs Martin Fischer, Ludwig Kappos, Claudio Gobbi, Cristina Granziera, David Leppert, Eline AJ Willemse, Jens Kuhle

P5.3-017

Predicting the Final Clinical Phenotype after the First Attack of Optic Neuritis – Shlok Sarin, Nikhil Modak, Rongyi Sun, Mhd. Omar Subei, Alessandro Serra, Michael L. Morgan, Hesham Ahmed Abboud

P5.3-018

Patterns and Predictors of Multiple Sclerosis

Phenotype Transitions: A Longitudinal Analysis Using the CLIMB Study – Gauruv Bose, Nupur Greene, Brian Curran Healy, Howard L. Weiner, Lisa E. Farnett, Keiko Higuchi, Tanuja Chitnis

4 General Neurology

General Neurology: Case Reports 2

P5.4-001

Two Cases of Anti-PD1 Antibody Associated Neurological Immune-Related Adverse Effects –Grace Elizabeth Vitek, Harjot Hansra

P5.4-002

From WEMINO To WEBINO With Unilateral LMN Facial Palsy – Yasodara Priyadharsi Senthamarai Siddharthan, Michael Andrew Witt, Tonse Ashwini Kini, Rani Priyanka Vasireddy, Vishakhadatta Mathur Kumaraswamy

P5.4-003

Neurological Manifestations in Post Renal Transplant Patients at Sindh Institute of Urology and Transplantation, Pakistan – Sadia Nishat, Mughis Sheerani

P5.4-004

CT IR Cyst Lumbar Rupture Efficacy (CIRCLE): A case series – Katrina Bernardo, Ajay K. Misra

4 General Neurology

General Neurology: Clinical Practice 1

P5.4-005

Direct Clinical Applications of Natural Language Processing in Common Neurological Disorders: A Systematic Review – Ilana Lefkovitz, Samantha Walsh, Leah Blank, Nathalie Jette, Benjamin R. Kummer

P5.4-006

Validation of a Neurofilament Light Chain Assay on a Clinical Autoanalyzer – Bradley Collier, Andre Valcour, Joseph Volpe, Russell Grant

P5.4-007

The Frequency of Symptoms in Patients with a Diagnosis of Degenerative Cervical Myelopathy: Results of a Scoping Review – Lindsay Tetreault, Elina Zakin

5 Autoimmune Neurology

Autoimmune Neurology: Autoimmune Encephalitis / Paraneoplastic Neurologic Disorders 1

P5.5-001

Refractory anti-NMDA Receptor Encephalitis

During Pregnancy: Treatment and Neonatal Outcome with Review of Literature – Brandon J. Lew, Afsaneh Shirani, Lakshman Narain Arcot Arcot Jayagopal

P5.5-002

Persistent meningitis followed by anti-NMDAR encephalitis: case series and literature review –Naoki Yamahara, Nobuaki Yoshikura, Akio Kimura, Takayoshi Shimohata

P5.5-003

Whole-exome sequencing shows no specific mutation in ovarian teratoma of NMDAR-antibody encephalitis – Yoonhyuk Jang, Soo Hyun Ahn, Kwanghoon Lee, Kyung Il Park, Sang Kun Lee, Kon Chu, Cheol Lee, JaeKyung Won, Soon-Tae Lee

P5.5-004

A Case series with comparative analysis of children and young adults with Anti-N-Methyl-DAspartate Receptor Encephalitis – Rani Priyanka Vasireddy, Qutubuddin G. Khan, Zain Guduru

P5.5-005

Characteristics and Treatment of anti-NMDAR Encephalitis in People Living with HIV: A Case Report and Literature Review – Emily I. White, Cayla Vila, Stephanie L. Bissonnette, Sergi MartinezRamirez, Pria Anand, Anna Marisa CervantesArslanian

P5.5-006

Longitudinal clinical outcomes, cognitive impairment, and mood symptoms in anti-NMDAR encephalitis – Annalisa Morgan, Yadi Li, Nicholas Thompson, Alexander D. Rae-Grant, Justin Abbatemarco, Vineet Punia, Stephen Hantus, Rachel Galioto, Amy Kunchok

P5.5-007

Epidemiological and Demographic Characteristics Related to Social Determinants of Health in Patients with Anti-NMDAR Encephalitis – Sarah Shapiro, Melissa Ann Wright, Trieste Francis, Sama Noroozi Gilandehi, Tammy L. Smith, Ka-Ho Wong, Stacey Clardy

P5.5-008

Anti-NMDAR encephalitis mimicking rapidly progressive neurodegenerative disorder in a toddler: a case report – Linda Nguyen, Marie Varnet, Cynthia X. Wang

P5.5-009

Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis, Already at Diagnosis: The NEOS2 Model . – Juliette Brenner, Anna Bastiaansen, Marlieke De Bruijn, Frank Leypoldt, Jerome Honnorat, Josep O. Dalmau, Takahiro Iizuka, Mareike Jansen, Ina Schroder, Sergio Muniz-Castrillo, Yvette Crijnen, Juna Marcella De Vries, Marco Schreurs, Amaia Munoz, Mar Guasp, Peter Sillevis Smitt, Maarten Jan Titulaer

P5.5-010

Post-Abortum NMDA Encephalitis – Rozaleen Aleyadeh, Eduardo Inacio Nascimento Andrade, Zakir Iqbalbhai Shaikh, Abigail Suprova Bose, Raffaella Umeton

P5.5-011

Diagnostic Challenges in Pediatric Anti-NMDA Receptor Encephalitis – Melissa Ann Wright, Suzanne Liu, Ka-Ho Wong, Sama Noroozi Gilandehi, Sarah Shapiro, Tammy L. Smith, Lisa Kay Peterson, Stacey Clardy

P5.5-012

Missing Piece of Puzzle: Electro-Convulsive Therapy (ECT) in Patients with anti-NMDA Receptor Encephalitis – Lara Carine Wadi, Vishal Mandge

P5.5-013

Biomarkers of Neuronal and Glial Injury in LeucineRich Glioma Inactivated-1 (LGI1) Autoimmune Encephalitis Patients: A Pilot Study – Tyler Lee Borko, Christopher Steven Mizenko, Ryan Kammeyer, Alanna Marie Ritchie, Sean Selva, Britney Barrera, Brooke L. Valdez, Stefan Sillau, Gregory Owens, Timothy L. Vollmer, Kavita Nair, Jeffrey L. Bennett, Amanda Lee Piquet

P5.5-014

A Pediatric Case of LGI1 Autoimmune Encephalitis Presenting with Faciobrachial Dystonic Seizures –Cheryl Fields, Nagma Dalvi, Susan Erin Duberstein Coad, Donya Eizadkhah, Solomon L. Moshe

P5.5-015

Monitoring Faciobrachial Dystonic Seizures with Wearable Devices – Richard Cui, Louis Faust, Boney Joseph, Divyanshu Dubey, Benjamin Henry Brinkmann

P5.5-016

Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis

– Saskia Raeuber, Christina Barbara Schroeter, Christine Strippel, Gerd Meyer Zu Horste, Nico Melzer

P5.5-017

Structural Lesion Facade Hiding an Insidious Autoimmune Encephalitis – Doris Xia, Claude Steriade, Elina Zakin, Blanca R. Vazquez

P5.5-018

New method to detect a diagnostic marker antiNH2–terminal of a–enolase autoantibody for Hashimoto’s encephalopathy – Makoto Yoneda, Rinako Nakayama, Akiko Matsunaga, Kazuyoshi Togashi

P5.5-019

Prognosticating Outcomes in Patients with CRMP5-IgG Associated Paraneoplastic Neurologic Disorders – Sanem Pinar Uysal, Yadi Li, Nicholas Thompson, Devon Conway, Kerry H. Levin, Amy Kunchok

P5.5-020

Sudden Death in Autoimmune GFAP Astrocytopathy – Bishow Chandra Mahat, Katharine Dermigny, Lamees H. Alzyoud, Madison Pilato

P5.5-021

Incidental Detection of Anti-IgLON5: A Diagnostic and Therapeutic Dilemma – Samir Alkabie, Brian James Murray, Adrian Budhram

P5.5-022

Diaphragmatic paralysis associated with IgLON5 autoimmunity – Smathorn Thakolwiboon, Christopher J. Klein, Divyanshu Dubey

P5.5-023

An Atypical Presentation of GABA-B Encephalitis –Mac DeHart-McCoyle, Zhi-Jian Chen

P5.5-024

Case Report of Anti-DPPX Encephalitis: Diagnostic Challenges in Hematologic-Oncologic Comorbidities – Emily Rose Fisher, Kalina Misiolek, Monica Buckley

P5.5-025

Anti-Tr/DNER Paraneoplastic Cerebellar Degeneration with Marked Cerebellar and Psychological Symptoms Responsive to Plasma Exchange – Paul Daniel Crane, DonRaphael Pratt Wynn, L Dana DeWitt, John E. Greenlee

P5.5-026

Paraneoplastic Neurologic Syndromes with ANNA-2/anti-Ri: a Contrasting Story of Two Cases – Nanthaya Tisavipat, Bryce Chang, Farwa Ali, Sean J. Pittock, Eoin P. Flanagan

P5.5-027

Clinical features and biomarkers of acute encephalitis with claustrum sign – Takayoshi Shimohata, Akira Takekoshi, Kimihiko Kaneko, Juichi Fujimori, Tetsuya Ioku, Keisuke Imai, Akio Kimura

P5.5-028

Anti-IgLON-5 Associated Neurological Disease Presenting with Bilateral Optic Neuritis, Orthostatic Intolerance, Sleep-Related Movements in Setting of Testicular Mass: Expanding Clinical Phenotypes in the Disease – Aditi Vian Varma-Doyle, Bart Chwalisz, Jenny Linnoila

P5.5-029

Clinical Manifestation, Auxiliary Examination Features and Prognosis of GFAP Autoimmunity:a

Chinese Cohort Study – Lei Liu, Jingxiao Zhang

P5.5-030

A Rare Case of Anti-SOX1 Antibody Positive Paraneoplastic Cerebellar Degeneration in Prostate Cancer – Hadi Mohammad Khanli

P5.5-031

Expanded Spectrum of Gad-65 Associated Autoimmune Encephalitis in Pediatric Patients . –Geetanjali Singh Rathore

P5.5-032

Pediatric CLIPPERS? Think Again! – Daniel Zhou, Mohamed Darwish, James B. Ford, Sachit Patel, Sookyong Koh, Geetanjali Singh Rathore, Rana K. Zabad

6

Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Emerging Topics in Alzheimer’s Disease

P5.6-001

Decline in Visual and Posterior Cortical Functions in Logopenic Progressive Aphasia – Neha Atulkumar Singh, Jonathan Graff-Radford, Arenn Faye Carlos, Mary M. Machulda, Christopher Schwarz, Matthew Senjem, Clifford R. Jack, Val John Lowe, Keith A. Josephs, Jennifer Louise Whitwell

P5.6-002

Beyond impairment of language: empathy deficit in logopenic variant of Primary Progressive Aphasia

– Giulia Giacomucci, Cristina Polito, Valentina Berti, Sonia Padiglioni, Giulia Galdo, Salvatore Mazzeo, Enrico Bergamin, Valentina Moschini, Carmen Morinelli, Claudia Nuti, Maria Teresa De Cristofaro, Silvia Bagnoli, Benedetta Nacmias, Sandro Sorbi, Valentina Bessi

P5.6-003

Prevalence of Amyloid-Related Imaging

Abnormalities in APOE4/4 Homozygotes with Early Alzheimer’s Disease: Baseline Findings from Ongoing Clinical Trials of Oral Anti-Amyloid Agent

ALZ-801 (Valiltramiprosate) – Sawsan (Susan) R. Abushakra, Rosalind Mandelbaum, Jerome Barakos, Philip Scheltens, Anton P. Porsteinsson, David Watson, J Emer MacSweeney, Marwan N. Sabbagh, Earvin Liang, Patrick Kesslak, Joyce Suhy, Aidan Power, John A. Hey, Martin Tolar

P5.6-004

A Novel Presenilin-1 Mutation Associated with Dementia and Spastic Paraplegia – Bridget Ollesch, Nicholas A. Frost, Jumana Tariq A Alshaikh

P5.6-005

Clinical and Imaging Features of Early Onset

Alzheimer’s Disease with a SORL1 Nonsense Variant

– Conor T. Flavin, Christine Cliatt Brown, Jared Bartell, Emily Spoth, Satoshi Minoshima, Paolo M. Moretti

P5.6-006

Eligibility for Anti-Amyloid Treatment in a Population-Based Cohort Study of Aging – Rioghna R. Pittock, Jeremiah Aakre, Anna Castillo, Vijay K. Ramanan, Clifford R. Jack, Prashanthi Vemuri, David S. Knopman, Ronald C. Petersen, Jonathan GraffRadford, Maria Vassilaki

P5.6-007

Early engagement with the Alzheimer’s disease community to gain insights into designing the SKYLINE trial for pre-symptomatic Alzheimer’s disease– Gesine Respondek, Fiona Rose, Nancy Lynn, Jessica Langbaum, Carolyn Langlois, Emma Dodd, Jannice Roeser, Susanne Ostrowitzk

P5.6-008

A positive feedback loop between chronic lysosomal dysfunction and circRNAs in Alzheimer’s disease mouse models – Skarleth Cardenas

Romero, Abdallah M. Eteleeb, Niko Nykanen, Kevin O’Dell, Marie Sutherland Nunez, Oscar Harari, John Cirrito, Mark Sands, Bruno Benitez

P5.6-009

Identifying The Normal Function of Amyloid-Beta and Its Role in Alzheimer’s Disease – Rachel Hunsucker, Hani Atamna, Triet Vo

P5.6-010

Associations Between CDR-Global and Meaningful Outcomes in Patients with Alzheimer’s Disease –Merce Boada Rovira, Krista Lanctot, Pierre Tariot, Firas Dabbous, Julie Hviid Hahn-Pedersen, Lars Lau

L. Raket, Sariya Udayachalerm, Cynthia SaiontzMartinez, Wojciech Michalak, Luis Rafael SolísTarazona, Jeffrey Lee Cummings

P5.6-011

Medial Temporal Tau Predicts Memory Decline in Cognitively Unimpaired Elderly – Angela T.H. Kwan, Saman Arfaie, William Joseph Therriault, Zahra Azizi, Firoza Zubeida Lussier, Cecile Tissot, Mira Chamoun, Gleb Bezgin, Stijn Servaes, Jenna Stevenson, Nesrine Rahmouni, Vanessa Pallen, Pedro Rosa Neto

7

Neuro Trauma and Critical Care

Neurocritical Care: Acute Brain Injuries

P5.7-001

Elucidating Mechanism of Ammonia Toxicity Using Cortical Organoids – Shawn Michael Barton, Alexia King, Anson Sing, Maureen McGuirk Sampson, Steven Sloan

P5.7-002

Predictors Of Outcome In ICH Patients Initially Admitted To The ICU Who Are Transferred To Inpatient Rehab – Mohammad Jamil Ahmad, Muhammad Bilal Tariq, Christin Silos, Anna Hernandez, Gloria Contreras, Sean I. Savitz

P5.7-003

Antidepressant Use and Associations with Delirium in Patients with Intracerebral Hemorrhage –Helen Yin Zhou, Seth Margolis, Lori Daiello, James Rudolph, Richard Jones, Michael E. Reznik

P5.7-004

Acute Loss Of Brain Stem Reflexes Following Intracranial Hemorrhage – Stefano Malerba, Matthew Sontag Davitz, Shanna Patterson, Sarah E. Nelson, Spyridoula Tsetsou

P5.7-005

Clinical Trajectories in Patients with Severe Acute Brain Injury Requiring Mechanical Ventilation: A Descriptive Analysis of a Single-Center Prospective Observational Cohort Study – Natalie Smith, Adrienne James, Nassim Matin, Kasra Sarhadi, James A. Town, Claire Creutzfeldt, Chiara Robba, Giuseppe Citerio, Abhijit Lele, Sarah Wahlster

P5.7-006

Long-Term Trajectories Following Severe Acute Brain Injury Requiring Mechanical Ventilation: A Mixed-methods Study to Assess Outcomes of Patients and Their Surrogate Decision-Makers

– Sarah Wahlster, James A. Town, Nassim Matin, Natalie Smith, Adrienne James, Nicole Mazwi, Robert Bonow, Abhijit Lele, Erin Kross, Claire Creutzfeldt

8

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Autoimmune, Multisystem, and Mitochondrial Neuromuscular Disorders

P5.8-001

Development and Validation of Machine

Learning and Electronic Medical Records-Based Characterization of Stiff Person Syndrome – Soo Hwan Park, Seo Ho Song

P5.8-003

Autoimmune Isaac’s Syndrome With CASPR2 Antibodies Secondary To Mercury Toxicity –Anooshah Ata, Nadia Khalil, Neena Viswanathan, Sanita Raju, Anthony M. Bradshaw, Rebecca L. Hurst, Alfred T. Frontera

P5.8-004

Multisystem Proteinopathies (MSP) and MSPlike Disorders: Clinical-Pathological-Molecular Spectrum and Long-term Follow Up – Pitcha Chompoopong, Bjorn E. Oskarsson, Nicolas N. Madigan, Igal Mirman, Jennifer Marie MartinezThompson, Teerin Liewluck, Margherita Milone

P5.8-005

Clinical and Electrophysiological Presentation of a Patient with Multisystem Proteinopathy Associated with Valosin-Containing Protein Mutation –Matthew Halber, Sabrina Bulancea, Simona Treidler

P5.8-006

Investigation of the Circulating Cell-free Mitochondrial DNA in Inflammation Related Neuromuscular Diseases – Ayse Tulay Aydinoglu, Evrim Aksu-Menges, Can Ebru Kurt, Sevim ErdemOzdamar, Ersin Tan, Burcu Balci-Hayta

P5.8-007

A Rare Case of Kearns-Sayre Syndrome (KSS) with the Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS)

Phenotype – Shrikant Mishra, Shaweta Khosa, Bhavesh Trikamji

P5.8-008

Progressive Longitudinally Extensive Myelopathy following Stroke in a Patient later found to have m 14484T>C Mutation in Leber’s Hereditary Optic Neuropathy (LHON) gene – Kathryn Eszes, Lawrence M. Samkoff, Jordan Bontrager

P5.8-009

Atypical Presentation of MELAS in a 7-yearold Male: A Case Report – Clare Elise Schrodt, Muhammad Khurram Afzal, Jafar Kafaie 8

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Inherited Muscle Disorders 2

P5.8-010

Twelve-month functional change in Limb Girdle Muscular Dystrophy R9 / 2I – Nicholas Elwood Johnson, Kameron Bates, Han Xie, Lindsay N. Alfano, John Vissing, Tahseen Mozaffar, Katherine D. Mathews, Linda Pax Lowes, Matthew P. Wicklund, Conrad Weihl, Doris G. Leung, Peter B. Kang, Carla D. Zingariello, Urvi G. Desai, Erin DeSpain, Mary St. Romain, Jeffrey Statland

P5.8-011

Muscle Ultrasound in an Open-Label Study of Losmapimod in Subjects with FSHD1 – Joost Kools, Nicol Voermans, Karlien Mul, John Jiang, Jennifer Shoskes, Kelly Marshall, Markus Karlsson

P5.8-012

EMBARK, a Phase 3 Trial Evaluating Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Duchenne Muscular Dystrophy (DMD): Study Design and Baseline Characteristics

– Francesco Muntoni, Eugenio Mercuri, Ulrike Schara Schmidt, Hirofumi Komaki, James Antony Richardson, Tejdip Singh, Maitea Guridi, Stefanie Mason, Alexander Peter Murphy, Lixi Yu, Carol Reid, Eddie Darton, Christoph Wandel, Jerry R. Mendell

P5.8-013

Analysis of Vector Shedding Following Treatment with Delandistrogene Moxeparvovec (SRP-9001), an Investigational rAAVrh74-Based Gene Therapy for Duchenne Muscular Dystrophy (DMD) – Jyoti Malhotra, Elizabeth Stone Smith, Sarah Lewis, Xiaolan Zhang, Damon Asher, Shufang Wang, Lilly East, Rachael Potter, Louise R. Rodino-Klapac

P5.8-014

Motor Performance and Lower Extremity Fat Fraction in Myotonic Dystrophies Type 1 and Type 2, and Controls – Diana Alejandra Madrid, Rebecca Knapp, Paula R. Clemens, Ashley A. Weaver, Araya Puwanant

P5.8-015

Caregivers Perspectives on Multidisciplinary Clinic Visits for Duchenne and Becker Muscular Dystrophy – Aravindhan Veerapandiyan, Cade Haynie, Tiffany Boyd, Ellen PPMD, Rachel Schrader, Ryan Fischer

9

Health Care Disparities

Health Care Disparities: Education, Social Work, Access

P5.9-001

Social Work in Outpatient Neurology at a SafetyNet Hospital: A 200-Hour Profile – Cayla Vila, Jenny Madsen, Pria Anand, K. H. Vincent Lau

P5.9-002

US Census Tracts with Higher Proportions of Hispanics, Individuals with Disabilities, and Rural Location have Worse Geospatial Access to Neurological Care – Marisa P. McGinley, Tucker Harvey, Daniel Ontaneda, Robert Blake Buchalter

P5.9-003

Diversity, Equity, and Inclusion (DEI) Curriculum for Neurology Residency Program – Diana Andino, Sean D. Ruland, Anam Syed, Fady Mousa-Ibrahim

P5.9-004

Diversity, Equity, and Inclusion in Local Clinical Trials – Saketh Annam, Solmaz Ramezani Hashtjin, Shayan Khan, Abbey Staugaitis, Christopher Streib

P5.9-005

The Impact of Establishing a Diversity, Equity, and Inclusion Committee in a Single US Adult Neurology Residency Program – Mathura Ravishankar, Keiko Aun Fukuda, Lamees H. Alzyoud, Priya Nidamanuri, Rebecca Pollard, Anne C. Van Cott, Paula R. Clemens, Alexandria Sadasivan, Page B. Pennell, Ajitesh Ojha

P5.9-006

Broad Inclusion of Roles for a Neurology Department Diversity, Equity, and Inclusion Committee: Working Towards a Future of DEI Throughout Medicine – Olajide Abiola, Andrea Lendaris, Emma Wallace, Cynthia Emilie Armand, Amelia Bartolomeo, Eleni Drakou, Charles Esenwa, Nana Keita Fofana, Jonathan Gursky, Liane E. Hunter, Fabreena Napier, Jelena M. Pavlovic, Elise Poole, Apirada Thongsing, Maria Vlasaty, Jessica Zwerling, Erica Weiss, Daniel Jose Correa

9 Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Movement Disorders

P5.9-007

Increasing Ecopipam Exposure Improves Yale Global Tic Severity Scale-Total Tic Scores (YGTSS-TTS) in Children and Adolescents with Tourette Syndrome (TS): Results from a Population Pharmacokinetic (popPK) Model-Based Simulation Using D1AMOND Trial Data – Soha Rida Freidy, Teodora Pene Dumitrescu, Virginia D. Schmith, Donald Gilbert, Atul Mahableshwarkar, Jordan Scott Dubow, Timothy Cunniff, David J. Kim, Meredith M. Miller, Stephen Wanaski

P5.9-008

Biofeedback-based Video Game Device to Treat Rage Attacks in Youth with Tourette Syndrome –Matthew Tae, Samantha Paige Myers, Jason Kahn, Nicole Walsh, Emily Ann Stone, Alyssa L. Peechatka, Jessica Ragnio, Jonathan W. Mink, Jennifer Anne Vermilion

P5.9-009

High Dose Clonidine as a Novel Therapy for Symptomatic Status Dystonicus in a Pediatric Patient – Sean Bradley Woods, Erika Beth Chandler, Christopher Ryan Barton

P5.9-010

Pediatric opsoclonus myoclonus ataxia syndrome in the setting of COVID-19 – Maayan Joy Yakir, Dana Most, Jonathan Alexander Hermel, Michael Richard Zimbric, Jennifer R L Friedman, Jong Rho

P5.9-011

Painful Hemidystonia - A Rare Presentation of Uremic Encephalopathy – Manasa Sudheendra, Mariam Hull

P5.9-012

Identifying Upper Extremity Features of Dystonia in People with Cerebral Palsy – Laura Gilbert, Sushma Gandham, Toni Pearson, Keisuke Ueda, Bhooma Rajagopalan Aravamuthan

Infectious Disease

Infectious Disease: COVID-19

Observations

P5.10-001

The Experience of The COVID-19 Pandemic in a Population-Based Study of Cognitive Aging –Khaled Ghoniem, Jeremiah Aakre, Anna Castillo, Mohamed Elminawy, Mary M. Machulda, Yonas E. Geda, Prashanthi Vemuri, Clifford R. Jack, Jonathan Graff-Radford, David S. Knopman, Ronald C. Petersen, Maria Vassilaki

P5.10-002

COVID-19 Induced Elimination of First Taste

Phenomenon – Drushti Deepak Birwatkar, Shweta Kalita, Alan R. Hirsch

P5.10-003

Neurological manifestations in COVID-19 survivors: Observations in one of the largest only COVID-19 centers in México . – Raul Anwar Garcia Santos, Monica Saray Rodríguez, Diana Lopez Gonzalez

P5.10-004

The Analysis of 607 Volunteers Shows a Reduction of Workability in Individuals With LONG-COVID Syndrome Associated With Neuropsychiatric Symptoms – Gabriel Monteiro Salvador, Mateus Nogueira, Lucas Scárdua Silva, Italo Karmann Aventurato, Fernando Cendes, Marcia Bandini, Antonio De Cesare Del Nero, Clarissa L. Yasuda

P5.10-005

Body mass index and its association with COVID-19 clinico-neurological outcomes: Findings from the Philippine CORONA study – Adrian Isidoro Espiritu, Nikolai Gil Diwa Reyes, Carl Froilan Leochico, Marie Charmaine Cootauco Sy, Emilio Villanueva III, Michelle Anlacan, Roland Dominic Jamora

P5.10-006

Men with dementia are at increased risk of allcause mortality following SARS-CoV-2 Vaccination

– Jongmok Ha, Suyeon Park, Hyunwook Kang, Taeeun Kyung, Namoh Kim, Dong Kyu Kim, Hyeonjoon Kim, Kihoon Bae, Min Cheol Song, Kwang June Lee, Euiho Lee, Beom Seuk Hwang, Kunhee Park, Jin Myoung Seok, Jinyoung Youn

11 Movement Disorders

Movement Disorders: Environmental Factors and Phenotyping Parkinsonisms 1

P5.11-001

Antibiotic exposure and risk of Parkinson’s disease in the United Kingdom: A case-control study

– Gian D. Pal, Laura Bennett, Jason Roy, Abner Nyandege, M. Maral Mouradian, Tobias Gerhard, Daniel Horton

P5.11-002

Neurophysiological Measures can be Used as Stratification Tool for Parkinson’s Disease

Subtypes – Inbal Maidan, Anat Mirelman

P5.11-003

Categorizing Movement Disorders Associated with Toxic Exposures at Camp Lejeune Military Base

– Jacqueline Hirschey, Kalea Lynn Colletta, Amna Amad Siddiqui, Ashley Raedy, Frances Weaver, Sandra Kletzel

P5.11-004

Assessing the swallow tail sign in a real life scenario – Maria Agustina Ruiz Yanzi, Michele Matarazzo, Elena Natera-Villalba, Jose A PinedaPardo

P5.11-005

Partially reversible bilateral Lenticular fork sign and acute Parkinsonism in diabetic uremic syndrome – Yazan Nofal, Zeba Noorain, Abeer Safan, Gholam Adeli, Tag-Eldin Sokrab

P5.11-006

Amyloid plaque burden and dual tasking impairments on the Timed up and go test in Parkinson disease – Ashley Harrie, Benjamin Hampstead, Catherine Lewis, Emily Herreshoff, Vikas Kotagal

P5.11-007

DaT Scan Positive Parkinson’s Disease in a Patient with Anti-MuSK Positive Myasthenia Gravis – Gina Marina Andraos, Venka Veerappan

11 Movement Disorders

Movement Disorders: Essential Tremor and Other Tremor Disorders 1

P5.11-008

Treatment Perceptions and Decision-Making Among Physicians Treating Essential Tremor –Margaret Gerbasi, Rodger J. Elble, Eddie Jones, Alexander James Gillespie, John Jarvis, Elizabeth Chertavian, Zachary James Smith, Kemi Bankole, Sriram Shankar, Ludy Chen Shih

P5.11-009

Fragile-X-associated Tremor/Ataxia Syndrome in a Woman with Full Mutation: A Case Report – Serdar Kazanci, Elizabeth M. Berry-Kravis, Deborah Hall

P5.11-010

Palato-ocular synchrony: Seeing what is behind closed eyelids in palatal tremor – Stephen G. Reich, Daniel R. Gold

P5.11-011

Cyst Formation following DBS Electrode Placement: A Rare Complication – Su Htet Htet Naing, Sidish Venkataraman, Stephen B. Tatter, Adrian Laxton, Mustafa S. Siddiqui

P5.11-012

Does chromosome 16p12 1-p12 2 harbor a novel gene for essential tremor? – Talita D’Aguiar Rosa, Muhammad Ismail Khalid Yousaf, Peter Hedera

11 Movement Disorders

Movement Disorders: Surgical Therapies for Parkinson’s Disease 2

P5.11-013

Utilization of intraoperative Subthalamic Nucleus local field potential recordings to guide postoperative Deep Brain Stimulation programming in Parkinson’s disease – Shumaila Anwer, Thomas James Paxton, Shervin Rahimpour, Jumana Tariq A Alshaikh, D. James Ballard, John D. Steffens, Meghan Zorn, Panagiotis Kassavetis

P5.11-014

Association of Subthalamic Beta Frequency Sub-bands to Symptom Severity in Patients with Parkinson’s Disease: A Systematic Review –Rebekah Summers, Nathan Morelli

P5.11-015

Patient perceptions and knowledge of Deep Brain Stimulation (DBS) in Parkinson’s disease (PD) (KNOW-DBS) – Shilpa Chitnis, Bilal Haque, Nida Jasmein Ahmed, Austin Oblack, Meagen Salinas, Bradley McDaniels, Nader Pouratian, Umar Yazdani

P5.11-016

Are Cognitively Impaired Patients Selectively Recruited to Pallidal Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD)? – Sarah Marmol, Matthew Feldman, Scott Harcourt, Annelly Buré-Reyes, Dayana Rodriguez, Corneliu C. Luca, Jonathan Jagid, Ihtsham Haq, Marina Sarno

P5.11-017

Real-World Outcomes in USA using DBS Systems with Directionality and Multiple Independent Current Control – Michael S. Okun, Kelly D. Foote, Theresa A. Zesiewicz, Yarema B Bezchlibnyk, Alexander M. Papanastassiou, Jonathan Carlson, Jason Lamar Aldred, Vibhor Krishna, Aristide Merola, Corneliu C. Luca, Jonathan Jagid, Jennifer Lyn Durphy, Leonard Verhagen Metman, Sepehr Sani, Steven Ojemann, Drew S. Kern, David Weintraub, Ritesh Ramdhani, Abdolreza Siadati, Bharathy E. Sundaram, Cong Zhi Zhao, Derek Martinez, Mustafa S. Siddiqui, Stephen B. Tatter, Lilly Chen, Roshini Jain

Aging, Dementia, Cognitive, and Behavioral Neurology

Behavioral and Cognitive Neurology in Clinical Practice

P5.12-001

Improving Early Recognition of Potentially Treatable Causes of Rapidly Progressive Dementia

– Nihal Satyadev, Philip W. Tipton, Yuka Atagi Martens, Steven Richard Dunham, Michael D. Geschwind, John C. Morris, Neill R. Graff-Radford, Gregory S. Day

P5.12-002

Clinical Experience with SATURN, a Public Domain Self-administered Cognitive Screening Test –Maria Florendo, David P. Bissig

P5.12-003

Cognitive Assessment is Feasible After Acute Stroke and Can Identify Co-occurrence of Spatial Neglect – Sabrina Hickle, Janice Convoy-Hellmann, David W. Loring, Jessica Saurman, Karima Benameur, Shilpa Krishnan, Fadi B. Nahab, A. M. Barrett

P5.12-004

The contribution of thalamic pathology to the clinical manifestations of frontotemporal dementia phenotypes – Mary Clare McKenna, Siobhan Hutchinson, Peter Bede

P5.12-005

DOC screen completion time: a novel marker of executive function, speed of processing and fluency – Sajeevan Sujanthan, Alisia Southwell, Arunima Kapoor, Richard H. Swartz

P5.12-006

A comprehensive cognitive profile of patients with cervical dystonia – Madeleine Diepman, Shameer Rafee, Ruth Monaghan, Derval McCormack, Michael Hutchinson, Fiadhnait O’Keeffe

P5.12-007

Towards a Trauma Subtype of Functional Neurological Disorder: Impact on Symptom Severity and Physical Health – David L. Perez, Andrew John Guthrie, Sara Paredes-Echeverri

P5.12-008

The Effects of Anesthesia on Post-Operative Cognitive Dysfunction: A Systematic Review –Rayan Hassan, Eiman Dai, Asma Mustafa, Duaa Nasereldin, Maya Advani, Amal Alamin, Mayra Mezzoni, Shaima Elsheikh, Nadir Adbelrahman

P5.12-009

Analysis of Alzheimer’s Cerebrospinal Fluid Markers in Idiopathic Normal Pressure Hydrocephalus Pre- and Post-High Volume Lumbar Puncture – Lealani Mae Acosta, Amanda Puckett, Anna Pfalzer

P5.12-010

RT-QuIC Testing for Prions: Applying a Sensitive but Imperfect Test in Clinical Practice – Samuel Matthew Jones, Evelyn Lazar, Amanda Lynn Porter, Christian Cameron Prusinski, Matthew Brier, Bob Bucelli, Gregory S. Day

13 Sleep Sleep Therapeutics 2

P5.13-001

Effects of Lower-Sodium Oxybate on 24-Hour Total Sleep Time: Data From a Phase 3 Clinical Study in Adults With Idiopathic Hypersomnia – Anne Marie Morse, Abby Chen, Teresa Steininger, Wayne Macfadden

P5.13-002

Increased Risk of Hypertension Onset Among Patients With Narcolepsy Newly Treated With High-Sodium Oxybate – Rami Ben-Joseph, Virend Somers, Jed Black, Ralph Dagostino, Ragy Saad, Mat D. Davis, Wayne Macfadden, Katherine Mues, Clark Jackson, Weiyi Ni, Michael Nolan Cook, Julia Pitino, Helen Latimer, Elizabeth C. Dabrowski, William B. White

P5.13-003

Effectiveness and Optimization of Lower-Sodium Oxybate in Participants With Narcolepsy Switching From Sodium Oxybate: Interim Data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav (SEGUE) Study – Eileen Leary, Todd Kirby, Roman Skowronski, Kan Xu, Craig Jeffrey Pfister, Wayne Macfadden

P5.13-004

Patient Preference and Nocturnal Experience With Oxybate Treatment for Narcolepsy: Interim Analysis of Data From RESTORE – Asim Roy, John Harsh, Akinyemi Ajayi, Thomas Patrick Stern, David J. Seiden, Jordan Scott Dubow, Jennifer Gudeman

P5.13-005

Long-Term Safety of Once-Nightly Sodium Oxybate: Interim Analysis of Data From RESTORE

– Thomas Patrick Stern, Asim Roy, Colin Shapiro, John Harsh, Akinyemi Ajayi, Sally Ibrahim, David J. Seiden, Jordan Scott Dubow, Jennifer Gudeman

P5.13-006

Long-term Safety During a Clinical Trial of LowerSodium Oxybate in Participants With Narcolepsy With Cataplexy – Richard K. Bogan, Nancy R. Foldvary-Schaefer, Roman Skowronski, Abby Chen, Michael J. Thorpy

1 Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): Health Care Utilization

P6.1-001

Correlation of Patient-Reported Outcomes Measurement Information System (PROMIS) measures with unplanned healthcare resources utilization (HRU) among patients with epilepsy (PWE): a retrospective cohort study – Alexandra Urban, Laura Anne Kirkpatrick, Vijayalakshmi Rajasekaran, Joanna S. Fong, Janel Hanmer, Anto Bagic, Parthasarathy Thirumala

P6.1-002

Nationwide Patterns of Healthcare Utilization and Health related Quality of Life among US Adults with Epilepsy – Yunting Yu, Alain Zingraff Lekoubou Looti, Kinfe Bishu, Bruce I. Ovbiagele

P6.1-003

An Audit of Electroencephalography Requests to a Tertiary Hospital Neurophysiology Department – Desiree Sasha D’Souza, Stephen Klaus, Emily Feeney, Yvonne Langan

P6.1-004

The Clinical Utility of Long-Term Video-EEG Monitoring in Patients Hospitalized for New-Onset Seizures – Yao Cheng, Fnu Rameez, Shan E. Abbas, David E. Burdette, Evan Christopher Tank, Edward Yuder Chen, Rachel R. Fabris, Erin M. Okazaki, Mohammad Haykal

P6.1-005

Ceribell Use in the Emergent Hospital Setting: Educating Non-Neurologists on its appropriate use, a Quality Improvement Project – Lauren Victoria Hatcher, LynnMarie Jarratt, Annapoorna Bhat

P6.1-006

A Potential Systematic Barrier to Community Health Literacy about Epilepsy Surgery: A Preliminary Readability Analysis of Online Health Education Materials in the United States – Namal Seneviratne, Sophey Ho, Daniel Jose Correa

1

General Neurology

TRANSCENDS Scholarship Recipients

P6.1-007

Female And Minority Participants Are Underrepresented In Stroke Motor Recovery Trials Over The Last Decade – Sara Hassani

P6.1-008

Pesticide’s exposure and early age at onset of VPS35 p A320V mutation carriers – Oswaldo

Lorenzo Betancor

P6.1-009

Generic Polymorphisms to Predict Aneurysm Healing – Dimitri Laurent

P6.1-010

Investigation of Putative Autosomal Dominant Speech Apraxia – Martin Mwangi

P6.1-011

Examination of Racial Disparities in Multiple Sclerosis Clinical Care – Kimystian Harrison

P6.1-012

TRANSCENDS Scholarship Poster Presentation –Jemima Akinsanya 2

Education, Research, and Methodology

Education, Research, and Methodology: Diversity, Equity, and Inclusion Pertaining to Students and Neurology Residents

P6.2-001

Investigating Black/African-American Medical Student Interest in Neurology as a Profession –Krisna Scarlett Maddy, Uche C. Ezeh, Ralph L. Sacco, Teshamae Monteith

P6.2-002

Addressing the Gender Gap in Residency Clinical Awards Using a Structured Blinded Selection Process – Clare McGarvey Lambert, Vanessa Cooper, Reshma Narula, Jeremy Moeller

P6.2-003

Teaching Cognitive Bias in Medical Decision Making to Neurology Residents – Erafat Rehim, Colin M. Smith, Jonathan Cheponis

P6.2-004

Applying Representation Quotient Methodology to Racial/Ethnic and Gender Trends of Applicants and Matriculants to Neurology Residency Programs from 2007–2021 – Elijah Malik Persad-Paisley, Saba S. Paracha, Sanaya Daruvala, Ali Mahta, Neishay Ayub

P6.2-005

Trends in Demographics of Neurology House Staff in the United States – Thirumalaivasan Dhasakeerthi, Carolina Gil Tommee, Abhilash Thatikala, Krishna Nalleballe, Sanjeeva Reddy Onteddu 3

MS and Inflammatory Disease

P6.3-002

Disease Outcomes With Ublituximab in Participants With Highly Active Disease: Subpopulation Analyses of the Phase 3 ULTIMATE I and II Studies in Participants With Relapsing Multiple Sclerosis – Enrique Alvarez, Lawrence Steinman, Hans-Peter Hartung, Edward J. Fox, Peiqing Qian, Sibyl E. Wray, Derrick Robertson, Koby Mok, Chris Garner, Bruce A. C. Cree

P6.3-003

Comparison of 2-year Teriflunomide Outcomes between DMT-naive and switch patients with Relapsing MS: subanalysis of the Real-World TERICARE study – Jose Meca Lallana, Josefa Maria Prieto, Ana Belen Caminero Rodriguez, Javier Olaskoaga, Rosa Casademont Portell, Mireia Forner

P6.3-004

WITHDRAWN

P6.3-005

Improvement in Cognitive Processing Speed With Ofatumumab in Patients With Relapsing Multiple Sclerosis – Ralph H. B. Benedict, Iris Katharina Penner, Gary Raymond Cutter, Ludwig Kappos, Patricia K. Coyle, Daniela Piani Meier, Amin Azmon, Ibolya Boer, Wendy Su, Jeffrey Alan Cohen

P6.3-006

Lack of Rebound Disease Activity in Participants with Relapsing Multiple Sclerosis Following Placebo Run-out in the Tolebrutinib Phase 2b Trial – Anthony Traboulsee, Robert J. Fox, Douglas L. Arnold, Sana Syed, Atuyota Larry Orogun, Deborah Dukovic, Timothy J. Turner, Daniel Reich, Jiwon Oh

P6.3-007

Longitudinal Clinical and MRI Outcomes in Relapsing Multiple Sclerosis (RMS) Patients After Short-term Ponesimod Treatment Interruption and Re-initiation – Alexander Keenan, Ludwig Kappos, Maria Ait Tihyaty, Kavita Gandhi, Ibrahim Turkoz, Janice Chun Yee Wong, Tatiana Sidorenko, Fred D. Lublin

P6.3-008

A randomized, controlled trial of low-fat diet for fatigue in multiple sclerosis – Vicky Chen, Emma Chase, Michael A. Lane, Lindsey B. Wooliscroft, Claire Adams, Priya Srikanth, Elizabeth Silbermann, Jessica Rice, Chris Hollen, Allison Fryman, Kayla Martin, Carly Vong, Anna Orban, Akram Khan, Angela Horgan, Vijayshree Yadav

P6.3-009

MS Clinical Trials

P6.3-001

Effects of Ozanimod on Cognitive Processing Speed: Findings From the Phase 3 SUNBEAM and DAYBREAK Extension Trials – John DeLuca, Jeffrey Alan Cohen, Bruce A. C. Cree, Chun-Yen Cheng, James K. Sheffield, Jon V. Riolo, Diego Silva, Giancarlo Comi, Ludwig Kappos

Final results of the PANGAEA 2 0 study: Treatment benefits of fingolimod for active RRMS patients switching from other DMTs – Cordula Weiss, Tjalf Ziemssen

P6.3-010

Fatigue and Other Patient-Reported Outcomes in Patients With RRMS who Switched to Ocrelizumab: 4-Year Data From CASTING-LIBERTO – Ilya Kister, Ralph H. B. Benedict, Giancarlo Comi, Gary Raymond Cutter, Celia Oreja Guevara, Susanne Clinch, Thomas Kuenzel, Petra Dirks, Patrick Vermersch

P6.3-011

Effect of RIPK1 Inhibitor, SAR443820, on Serum Neurofilament Light Levels in Patients with Multiple Sclerosis: A Phase 2 Trial Design – Xavier Montalban, Jens Kuhle, Robert J. Fox, Timothy K. Vartanian, Dana Horakova, Massimo Filippi, Ernerst Roos, Erik Wallstroem, Nazem Atassi

P6.3-012

MRI Outcomes from the Long-term Extension Study of Tolebrutinib in Patients with Relapsing Multiple Sclerosis: 2-Year Results – Daniel Reich, Anthony Traboulsee, Sana Syed, Zhixing Xu, Timothy J. Turner, Douglas L. Arnold

P6.3-013

Long-term Effect of Ofatumumab Treatment on Serum Neurofilament Light Chain Levels and NEDA-3 Status in Patients With RMS: Results From ASCLEPIOS I/II and ALITHIOS – Enrique Alvarez, Jens Kuhle, Ludwig Kappos, Tjalf Ziemssen, Douglas L. Arnold, Anne H. Cross, Ibolya Boer, Ayan Das Gupta, Xixi Hu, Petra Kukkaro, Bernd C. Kieseier, Ronald Zielman, Stephen L. Hauser

P6.3-014

Results of a Phase III, Multinational, Doubleblind, Placebo-controlled Study in Subjects with Relapsing Forms of Multiple Sclerosis (RMS) to Assess the Efficacy, Safety, and Tolerability of GA Depot, a Long-Acting IM Injection of Glatiramer Acetate, Administered Once Every Four Weeks – Aaron E. Miller, Laura Popper, Joseph R. Berger, Nadav Bleich Kimelman, Shai Rubnov, Uri Danon, Ehud Marom

P6.3-015

Ublituximab Efficacy in Treatment-Naive Participants With Relapsing Multiple Sclerosis in the Phase 3 ULTIMATE I and II Studies – Lawrence Steinman, Edward J. Fox, Hans-Peter Hartung, Enrique Alvarez, Peiqing Qian, Sibyl E. Wray, Derrick Robertson, Deren Huang, Krzysztof W. Selmaj, Daniel R. Wynn, Jenna Bosco, Koby Mok, Chris Garner, Bruce A. C. Cree

P6.3-016

Efficacy of Early Ofatumumab vs Late Switch From Teriflunomide: Subgroup Analysis of the ALITHIOS Open-label Extension Study by Previous DiseaseModifying Therapy Exposure and Age – Heinz Wiendl, Jeffrey Alan Cohen, Ralf Gold, Jerome De Seze, Derrick Robertson, Sibyl E. Wray, Francesco Sacca, Ronald Zielman, Amin Azmon, Miriam King, Simone Fantaccini, Ludwig Kappos

P6.3-017

MRI, Efficacy, and Safety of Tolebrutinib in Patients with Highly Active Disease (HAD): 2-Year Data from the Phase 2b Long-term Safety (LTS) Study – Robert J. Fox, Jiwon Oh, Douglas L. Arnold, Sana Syed, Zhixing Xu, Timothy J. Turner, Anthony Traboulsee, Daniel Reich

P6.3-018

Early Onset of Action and Sustained Efficacy of MRI Outcomes During Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-year MAGNIFY-MS Study – Nicola De Stefano, Anat Achiron, Frederik Barkhof, Andrew Chan, Tobias Derfuss, Suzanne J. Hodgkinson, Letizia M. Leocani, Xavier Montalban, Alexandre Prat, Klaus Schmierer, Finn Sellebjerg, Patrick Vermersch, Heinz Wiendl, Birgit Keller, Andrzej Smyk, Lidia Gardner

4 General Neurology

General Neurology: New Treatments

P6.4-001

Phase 3, Open-Label, Multicenter Safety Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis (MT-1186-A01): 48-Week Results

– Angela L. Genge, Gary L. Pattee, Gen Sobue, Philippe Couratier, Daniel Selness, Sachin Bidani, Manabu Hirai, Takeshi Sakata, Alejandro Salah, Stephen Apple

P6.4-002

A Phase 1 First-in-human Study to Investigate the Safety, Tolerability and Food Effect of ABBVCLS-7262 – Bill Cho, Anna Jeong, Paul Ravi Malik, Joey C. Boiser, Xiu Huang, Matthew Rosebraugh

P6.4-003

Feasibility Assessment of Facilitated Subcutaneous Immunoglobulin 1 0 G/Kg with Abbreviated Dose Ramp-Up and without RampUp: A Phase 1 Tolerability and Safety Study in Healthy Adults – Zhaoyang Li, Andras Nagy, Noor Khaskhely, Dirk Lindner, Kimberly Duff, Enrique E. Garcia, Hakan AY, Juan Rondon, Leman Yel

P6.4-004

Efficacy and Safety of Vilazodone treatment for Major Depressive Disorder (MDD): A Pooled analysis of 3390 patients – Mohamed Ibrahim Gbreel, Mohammed Al-kafarna, Bashar Khaled Almaghary, Hamdy Khaled Taher Sabra, Mustafa M A Adwan, Osama Khalid Abdelgawad, Fatma Abdelaal Elsheikh, Ahmed Mahmoud, Hossam W S Almadhoon, Esraa Abdelhameid Amer, Ahmed Bostamy Elsnhory

P6.4-005

Treatment Outcomes for Patients With Amyotrophic Lateral Sclerosis Receiving Intravenous Edaravone From a Home and Alternative-Site Infusion Provider – Polina Da Silva, Malgorzata Ciepielewska, Quan Do, Marlena Anderson, Karen Martin, Kayla Ortlip

P6.4-006

Transcranial Motor Evoked Potentials as a Predictive Modality for Postoperative Deficit in Cervical Spine Surgery – A Meta-analysis – Rajiv Reddy, Vamsi Krishna Gorijala, Robert Chang, Katherine Melonakos Anetakis, Jeffery R. Balzer, Donald Crammond, Varun Shandal, Joon Lee, Jeremy Shaw, Parthasarathy Thirumala

4 General Neurology

General Neurology: Spinal Cord

P6.4-007

Central Pontine Myelinolysis in a Patient with Hepatosplenic T Cell Lymphoma and Hemophagocytic Lymphohistiocytosis – Stephen Daniel Avila, Alex Chap Wee Aw, Ron Josef Danziger, Chae Yoon Kim, Christina Tan, Konrad Schlick

5 Cerebrovascular Disease and Interventional Neurology

Cerebrovascular Disease and Interventional Neurology: Clinical Science and Systems of Care Research 1

P6.5-001

Managing Recurrent Ischemic Cerebrovascular Events in Patients with Atrial Fibrillation Compliant with Oral Anticoagulant Therapy – Ehab Yaser

Khaled Harahsheh, Omer Elshaigi, Nour Sami Ahmad Alhayek, Vanesa Vanderhye, Cumara Barahona O’Carroll, Oana Maria Dumitrascu

P6.5-002

Is Obesity Driving the Increase in Young Stroke? –Jonathan Solomonow, Karen Yarbrough, Seemant Chaturvedi, Prachi Mehndiratta

P6.5-003

Women and Stroke: Disparities in Clinical Presentations, Severity, and Short and Long-Term Outcome – Hiba Naveed, Muna Bassam Almasri, Bahram Kazani, Areej Nauman, Ravir Singh, Salman Al Jerdi, Naveed Akhtar, Ashfaq Shuaib

P6.5-004

Ischemic Stroke and TIA in a Cohort of Adults with Congenital Heart Disease: A Single Center Cross Sectional Study – Gular Mammadli, Jonathan Kochav, Melissa Argenio, Mehriban Sariyeva, Amanda Esther Bilski, Chinwe Ibeh, Joshua Z. Willey, Marlon Rosenbaum, Matthew Lewis, Eliza Cushman Miller

P6.5-005

Psychosocial Needs and Coping Strategies of Stroke Survivors with Upper-Extremity Motor Deficits in the First Two Years – Galina Gheihman, Julie A. DiCarlo, Nicole Lam, Alison Cloutier, Kimberly S. Erler, David Lin

P6.5-006

Higher Lifetime Exposure to Gonadal Hormones is Associated With Lower White Matter Hyperintensities Burden: A UK Biobank Study in Post-Menopausal Women – Thomas-Louis Perron, Samantha Cote, Jean-Francois Lepage, Christian Bocti, Kevin Whittingstall

P6.5-007

Clinical Characteristics and Outcome of Spontaneous Intracerebral Hemorrhage in Patients with End Stage Renal Disease on Hemodialysis – Kotaro Tsutsumi, Masaki Nagamine, Jonathan W. Chou, Dana Stradling, Diana Dench, Wengui Yu

P6.5-008

Utility Of Transesophageal Echocardiogram In Acute Ischemic Stroke For Cardioembolic Sources Diagnosis: A Retrospective Cohort Study In A Third Level Hospital In Buenos Aires, Argentina –Alejandra Heriz, Rocio Veronica Marquez, Jeremias Sebastian Ayerbe, Juan Pablo Rodriguez, Rodrigo Joaquin Sanjinez, Facundo Escandon, Otto Jesus Vega, Guido Stupenengo, Natalia Balian, Marcelo Rugiero Rodriguez

P6.5-009

Days Alive and Out of Hospital as a Measure of Stroke Outcome in Patients Receiving Hyperacute Stroke Intervention – Joseph Donnelly, Jae Beom Hong, Luke Boyle, Vivien Yong, William Diprose, Doug Campbell, Alan Barber

P6.5-010

Atrial Fibrillation and Stroke: Predictors of Anticoagulation Therapy Modification – Lara

Carvalho de Oliveira, Andrew Webb, Ana Ponciano, Suzete Nascimento Farias Da Guarda, Pinar Yilmaz, Aneesh B. Singhal, Anand Viswanathan, Syed

Daniyal Asad

P6.5-011

Hyperglycemia Is Associated with Intraventricular Extension Among Patients with Spontaneous Intracerebral Hemorrhage – Alvin Das, Elizabeth Heistand, Robert W. Regenhardt, Corey R. Fehnel, Jennifer L. Dearborn-Tomazos, Vasileios-Arsenios

Lioutas, Sandeep Kumar, Magdy H. Selim

P6.5-012

Patient Reported Outcomes by Location in Patients with Cavernous Malformation – Kim Griffin, Giuseppe Lanzino, Kelly D. Flemming

P6.5-013

Barriers and Facilitators to Telehealth Timed Up and Go (TUG) Assessment in an Underserved Urban Stroke Population – Clare Bassile, Jennifer Mae McIntyre, Lacey Jean Powell, Kiran Sareen, Christina Karsos, Imama Ali Naqvi

P6.5-014

Clinical Features, Etiologies and Mechanisms of In-hospital Acute Ischemic Stroke: A Retrospective Analysis – Juanjuan Wu, Guangsong Han, Yuhui Sha, Lixin Zhou, Jun Ni

P6.5-015

The correlation of embolic sources with infarct pattern in patients with embolic stroke –Yasumasa Yamamoto

P6.5-016

Advance Directives Among Community-Dwelling Stroke Survivors – Soumya Gupta, Bridget Jane Chen, Deji Suolang, Rachel Cooper, Rebecca F. Gottesman, Romanus R. Faigle

P6.5-017

Renal function association with infarct growth rate in anterior circulation large vessel occlusion strokes – Mohammad Nathier Kayyali, Bishow Chandra Mahat, Jessica Choi, Shlee S. Song, Marcelo Rocha

P6.5-018

Utility Of Transthoracic Echocardiogram Compared With Transesophageal Echocardiogram For Cardioembolic Source Detection In Patients With Acute Ischemic Stroke: A Retrospective Cohort Study In A Third Level Hospital In Buenos Aires, Argentina . – Alejandra Heriz, Jeremias Sebastian Ayerbe, Rocio Veronica Marquez, Guido Stupenengo, Otto Jesus Vega, Juan Pablo Rodriguez, Facundo Escandon, Rodrigo Joaquin Sanjinez, Natalia Balian, Marcelo Rugiero Rodriguez

P6.5-019

Stages and Processes of Change for Weight Loss in Acute Stroke or TIA Patients Living with Obesity

– Mitchell Wilson, Hailey Amanda Orgass, Jennifer L. Dearborn-Tomazos

P6.5-020

Association Between Cardioembolic Sources On Transesophageal Echocardiogram In Acute Ischemic Stroke And Atrial Fibrillation In Follow-Up Holter: A Retrospective Cohort Study In A Third Level Hospital In Buenos Aires, Argentina – Rocio Veronica Marquez, Alejandra Heriz, Facundo Escandon, Juan Pablo Rodriguez, Rodrigo Joaquin Sanjinez, Otto Jesus Vega, Guido Stupenengo, Natalia Balian, Jeremias Sebastian Ayerbe, Marcelo Rugiero Rodriguez

P6.5-021

Workflow in Simultaneous acute code Stroke activations in the emergency department – Robert Joseph Cruz Sarmiento, Gurpriya Bhangoo, Thomas J. Jeerakathil, Ashfaq Shuaib, Brian Hilton Buck, Colleen L. Taralson, Nadine Moniz, Mahesh Pundlik Kate

P6.5-022

Hypoperfusion intensity ratio is correlated to infarct growth rate parameters when modelled as a logistic growth function – Milagros GalecioCastillo, Marco Moises Malaga, Darko Ernesto Quispe Orozco, Juan A. Vivanco-Suarez, Aaron Eduardo Rodriguez-Calienes, Cynthia Zevallos, Jessica Kobsa, Ayush Prasad, Mudassir Farooqui, Nils Petersen, Santiago Ortega Gutierrez

P6.5-023

Association Between Mean Platelet Volume and Functional Outcome in Patients with Acute Ischemic Stroke: A Systematic Review with Meta-Analysis – Milagros Del Pilar PascualGuevara, Miguel Francisco Cabanillas Lazo, Claudia Cruzalegui Bazán, Carlos Rodrigo Quispe Vicuña, Milenka Del Rosario Del Rosario Cierto Torre, Renzo Gabriel Vallejos, Joel Mario Sequeiros Chirinos, Carlos Alva-Diaz

P6.5-024

Expediting the TIA Workup – Patrick Wen

P6.5-025

Financial Burden of Acute Cerebrovascular Disease in United States Healthcare During 19932019 – Alexis Lorio, Madeline Malone, Carlos Garcia Rodriguez, Ali Seifi

P6.5-026

Factors Impacting Outcomes in Brainstem

Hemorrhage: A Single-center Experience Investigating Functional Outcome – Muhammed Enes Gunduz, Victoria Fleming, Shravan Sivakumar, Zakir Iqbalbhai Shaikh, Raphael A. Carandang 5

Cerebrovascular Disease and Interventional Neurology

Cerebrovascular Disease and Interventional Neurology: Interesting Cases 3

P6.5-027

Spinal Cord Ischemia in a Young Patient Following Strenuous Exercise – Sonia Sunil Bellara, Robert Samuel Sacks, Hyunah Choi, Elizabeth Chernyak, Nuri Jacoby, Steven R. Levine

P6.5-028

Bilateral Lateral Geniculate Body Infarction: A Systematic Review – Nils Henninger, Bahadar Singh Srichawla, Raymond Manuel Catton, Alexander Lichtenberg

P6.5-029

A Case of Hematomyelia in a Teenager with Behcet’s Disease due to both Warfarin and Intramedullary Cavernous Malformation – Robert Samuel Sacks, Simona Treidler

P6.5-030

Atypical Posterior Reversible Encephalopathy Syndrome with Obstructive Hydrocephalus and Impending Tonsillar Herniation – Juan Solano, Saman Zafar, George C. Newman

P6.5-031

Non-Iatrogenic Cerebral Air Embolism: A Case Report of an Extremely Rare Cause of Ischemic Stroke – Ye Su, Vanil Pandya, Cleo Zarina Alejo Reyes, Sathvik S Shastry, Preet M. Varade

P6.5-032

Artery of Percheron Infarction: Clinical Presentation and Outcomes – Solmaz Ramezani Hashtjin, Salman Ikramuddin, Christopher Streib

6 Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Innovation in Cognitive and Functional Assessments

P6.6-001

Telehealth Equivalence of the Montreal Cognitive Assessment (MoCA): Results from the Emory Healthy Brain Study (EHBS) – David W. Loring, James J. Lah, Felicia Goldstein

P6.6-002

Examining a Preclinical Alzheimer’s Cognitive Composite for Telehealth Administration, the tPACC, for Reliability between In-Person and Remote Cognitive Testing – Tugce Duran, Sarah Gaussoin, Samuel Neal Lockhart, Melissa Rundle, Mark Espeland, Benjamin J. Williams, Tim Hughes, Suzanne Craft, Bonnie Sachs, James R. Bateman

P6.6-003

Instrumental Activities of Daily Living (IADL) as a Digital Biomarker of Cognitive Decline in Older Adults – Myeounggon Lee, Ram Kinker Mishra, Michele K. York, Mark Kunik, Gregory Barchard, Ashkan Vaziri, Bijan Najafi

P6.6-004

Assessing Social Cognition Across Dementia Subtypes – Mary Grace Lorino, Meredith F. Yang, Rachel Covaciu, Kaitlin Seibert

P6.6-005

Reliability of tablet-based Digital Clock Drawing Task (DCTclock) for Automated Detection of Cognitive Impairment – Timothy Helbig, Claudio Toro-Serey, Karl Thompson, Connor Patrick Higgins, Ali Jannati, Russell E. Banks, Joyce Rios GomesOsman, Alvaro Pascual-Leone, David James Bates, John W. Showalter, Sean Tobyne

P6.6-006

Feasibility of at-home motor assessments using wireless technology in patients with myelopathy: year 1 follow up of CYGNET, an observational study of patients with adrenomyeloneuropathy

– Caroline Bergner, Wolfgang Koehler, Joshua Bonkowsky, Christopher D. Stephen, Asif M. Paker, Florian Eichler, Lauren Glenn, Steven Zelenkofske, Marc Engelen

P6.6-007

The SLU-AMSAD, a Short Screening Tool for Diagnosing Depression in Dementia Patients –Renee Gao, Binu Chakkamparambil, Theodore Malmstrom, Jason Xin, George Grossberg

P6.6-008

Use Of The Addenbrooke´S Cognitive Examination III (ACE-III) For The Diagnosis Of Cognitive Impairment In Lima, Peru – Nilton Custodio Capunay, Marco Moises Malaga, Rosa Montesinos, Diego Chambergo-Michilot, Fiorella Alejandra Baca, Juan Carlos Carbajal, Jose Carlos Huilca, David Lira, Eder Herrera-Perez, Monica M. Diaz, Serggio Lanata

P6.6-009

A Pilot Study of Free and Cued Selective Reminding Test in a Lebanese Sample: A study on Normal, MCI and AD patients – Fadi Karim Abou-Mrad

P6.6-010

Aphasic Binary Reversals as a Novel Biomarker Across Dementia Syndromes – Rian Lee Bogley, Maxime Montembeault, Isabel Allen, Salvatore Spina, Lea Grinberg, Eric Jinsheng Huang, Joel Kramer, Katherine L. Possin, Katherine P. Rankin, Howard J. Rosen, Adam L. Boxer, Gil Dan Rabinovici, William Seeley, Virginia Sturm, David C. Perry, Bruce L. Miller, Maria Gorno Tempini, Zachary Miller

P6.6-011

Cognitive Function Remains Associated with Global Functional Impairment in Profound Dementia due to Alzheimer’s Disease and Dementia with Lewy Bodies – Ihika Rampalli, Valory Pavlik, Melissa Yu, Jeffrey Scott Bishop, Chi-Ying Lin

7 Practice, Policy, and Ethics

Practice, Policy, and Ethics: Removing Barriers to Practice and Profession 1

P6.7-001

Differences in Electronic Medical Record Time Usage Depending on Neurology Trainee Gender –Billie Wiggins, Thy Nguyen

P6.7-002

Telemedicine in Neurology: Lessons Learned

During the COVID-19 Pandemic – Abrar Omar AlFaraj, Omar Mohtar, Dickson Tik Sang Chen, Vibhav Jha, Jessica LeClair

P6.7-003

Defining and prioritizing urgency for outpatient neurology referrals – Noellie M. Rivera-Torres, Savannah Quigley, Zachary Roberts, David Do

P6.7-004

To Neuro or not to Neuro ; that is the Question: A focus on Women Neurologists – Aparna M. Prabhu

P6.7-005

Electronic Consultations in a Community Neurology Practice: Assessment of Safety and Risk Factors for Subsequent Face-to-Face Neurological Consultation – Nathan Seven, Nathan P. Young, Karen A. Truitt

P6.7-006

Increasing Efficiency in Addressing Patient Portal Messaging Demands on Healthcare Systems –Barbara S. Gordon-Kundu, Babar Khokhar

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Inherited Muscle Disorders 3

P6.8-001

Shoulder injuries in Facioscapulohumeral muscular dystrophy patients – William Wei Liu, Alrabi Tawil, Jeffrey Statland

P6.8-002

ENVOL, a Phase 2, Open-Label Trial Evaluating the Safety and Expression of Delandistrogene Moxeparvovec (SRP-9001) in Duchenne Muscular Dystrophy (DMD): Study Design – Eugenio Mercuri, Isabelle Desguerre, Andrea Gangfuss, Laurent Servais, Andrés Nascimento, Becca Zhang, Alexander Peter Murphy, Carol Reid, Christoph Wandel, Tejdip Singh, Maitea Guridi, Francesco Muntoni

P6.8-003

Differential Dysferlin Expression in Human Fast and Slow Muscle: Clinical Correlation with LGMD-D2 Evolution – Marija Meznaric, Corrado Angelini

P6.8-004

Design of a Phase 1, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses of PGN-EDODM1 in Adult Participants with Myotonic Dystrophy Type 1 (DM1) – Michelle L. Mellion, Jane Larkindale, Jennifer Cormier, Holly L. Hand, Sarah Vacca, Pallavi Lonkar, Ashling Holland, Brijesh Garg, Jeffrey Foy, James McArthur

P6.8-005

Neck Muscle Flexion Weakness, as the predominant manifestation of Myotonic Dystrophy, type 2 – Khalil Ali, Leila Darki, Said R. Beydoun

P6.8-006

Atypical Overlapping Features Complicating Diagnoses of Dysferlinopathy and ImmuneMediated Necrotizing Myopathy . – Adrienne Leigh Murphy Stout, Xiaowei W. Su

P6.8-007

Design of REACH: Phase 3 Randomized, DoubleBlind, Placebo-Controlled, 48-Week Study of the Efficacy and Safety of Losmapimod in FSHD

– Alrabi Tawil, Jay Han, Leo Hong-Li Wang, John Vissing, Jeffrey Statland, Jennifer Shoskes, John Jiang

P6.8-008

Novel ACTA1 Mutation in a Family with Congenital Myopathy and Variably-penetrant Cardiomyopathy

– Brendan Putko, Laura Michelle Schmitt, Gavin Oudit, Cecile L. Phan, Grayson Bernard Beecher

P6.8-009

Misdiagnosis of Late-Onset Pompe Disease: A Case Series – Dennis Huang, Tahseen Mozaffar

P6.8-010

Neurogenetics: Congenital Myotonic Dystrophy with asymptomatic mother may be missed by whole exome sequencing; Biopsy, DMPK1 gene testing and EMG may be required to resolve VUS in neonates, A Case report . – Felix Asiamah Appiah, Tea Shergelashvili, Bonnie Marr, Ahmed Eldokla, Robert Lebel, Ai Sakonju

P6.8-011

LGMD-D2 TNPO3 related : a wide clinical spectrum

Quality of Life and microRNAs study in two families

– Alicia Aurora Rodríguez, Valentina Pegoraro, Corrado Angelini

P6.8-012

A Rare Case of Familial TWNK Related Myopathy

– Omar Muhsin Ali Al-Janabi, Zabeen Kaizar

Mahuwala

P6.8-013

Myalgia in a Patient with Adult-Onset Asthma with Periocular Xanthogranuloma (AAPOX) due to Myotonic Dystrophy type 2 – Michael Paul Skolka, Shreyasee Amin, Teerin Liewluck

P6.8-014

Muscle Pathology in a Case of Glycogen Storage Disease III – Khalid Mohammed Alrasheed, Tahseen Mozaffar, Mari Perez-Rosendahl

P6.8-015

Brody myopathy associated with novel compound heterozygous ATP2A1 mutations – Sargun Walia, Xiaowei W. Su

9 Health Care Disparities

Health Care Disparities: Stroke, Epilepsy, ER

P6.9-001

Neighborhood Deprivation and Race Synergistically Contribute to Undiagnosed Hypertension Leading to Acute Ischemic Stroke: Results from the All of Us Research Program

– Victor Manuel Torres-Lopez, Daniela Brenda Renedo, Julian Acosta, Thomas Gill, Kevin N. Sheth, Guido Jose Falcone, Cyprien Rivier

P6.9-002

Factors Mediating Public Perceptions of Therapeutic Closed-Loop Brain Implants for Epilepsy and Mood Disorders – Abraham Dada, Bryan B. Chen, Tobias Haeusermann, Kristina Celeste Fong, Roy H. Hamilton, Jennifer James, Daniel Dohan, Winston Chiong

P6.9-003

Establishing a Roadmap for Acute Stroke Care in the Caribbean Region: The Mission Thrombectomy 2020+ Caribbean Experience – Ryna Then, Gillian L. Gordon-Perue, Francene Angelique Gayle, Herbert A. Manosalva Alzate, Cosme Miguel Gonzalez Villaman, Luis Eduardo Suazo, Romnesh Mario De Souza, Madihah Amima Hepburn, Santiago Ortega Gutierrez, Sheila Martins, Dileep R. Yavagal, Violiza A. Inoa

P6.9-004

Feasibility of Screening for Food Insecurity in an Outpatient Stroke Care Setting – Maha Almohamad, Dania Mofleh, Daphene AltemaJohnson, Mariam Ahmed, Joseph Fries, Munachi Nkiru Okpala, Audrey Sarah Cohen, Daphne C. Hernandez, Anjail Sharrief

P6.9-005

Demographic factors associated with unplanned healthcare resource utilization (HRU) among people with epilepsy (PWE) – Alexandra Urban, Laura Anne Kirkpatrick, Vijayalakshmi Rajasekaran, Joanna S. Fong, Anto Bagic, Parthasarathy Thirumala

P6.9-006

Access and Equity of Epilepsy Care in the Veterans Health Administration – Hamada Hamid Altalib, Rizwana Rehman, Zulfi Haneef

P6.9-007

Assessment Of Acute Ischemic Stroke Disparities

By Primary Language In A High Patient Volume Comprehensive Stroke Center Serving A Diverse Metropolitan City: – Jennifer Harris, Lindsey Ross, Jim Mirocha, Harlem Lee, Elisa Ditman

P6.9-008

BEFAST Assessment in a Rural Community Hospital - the BIRCH Study – Caroline Knight, Eileen Hawkins, Hilary Merrifield, Laura Stein, Robert W. Stein

P6.9-009

Access to Neurology Healthcare Professionals in the United States Among Medicaid Patients with Epilepsy – Herbert Peeples, Christopher Dieyi, Keshia Maughn, Emily Achter

P6.9-010

Who Do You Order Drug Screening For?: The Relationship Between Race and Urine Drug Screens in Patients with Altered Mental Status or Encephalopathy in the Emergency Department –Sojung Kara Park, Byoungchul Kim, Tracy J. Koehler, Aileen Antonio

P6.9-011

Focus on Equitable Delivery of Neurologic Care: from ED to Clinic – Mimi Tra Giang, Enmanuel Perez

P6.9-012

A Multicenter Assessment of Patient- and Provider-Reported Outcomes to Inform Healthcare Disparities in Epilepsy Care – Lilian Coelho, Aya ElHassan, Yashmi Shirish Sevak, Maria Andrea Donahue, Jeffrey R. Buchhalter, William H. Trescher, Jacob Pellinen, Susan T. Herman, Brandy Fureman, Lidia Maria Veras Rocha Moura

10 Infectious Disease

Infectious Disease: COVID-19 Reports

P6.10-001

Peripheral Neuropathy in Long-COVID Patients: Demographic Distribution and Risk Factors –Jason Li, Camden James Bohn, Noah Todd, Jessica A Pater, Jeanne Carroll, Brian Henriksen, Fen-Lei F. Chang

P6.10-002

A Rare Case of Rhombencephalitis after Covid-19 infection: A Case Report – Kaneez Zahra, Chun Chin Huang, Saher Choudhary

P6.10-003

COVID-19 Infection Presents as Acute Cerebellar Ataxia – Alexander Carvajal- Gonzalez, Michelle Benjamin, Sheila Joyce Asghar

P6.10-004

Rare Case of Miller-Fischer Syndrome Linked to COVID-19 Infection – Aleeya Shareef, Tahir Khan, Mohammad Shahid

P6.10-005

COVID-19 Induced Enantiopathy to Hyperosmia –Shweta Kalita, Drushti Deepak Birwatkar, Alan R. Hirsch

P6.10-006

Meningoencephalitis Secondary To Cerebrospinal Fluid Leakage From Nasopharyngeal COVID-19 Swab – Mohammed Saleh Alnafisah, Abdulrahman Altowairqi

P6.10-007

Pediatric Shigellosis Encephalopathy with Atypical Brain Imaging – Ging Tang Huang, Radostina Iordanova, Keng Lam

11 Movement Disorders

Movement Disorders: Environmental Factors and Phenotyping Parkinsonisms 2

P6.11-001

Data-Driven Discovery of Novel Motor Biomarkers for Freezing-of-Gait in Parkinsonism from Fullbody Kinematics using Artificial Intelligence –Hyeokhyen Kwon, Gari D. Clifford, Christine Doss Esper, Stewart A. Factor, Johnathan Lucas McKay

P6.11-002

Resting-State Electroencephalography Reveals Three Subphenotypes of Parkinson’s Disease –Sahar Yassine, Ute Gschwandtner, Manon Auffret, Joan Duprez, Marc Verin, Peter Fuhr, Mahmoud Hassan

P6.11-003

Demographic and Clinical Profile of South Asian vs non-South Asian Patients with Parkinson’s disease – Sid Srinivasan, Eric Lynn Hargreaves, Deborah Lynn Caputo, Jasdeep Hundal, Shabbar Danish, Jennifer Chen, Gian D. Pal

P6.11-004

Clinical Characteristics of Early-Onset Parkinson Disease in Mayo Clinic Population – Khaled Ghoniem, Jessie Jacobson, Aidan Mullan, Pierpaolo Turcano, Emanuele Camerucci, Cole Daniel Stang, James H. Bower, Rodolfo Savica

P6.11-005

Environmental Exposure Speeds Symptom

Progression in PD – Ethan G. Brown, Samuel Goldman, Marta San Luciano, Monica Korell, Caroline M. Tanner

P6.11-006

Data-driven Approach to Identify Subtypes and Progression of Parkinson’s disease using Multimodal Imaging Data – Anupa Ambili

Vijayakumari, Hubert H. Fernandez, Benjamin L. Walter

P6.11-007

Phenotyping Motor-subtypes of Parkinsonism from Full-body Kinematics using Machine Learning –Naiji Jabin Gong, Hyeokhyen Kwon, Gari D. Clifford, Christine Doss Esper, Stewart A. Factor, Johnathan Lucas McKay

P6.11-008

Data-driven phenotypic clustering of Parkinson’s disease patients seeking deep brain stimulation

– Joohi Jimenez Shahed, Arthur Berg, Michele K. York, Jason Schwalb, James Kirk, Mustafa S. Siddiqui, James McInerney

11 Movement Disorders

Movement Disorders: Parkinson’s Disease

Non-motor Symptoms 1

P6.11-009

Participants United Through Retention and Education (PURE) Program for Non-motor Symptoms of Parkinson’s Disease – Stephen Lee, Stacey Hilaire Dubreus, Sherline Sauveur, Chantale Octavia Branson

P6.11-010

Risk of Psychosis among those with Parkinson’s disease with and without Minor Hallucinations –Ruth Schneider, Peggy Auinger, Taylor Myers, Kelly A. Mills, Roseanne D. Dobkin, Gregory Pontone, Catherine Victoria Kulick, Melissa J. Nirenberg

P6.11-011

Structural Connectivity Differences in People with Parkinson’s Disease With Visual Hallucinations – Emma Wetmore, Daniel Hebra Lench, Gonzalo Revuelta, Travis H Turner, Federico J. RodriguezPorcel

P6.11-012

Characterizing Delirium in a Parkinson’s Disease Population: Demographics, Common Etiologies and Co-Morbidities at a Single Institution – Phil Joseph Schmitt, Megan Coghlan, James Reid Johnson, Jessica Michelle Fulkerson, Satya Alluri, Victoria Nicole Holiday, Peter Hedera

P6.11-013

Impulse Control Disorder and medication management in Patients with Early-Onset

Parkinson’s Disease – Jessie Jacobson, Khaled Ghoniem, Aidan Mullan, Pierpaolo Turcano, Emanuele Camerucci, Cole Daniel Stang, James H. Bower, Rodolfo Savica

P6.11-014

Apathy and Parkinson’s Disease Motor Phenotypes: A Preliminary Study – Abhishek Lenka, Yunglin Gazes, Nora Vanegas-Arroyave

P6.11-015

Resting-state EEG Predicts Cognitive Impairment in Parkinson’s Disease – Ergun Y. Uc, Md Fahim Anjum, Soura Dasgupta, Nandakumar Narayanan

P6.11-016

Are there predictors of neuropsychological cognitive decline in Parkinson’s Disease patients who have undergone Deep Brain Stimulation Surgery? – Christine St Clair, Sofia Alba Magee, Christina Palmese, Joohi Jimenez Shahed

12 Aging, Dementia, Cognitive, and Behavioral Neurology

Behavioral and Cognitive Neurology: Neuroimaging Studies in Cognitive and Behavioral Neurology

P6.12-001

WITHDRAWN

P6.12-002

Identifying mixed Lewy body and Alzheimer’s disease pathologies using functional neuroimaging – Soumya Bouchachi, Jessica Truelove, Kristina Rawson, Jennifer Icenhour, Michael Knopp, Chadwick L. Wright, Douglas W. Scharre

P6.12-003

Smoking History and Increasing Pack Years Predict Brain Volume Loss in 8831 Healthy Participants – Somayeh Meysami, Cyrus A. Raji, Sam Hashemi, Saurabh Garg, Thanh Duc Nguyen, Yosef Chodakiewitz, Nasrin Akbari, Ahmed Gouda, Raj Attariwala

P6.12-004

Deep Learning Derived Visceral Abdominal Fat Predicts Brain Atrophy at Midlife in 7507 Individuals – Cyrus A. Raji, Somayeh Meysami, Sam Hashemi, Saurabh Garg, Nasrin Akbari, Ahmed Gouda, Yosef Chodakiewitz, Thanh Duc Nguyen, Raj Attariwala

P6.12-005

Asymmetry of radiomics features in the white matter of patients with Primary Progressive Aphasia – Benedetta Tafuri, Marco Filardi, Daniele Urso, Valentina Gnoni, Roberto De Blasi, Salvatore Nigro, Giancarlo Logroscino

P6.12-006

Vigorous Physical Activity Predicts Deep Learning Derived Brain Volumes in 8823 Individuals – Cyrus A. Raji, Somayeh Meysami, Sam Hashemi, Saurabh Garg, Nasrin Akbari, Thanh Duc Nguyen, Ahmed Gouda, Yosef Chodakiewitz, Raj Attariwala

P6.12-007

Assessment of Shared Neurologic Radiomic Markers Among Patients Diagnosed with Functional Seizure Disorder Utilizing a Novel Machine Learning Model – Jonah Robert Moss, Elizabeth Schmid, Adriana C. Bermeo Ovalle, Travis Stoub, Rebecca O’Dwyer

Headache

Headache: Clinical Trials and Real World Studies 1

P6.12-008

Early Clinical Experience With Eptinezumab From a Retrospective, Observational Study of Real-World Patient Response – Amaal J. Starling, Steven Kymes, Divya Asher, Seema Soni-Brahmbhatt, Meghana Karnik-Henry

P6.12-009

Real-world Adherence to Subsequent Prophylactic Therapy Among Chronic Migraine (CM) Patients Initially Treated With a Calcitonin Gene–related Peptide Monoclonal Antibody (CGRP mAb) –Amanda Vida Gusovsky, Yanan Dong, Changgeng Zhao, Tae Jin Park, Darshini Shah

P6.12-010

CGRP Antagonist (Gepant) vs Triptan use Profiles in Individuals with Migraine: A Multicenter Electronic Medical Record Analysis of Patient Characteristics and Emergency Department Services Utilization –Victor Wang, Steven Bieser, Austin Lowe, Michael Li, Hsiangkuo Yuan

P6.12-011

Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment

– Amira Salim, Atia Najjar, Zubair Ahmed, Ignacio Mata

13 Sleep

Sleep: REM Behavior Disorder

P6.13-001

Neurogenic Orthostatic Hypotension is Common in Isolated REM Sleep Behavior Disorder – Mitchell G. Miglis, Miranda M. Lim, Jennifer Zitser-Koren, Emmanuel H. During, Donald Biwise, Daniel Huddleston, Michael J. Howell, Erik Kent St. Louis, Jean-Francois Gagnon, Aleksandar Videnovic, Alon Y. Avidan, Carlos H. Schenck, Ronald Postuma, Bradley F. Boeve, Yo-El Ju, Jonathan Elliott

P6.13-002

Evidence of Sympathetic Overactivity in Subjects with REM Behavior Disorder at Risk for Parkinson’s Disease – Michele Tagliati, Michele Lima Gregorio, Helia Maghzi, Gloria Obialisi, Elliot James Hogg, Camille Malatt, Echo Tan, Roy Artal, Michael Shehata, Brian Renner, Pascal Sati

P6.13-003

Sex Differences at Presentation in Isolated Rapid Eye Movement Sleep Behavior Disorder – Christina Anne Alexandres, Stuart McCarter, Grace Marie Tabatabai, John Craig Feemster, Thomas Gossard, Paul Timm, David J Sandness, Diego Z. Carvalho, Jack Thomas Jagielski, Emma Strainis, Laurene Leclair-Visonneau, Mithri R. Junna, Maja TippmannPeikert, Bradley F. Boeve, Melissa C. Lipford, Layne Moore, Erik Kent St. Louis, Michael H. Silber

P6.13-004

Continued Validation of the RBD Symptom Severity Scale (RBDSSS) in Participants of the North American Prodromal Synucleinopathy (NAPS) Consortium – Andrea Oana Busicescu, Parichita Choudhury, Joyce K. Lee-Iannotti, Pooja Rangan, Maria Livia Fantini, David Shprecher, Miranda M. Lim, John Elliott, Alon Y. Avidan, Daniel Huddleston, Donald Biwise, Michael J. Howell, Carlos H. Schenck, Susan Criswell, Chengjie Xiong, Jennifer Svoboda McLeland, Emmanuel H. During, Emmanuel Mignot, Amelie Pelletier, Jean-Francois Gagnon, Leah Kathleen Forsberg, Julie A. Fields, Erik Kent St. Louis, Aleksandar Videnovic, Yo-El Ju, Bradley F. Boeve, Ronald Postuma

P6.13-005

Characteristics of REM Sleep Behavior Disorder Affect the Risk of Developing an Overt Synucleinopathy – Toji Miyagawa, Scott Przybelski, Hoon-Ki Min, Lennon Jordan, Cynthia Vernon, Timothy Lesnick, Stuart McCarter, Erik Kent St. Louis, Michael H. Silber, Jonathan Graff-Radford, David T. Jones, David S. Knopman, Ronald C. Petersen, Walter Kremers, Leah Kathleen Forsberg, Julie A. Fields, Tanis J. Ferman, Hugo Botha, Vijay K. Ramanan, Laura Andelman Allen, Kejal Kantarci, Val John Lowe, Bradley F. Boeve

P6.13-006

Estimating brainstem dysfunction with video Head-impulse test(vHIT) in idiopathic REM sleep behavior disorder(iRBD) patients – Young Hun Kim, Eun-Yeon Joo, Byung-Euk Joo, Hyujin Jo

1 Neuro Trauma and Critical Care

Neuro Trauma and Sports Neurology: Symptoms and Therapies

P7.1-001

Expanding Applications of CGRP Modification for Post-traumatic Brain Injury Symptom Control –Julia Wang, Dechen Samdrup, Paige Buddenhagen, Kate M. Essad

P7.1-002

Comparing Symptom Severity and Time to Recovery in Concussions Sustained in Sport

Activity Versus Motor Vehicle Accidents – Dallin Stevens, Chase Michael Irwin, Jamie Pardini

P7.1-003

Symptomatic and Functional Recovery Following Concussion in Adolescents With and Without a History of Psychiatric Disorder – Kiersten Mangold, Jacob Kay, Alexander Wagner, Jeffrey Holloway, R. Davis Moore

P7.1-004

Remotely Supervised tDCS for Persistent PostTraumatic Headache in Veterans (ReStore) – Leigh Elkins Charvet, Kiersten Mangold, Taylor Marie Wynne, R. Davis Moore, Siyuan Guo, Jiajia Zhang, Abhishek Datta, Xiao M. Androulakis

P7.1-005

A System-wide Retrospective Cohort Analysis of the Development of Psychiatric Conditions

Following Concussion – Patrick Brown, Seth Thomas Kazmer, Jose H. Posas

P7.1-006

A combined heart rate variability biofeedback and progressive aerobic exercise intervention for remediating persistent post-concussive symptoms – R. Davis Moore, Brett Steven Gunn, Jacob Kay

P7.1-007

A Retrospective Analysis of Cannabidiol (CBD) Use in a Concussion Cohort – Daniel Rafie, Philip Rosenbaum, Kevin Bickart, Neil Avinash Bhathela, Joshua Chung, Christopher Giza, Meeryo Choe

P7.1-008

Impact of Return-to-Exercise on Traumatic Brain Injury Recovery in a Community Setting – Edward Joseph Weldon, Ryan Nakamura, Tracy Van, Ana Nakamura, Chancen Law, Connor Goo, Meliza Roman, Enrique Carrazana, Jason Viereck, Kore K. Liow

P7.1-009

The Impact of Antithrombotic Agents on In-Patient and Post-Discharge Mortality after Trauma Brain Injury – April DeStefano, Satyanarayana Vedula, Joshua Stodghill, Jacob Gillen, Michael Nussbaum, Katie Bower, Tonja Locklear, Bryan Collier

P7.1-010

Impact of cognitive exertion on autonomic reactivity in individuals with persistent postconcussive symptoms – R. Davis Moore, Taylor Marie Wynne, Steven Broglio, Troy Herter

P7.1-011

New-onset Synesthesia and Heightened Creativity in a Musician after Traumatic Brain Injury – Lealani Mae Acosta, Rima Abou-Khalil

P7.1-012

A Rare Case of Traumatic Cervicogenic Exophthalmos: A Case Report – Ye Su, Sayyeda Zahra, Satinderpal Singh, Preet M. Varade 2

Education, Research, and Methodology

Education, Research, and Methodology: Technology and Education 1

P7.2-001

The Power of a Post-It: The Reach and Impact of the Twitter Teaching Initiative

“#NeuroPostItPearls” – Casey S.W. Albin, Antreas Charidimou, Lyell K. Jones

P7.2-002

Neudrawlogy: Simplifying Neurology to Create a Global Social Media Impact – Gabriela Figueiredo Pucci, Casey S.W. Albin

P7.2-003

We Don’t Talk About Twitter: The Nuts and Bolts of Social Media for Neurologists – Justin Rosati, Kathryn Leigh Idol Xixis, Jaclyn Martindale, Nancy E. Bass, Jessica Helena Goldstein

P7.2-004

A Survey-Based Study to Assess Twitter Use by Neurologists Professionally – Aaron Simon Zelikovich, Joseph E. Safdieh, Matthew S. Robbins

P7.2-005

Measuring The Impact of a Twitter-Based Educational Initiative: The #EmoryNCCTweetorials Project – Erika Sigman, Cederic M. Pimentel, Prem Kandiah, Eric Christopher Lawson, Casey S.W. Albin

3 MS and Inflammatory Disease

MS Therapeutics 1

P7.3-001

Intranasal Delivery of TGFa – A Novel Therapeutic Approach for Lesion Resolution in Multiple Sclerosis? – Lena Loesslein, Mathias Linnerbauer, Thanos Tsaktanis, Francisco J. Quintana, Veit Rothhammer

P7.3-002

Relationship Between Infections and Absolute Lymphocyte Count During Phase 3 and Openlabel Extension Trials of Ozanimod in Patients With Relapsing Multiple Sclerosis – Hans-Peter Hartung, Lawrence Steinman, Amit Bar-Or, James K. Sheffield, Sarah Harris, Jon V. Riolo, Chun-Yen Cheng, Diego Silva, Bruce A. C. Cree

P7.3-003

Infusion-Related Reactions With Ocrelizumab: Risk Factors, Symptom Management and Patient Choices in the ENSEMBLE PLUS Study – Robert A. Bermel, Joep Killestein, Thomas Alois Berger, Bruno Brochet, William M. Carroll, Mark S. Freedman, Trygve Holmoy, Rana Karabudak, Carlos Nos, Francesco Patti, Amy Perrin Ross, Ludo J. Vanopdenbosch, Timothy L. Vollmer, Regine Buffels, Karen Kadner, Oscar Bortolami, Hans-Peter Hartung

P7.3-004

Retrospective comparison clinical presentation and outcome of Natalizumab and Fingolimodassociated PML – Raphael Bernard-Valnet, Julie Blant, Nicola De Rossi, Christoph Schroeder, Aude Maurousset, Markus Kraemer, Kodai Kume, Tatsuro Misu, Jean C. Ouallet, Maud Pallix Guyot, Ralf Gold, Simonetta Gerevini, Ilya Ayzenberg, Renaud A. Du Pasquier

P7.3-005

Evobrutinib therapeutic response is associated with an increase in the number and maturation of peripheral and central classical dendritic cells – Diego Clemente, Mari Paz Serrano Regal, Leticia Calahorra, Inmaculada Alonso García, Ursula Boschert Shafaatian, Philipp Haselmayer, Maria Cristina Ortega, Isabel Machín Díaz, Celia Camacho Toledano, Jennifer García Arocha

P7.3-006

Lack of B-cell Depletion with Ocrelizumab – Sergio Saldivar, Mark S. Freedman, Carolina A.E. Rush, John A. Brooks

P7.3-007

Long-term Safety of Ozanimod in Relapsing Multiple Sclerosis and Moderately to Severely Active Ulcerative Colitis – Bruce A. C. Cree, Silvio Danese, Douglas C. Wolf, Olga Alekseeva, Lorna Charles, AnnKatrin Petersen, James K. Sheffield, Chun-Yen Cheng, Jon V. Riolo, Diego Silva, Fred D. Lublin, David Rubin, Jeffrey Alan Cohen

P7.3-008

Rates and Predictors of Serious Infections in MS and NMOSD Patients treated with Anti-CD20 Therapy – Hesham Ahmed Abboud, Veronica Lee Mears, Collin Jakubecz, Alessandro Serra

P7.3-009

Long-Term Safety and Effectiveness of Delayedrelease Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice, an updated analysis of the ESTEEM Study – Krupa Shah Pandey, Kathryn Giles, Konstantin E. Balashov, Richard A L Macdonell, Jorg Windsheimer, Mikel Martinez, Ivan Bozin, Xiaotong Jiang, Jennifer Lyons, Oksana Mokliatchouk, Annette Okai

P7.3-010

Updated Post-Approval Safety of Cladribine Tablets in the Treatment of Multiple Sclerosis, With Particular Reference to Liver Safety – Gavin Giovannoni, Thomas Leist, Dominic Jack, Andrew Galazka, Axel Nolting

P7.3-011

Ublituximab, a Novel, Glycoengineered AntiCD20 Monoclonal Antibody (mAb), Demonstrates Enhanced Antibody-Dependent Cellular Cytotoxicity (ADCC) Relative to Other Anti-CD20 mAbs – Deren Huang, Enrique Alvarez, Hari Miskin, Lily Lee, John F. Foley

P7.3-012

Comparison of Strategies to Address Hypogammaglobulinemia Secondary to B-cell Depleting Therapies in Neuroimmunology Patients

– Hannah Kelly, Anastasia Vishnevetsky, Lori Chibnik, Michael Levy

P7.3-013

Safety of the Concurrent Administration of Serotonergic Antidepressants and Ozanimod in Patients With Relapsing Multiple Sclerosis –Robert T. Naismith, Jeffrey Alan Cohen, Amit Bar-Or, Giancarlo Comi, Krzysztof W. Selmaj, Hans-Peter Hartung, James K. Sheffield, Anthony Krakovich, Chun-Yen Cheng, Jennifer L. Reardon, Jon V. Riolo, Diego Silva, Bruce A. C. Cree

P7.3-014

Trends and Predictors of Peripheral CD19+ B-cell Repopulation in Patients Treated with Ocrelizumab during COVID-19 Pandemic – Elizabeth Padron, Sopiko Jimsheleishvili, Leticia Tornes, Sylvia R. Delgado, Neeta Garg

P7.3-015

Remibrutinib: A Novel BTKi in Development for MS With a Favorable Safety Profile in Various Autoimmune Disorders – Mitzi Joi Williams, Laura Airas, Tanuja Chitnis, Sarbjit Saini, Michihiro Hide, Gordon Sussman, Jin Nakahara, Robert A. Bermel, Thomas Doerner, Brett Loop, Marina Ollervides Ziehn, Roman Willi, Bernd C. Kieseier, Ivan Nikolaev, Sibylle Haemmerle, Artem Zharkov, Richard Siegel, Bruno Cenni, Heinz Wiendl, Marcus Maurer, Ana M. Gimenez-Arnau, Xavier Montalban

P7.3-016

Influence of Body Mass Index on B Lymphocyte Repopulation in Multiple Sclerosis Patients Treated with Anti-CD20 Therapy – Jacob Walter Loeffler, May Han

P7.3-017

Symptom stability throughout Ocrelizumab infusion cycle in patients with Multiple Sclerosis: final results of SYMptom Burden on Ocrelizumab, a Longitudinal Study (SYMBOLS) – Ilya Kister, Cheongeun Oh, Elizabeth Douglas, Isabella O’Shea, Tamar Bacon, Andrew Joseph Bouley, Ellen Lathi, Joshua D. Katz

P7.3-018

Improvements in Quality of Life of Patients with Multiple Sclerosis receiving Alemtuzumab in Clinical Practice: LEMVIDA study – Jose Meca Lallana, Sara Eichau Madueno, Bonaventura Casanova, Elena Alvarez Rodriguez, Antonio Pato, Baldo Toledo, Mireia Forner

4 General Neurology

General Neurology: Clinical Practice 2

P7.4-001

The Value of Clinical Tests in the Diagnosis of Degenerative Cervical Myelopathy: Results of a Systematic Review – Lindsay Tetreault, Elina Zakin

P7.4-002

Diagnostic Accuracy of Somatosensory Evoked Potential monitoring during Scoliosis correction surgery in the pediatric population: A Systematic Review – Vamsi Krishna Gorijala, Likhita Shaik, Parthasarathy Thirumala, Katherine Melonakos Anetakis, Jeffery R. Balzer, Donald Crammond, Varun Shandal, Joon Lee, Jeremy Shaw, Rajiv Reddy

P7.4-003

“Trident Sign” in Spinal Cord Lymphoma – Kim Griffin, Michel Toledano, Eoin P. Flanagan, Rafid Mustafa

P7.4-004

The Quix Test: Identifying Vestibular Dysfunction in the “Dizzy Patient” – Kayla Schusterman, Jeremy Michael Kuder, Amanda Walker, Julianne Lee, Isabella Canut, Anthony Thompson, Charles Maitland, Philippe R. Gaillard, Farnaz Solatikia

P7.4-005

WITHDRAWN

P7.4-006

Assessment of altered mental status in the Emergency Department using quantitative pupillometry: a prospective cohort study – Maya Alexis, Felix E. Fernandez-Penny, Benjamin Abella

P7.4-007

Clinical Experience of ‘My Sleep’ Sleep Digital Recording Application with Web-based Physician Program for Sleep Disorders – Pamela Song, Hea Ree Park, Seo-Young Lee, Eun-Yeon Joo, Jee Hyun Kim

5Cerebrovascular Disease and Interventional Neurology

Cerebrovascular Disease and Interventional Neurology: Thrombolytic Therapy and Acute Stroke Treatments

P7.5-001

Effect of Antiplatelet Therapy in Acute Ischemic Stroke with Tandem Lesions – Mudassir Farooqui, Milagros Galecio-Castillo, Afshin A. Divani, Amer Malik, Nils Petersen, Michael George Abraham, Johanna Therese Fifi, Waldo Guerrero, James E. Siegler, Thanh Ngoc Nguyen, Sunil Sheth, Albert J. Yoo, Guillermo Linares, Nazli A. Janjua, Syed F. Zaidi, Jessica Kobsa, Ayush Prasad, Asad Ikram, Cynthia Zevallos, Darko Ernesto Quispe Orozco, Manuel Requena, Marta Olive Gadea, Abid Qureshi, Tiffany Barkley, Andres Dajles, Stavros Matsoukas, Ameena Rana, Mohamad Abdalkader, Sergio Arturo Salazar Marioni, Jazba Soomro, Juan A. VivancoSuarez, Randall Edgell, Maxim Mokin, Dileep R. Yavagal, Mouhammad A. Jumaa, Ameer Hassan, Santiago Ortega Gutierrez

P7.5-002

Safety Profile of Rescue Stenting Following Thrombectomy for Acute Basilar Artery Occlusion – PC SEARCH Registry Analysis – Ehad Afreen, Adam T. Mierzwa, Syed F. Zaidi, Nameer Aladamat, Khaled Gharaibeh, Ashley Nelson, Santiago Ortega Gutierrez, Mudassir Farooqui, Juan A. VivancoSuarez, Ashutosh P. Jadhav, Shashvat Desai, Gabor Toth, Anas Mohammed Alrohimi, Thanh Ngoc Nguyen, Piers Klein, Mohamad Abdalkader, Aditya S. Pandey, Sravanthi Koduri, Shivangi Vora, Nirav Vora, Mouhammad A. Jumaa, Sami Alkasab

P7.5-003

Trends in Thrombectomy Utilization in Stroke: Basilar Artery versus ICA/MCA – Karan Patel, Kamil Taneja, Michael Joseph Diaz, Aleem Mohamed, Sai Batchu, Jesse Thon, James E. Siegler

P7.5-004

In-hospital Delays of Acute Ischaemic Stroke Treatment and Their Influence on Outcomes in Korle Bu Teaching Hospital, Ghana – Fiifi Duodu, David Brodie-Mends, Babbel Agbinko-Djobalar, Prince Kwabla Pekyi-Boateng, Kodwo Oduro Nkromah, Patrick Adjei, Albert K. Akpalu

P7.5-005

Clinical outcome in patients with acute hypertensive hemorrhagic stroke with intravenous fluid versus no intravenous fluid: a randomized controlled study – Abhishek Pathak

P7.5-006

Stroke Hospitalization Administration & Monitoring: Routine Or Covid-19 Care (SHAMROCC) – Timothé

Langlois-Thérien, Michel C. Shamy, Brian Dewar, Ronda Lun, Dariush Dowlatshahi, Dylan Paul Vincent Blacquiere, Grant J. Stotts, Robert Fahed, Célina Ducroux

P7.5-007

Reperfusion Therapy for Acute Ischemic Stroke in Cardiomyopathy Patients with Heart Failure: A National Inpatient Sample-based Analysis –Serena Wong, Brittany Russo, Aiden Liu, Maya Pandit, Fawaz Al-Mufti

P7.5-008

Racial and Socioeconomic Disparities in Ischemic Stroke Outcomes among Non-lytic/Thrombectomy

Patients – Riya Bhavsar, Tariq Nisar, Alan P. Pan, Amber Criswell, Farhaan S. Vahidy, Charles David McCane, Thao Dinh, Ken Ling, David Chiu, Rajan Ramji Gadhia

P7.5-009

System-wide implementation of Computed Tomography Perfusion (CTP) Imaging for Acute Stroke: Impact on Quality, Safety and Outcomes

– Nancy Eudalia Abarca, Anvita Potluri, Malgorzata

Miller, Alicia Stowe, Brian Wideman, Jenny Peih-Chir Tsai, Tricia Tubergen, Todd Mulderink, Jiangyong Min, Nabil Wees, Nadeem I. Khan, Asad Ahrar, Justin Singer, Paul Mazaris, John Oostema, Muhib Khan

P7.5-010

Patient and Hospital Sources of Disparity Predicting Differences in Acute Stroke Treatment in Community and Academic Hospitals – Jerry Shen, Lester Y. Leung

P7.5-011

Addressing the Health Disparities in Acute Ischemic Stroke Outcomes in Africa– Olivier Uwishema, Abdelmonem Siddiq

P7.5-012

Thrombectomy versus tPA in Basilar Artery

Occlusion Stroke – Karan Patel, Kamil Taneja, Michael Joseph Diaz, Aleem Mohamed, Sai Batchu, Jesse Thon, James E. Siegler

P7.5-013

Aspirin-Dipyridamole in Fluctuating Small Vessel Disease Ischemic Strokes – Catlin Moran, Katherine March, Katherine Nearing

P7.5-014

Treatment of Refractory Vasospasm after Aneurysmal Subarachnoid Hemorrhage: What else could we do for our patients? A Case Report and Systemic Literature Review – Chhitij Tiwari, Rizk Alghorazi, Jamie Conklin, Matthew Mauck, James Pham Ho, Kassie Lyn McCullagh, Clio A. Rubinos

P7.5-015

The Effect of Metformin on Stroke Prognosis in Diabetic Patients; a Clinical Trial – Sara Esmaeili, Zahra Mirzaasgari

P7.5-016

Efficacy and Safety of Injection Tenecteplase in 4 5 to 24 hours imaging eligible window patients with Acute Ischemic Stroke (EAST-AIS) – Arti Jatwani, Awadh K. Pandit, Poorvi Tangri, Achal K. Srivastava, Rohit Bhatia, Ajay Garg, Deepti Vibha, Vishnu VY, Animesh Das, Divya M. MR

P7.5-017

Life-threatening Neutropenia After a Short Course of Dual Antiplatelet Therapy for Minor Stroke –Collin Culbertson, Lawrence Scott Blaszkowsky

P7.5-018

Comparison of the effectiveness and side effects of intravenous TPA injection in acute stroke patients between 0 to 4 .5 hours and the first 4 .5 to 6 hours from the onset of symptoms – Mehdi Maghbooli

P7.5-019

90-Days Outcomes In Patients With Minor Strokes Or Transient Ischemic Attacks Discharged On Single Vs Dual Anti Platelet-Therapy In the Middle East – Hiba Naveed, Naveed Akhtar, Ashfaq Shuaib, Salman Al Jerdi

P7.5-020

Rivaroxaban for the treatment of cerebral venous thrombosis – Zahra Mirzaasgari, Sara Esmaeili

P7.5-021

Delay of Aspirin Administration in patients after Stroke Code Activation, who are not candidates for tissue Plasminogen Activator (t-PA) or Mechanical Thrombectomy (MT) pre- and post-COVID pandemic – Muhammad Waseem Anjum, Arvin Parvathaneni, Vijayakumar Javalkar, Oleg Y. Chernyshev

P7.5-022

Single Center Experience of Intrathecal Nicardipine Use in The Treatment of VasospasmLessons Learned – Aaisha Mozumder, Anqi Luo, Davana Ramaswamy, Shadman Sakib Mozumder, Firas Kaddouh

P7.5-023

An Experience of a Single Comprehensive Stroke Center after Implementation of Routine Tenecteplase Administration for Acute Ischemic Stroke Treatment – Cara Cawley, Devin Simon, Shana Lynn Radomski, Brianne Kuns, Ulind Bejleri, Hyeyoung Seol, Anmar Razak

P7.5-024

Cerebral Small Vessel Disease Subtypes and Blood Pressure Control after Intracerebral Hemorrhage – Akashleena Mallick, Alvin Das, Sophia Keins, Jessica Abramson, Juan Pablo Castello, Marco Pasi, Dominique Popescu, Leidys Gutierrez-Martinez, Ernst Mayerhofer, Christina Kourkoulis, Axana Rodriguez-Torres, Andrew D. Warren, Elif Gokcal, Anand Viswanathan, Steven M. Greenberg, Christopher D. Anderson, Jonathan Rosand, Edip M. Gurol, Alessandro Biffi

P7.5-025

Examining the Relationship between Hospital Admission Ischemic Stroke Mortality Score and Hospital Discharge Disposition – Zachary Hodosevich, Dawn Meyer, Kunal Agrawal

P7.5-026

Acute Intracerebral Hemorrhage (ICH) and Systemic Acidosis: Associations with Functional Outcomes and Mortality – Alexander Andreev, Mitchell Wilson, Jia-Yi Wang, Daniel Wang Forsman, Nadia McMillan, Sonu Sahni, Magdy H. Selim, Vasileios-Arsenios Lioutas

P7.5-027

Impact of Circle of Willis Anatomical Variations on Outcomes in Aneurysmal Subarachnoid Hemorrhage – Scott Moody, John Pham, Evrim Efe Ozcan, Ariyaporn Haripottawekul, Thanujaa Subramaniam, Michael E. Reznik, Karen L. Furie, Shadi Yaghi, Ali Mahta

P7.5-028

Comparing characteristics and outcomes of in-hospital stroke and community-onset stroke – Zi-Yue Liu, Guangsong Han, Juanjuan Wu, Yuhui Sha, Yuehui Hong, Hanhui Fu, Lixin Zhou, Jun Ni, Yi-Cheng Zhu

P7.5-029

Differences in Stroke Outcomes and Experiences between White and Minority Patients and Providers – Nikash Shankar, Mykaiya Sumling, Mary Carter Denny

P7.5-030

Prophylactic Levetiracetam for the Prevention of Seizures in Acute Nontraumatic Intracerebral Hemorrhage: A Retrospective Propensity-matched Patient Outcome Analysis – Uyen Nguyen, Debarati Bhanja, David Hallan, Kevin Cockroft, Elias Rizk

5 Autoimmune Neurology

Autoimmune Neurology: Autoimmune Encephalitis / Paraneoplastic Neurologic Disorders 2

P7.5-031

Paraneoplastic and non-paraneoplastic limbic encephalitis: distinguishing features and outcomes – Smathorn Thakolwiboon, Abhigyan Datta, Jennifer McCombe, Ajay Madhavan, Anastasia Zekeridou, Eoin P. Flanagan, Sean J. Pittock, Andrew McKeon, Divyanshu Dubey

P7.5-032

MRI hallmarks of LGI1- and CASPR2-antibody encephalitis – Mark J. Kelly, Eleanor Grant, Andrew Murchison, Christopher Edward Uy, Sophie Binks, Sundarshini Ramanathan, Fintan Brian John Sheerin, Sarosh Irani

6

Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Mild Cognitive Impairment

P7.6-001

Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer’s Disease pathology in Subjective Cognitive Decline – Giulia Giacomucci, Salvatore Mazzeo, Silvia Bagnoli, Assunta

Ingannato, Sonia Padiglioni, Sandro Sorbi, Valentina Bessi, Benedetta Nacmias

P7.6-002

Retrospective Cohort Study to Quantify the Economic Impact of Mild Cognitive Impairment

– Feride H. Frech, Gang Li, Yingjie Ding, Colette Ndiba-Markey, Andrew Rava, Richard Batrla, Harald Hampel

P7.6-003

Impact of Incidental Synucleinopathy in Mild Cognitive Impairment due to Alzheimer’s Disease

– Jahnavi Shriram, Michael Malek-Ahmadi, Marwan N. Sabbagh

P7.6-004

Early Neuropsychiatric Symptoms of Mild Cognitive Impairment Subtypes: An Analysis of the National Alzheimer’s Coordinating Center Database –Joseph Eric Malone, Mohamed Elkasaby, Brian Appleby, Charles J. Duffy, Lindsay Miller Scott, Tamara Murphy, Paula K. Ogrocki, Alan Lerner

P7.6-005

Subjective cognitive decline: 15 years of follow-up experience from a memory clinic – Salvatore Mazzeo, Sonia Padiglioni, Silvia Bagnoli, Giulia Giacomucci, Juri Balestrini, Assunta Ingannato, Valentina Moschini, Carmen Morinelli, Filippo Emiliani, Giulia Galdo, Benedetta Nacmias, Sandro Sorbi, Valentina Bessi

6 Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Therapeutics 1

P7.6-006

Decentralized approaches in TRAILBLAZER-ALZ 3

– Roy Yaari, Jessica Langbaum, Paul Maruff, Ralph Lee, Elly Lee, Alette Wessels, Karen C. Holdridge, Margaret Ferguson

P7.6-007

Repeat IV and SC Dosing of the Anti-Sortilin Antibody AL101 – Lovingly Park, Daniel Maslyar, Michael Ward, Felix Leejia Yeh, Hua Long, Michael Kurnellas, Mayura Vadhavkar, Balasubrahmanyam Budda

P7.6-008

HARBOR: ABBV-916 In Subjects With Early Alzheimer’s Disease Combined MultipleAscending Dose/Proof-Of-Concept Study Design

– David Watson, Shau Yu Lynch, Hana Florian, Deli Wang, Sagar Bachhav, Joey C. Boiser, Anthony Bannon, Eddie Stage, Ole Graff

P7.6-009

Alzheimer’s Disease Linkage to Evidence (ADLINE) Study Early Results: Linking Real-World Claims Data to Phase III GRADUATE Study of Gantenerumab – Chris Wallick, Howard Fillit, Oleg Tcheremissine, Ibrahim Abbass, Carmen Ng, Tu My To, Sheila Seleri

P7.6-010

Multi-Modal Correlation Analyses From a Phase 2, Open-Label Study of NE3107 in Patients With Cognitive Decline Due to Degenerative Dementias

– Joseph Michael Palumbo, Jeffrey Zhang, Kennedy Mahdavi, Victoria Venkatraman, Sergio Adrian Becerra, Jonathan Haroon, Kaya Jordan, Elisabeth Rindner, Jean Rama Surya, Taylor P. Kuhn, Bijan Pourat, Sheldon E. Jordan

7 Practice, Policy, and Ethics

Practice, Policy, and Ethics: Removing Barriers to Practice and Profession 2

P7.7-001

Tool to Track Post-Discharge Lab Results Leads to Improved Rates of Follow Up – Olivia Kingsford, Harjot Hansra, Judea Wiggins, Jonathan Bryant, Bryan Franzen, Jay Patel, Laura Greenwood, Michael Vincent Robers

P7.7-002

Tackling resident burn-out through enhancing the work environment amidst the COVID-19 pandemic

– Aya A. Ouf, Azka Shaikh

P7.7-003

Characterizing neurologist EHR use: a crosssectional analysis – Jorge Rodriguez-Fernandez, Daniel B. Hier, Jeffrey A. Loeb

P7.7-004

Assessment of Electronic Medical Record Efficiency in Neurologists – Babar Khokhar, Troy Brown, Paul Votto, Dinesh Pashankar

P7.7-005

A Survey of Parental Leave Academic Faculty Experiences Identifies an Overlooked Need – Thy Nguyen, Bethany Williams, Anjail Sharrief

P7.7-006

A Comparison of the Telemedicine Experience in the Early Pandemic (2020) Vs Later Pandemic (2021) Periods: Results of a Mixed Methods

Comparison – Kelly Ann Pring, Sharon Thomson, Carly Jo Olszewski, Rebecca Siobhan-Ivy Cox, Rebecca Merrill, Emily Fishman, Alexander Paul Ambrosini, Kevin Alexander Soltany, Gabriella Marie Bognet, Lauren Doyle Strauss, Rachel Graham, Amy K. Guzik, Roy E. Strowd

8Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Neuromuscular Junction Disorders 3

P7.8-001

COVID19 Infection in Myasthenia Gravis: Predictors of Severity – Husam Al Sultani, Rocio Carolina Garcia Santibanez, Hani Kushlaf, Shaida Khan, Yessar M. Hussain, Thy Nguyen, Kelly G. Gwathmey, Aziz I. Shaibani

P7.8-002

Sex Differences in Therapy for Myasthenia Gravis

– Benjamin Frank Beland, Gordon Jewett, Angela Lee, Tefani Perera, Lawrence Korngut

P7.8-003

Serum Cytokines Levels in Patients with Myasthenia Gravis and Their Changes After Treatment – Doruk Arslan, Zeynep Ergül Ülger, Sibel Goksen, Gunes Esendagli, Sevim Erdem-Ozdamar, Ersin Tan, Can Ebru Kurt

P7.8-004

Stimulated Jitter Analysis for the Evaluation of Neuromuscular Junction Disorders in Children –Vishva Natarajan, Sumit Verma

P7.8-005

BioDigit MG: A Pilot Study Examining a Digital Technology for Quantitative Assessment and Remote Monitoring of Myasthenia Gravis –Amanda C. Guidon, Ram Kinker Mishra, Abby Lindsay, Raghu Mulukutla, Ashkan Vaziri

P7.8-006

The Impact of Generalized Myasthenia Gravis

Severity on Work and Daily Activities: A Real World Study – Jacqueline Pesa, Zia Ulhaq Chaudhry, Tiina Drissen, Jonathan de Courcy, Sophie Barlow, Emma Chatterton, Owen Thomas, Gregor Gibson

P7.8-007

Identifying Digital Biomarkers for the SelfMonitoring of Patients Living with Generalized Myasthenia gravis: a Proof of Concept – Pascal Laforet, David Orlikowski, Guillaume Nicolas, Helene Prigent, Edouard Berling, Ghislain N’DahSekou, Clarissa Gorin, Ana Julia Moreira, Juliette Narcy, Angéline Plaud, Emma Touré Cuq, Martin Keller, Brian Werneburg, Emrah Aras, Michael G. Benatar

P7.8-008

A Quantifiable Telemedicine Approach to the Myasthenia Gravis Neurological Exam – Marc

Garbey, Guillaume Joerger, Quentin Lesport, Helen Girma, Sienna McNett, Mohammad Abu-Rub, Henry J. Kaminski

P7.8-009

Eculizumab for Acetylcholine Receptor-positive

Generalized Myasthenia Gravis: Single Center

Experience – Hacer Durmus, Arman Cakar, Fatma

Yesim Parman

P7.8-010

Comorbid Contributors to Fatigue in Myasthenia

Gravis – Kelly G. Gwathmey, Deep Patel, Emma Marie Parolisi

P7.8-011

A Quantitative Approach to Telemedicine Assessment of Ptosis and Ocular Motility for Patients with Myasthenia Gravis – Quentin Lesport, Guillaume Joerger, Henry J. Kaminski, Helen Girma, Sienna McNett, Mohammad Abu-Rub, Marc Garbey

P7.8-012

Real World Experience of New MG Therapies: Single Center Cohort Study – Matthew Anderson, Omar Jawdat, Duaa Jabari, Swathy Chandrashekhar, Constantine Farmakidis, Mazen M. Dimachkie, Mamatha Pasnoor

P7.8-013

Myasthenia Gravis Treatments Are Associated with Negative Patient Sentiment in Digital Conversation

Data – Jacqueline Pesa, Zia Ulhaq Chaudhry, Tiina Drissen, Caroline Brethenoux, Patrick Furey, Liliana Gil Valletta, Laura Gonzalez Quijano, Alex Lorenzo

P7.8-014

MGBase: The launch of an international electronic database for patients with Myasthenia Gravis –Stephen Reddel, Carolina Barnett Tapia, Helmut Butzkueven, Katherine Buzzard, Gary Raymond Cutter, Henry J. Kaminski, Anneke Van Der Walt, Wenwen Zhang

9

Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Spinomuscular Atrophy/ Muscular Dystrophies

P7.9-001

Real-world Outcomes of Nusinersen or Onasemnogene Abeparvovec (OA) Monotherapy, or Switching to OA from Nusinersen in SMA Patients Aged ≥6 Months – Omar Dabbous, Min Yang, Mihaela Georgieva, Walter Toro, Nicole LaMarca, Anish Patel, Annika Anderson, Hanane Akbarnejad, Sandra P. Reyna

P7.9-002

Association between myocardial oxygenation and fibrosis in Duchenne Muscular Dystrophy: analysis by oxygenation-sensitive and T1 mapping cardiovascular magnetic resonance – Ziqi Zhou

P7.9-003

Baseline Characteristics and Interim Safety in RESPOND: A Phase 4 Study in Children with Spinal Muscular Atrophy (SMA) Treated With Nusinersen After Onasemnogene Abeparvovec – Nancy L. Kuntz, Julie Anne Parsons, John Brandsema, Crystal M Proud, Richard S. Finkel, Kathryn J. Swoboda, Ricardo Masson, Yingying Liu, Corinne Makepeace, Angela Paradis, Zdenek Berger, Kathleen C. Somera-Molina

P7.9-004

JEWELFISH: 24-month Safety, Pharmacodynamic and Exploratory Efficacy Data in Non-TreatmentNaïve Patients with Spinal Muscular Atrophy (SMA) Receiving Treatment with Risdiplam – Claudia A. Chiriboga, Claudio Bruno, Tina Duong, Dirk Fischer, Janbernd Kirschner, Mariacristina Scoto, Eugenio Mercuri, Marianne Gerber, Ksenija Gorni, Heidemarie Kletzl, Imogen Carruthers, Carmen Martin, Teresa Gidaro, Francesco Muntoni

P7.9-005

Feasibility of a Home-Based Exergame Therapy for Youth with Spinal Muscular Atrophy – Xing Chen, Kathy Selby, David Herzig, Katrina Cardiff, Niamh Cushen, Yan Defosses, Hernan D. Gonorazky, Juergen Gottowik, Renee Haldenby, Ivan Jurisic, Shaainthabie Karthigesu, Leigh Macintyre, Alex MacKenzie, Jean K. Mah, James R. McCullough, Pamela Ng, Slawomir Opalka, Michal Openchowski, Svetlana Petkun, Beth Potter, Jordan Sheriko, Maureen Smith, Martin Christian Strahm, Sarah Turgeon Desilets, Angelina Woof, Maryam Oskoui

P7.9-006

Long-Term Follow-Up of Onasemnogene Abeparvovec Gene Therapy in Patients with Spinal Muscular Atrophy Type 1 – Jerry R. Mendell, Melissa Wigderson, Iulian Alecu, Lina Yang, Lesa Mehl, Anne M. Connolly

P7.9-007

Outcomes in Patients with Spinal Muscular Atrophy and Four or More SMN2 Copies Treated with Onasemnogene Abeparvovec: Findings from RESTORE – Richard S. Finkel, Kamal Benguerba, Manish Gehani, Dheeraj Raju, Eric Faulkner, Nicole LaMarca, Laurent Servais

P7.9-008

Bulbar Function in Children with Two or Three SMN2 Copies Who Received Onasemnogene Abeparvovec Presymptomatically for Spinal Muscular Atrophy – Katlyn McGrattan, Richard Shell, Rebecca Hurst-Davis, Sally Dunaway, Giovanni Baranello, Arseniy Lavrov, Eamonn O’Brien, Shiri Wallach, Nicole LaMarca, Sandra P. Reyna, Basil T. Darras

P7.9-009

FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA) – Basil T. Darras, Giovanni Baranello, Odile Boespflug-Tanguy, John W. Day, Nicholas Deconinck, Andrea Klein, Ricardo Masson, Maria Mazurkiewicz-Beldzin, Eugenio Mercuri, Kristy Rose, Dmitry Vlodavets, Hui Xiong, Edmar Zanoteli, Muna El-Khairi, Marianne Gerber, Ksenija Gorni, Heidemarie Kletzl, Laura Palfreeman, Angela Dodman, Laurent Servais

P7.9-010

Treatments and Outcomes for Patients with Spinal Muscular Atrophy Type 2: Findings from RESTORE Registry – Laurent Servais, Kamal Benguerba, Darryl C. De Vivo, Jan Kirschner, Francesco Muntoni, Crystal M Proud, Eduardo Tizzano, Susana QuijanoRoy, Isabelle Desguerre, Kyoko Saito, Dheeraj

Raju, Nicole LaMarca, Rui Sun, Fred Anderson, Eric Faulkner, Richard S. Finkel

P7.9-011

Could Ultrasound be a Game Changer in the Diagnosis of Duchenne Muscular Dystrophy? A Systematic Review and Meta-analysis of the Recent Evidence – Mohamed A. Ebrahim, EzzEldin Hesham Abouelatta, Aya Moustafa

Aboutaleb, Yousif Gamal Hassan, Imene Maallem, Abdulrahman Ayman Ebrahim, Rana Samir Rouby Ahmed, Yasmeen Sayed Mohamed, Dima Hisham Fikry, Muhammad Moataz Al Aref, Dina Mounir, Khaled Ashraf Mohamed, Ramy Abdelnaby

P7.9-012

Sex Differences in Olfactory Spatial Learning in Postnatal Day 13 Mice – Sarah Doebley, Sofia Eugenia Nicolayevsky, Sheyenne Sheyenne Gillis, Sanghee Yun, Amelia Eisch, Danielle G. Barber

10 General Neurology

Neurologist-in-training Clinical Ethics

Elective

P7.10-001

Self vs machine: clinical and ethical implications of the effects of deep brain stimulation on cognition–Laura De Lima Xavier

P7.10-002

Neurologist-in-training Clinical Ethics Elective (NITCEE) Poster Presentation – Danielle Feng

P7.10-003

Managing racial tensions in inpatient neurology –Andrew Phillip Huang

P7.10-004

Neuro-Devastation: What Neurologists Think and How Cultural Concordance Matters – Pallavi Juneja

P7.10-005

A Case Based Ethical Approach to Medical Assistance in Dying in Canada for Patient with Cognitive Impairment – Victoria Reedman

P7.10-006

Factors Underlying Delayed Diagnosis and Initiation of Treatment for Alzheimer’s Disease in Racial and Ethnic Minoritized Patients – Deborah

P7.10-007

Helping Families Make Ethical Choices for Children With Severe Neurological Impairment – Sabrina

11 Movement Disorders

Movement Disorders: Essential Tremor and Other Tremor Disorders 2

P7.11-001

The Effects of Thalamic Deep Brain Stimulation on Gait in Essential Tremor: a Kinematic Study – Paola Testini, Johnathan Lucas McKay, Richa Tripathi, Imari Genias, Grey Skelton, Douglas Bernhard, Svjetlana Miocinovic, Pratibha Aia, Cathrin M. Buetefisch, Lenora A. Higginbotham, Laura M. Scorr, Shirley Triche, Stewart A. Factor, Christine Doss Esper

P7.11-002

Burden of Essential Tremor: Associated Morbidities, Healthcare Resource Utilization and Costs in Commercially Insured Patients on Drug Therapy – Liana Hennum, Ali Samiian, Dhira Khosla, Elan D. Louis

P7.11-003

Serum Neurofilament Light-chain Concentrations in Essential Tremor: A Case-Control Study –Meagen Salinas, Victor Hernan Salinas, Nora Hernandez, Elan D. Louis

P7.11-004

Tremor Reduction using DBS: Outcomes of a Realworld, Prospective, Multicenter Essential Tremor Registry – Guenther Deuschl, Griet Loret, Norbert Kovacs, Frederik Clement, P.R. Schuurman

P7.11-005

Investigating synaptic changes in Essential Tremor with PET Imaging – Yanghong Yang, Mika Naganawa, Nora Hernandez, Neil Nguyen, Nabeel Nabulsi, Yiyun Huang, Richard Carson, David Matuskey, Elan D. Louis

P7.11-006

Efficacy and Safety of Unilateral MRgFUS Thalamotomy for Essential Tremor – Ka Loong Kelvin Au, Kelly E. Lyons, Lauren O’Brien, Vibhash D. Sharma, Jennifer Cheng, Michael Kinsman, Rajesh Pahwa

P7.11-007

Therapeutic Outcomes of Directional Deep Brain Stimulation in Essential Tremor Patients – Alina Shub, Donald A. Smith, Theresa A. Zesiewicz, Teresita Malapira, Yarema B Bezchlibnyk

P7.11-008

The Impact of Deep Brain Stimulation on the Embarrassment and Self-Esteem of Patients with Essential Tremor – Akanksha Dave, Jessica Frey, Jun Yu, Janine Lemos Melo Lobo Jofili Lopes, Christopher Hess

P7.11-009

Improved electrode configuration for Transcutaneous Afferent Patterned Stimulation for Essential Tremor and Parkinson’s Disease –Alexander Kent, Shahrose Aratia, Dhira Khosla, Ruta Deshpande, Kathryn Rosenbluth

11 Movement Disorders

Movement Disorders: Parkinson’s Disease

Non-motor Symptoms 2

P7.11-010

Sleep Disturbances in Early Onset Parkinsonism

– Stuart McCarter, Emanuele Camerucci, Aidan Mullan, Cole Daniel Stang, Pierpaolo Turcano, Erik Kent St. Louis, Bradley F. Boeve, James H. Bower, Rodolfo Savica

P7.11-011

Neuropathic Symptoms in Parkinson’s Disease –Divya R. Ganugapati, Darce Costello, Neha Prakash, Matthew Imperioli, Fernanda Wajnsztajn

P7.11-012

Data-Driven Genome-Wide Association Study of Pain Trajectories in Persons with Parkinson’s Disease – Shiying Liu, Doug Gunzler, Steven Alexander Gunzler, Dana Crawford, Farren Briggs

P7.11-013

Subclinical Liver Fibrosis is Associated with More Rapid Cognitive Decline in Parkinson’s Disease

– Aryeh Zolin, Cenai Zhang, Hwai Yin Ooi, Harini Sarva, Hooman Kamel, Neal S. Parikh

P7.11-014

Pilot Tailored Lighting Intervention on Sleep Disturbances in Parkinson disease – Andrea Sujung Yoo, Roberto P. Ortega, Deborah Raymond, Rachel Gerber, Maggie Markgraf, Judy Liang, Rivka Zians, Adina Wise, Maya Rawal, Barbara Plitnick, Jennifer Brons, Susan B. Bressman, Mariana Gross Figueiro, Rachel J. Saunders-Pullman

P7.11-015

Screening and Treatment of Depression in Parkinson’s Disease Within Movement Disorders

Centers – James Beck, Zachary Meyer, Anna Naito, Connie C. Marras, Daniel Weintraub, Nabila Dahodwala, Meredith Spindler, Thomas L. Davis, Amy Brown, Janis Miyasaki, Kelly A. Mills, Eugene Nelson, Marilyn Neault, Sneha Mantri, Allison Marie Allen

Headache

Headache: Clinical Investigations in Headache 2

P7.12-001

What trade-offs are patients willing to make when selecting between novel preventive treatments for migraine? Evidence from a Discrete Choice Experiment – CL Whichello, Antje TockhornHeidenreich, Matt Quaife, Myrto Trapali, Tommi Tervonen, Lars Viktrup, April Naegeli

P7.12-002

Characterizing the Patient Experience During the Prodrome Phase of Migraine: A Qualitative Study of Symptoms and Their Timing – Jonathan Stokes, Richard B. Lipton, Christopher Evans, Elizabeth Hribal, Kailee White, Katelyn R. Keyloun, Krutika Jariwala-Parikh, Pranav Gandhi, David W. Dodick

P7.12-003

Autosomal Dominant Trigeminal Neuralgia –Ashley Becker, Jonathan Perk

P7.12-004

Patient Preferences for Attributes of Advanced Migraine Prevention Medications: Findings from a Discrete Choice Experiment – Todd J. Schwedt, Ashley Ann Martin, Steven Kymes, Brian Talon, Xin Ying Lee, Roger Cady, Divya Asher, Meghana Karnik-Henry, Emily H. Mulvihill, Dawn Bates, Kathleen Beusterien

P7.12-005

Lasting Electrographic Footprint of Familial Hemiplegic Migraine – Mahjabeen Ahmed Khan, Cynthia Morris, Sean Goretzke

P7.12-006

Exploring within-person differences in migraineassociated symptoms across phases of the migraine cycle: Results of the MiCOAS Qualitative Study – James McGinley, Richard B. Lipton, Rikki Mangrum, Dawn C. Buse, Calvin James Hall, Carrie R. Houts, Tracy K. Nishida, RJ Wirth

P7.12-007

Characterizing inter- and intra-individual differences in migraine-related cognitive symptoms and impairment across the migraine cycle: An analysis of the MiCOAS qualitative project – James McGinley, Rikki Mangrum, Dawn C. Buse, Calvin James Hall, Carrie R. Houts, Tracy K. Nishida, RJ Wirth, Richard B. Lipton

P7.12-008

The relationship between anxiety and depressive symptoms and migraine-related outcomes in children and adolescents: a prospective clinical cohort study – Bilal Rizvi, Lydia Cho, Jonathan William Perry Kuziek, Paul Ronksley, Melanie Edward Noel, Serena Orr

P7.12-009

Identifying Areas of Unmet Need Among People with Migraine with an Inadequate Response to Prior Acute Therapies: Results from the MOMENTUM trial – Zachariah Thomas, Amanda Jones, Angad Chhabra, Shawn Alter, Herriot Tabuteau, Richard B. Lipton

P7.12-010

Migraine-Related Stigma in Adults With Current Versus Previous High-Frequency Migraine and Acute Medication Overuse: Results of the Harris Poll Migraine Report Card Survey – Dawn C. Buse, Roger Cady, Amaal J. Starling, Meghan R. Buzby, Charles Spinale, Kathy Steinberg, Steven Kymes

P7.12-011

Switching from galcanezumab to fremanezumab in migraine patients: a retrospective analysis –Tsubasa Takizawa, Seiya Ohtani, Narumi Watanabe, Keiko Ihara, Nobuyuki Takahashi, Naoki Miyazaki, Ryo Takemura, Satoko Hori, Jin Nakahara

P7.12-012

Efficacy and tolerability of anti-CGRP monoclonal antibodies in patients aged ≥65 years with episodic or chronic migraine – Sudipa Biswas, Amira Salim, Elise Ruth Hennessy, Aarushi Suneja, Zubair Ahmed, Ignacio Mata 13

Neuro-oncology

Neuro-oncology: Advancing Outcomes in Neuro-oncology

P7.13-001

Glioblastoma as a Herpes Simplex Encephalitis Mimic: A Potential Imaging Trap – Nameer Aladamat, Khaled Gharaibeh, Fahham Asghar, Ajaz Sheikh

P7.13-002

How much does having a neurologic disease affect QoL in non-CNS cancer patients? – Bernardo Cacho Diaz

P7.13-003

Barriers to participation in a prospective clinical trial for schwannomatosis-related pain – Scott R. Plotkin, Jennifer Da, Vanessa Merker, Justin T. Jordan, Ina Ly, Alona Muzikansky, Michael Parsons, Pamela Wolters, Lei Xu, Mark T. Brown, Scot Styren

P7.13-004

Investigating the Molecular Epidemiology and Prognosis of Smoking and Gliomas – Gabriella Marie Bognet, Sarah Grace Ahr, Shakti Ramkissoon, Michael Chan, Christina Cramer, Stephen B. Tatter, Adrian Laxton, Jaclyn White, Glenn Lesser, Roy E. Strowd

P7.13-005

Geriatric-8 Assessment is Predictive of Hospitalization in Patients with Glioblastoma –Wade J. Whitt, Lauryn Hemminger, Sarah Cawley, Nimish A. Mohile, Andrea C. Wasilewski, Sara Hardy

P7.13-006

Using Qualitative Interviews to Improve Quantitative Assessments of Quality of Life in Patients with Neurofibromatosis 2 – Liesel Von Imhof, Scott R. Plotkin, Kaleb H. Yohay, Phioanh Leia Nghiemphu, Dusica Babovic-Vuksanovic, Vanessa Merker

1 Neuro Trauma and Critical Care

Neuro Trauma and Sports Neurology

P8.1-001

Agglomerative Hierarchical Clustering of LongLasting Post-Concussive Symptoms: SymptomCentric Association with Functional Impairments – Narayan Kuleindiren, Federico Tiersen, Monika Johal, Aaron Lin, Hamzah Selim, Raphael RifkinZybutz, Mohammad Mahmud

P8.1-002

Utilizing Augmented Reality to Quantify Information Processing and Motor Performance in Military Personnel to Detect Mild Traumatic Brain Injury – Ryan Kaya, Anson Rosenfeldt, Colin Waltz, Elizabeth Jansen, Kelsey M. Owen, MacKenzie Dunlap, Karissa Hastilow, Kathryn Scelina, Eric Zimmerman, Morgan McGrath, Amanda Penko, Jay L Alberts

P8.1-003

Amygdala Perfusion Is Associated with Persistent Affective Symptoms after Sports-Related Concussion – Sriramkumar Sridharan, Christopher Andrew Sheridan, Daniel Hudson, Megan E. Lipford, Kevin Bickart, Corey M. Thibeault, Christopher Giza, Robert Hamilton, Meeryo Choe, Christopher Thomas Whitlow

P8.1-004

Inter- and Intra-Rater Reliability of a Virtual Concussion Assessment During the Era of the COVID-19 Pandemic – Alani Jack, Helena Digney, Carter Alden Bell, Binu Joseph, Sara Wesley Hyman, Steven Galetta, Laura J. Balcer, Barry Stewart Willer, Mohammad Nadir Haider, Ghazala T. Saleem, Scott Grossman, John J. Leddy, Neil A. Busis, Daniel Torres

P8.1-005

Evaluating Quality of Website-Derived Concussion Information – Mehul Mehra, Pierce Brody, Simran Mehrotra, Om Sakhalkar, Todd Allen Maugans

P8.1-006

Increasing SUR1-related pathway activity with increasing injury severity in immune and neurovascular cells after murine TBI – Chaim T. Sneiderman, Zujian Xiong, Dhivyaa Rajasundaram, Dennis William Simon, Joshua Catapano, Sandra Mihaljevic, Shima Shahjouei, Sudhanshu P. Raikwar, Anupama Rani, Ria Trivedi, Jarrod Rulney, Ethan Winkler, Margaux Miller, Lance Lim, Keri Feldman, Vincent Vagni, Gary Kohanbash, Patrick M. Kochanek, Ruchira M. Jha

P8.1-007

Delay in Clearance of Labeled Protons in Patients with Acute Head Trauma Utilizing MRI 3D TGSE

PASL MRI (Arterial Spin Labeling) – Jubin Kang, Marija Zivcevska, Bryce Grohol, Bradley W. Clark, Ian Shepherd Dorman, Joshua Lencke, Connor James Arrasmith, Stephan Kim, Ethan Rich, Charles R. Joseph

P8.1-008

Synthesis of Behavioral Health Outcomes in Mild Traumatic Brain Injury using Principal Component Analysis (PCA) – Teena Shetty, Jonathan Westafer, Joseph T Nguyen, Luella Coffey

P8.1-009

A Systematic Review of Resting-State fMRI in Traumatic Brain Injury Across Injury Age, Severity, Mechanism, Chronicity, and Imaging Methods –Kevin Bickart, Christopher Andrew Sheridan, Daniel Michael Frees, Kaylee Kang, Jesse Fischer, Christian Parks, Alexander Kashou 1

Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): Women with Epilepsy 1

P8.1-010

Audit of Guidance on Contraceptive Measures and Folic Acid Supplementation in Women with Epilepsy – Emily Feeney, Lara Gander, Colin Doherty

P8.1-011

Pregnancy Seizure Outcomes for Epilepsy Patients with Catamenial Seizure Exacerbation – Paula Emanuela Voinescu, Hernan Nicolas Lemus Esquivel, Lena Liu, Stephanie Allien, Page B. Pennell

P8.1-012

A Look At Social Disparities in Pregnancy Outcomes in Women With Epilepsy – Jasmine Shareen Coles, Aila Rahman, Deepti Zutshi

2

Education, Research, and Methodology

Education, Research, and Methodology: Resident Education Through Simulation 1

P8.2-001

Utility and Feasibility of Simulation-based Training in Teaching Concepts of Traumatic Brain Management to Neurology Trainees – Eva Franzova, Greer Waldrop, Ifeyinwa Nwankwo, Jeremy Ader, Michelle Bell, Angela M. Velazquez, Sachin Agarwal, David J. Roh, Soojin Park, Sander Connolly, Jan Claassen, Jonathan Amiel, Shivani Ghoshal

P8.2-002

Training Neurology Residents to Address Uncomfortable Patient Behavior Through a Simulated Experience – Sakinah Sabadia, Arielle Marisa Kurzweil, Kaitlyn Lillemoe, Ariane Lewis, Perrin A. Pleninger, Brandon Giglio, Mordechai Z. Smith, Elina Zakin, Sondra Zabar

P8.2-003

Teaching Neurology Trainees to Lead a Goals of Care Conversation using Simulation – Brandon Giglio, Ariane Lewis, Kaitlyn Lillemoe, Perrin A. Pleninger, Sakinah Sabadia, Mordechai Z. Smith, Elina Zakin, Sondra Zabar, Arielle Marisa Kurzweil

P8.2-004

Simulation-based Assessment of Brain Death Determination for ACGME Milestones of Adult Neurology Residents – Briana Wasserstrom, Carolina B. Maciel, Christina Wilson, Jenna Ford

2

Education, Research, and Methodology

Education, Research, and Methodology: Technology and Education 2

P8.2-005

A Telehealth Training Program for Neurology Residents – Matthew Sontag Davitz, Katherine Emily Leaver, Maryna Skliut, Viktoriya Katsnelson, Matthew Swan, Vicki Shanker

P8.2-006

Resident Perceptions of a Teleneurology Curriculum – Shivika Chandra, Alicia Zha, Rohini D. Samudralwar, Shima Bozorgui, Ieshia Deal, Abigail S Betner, Amanda L. Jagolino-Cole

3 MS and Inflammatory Disease

MS Therapeutics 2

P8.3-001

Diroximel Fumarate in Patients with RelapsingRemitting Multiple Sclerosis: NEDA-3 after Re-baselining in the Phase 3 EVOLVE-MS-1 Study – James D. Bowen, Jessica Stulc, Samuel F. Hunter, Ariel Antezana, Hailu Chen, James B. Lewin, Matthew Scaramozza, Ivan Bozin, Florian Then Bergh

P8.3-002

Compliance and Persistence With Ofatumumab Treatment in Patients With Relapsing Multiple Sclerosis in Clinical Trials for Up to 4 Years –Enrique Alvarez, Carrie Michelle Hersh, Derrick Robertson, Ayan Das Gupta, Xixi Hu, Ronald Zielman, Ibolya Boer, Andy Cheadle, Jeffrey Alan Cohen

P8.3-003

Remibrutinib, a Novel Bruton’s Tyrosine Kinase Inhibitor, Exhibits Improved Target Selectivity and Potency In Vitro – Bruno Cenni, Robert Pulz, Daniela Angst, Denis Eichlisberger, Marina Ollervides Ziehn

P8.3-004

Five-Year Safety of Ofatumumab in People Living With Relapsing Multiple Sclerosis – Jeffrey Alan Cohen, Stephen L. Hauser, Anne H. Cross, Kevin Winthrop, Heinz Wiendl, Jacqueline Ann Nicholas, Sven G. Meuth, Paul Giacomini, Francesco Sacca, Ronald Zielman, Ayan Das Gupta, Xixi Hu, Roseanne Sullivan, Virginia De Las Heras Revilla, Ludwig Kappos

P8.3-005

A systematic review and meta-analysis of extended interval dosing (EID) vs standardinterval dosing (SID) of Natalizumab for multiple sclerosis patients – Eslam Mohammed Rabea, Mohamed Mohamed Belal, Anas Zakarya

Nourelden, Ashraf Hassan El-banna, Mahmoud Ahmed Khalifa, Nada Hisham Mahmoud, Mohamed Zaazouee

P8.3-006

The initial reduction in the percentage of peripheral lymphocytes and long disease course are associated with sustained response to Dimethyl Fumarate (DMF) in a small cohort of patients with Relapsing-Remitting Multiple Sclerosis – Oscar Danilo Ortega, Silvia Presas, Cristina M. Ramo

P8.3-007

New Mitigation Protocol for Alemtuzumab Infusion Related Reactions in a Chilean Cohort – Lorna Marisalva Galleguillos Goiry, Jose Miguel Valdes Valdes, Vicente Alba, Florencia Capdeville, Marianella Hernandez, Nicolas Andres Rebolledo, Ricardo Alonso, Felipe Condeza

P8.3-008

Aspirin Precooling Improves Exercise Performance in Multiple Sclerosis: Results of a double-blind randomized controlled trial – Victoria Leavitt, Katelyn A. Nelson, Amelia Katharine Boehme, Jaime Donnelly, Michael Spinner, Claire Riley, Joel Stein, Kaho Onomichi

P8.3-009

Ketogenic Diet Intervention Improves Sleep in Patients with Relapsing Multiple Sclerosis –Jacob Ben Perlman, Diana Lehner-Gulotta, Emma Wetmore, Rachael Coleman, Brenda Banwell, A. G. Christina Bergqvist, Shanshan Chen, Mark Conaway, Myla D. Goldman, Anne Marie Morse, James Nick Brenton

P8.3-010

Siponimod Stabilizes Physical Disability Scores in People Living With Secondary Progressive Multiple Sclerosis After 2 Years of Treatment: Analysis From the Novartis Global Managed Access Program –Gina Mavrikis Cox, Virginia De Las Heras Revilla, Suzannah Ryan, Roxana Oana Istrate, Soudeh Ansari, Sophie Arnould, Daniela Piani Meier

P8.3-011

Ocrelizumab and Cladribine had similar EDSS stability and safety profile in patients with highly active multiple sclerosis – Fatemah Alshawaf, Samar Farouk Ahmed, Jasem Yousef Al-Hashel, Raed Alroughani

P8.3-012

Evaluating the Effect of Disease Duration in High Efficacy Versus Mid Efficacy Disease Modifying Therapies: Could This Help in Deciding When to De-escalate? – Brandi L. Vollmer, Kavita Nair, Stefan Sillau, John Corboy, Enrique Alvarez

P8.3-013

AMASIA study: Real world insights on the impact of early siponimod treatment on SPMS patients in Germany – Olaf Hoffmann, Herbert Schreiber, Luisa Hildegard Klotz, Martin Weber, Cordula Weiss, Tjalf Ziemssen

P8.3-014

Safety and efficacy of Cladribine in real life sitting, Kuwait Experience – Malak AlMojel, Jasem Yousef Al-Hashel, Raed Alroughani, Samar Farouk Ahmed

P8.3-015

Efficacy and Safety Profile of Cladribine Tablets in an Italian Real-Life Cohort of Relapsing-Remitting Multiple Sclerosis Patients: A Monocentric Longitudinal Observational Study – Chiara Zanetta, Maria Assunta Rocca, Alessandro Meani, Vittorio Martinelli, Laura Ferrè, Lucia Moiola, Massimo Filippi

P8.3-016

Progressive Multifocal Leukoencephalopathy (PML) With Anti-CD20 and Other Monoclonal Antibody (mAb) Therapies in Multiple Sclerosis –Kanika Sharma, Samiksha Srivastava, Anek Jena, Mihir Kakara, Shitiz K. Sriwastava, Maha Daimee, Jian Xu

P8.3-017

Male MS Patients’ Safety, Tolerability and Efficacy Outcomes Do Not Differ from Female Patients Treated with Diroximel Fumarate: EVOLVE-MS-1 Ad-hoc Analysis – Annette Wundes, John William Lindsey, Hailu Chen, Matthew Scaramozza, Filipe Branco, Wanda Castro-Borrero, Sai L. Shankar, Robert T. Naismith

P8.3-018

A Case Report: Simultaneous Presentation of Morphea and Multiple Sclerosis, a Diagnostic and Management Challenge – Richa Mehta Thakkar, Robert John Sharkus, Patrick McMahon, Jesse Thon, Olga Thon

4 General Neurology

General Neurology: Neuroimaging

P8.4-001

Identifying Neuroimaging Patterns in Mitochondrial Leukoencephalopathies – Sonal Sharma, James Peterson, Cesar Alves, Amy Goldstein

P8.4-002

Generative Editing via Convolutional Obscuring (GECO): A Generative Adversarial Network for MRI de-artifacting – Bryce Allen Bagley, Sergei Petrov, Ge Cheng, Matei A. Armanasu, Nancy Fischbein, Bin Jiang, Michael Iv, Eric Tranvinh, Michael Zeineh, Olivier Gevaert

P8.4-003

Radiological features of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and its longitudinal progression – Rajasimhan Rajagovindan, Ryan O’Mara, Andreas Meier, James MacDougall, Elizabeth Finger, Jennifer Lauren Orthmann Murphy, Daniel Broderick, Zbigniew K. Wszolek, Spyros Papapetropoulos

P8.4-004

A Multimodal Neuroimaging Feature Extraction Framework for Biomarker Discovery in Myotonic Dystrophies – Tahereh Kamali, John W. Day, Jacinda B. Sampson, Alejandro Murad, Jeremy Chaufty

P8.4-005

A Case Report on the Elusivity of Imaging in Detecting a Ruptured Dermoid Cyst – Simerun Singh, Rawan Albadareen

P8.4-006

Neuroimaging in Acute Ethylene Glycol Toxicity – James Christian Hiana, Yohannes Simeneh Mulatu, Kush Sharma, Arsen Askandaryan, Biniyam Simeneh Mulatu, Yaacov Anziska

P8.4-007

Diabetic Striatopathy; A Differential Worth Considering in Diabetic Patients with Acute Onset Hyperkinetic Movements or Basal Ganglia (Striatal) Abnormalities on Imaging . – Samuel Durojaye, Nicholas Kento Sammond, Rana Moosavi

5

Cerebrovascular Disease and Interventional Neurology

Cerebrovascular Disease and Interventional Neurology: Interventional Neurology

P8.5-001

Lack of Better Functional Outcomes in Young Border Hispanic Patients with Acute Ischemic Stroke after Endovascular Thrombectomy

Compared to Older Patients: A Retrospective Chart

Review – Saisree Ravi, Sohum Desai, Sherief Ghozy, Wondwossen G. Tekle, Ameer Hassan

P8.5-002

Optimizing Management and Outcomes of Large Vessel Occlusion Ischemic Stroke Utilizing Mobile Stroke Units – Muhammad Bilal Tariq, Stephanie Parker, Asha Philip Jacob, Mengxi Wang, Noopur Singh, Jose-Miguel Yamal, Kenny Phan, Patti Bratina, Ritvij Bowry, James C. Grotta, Alexandra L. Czap

P8.5-003

Short-Term Follow-Up Pilot Study of Sole Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Influence of Internal Architecture on the Radiological Outcomes –Mazhar Khalid, Uttam K. Bodanapally, Dheeraj Gandhi

P8.5-004

The BAND score: a simple upfront predictive model for futile recanalization to guide patient selection for endovascular thrombectomy during acute ischemic stroke triage – Huanwen Chen, Marco Colasurdo, Michael Phipps, Timothy Ryan Miller, Jacob Cherian, Jose Marino Granados, Carolyn Cronin, Marcella A. Wozniak, Dheeraj Gandhi, Seemant Chaturvedi, Gaurav Jindal

P8.5-005

Tenecteplase Versus Alteplase for Acute Ischemic Stroke in a Community Hospital Setting – Latha Ganti, Trilok Stead

P8.5-006

Patterns in the Number of Interventionalists for Endovascular Treatment of Acute Ischemic Stroke in the US – Ankita Tripathi, Laura Stein, Mandip Singh Dhamoon

P8.5-007

Endovascular thrombectomy beyond 24 hours in acute ischemic stroke: Characteristics and Outcomes in comparison to patients treated within 24 hours standard window – Amit Kansara, Tamela Stuchiner, Leslie Corless, John Zurasky

P8.5-008

Intra-Arterial Thrombolysis Associated with Symptomatic Intracranial Hemorrhage in Acute Basilar Artery Thrombectomy, PC-SEARCH

Registry Analysis – Adam T. Mierzwa, Syed F. Zaidi, Khaled Gharaibeh, Nameer Aladamat, Ehad Afreen, Sami Alkasab, Ashley Nelson, Santiago Ortega Gutierrez, Mudassir Farooqui, Juan A. VivancoSuarez, Ashutosh P. Jadhav, Shashvat Desai, Gabor Toth, Anas Mohammed Alrohimi, Thanh Ngoc Nguyen, Piers Klein, Mohamad Abdalkader, Aditya S. Pandey, Sravanthi Koduri, Shivangi Vora, Shivangi Vora, Mouhammad A. Jumaa

P8.5-009

Stenting Plus Medical Therapy versus Medical Therapy Alone in Patients With Symptomatic Intracranial Stenosis: A Systematic Review and Meta-Analysis – Gabriel Marinheiro Marinheiro Dos Santos-Bezerra, Carlos Alberto Campello, Mariana Delariva Sakiyama, Pedro De Padua Amatto, Everton Bruno Castanha, Artur Menegaz de Almeida, Daniel Campinho Schachter

P8.5-010

Real World Experience with Viz .ai Automated Large Vessel Occlusion in CT Angiogram – Nick Mannix, Elena Penhos, Shahid Nimjee, Mohammad Taimur Shujaat, Sharon Hammond-Heaton, Carol Aubrey Vitellas, Vivien H. Lee

P8.5-011

Improving Thrombectomy Times Utilizing Stroke Transfer Coordinators – Jessica Doyle Lee, Margie Campbell, Carrie Nicole Sawyers

P8.5-012

Predictors of Functional Recovery after Mechanical Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation – Milagros Galecio-Castillo, Juan José Mendez Gallardo, Aaron Eduardo Rodriguez-Calienes, Cynthia Zevallos, Mudassir Farooqui, Santiago Ortega Gutierrez, Juan A. Vivanco-Suarez

P8.5-013

Quality and Outcomes Following Implementation of Anesthesiology for all Mechanical Thrombectomy Cases – Madison McGann, Jose Marino Granados, Chad Schrier, Gaurav Jindal, Michael Phipps

P8.5-014

Pre-morbid Risk Factor Control Differences by Age in Patients Undergoing Thrombectomy for Acute Ischemic Stroke – Kathryn Margaret Grimes, Prachi Mehndiratta, Seemant Chaturvedi

P8.5-015

Acute Ischemic Stroke Large Vessel Occlusion treated with Mechanical Thrombectomy in the Pediatric Populatio – Jessica Glenn, Vivien H. Lee, Shahid Nimjee, Warren D. Lo, Cassandra Forrest, Randheer Yadav, Patrick Youssef

P8.5-016

Acute loading dose of antiplanets before Stentassisted repair of cerebral aneurysm associated with reduced ischemic events and good outcomes

– Yahia M. Lodi

P8.5-017

Intravenous Thrombolysis followed by Endovascular Thrombectomy compared with Direct Endovascular Thrombectomy for Stroke: a Systematic Review and Meta-analysis of Randomized and Non-Randomized Studies –Maurish Fatima, Saleha Azeem, Hafsa Shahid, Muhammad Ayyan, Afra Zahid, Muhammad Faiq Umar, Salman Sani, Aleena Ahmed, Huzaifa Ahmad Cheema, Bakhtawar Ahmad, Muhammad Aemaz Ur Rehman, Mohammad Ebad Ur Rehman, Waseem Khaliq, Jamir Pitton Rissardo

P8.5-018

Comparison of Tele-stroke transfer between intervention and non-intervention cases and 30-day outcome events – Shravan Sivakumar, Mehdi Ghasemi, Meghna Trivedi, Brian Silver, Nils Henninger, Kimiyoshi Kobayashi, Adalia M. JunO’Connell

P8.5-019

Area Deprivation Index (ADI) and Median Income Associations with Clinical Outcomes of Endovascular Therapy for ACLVO stroke – Murat Sari, Vanessa Dwairi, Rishabh Jain, Marcelo Rocha

P8.5-020

Indications and Outcomes of Carotid Artery

Stenting among Consecutive Patients over Age 70 at The Ottawa Hospital, a Comprehensive Stroke Centre in Ontario, Canada – Holly Sim, Kyra Rose Steiner, Brian Dewar, Derek Jason Roberts, Dariush Dowlatshahi, Michel C. Shamy

P8.5-021

Effect of Stroke Etiology on Mechanical Thrombectomy Outcomes in Young Adults: A Retrospective Data Analysis – Kriti Bhayana, Jonathan William Handshoe, Rahul Chandra, Maria Gabriela Martucci, Conor Reid, Maariyah Kharal, Hiba Afroze Saleem, Ehaab Naim Saleem, Andrew Schuster, Muhammad Shazam Hussain, Gabor Toth, Abbas Kharal

P8.5-022

Examining Predictors of Favorable 90-day Outcome in Stroke Patients with Active Cancer Undergoing Endovascular Therapy – Yasaman Pirahanchi, Constance McGraw, Russell E. Bartt, David Bar-Or

P8.5-023

Osteoarthritis is associated with lower likelihood of receiving stroke thrombectomy despite similar post-thrombectomy outcomes: a national study – Huanwen Chen, Mihir Khunte, Marco Colasurdo, Gaurav Jindal, Ajay Malhotra, Dheeraj Gandhi, Seemant Chaturvedi

P8.5-024

Onyx© Embolization of Dural Arteriovenous Fistulae at the Cranio-Cervical Junction – Khaled Gharaibeh, Mustafa Al-Chalabi, Marion Oliver, Mouhammad A. Jumaa

P8.5-025

Lack of Pre-treatment Thrombolysis and Low ASPECTS are Associated with Poor Rates of Recanalization After Mechanical Thrombectomy –Krithika Umesh Peshwe, Muhammad M. Alvi

P8.5-026

Bilateral Middle Meningeal Artery Embolization and Resection of a Large Parafalcine Meningioma: a Case Study – Melinda Christine Arthur, Samuel Lee, Rosemary Prianka Gomes, Hope Ajom

Okpokam, Adesh Tandon, Jonathon Jonas Lebovitz, Paul Wright

P8.5-027

Successful Prevention of Bow Hunter’s Stroke Associated with Rheumatoid Atlantoaxial Subluxation via Coil Occlusion – Tomoaki Miyake, Ryoichi Inoue, Yukihiro Yamao, Takakuni Maki, Ryosuke Takahashi

P8.5-028

Recanalized paramedian thalamoperforators after intraarterial tirofiban treatment in a patient with bilateral fetal-type PCAs – Minyoul Baik

P8.5-029

Large Vessel Occlusion Related Ischemic Stroke From Vitamin B12-Deficiency Related Homocysteine – Shruthi Harish, Anita Rau, Maria Virginia Diaz Rojas

P8.5-030

Anterior Cerebral Artery Associated “LimbShaking TIA” A3 Branch Stenosis Corrected With Submaximal Intracranial Angioplasty – Kholoud

Yaser Altarazi, Ram Mohan R. Sankaraneni

P8.5-031

Foreign Body Reaction After Endovascular Treatment with Pipeline Embolization Device – Ma Su Su Aung, Alexander Kaufman, Anna Moroz, Jennifer Axelband, Martin Oselkin

6 Palliative Care

Palliative Care

P8.6-001

Amyotrophic Lateral Sclerosis and Aid-inDying: Describing and Comparing ALS Patients Requesting Physician-Assisted Death with Patients Dying Directly of ALS in the Hospital Setting –Pierre Trudel, Marie-Hélène Quesnel-Olivo, Nicolas Dupre

P8.6-002

Simulation training in Neuropalliative Care –Rakhee Lalla, Alexandra L. Dobie, Stephanie L. Bissonnette, K. H. Vincent Lau, Asher Tulsky, Michelle Kaku

P8.6-003

Palliative and end-of-life care in Parkinson’s disease : a survey of patients’ perceptions and knowledge in France – Manon Auffret, Guillaume Robert, Matthieu Bereau, Marc Verin

P8.6-004

Are Neurologists Aware of the Neurology-Specific Hospice Criteria? – Daniel Minsuk Oh, Benjamin Stuart, Jorge Alexander Matta, Stephanie Qianhui Liang, Gene Y. Sung, Jennifer S. Hui

P8.6-005

Palliative Care Knowledge and Attitudes among Patients with Neurodemyelinating Diseases – Aliza Ben-Zacharia, Andrea J. Bartels, Helen Brugger, Jena Malchiodi, Stephanie Carbone, Angelo Volandes, Francois Bethoux

P8.6-006

P8.6-010

A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Effects of SAGE-718 in Patients with Alzheimer’s Disease: Study Design – Tiffany Lago, Aaron Koenig, Jason K. Johannesen, Sola Park, Sigui Li, Emily Freitag, Jeffrey Wald, Katrina Paumier, Michael Quirk, James Doherty

7 Neuro Trauma and Critical Care

Neurocritical Care: Status Epilepticus and Seizures

P8.7-001

EEG Characteristics of Mortality in Patients with Altered Mental Status and Seizures: A Matched Case-Control Study – Rizk Alghorazi, Shuai Huang, Carolyn Tsai, Zhu Hongtu, Angela Wabulya, Clio A. Rubinos

P8.7-002

Anti-seizure Medication Use and Outcomes in Older Adults with Acute Traumatic Brain Injury –Muhammad Aemaz Ur Rehman, Muhammad Saim, Marta Fernandes, Brian Edlow, Lidia Maria Veras Rocha Moura, Sahar Fatima Zafar

P8.7-003

Aging, Dementia, Cognitive, and Behavioral Neurology

Outpatient Palliative Care for Parkinson’s Disease: Results from a National Survey – Kei Sugiura, Umer Akbar, Sandhya Seshadri, Megan Dini, Peggy Auinger, Sally Norton, Jodi Summers Holtrop, Benzi Kluger 6

Aging and Dementia: Therapeutics 2

P8.6-007

Clinical Outcomes From a Phase 2, Open-Label Study of NE3107 in Patients With Cognitive Decline Due to Degenerative Dementias – Elisabeth Rindner, Kennedy Mahdavi, Jonathan Haroon, Kaya Jordan, Margaret Zielinski, Victoria Venkatraman, Jean Rama Surya, Dayan Goodenowe, Clarence Ahlem, Christopher Reading, Joseph Michael Palumbo, Bijan Pourat, Sheldon E. Jordan

P8.6-008

Allopregnanolone as a Regenerative Therapeutic for Alzheimer’s Disease (AD): A phase 2 proof-ofconcept clinical trial using hippocampal volume as a surrogate endpoint – Gerson David Hernandez Rivera, Claudia Lopez, Adam Raikes, Kathleen Rodgers, Dawn Matthews, Lon Schneider, Roberta Diaz Brinton

P8.6-009

A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of OnceWeekly Donepezil Transdermal Delivery System –Marwan N. Sabbagh, Philip Mathew, Alan Blau

The Utilization of the Ketogenic Diet for Adults with Status Epilepticus – Fernanda Jacinto Pereira Teixeira, Jacqueline Marie Shannon, Christopher Paul Robinson, Bakhtawar Ahmad, Jason Katz, Guanhong Miao, Jenna Seckar, Maria J. Bruzzone, Katharina M. Busl, Mackenzie Cervenka, Carolina B.

P8.7-004

A Modern Artillery to put off the Electric Storm of the Brain– A case report of aborting seizure with brivaracetam 2-minute intravenous bolus in a patient with a compromised airway – Maycky Tang, Prathyankara Premkumar

P8.7-005

High-Dose Levetiracetam: A Novel Post-Arrest Anti-Arrhythmic Medication? – Eric Stulberg, Patrick O’Connor, Shanna Swartwood

7 Practice, Policy, and Ethics

Practice, Policy, and Ethics: Removing Barriers to Practice and Profession 3

P8.7-006

Evaluating Barriers and Tools to Optimize Resident Call Scheduling on Neurology In-Patient Services

– James Joon Hyuck Im, Charles Kassardjian, Houman Khosravani, Sara Mitchell

8

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Amyotrophic Lateral Sclerosis 1

P8.8-001

Is ALS Onset Accelerated by Chloroviruses and Delayed by Antiviral Immune Responses? – Gary L. Pattee, Tom Petro, Ahmed Esmael, Irina Agarkova, David Dunigan, James Van Etten

P8.8-002

ALS Causative Mutations in KIF5A Disrupt Autoinhibition Leading to Toxic Gain of Function

– Jonathan R. Brent, Oliver Elise Sterling-Angus, Han-Xiang Deng

P8.8-003

At-Home Telespirometry [AHT] in Amyotrophic Lateral Sclerosis [ALS] – Eufrosina I. Young, Jenny Meyer, Dongliang Wang, Bhavya Narapureddy, Birendra Sah, Dragos Manta, Urvi G. Desai, Benjamin R. Brooks

P8.8-004

Evidence for Survival Benefit in ALS with CNMAu8 Treatment Across Three Study Populations

– James D. Berry, Nicholas J. Maragakis, Sabrina Paganoni, Melanie Quintana, Eric A. Macklin, Ben Saville, Jinsy Andrews, Jeremy M. Shefner, Michelle Detry, Parvathi Menon, William Huynh, Colin Mahoney, Elijah Stommel, Meghan Hall, Mariah Connolly, Gale R. Kittle, Marianne Chase, Alexander Sherman, Hong Yu, Lindsay Pothier, Kristin R. Drake, Lori B. Chibnik, Marie-Abele Bind, Matteo Vestrucci, Robert L. Glanzman, Michael Hotchkin, ResculeALS Investigators, Matthew Colm Kiernan, Merit E. Cudkowicz, HEALEY ALS Platform Study Group, Rescule-ALS Investigators

P8.8-005

Quantification of HLA Allele and Haplotype Frequencies in ALS and ALS-FTD – Darshan Pandya, Kory Johnson, Hemali Phatnani, Avindra Nath

P8.8-006

The role of systemic immunity in ALS: a population-based study – Maurizio Grassano, Umberto Manera, Fabiola De Marchi, Enrico Matteoni, Margherita Anna Rosa Daviddi, Cugnasco Paolo, Antonio Canosa, Rosario Vasta, Letizia Mazzini, Cristina Moglia, Andrea Calvo, Adriano Chio

P8.8-007

Small Molecule Positive Modulator of Hepatocyte Growth Factor (HGF)/MET, ATH-1105, Improves Function and Reduces Disease Biomarkers in a TDP-43 Mouse Model of Amyotrophic Lateral Sclerosis – Kayla Nicole Kleist, Andree-Anne Berthiaume, Jewel Johnston, Sherif Reda, Hans J. Moebius, Kevin Church

P8.8-008

Objective Measures of Gait Changes in ALS Correlate with Functional Rating Scale – Marcell Szabo, Laura Danielian, Taryn Haselhuhn, Allison Snyder, Justin Y. Kwan

P8.8-009

At-Home Telespirometry (AHT) In Amyotrophic Lateral Sclerosis (ALS) Implementation Science: Different Patient Rates of Erect Forced Vital Capacity (eFVC) 3 percent predicted (%p) Drops per Month in Two ALS Populations with Different Baseline Rates of Non-Invasive Ventilation (NIV) Utilization – Benjamin R. Brooks, Eufrosina I. Young, Dongliang Wang, Jenny Meyer, Urvi G. Desai, Bhavya Narapureddy, Birendra Sah, Dragos Manta

P8.8-010

The Integrated Stress Response Is Modulated by eIF2B Agonist DNL343: Results From Phase 1 Healthy Subject and Phase 1b ALS Patient Studies

– Linus D Sun, Richard M. Tsai, Ernie Yulyaningsih, Melania H. Fanok, Maurits Vissers, Jules Heuberger, Brittany Flores, Fen Huang, Lesley Ann Kane, Isaac V. Cohen, Shyeilla V. Dhuria, Meng Fang, Anthony A. Estrada, Maksim Osipov, Brent A. Willman-Yoswa, Romeo Maciuca, Sarah Dobbins, Roni Chau, Timothy Earr, Hoang Nhu Nguyen, Isabel Lopez, Kimberly Scearce-Levie, Tommy Bunte, Leonard H. Van den Berg, Carole Ho, Geert-Jan Groeneveld, Matthew D. Troyer

P8.8-011

A 40-week Phase 2B Randomized, Multicenter, Double-blind, Placebo-controlled Study

Evaluating the Safety and Efficacy of Memantine in Amyotrophic Lateral Sclerosis – Salman Bhai, Robert P. Bowser, Suzan Moser, Deborah Taylor, Andrew Heim, Susan Woolley-Levine, Dan H. Moore, Todd D. Levine, Richard J. Barohn

P8.8-012

Clusterin as a Candidate CSF Biomarker of Amytrophic Lateral Sclerosis – Petr Kanovsky, Michaela Kaiserova, Sandra Kurcova, Katerina Klicova, Dorota Konickova, Aneta Kupcova, Katerina Mensikova

P8.8-013

MicroRNA Expression in ALS: A Systematic Review and Bioinformatic Analysis – María Paula Aguilera Peña, Andres Felipe Cardenas Cruz, Cristian Andres Correa

P8.8-014

Introduction of Quantitative Scale for Fasciculations in ALS Patients – Sara Palacios, Julieta Casen, Cecilia Quarraccino, Gabriel Rodriguez

P8.8-015

Seronegative Isaac Syndrome Presenting as Focal Limb Stiffness Responsive to Plasma Exchange Therapy – Nadia Khalil, Anthony M. Bradshaw

9 Neuromuscular and Clinical Neurophysiology (EMG)

Autonomic Disorders 1

P8.9-001

Sex and Gender Differences Influence Urinary Symptoms and Management in Multiple System Atrophy – Elke Schipani Bailey, Sara J. Hooshmand, Negin Badihian, Paola Sandroni, Eduardo E. Benarroch, James H. Bower, Phillip A. Low, Wolfgang Singer, Elizabeth A. Coon

P8.9-002

Wearable Sensors for Quantitative Motor Assessments in Multiple System Atrophy – Daniel O. Claassen, Jessie Iregui, Amy Wynn, Charles Shaw Davis, Cynthia Wong, David A. Stamler

P8.9-003

Patient Concept Elicitation Interviews: Insights into Multiple System Atrophy (MSA) Patient Experiences and Relevance of a modified United Multiple System Atrophy Rating Scale – Michele Potashman, Isabella Huang, Susan Durham, Victoria Wirtz, Gilbert J. L’Italien, Vladimir Coric, Andrea De Palma, Triza Brion, Günter Höglinger, Horacio C. Kaufmann, Phillip A. Low, Nikolaus McFarland, Wassilios Meissner, Patricio Millar Vernetti, Huw R. Morris, Werner Poewe, Klaus Seppi, Wolfgang Singer, Steven Vernino, Irfan Qureshi

P8.9-004

Application of Phosphorylated Alpha Synuclein (p-syn) Skin Biopsy in Clinical Practice: Audit at an Academic Medical Center – Cheng Chin Wang, Nathaniel Michael Robbins

P8.9-005

Dysautonomia symptoms and quality of life in nonhospitalized neurology outpatients with post-acute sequelae of COVID-19 – Samarah Ahmed, Sara Wesley Hyman, Rachel Kenney, Sherry Fung, Azizi Seixas, Girardin Jean-Louis, Steven Galetta, Laura J. Balcer, Sujata P. Thawani

P8.9-006

A Case of Autonomic Failure in Superficial Siderosis – Bridget Ollesch, Perla C. Thulin, Lubdha Shah, Mark B. Bromberg, Kathleen B. Digre, Melissa M. Cortez

P8.9-007

Peripheral sudomotor abnormalities in postural tachycardia syndrome (POTS) – Anna Newman, Guillaume Lamotte, Jordan Langford, Luke Heyliger, Melissa M. Cortez

P8.9-008

Botulinum toxin for Sialorrhea in Patients with Parkinson’s disease & Atypical Parkinsonism: A Single Center Real-World Study – Danyaal Buttar, Mustafa S. Siddiqui

9 Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Seizures 3

P8.9-009

Adverse Childhood Experiences Are Associated with Seizures in Children: A Cross-Sectional Analysis – Marissa Anto, Shannon Catherine Shipley, Shavonne Massey, Christina Szperka

P8.9-010

Distinguishing TLE and TLE+ using magnetoencephalography virtual sensors –Seungrok Hong, Paul Horn, Jeffery R. Tenney

P8.9-011

PRAX-562-101: A Phase 1 Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of PRAX-562 in Healthy Volunteers – Brian Pfister, Rajeshwari Mahalingam, Michael Oldham, Dharit Patel, Henry Jacotin, Marjie Hard, Corey Puryear, Bernard Ravina, Marcio Souza, Steven Petrou

P8.9-012

PRAX-628: A Novel Sodium Channel Blocker with Greater Potency and Activity Dependence

Compared to Standard of Care – Kris Kahlig, Mark Chapman, Steven Petrou

10

Infectious Disease

Infectious Disease: WNV and Emerging Viral Pathogens 1

P8.10-001

Adult-Onset Acute Flaccid Myelitis with White Matter-predominant Longitudinally Extensive Transverse Myelitis Following Coxsackie B5 Enterovirus Infection: a case report – Olga Manouvakhova, Nuriel Moghavem, Johannes PulstKorenberg

P8.10-002

A Case Report of Parainfectious OpsoclonusMyoclonus Syndrome after Powassan Virus Meningitis – Stephanie Bridget Syc-Mazurek, Ashley Santilli, Reece Hass, Michael Paul Skolka, Michel Toledano, Scott D. Eggers

P8.10-003

Subacute Development of Parkinsonism as a Clinical Manifestation of Powassan Virus

Neuroinvasive Disease – Clifton Lewis

P8.10-004

Concomitant West Nile Virus Encephalitis and Ischemic Strokes – A Case Report and Review of the Literature – Karan Hingorani, Steven K. Feske, Anna Marisa Cervantes-Arslanian

10 Infectious Disease

Infectious Disease: CNS Infections

Overview

P8.10-005

A Retrospective Review on Encephalitis in the University of Colorado Health Care System and a Proposed Diagnostic Approach – Madeline Garza, Elizabeth Matthews, Brian M. Sauer, Eric Engebretson, Brooke L. Valdez, Stefan Sillau, Aaron M. Carlson, Amanda Lee Piquet

P8.10-006

What’s the Cure for These Hiccups?: A Case of Area Postrema Syndrome due to Ventriculitis –Audrey Wadood, Micah Etter, Jose Pedro Falero Pomales

P8.10-007

A Case of Blood Culture-Negative Infective Endocarditis Presenting as Recurrent Ischemic Stroke – Sydney Chatfield, Valerie Braddick, Fatemeh Sobhani

11

Movement Disorders

Movement Disorders: Atypical Parkinsonisms 1

P8.11-001

Perry syndrome – the genetic, clinical, and pathological characteristics of the disease –Jaroslaw Dulski, Shunsuke Koga, Philip W. Tipton, Shan Ali, Audrey Strongosky, Juliana Rose, Zoe Ariel Parrales, Judith Ann Dunmore, Dennis W. Dickson, Zbigniew K. Wszolek

P8.11-002

Rate of Change of Pons and Middle Cerebellar Peduncle Diameters is Diagnostic of Multiple System Atrophy of the Cerebellar Type (MSA-C)

– Christopher D. Stephen, Mark Vangel, Anoopum Gupta, Jason MacMore, Jeremy D. Schmahmann

P8.11-003

Sex Differences for Verbal Fluency Decline in Progressive Supranuclear Palsy – Leonardino Digma, Teodoro Del Ser, Irene Litvan, Ece Bayram

P8.11-004

Effect of APOE e4 genotype on age at onset and comorbid pathologies in multiple system atrophy

– Hiroaki Sekiya, Shunsuke Koga, Owen A. Ross, Dennis W. Dickson

P8.11-005

Characteristics and Outcome of Patients with Young-Onset Multiple System Atrophy – Negin Badihian, Rodolfo Savica, Charles H. Adler, Zbigniew K. Wszolek, Lauren Jackson, Eduardo E. Benarroch, Paola Sandroni, Phillip A. Low, Wolfgang Singer, Elizabeth A. Coon

P8.11-006

Predictors of Survival in Atypical Parkinsonian Syndromes in a Tunisian Cohort – Amina Nasri, Ikram Sghaier, Mrabet Saloua, Youssef Abida, Alya Gharbi, Amira Souissi, Mouna Bendjebara, Amina Gargouri, Imen Kacem, Riadh Gouider

P8.11-007

Longitudinal free-water changes in dementia with Lewy bodies – Shannon Chiu, Robin Chen, Wei-en Wang, Melissa Armstrong, Bradley F. Boeve, Kejal Kantarci, David Vaillancourt

P8.11-008

Altered network of limbic system in multiple system atrophy with mild cognitive impairment –Jinse Park, Jae-kwan Cha, Yeoung Deok Seo

P8.11-009

Retrospective Review of Amantadine Use in Progressive Supranuclear Palsy – Nikolaus McFarland, Ramsha Farrukh, Savanna Mahn

P8.11-010

Who Should Answer? How to Assess Psychosis in Demented Patients with Parkinson’s Disease or Lewy Body Dementia – Blake Beehler, Michelle HS Tosin, Glenn Thurston Stebbins, Christopher Goetz

11 Movement Disorders

Movement Disorders: Ataxias 1

P8.11-011

Efficacy of Omaveloxolone in Friedreich’s Ataxia: Post-Hoc Analysis Using Global Statistics Test to Strengthen Secondary Endpoint Analyses –Suzanne Hendrix, Angie Goldsberry, Colin Meyer, David R. Lynch

P8.11-012

Somatosensory evoked potentials in spinocerebellar ataxias type 3 and 10: Preliminary data – Leo Coutinho, Otto Jesus Hernandez Fustes, Thabata Emanuelle Mart Nunes, Patricia Bonilha, Beatriz Cassarotti, Dafne Luana Bayer, Alessandra Filpo, Emanuel Cassou, Helio Afonso Ghizoni Teive

P8.11-013

Anti-Ma2 Antibody Paraneoplastic Cerebellar Degeneration Associated with Renal Cell Carcinoma: A Case Report – Kaneez Zahra, Nada Ahmed, Delini Sivakumar, Enrique Urrea-Mendoza, Venka Veerappan

P8.11-014

Cala Trio wrist-worn medical device for tremor improvement in patient with Spinocerebellar Ataxia-12 – Syed Mehdi Husaini, Ahmad Muhammad Awd Almelegy, Gian D. Pal

P8.11-015

Intrafamilial Heterogeneity in Spinocerebellar Ataxia Type 21 – Emma Wetmore, Jessica Elizabeth Decker, Maysen Mesaros, Federico J. RodriguezPorcel

P8.11-016

Rapidly Progressive Cerebellar Ataxia and Dementia due to Cortical Cerebellar and Thalamic Degeneration: A Case Series of Two Autopsy Confirmed Patients – Shunsuke Koga, Shan Ali, Matthew Baker, Klaas Wierenga, Michelle Dompenciel, Dennis W. Dickson, Zbigniew K. Wszolek

Headache

Headache: Innovation, Quality, and Technology

P8.12-001

Impact of Updates in Headache Quality Measures on Adherence to Best Practices in a Neurology Resident Clinic – Robert Hemant Cascella, Christopher Charles Anderson, Enmanuel Perez

P8.12-002

A Machine Learning Model Including Questionnaire and Structural Imaging Data Predicts Headache Improvement in Patients with Acute Post-traumatic Headache Attributed to Mild Traumatic Brain Injury – Catherine Daniela Chong, Jing Li, Todd J. Schwedt, Visar Berisha, Devin Nikjou, Teresa Wu, Gina Dumkrieger, Katherine Ross, Lingchao Mao

P8.12-003

Development and validation of a novel model for characterizing migraine outcomes within electronic health records utilizing artificial intelligence – Steven Kymes, Roger Cady, Nada A. Hindiyeh, Kimberly Alexander, Dan Riskin

P8.12-004

Brain volume changes associated with the recurrence of spontaneous intracranial hypotension after epidural blood patch – Sun Ju Chung, Jooyoung Lee, Yun Su Hwang, Sungyang Jo, Chong Hyun Suh, Seung Hyun Lee

P8.12-005

Clinician Perspectives on Remote Monitoring for Patients with Headache Disorders – Aarti Raj Katara, Naomi Sara Lebowitz, Alexis George, Jane Ekhtman, Ramisha Aymon, Ishah Yusaf, Khushalee Oza, Ivy Charlotte Snyder, Mia T. Minen

P8.12-006

Asynchronous Telemedicine Platform Associated with Decreased Migraine-Related Emergency Room and Urgent Care Use – Sara C. Crystal, Alexander Mauskop, Alan M. Rapoport, Robert Cowan, Philip Arthur Bain, Jessica Kiarashi, Elizabeth Faust Murdoch, Adam B. Cohen, Neil Parikh

P8.12-007

Psychometric Evaluation of the Migraine-Specific Quality of Life Questionnaire (MSQ v2 1) Using Data From Phase 3 Clinical Trials in Patients With Chronic Migraine (CM) and Episodic Migraine (EM) – Jonathan Stokes, David W. Dodick, Richard B. Lipton, Diane Whalley, Julia Savva, Heather Gelhorn, Lauren Moore Nelson, Stuart Yarr, Pranav Gandhi

P8.12-008

Psychometric Evaluation of the Activity Impairment in Migraine-Diary (AIM-D) Using Data From a Phase 3 (PROGRESS) Clinical Trial in Patients With Chronic Migraine – Pranav Gandhi, Richard B. Lipton, David W. Dodick, Diane Whalley, Lauren Moore Nelson, Stuart Yarr, Jonathan Stokes

P8.12-009

A Telemedicine Platform to Increase Access to Migraine Care in Men – Sara C. Crystal, Alexander Mauskop, Alan M. Rapoport, Robert Cowan, Philip Arthur Bain, Jessica Kiarashi, Elizabeth Faust Murdoch, Adam B. Cohen, Neil Parikh

P8.12-010

Patient-identified most bothersome symptom as a driver of health-related quality of life experienced by patients with migraine – Linus Jonsson, Susanne Awad, Stephane Regnier, Brian Talon, Steven Kymes, Xin Ying Lee, Peter Goadsby

P8.12-011

CME-Certified Microlearning Platform Successful in Improving Knowledge on the Use of Preventive Migraine Therapies Among Neurologists and PCPs – Thomas Finnegan, Kathy Merlo, Rashmi B. Halker Singh

P8.12-012

Circulating microRNAs in migraine patients: Systematic review and bioinformatic analysis –Andres Felipe Cardenas Cruz, María Paula Aguilera Peña, Carolina García Alfonso

13

Neuro-oncology

Neuro-oncology: Cancer Predisposition Syndromes

P8.13-001

Economic Impact of a Multidisciplinary Neurofibromatosis Clinic in a Canadian Tertiary Care Hospital – Julien Rousseau, Sarah Lapointe

P8.13-002

Manifestations of Von Hippel Lindau syndrome: a retrospective single-institution review – Hans H. Shuhaiber

P8.13-003

Growth of Angiomyolipomas in Patients with Tuberous Sclerosis Complex Treated with mTOR Inhibitor Differs by Indication for Treatment –Lauren Alexandra Neal, Parth Udayan Thakker, Nicholas Mallett, Mary T. Silvia, Jane Boggs, Theodore B Stem, Ram Pathak, Roy E. Strowd

P8.13-004

Identifying Lesions of the Corpus Callosum in Patients with Neurofibromatosis Type I – Nora Rano Jandhyala, Mekka Rae Garcia, Monica Eunseo Kim, Devorah Segal, Kaleb H. Yohay

1 Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): Seizure Cluster and Status Epilepticus

P9.1-001

“The cluster before the storm”: Seizure Clusters and Status Epilepticus – Clara Tierney, Jacqui-Lyn Saw, Nicholas D. Lawn

P9.1-002

SEIzure InterVAL (SEIVAL) Between Seizure Clusters and Quality of Life Across Time From a Phase 3 Safety Study of Diazepam Nasal Spray for Seizure Clusters – Sunita N. Misra, Michael R. Sperling, Vikram Rao, Jurriaan Peters, Enrique Carrazana, Adrian L. Rabinowicz

P9.1-003

The NORSE/FIRES Family Registry: Comparing new-onset refractory status epilepticus (NORSE) without preceding fever to febrile infection-related epilepsy syndrome (FIRES) – Karnig Kazazian, Nicolas Gaspard, Lawrence J. Hirsch, Marissa Kellogg, Sara E. Hocker, Nora Wong, Raquel FariasMoeller, Krista L. Eschbach, Teneille Gofton

P9.1-004

Epilepsia Partialis Continua Presenting as Hypoxemic Respiratory Failure – Patrick O’Connor, Eric Stulberg, Brian Leif Johnson, Angela Yvonne Peters

P9.1-005

Comparison of three types of Epilepsy Surgery for the treatment of Refractory Status Epilepticus: A Single Center Experience – Subhan Ahmed Khan, Farhan Mirza, Sally Valentina Mathias

P9.1-006

Knowledge and practice towards status epilepticus among emergency room physicians in the Gaza Strip: a cross-sectional study – Belal Adel Aldabbour, Ayoub AbuNemer, Mohammad Ghazi Alfarra, Osama Adel Aldabbour, Yousef Mohammed Abu Zaydah, Haytham Mohammed Abuzaid

P9.1-007

Modernizing Identification of Non-Convulsive Seizures and Status Epilepticus: Neurologists’

Experience at a Level 1 Trauma Center – Joshua Luster, Zahari Tchopev, William Hoffman, Brent Jacobus, Adam M. Willis

P9.1-008

Dual antiglutamatergic treatment in patients with status epilepticus: a case series – Hassan Souidan, Rene Andrade Machado, Abdalhamid Lagnf, Shashwat Pokharel, Mona Elsayed

P9.1-009

Faster Time to Treatment of Seizure Clusters With Diazepam Nasal Spray Is Associated With Faster Cessation of Clusters and a Similar Rate of Second Dose Usage – Sunita N. Misra, Randa Ghazi Jarrar, John M. Stern, Danielle Becker, Adrian L. Rabinowicz, Enrique Carrazana

P9.1-010

Significant Improvements in SEIzure InterVAL (Time Between Seizure Clusters) Across Time Irrespective of Age or Change in Concomitant Treatments in a Long-Term, Open-Label Safety Study of Diazepam Nasal Spray – Michael R. Sperling, Sunita N. Misra, Vikram Rao, Jurriaan Peters, Enrique Carrazana, Adrian L. Rabinowicz

P9.1-011

Cushing’s Syndrome Presenting as Nonconvulsive Status Epilepticus: A Case Report and Literature Review – Kiley Cameron, Courtney Venegas, Ismail Mohammed Fahad, Subin Mathew

P9.1-012

Concomitant Cannabidiol Does Not Impact Safety and Effectiveness of Diazepam Nasal Spray for Seizure Clusters: Post Hoc Analysis of a Phase 3 Safety Study – Jurriaan Peters, Vinay Puri, Eric Segal, Richard M. Gustin, Sunita N. Misra, Adrian L. Rabinowicz, Enrique Carrazana

Education, Research, and Methodology

Education, Research, and Methodology: Resident Education Through Simulation 2

P9.2-001

Can a Single Acute Ischemic Stroke Simulation Course Facilitate Mastery? – Casey S.W. Albin, Erika Sigman, Melissa Betts Pergakis, Nirav R. Bhatt, Spencer Hutto, Sitara Koneru, Ehizele Osehobo, Joaquin Augusto Vizcarra, Nicholas Allen Morris

P9.2-002

Can Self-Reported Confidence be used as an Indicator for Performance? A Multi-Center Study of Simulation Training for Acute Ischemic Stroke –Melissa Betts Pergakis, Casey S.W. Albin, Benjamin Neustein, Nicholas Allen Morris

P9.2-003

Improving Knowledge and Diagnostic Comfort Levels through Brain Death Simulation Education – Erin Barnes, Jeremy Moeller, Emily Jean Gilmore, Rachel Beekman

3 MS and Inflammatory Disease

MS Special Populations

P9.3-001

Early clinical experience with cladribine tablets in a Black/Hispanic patient population – Amparo Gutierrez, Christine Ochoa

P9.3-002

Postpartum Relapse Patterns Among Multiple Sclerosis Patients with Exposure to Disease Modifying Therapy Before or During Pregnancy

– Riley Bove, Angela Applebee, Katrina Bawden, Celeste Fine, Anna Shah, Robin L Avila, Nicholas Belviso, Filipe Branco, Kinyee Fong, James B. Lewin, Jieruo Liu, Sarah England, Megan Vignos

P9.3-003

Diroximel Fumarate Pregnancy Outcomes in EVOLVE-MS-1 and Study Design of Diroximel

Fumarate Prospective MS Pregnancy Exposure Registry – Maria K. Houtchens, Annette Wundes, Benjamin Joseph Osborne, Ivan Bozin, Filipe Branco, Hailu Chen, Sarah England, Nancy Gerber, Seth Nathatn Levin, Xiaochen Lin, Matthew Scaramozza, Kerstin Hellwig

P9.3-004

Cognitive Function During Pregnancy In Multiple Sclerosis: Is There A Decline In Processing Speed?

– Ariana Meldaña Rivera, Yolanda Higueras, Elisa Rodriguez-Toscano, Jose Manuel Garcia

Dominguez, Haydee Goicochea Briceño, Elda María Maria Alba Suarez, Juan de-León Luiz, Carmen Martinez Asensio, Maria Luisa Martinez Gines, Juan Pablo Cuello

P9.3-005

Disparities in Multiple Sclerosis Mimickers in a Diverse Population of Urban Patients – Konstantin E. Balashov, Alexandra Rubenstein

P9.3-006

Multiple Sclerosis & Family Planning: Patient Experience – Erin Elizabeth Kelly, Casey Engel, Rylan Quinn Pearsall, Myla D. Goldman

P9.3-007

Implications for Age and Sex Differences on AntiHyperglycemic Therapy Exposure and Incidence of Newly Diagnosed Multiple Sclerosis in Propensity Score Matched Type 2 Diabetics – Gregory Lawrence Branigan, Georgina Torrandell Haro, Francesca Vitali, Roberta Diaz Brinton, Kathleen Rodgers

P9.3-008

Recognizing Health Disparities in Multiple Sclerosis: Experiences and Perspectives of Patients of Diverse Racial and/or Ethnic Background – Mitzi Joi Williams, Stephen Krieger, Annette Okai, Chloe Gianatasio, Natalie Goldberg, Hollie K. Schmidt, Sara Loud, Karen Minnis, Natalie Blake, Brian Moss

P9.3-009

Characteristics of Multiple Sclerosis and Demyelinating Disease in an Asian American Population – Jessica Hwei-Jay Fan, Jessa Alexander, Shane Poole, Jaeleene Zabala Wijangco, Lily Jung Henson, Ruth Dobson, Chu-Yueh Guo, Riley Bove

P9.3-010

African-Americans With Multiple Sclerosis Have a Higher Proportion of B-Cell Lineage Cells in Their Cerebrospinal Fluid (CSF) Than White Patients –Haotian Xue, Arnaldo Arbini, Hunter Melton, Ilya Kister

P9.3-011

Predictors of Conversion from Positive to Negative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Status – Adeline Hayman, Anastasia Vishnevetsky, Gabriela Romanow, Michael Levy

P9.3-012

Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies – Mohammad Mahmoud Samara, Nicholas Robert Delcimmuto, Ajaz Sheikh

P9.3-013

Functional Correlates of Intelligence Quotient and Cognitive Abilities Vary According to Maturation in Pediatric MS – Maria Assunta Rocca, Laura Cacciaguerra, Chiara Curatoli, Carmen Vizzino, Monica Margoni, Paola Valsasina, Massimo Filippi

P9.3-014

Pregnancy Outcomes in Patients With MS Following Exposure to Ofatumumab: Updated Results From the Novartis Safety Database – Riley Bove, Maria Pia Amato, Ruth Dobson, Kristen M. Krysko, Sharon Stoll, Sandra Vukusic, Bassem

I. Yamout, Ronald Zielman, Krishna Swetha Gummuluri, Valentine Jehl, Ulf Schulze Topphoff, Roseanne Sullivan, Simone Fantaccini, Kerstin Hellwig

P9.3-015

Contextualizing the MS Experience for Members of the Hispanic and Latinx Community Living with MS and the Trusted MS Experts Caring for Them –Alexis Crispino, Yahaira Rivera Bobadilla

P9.3-016

Patterns of Disease Modifying Therapy Utilization in Women with Multiple Sclerosis Before, During, and After Pregnancy – Anna Shah, Riley Bove, Angela Applebee, Katrina Bawden, Celeste Fine, Robin L Avila, Nicholas Belviso, Filipe Branco, Kinyee Fong, James B. Lewin, Jieruo Liu, Sarah England, Megan Vignos

P9.3-017

Threatening Illness Perception and Associated Factors in Early-stage Relapsing Remitting Multiple Sclerosis – Susana Sainz de la Maza, Rocío Gómez, Mónica Borges Guerra, Jesus Manuel Martin Martinez, Javier Sotoca, Ana María Alonso Torres, Ana Belen Caminero Rodriguez, Laura Borrega Canelo, Jose Luis Sanchez Menoyo, Francisco Barrero-Hernandez, Carmen Calles, Luis Brieva Ruiz, Rosario Blasco Quilez, Julio Dotor Garcia-Soto, Maria Campo Amigo, Laura Navarro, Eduardo Aguera Morales, Moises Garces Redondo, Olga Carmona, Gabaldon Torres Laura, Lucía Forero, Mariona Hervas Pujol, Jorge Maurino, Tamara Castillo-Trivino

P9.3-018

Application of Rasch Analysis for Measurement of Disability in Multiple Sclerosis – Nadia Azad, Andrew Tarr, Christina N. Fournier, William R. Tyor

4 General Neurology

General Neurology: Deficiency and Toxicity

P9.4-001

Cobalamin C Deficiency, an Inborn Error of Metabolism presenting with Subacute Neuropsychiatric Symptoms – Sarah Grace Engel, Salman Rashid, Ali Al-Beshri, Amitha Ananth

P9.4-002

Case Series of Nitrous Oxide Related Subacute Combined Degeneration from 2016 to 2022 –William Alexander Warren, Reid D. Taylor, Jennie P. Savage

P9.4-003

Taurine and Astrocytes: A Homeostatic and Neuroprotective Relationship – Sofia Ramirez Guerrero, Santiago Guardo-Maya, Germán J. Medina-Rincón, Ricardo Julian Cabezas, Rodrigo Gonzalez

P9.4-004

Just supplement Thiamine! A simple yet dramatic solution! – Bhagyashri Umakant Bhende, Saman Zafar, Aparna M. Prabhu, Anishee Shah Undavia

P9.4-005

Symptomatic Copper Deficiency Masquerading as Paraneoplastic Syndrome – Connor David Welsh, Justin Hoskin

P9.4-006

Case Report of Chronic Nitrous Oxide Abuse Presented with Cerebral Venous Thrombosis: –Marina AlNaser, Samer Kebbeh, Shauna Cheung

P9.4-007

Carcinoid Syndrome Induced B12 Deficiency Resulting in Subacute Combined Degeneration –Ravi Chilukuri, David J. Houghton, Katrina Binkley

5 Autoimmune Neurology

Autoimmune Neurology: Neurosarcoidosis / Vasculitis / Neurorheumatology

P9.5-001

Rise of the Biologics: Shifting Prescribing Patterns for Neurosarcoidosis – Elijah Lackey, Kristen Lea Veal, Suma Shah, Christopher Paul Eckstein

P9.5-002

Neurosarcoidosis Induced by TNF-alpha Inhibitor in a Patient with Ankylosing Spondylitis – Daod Pak, Elham Askari, Simona Treidler

P9.5-003

Diagnostic Relevance of the Medullary Vein Sign in Neurosarcoidosis – Samiksha Srivastava, Kanika Sharma, Joe Joseph, Parissa Feizi, Shitiz K. Sriwastava

P9.5-004

Cardiac Involvement In Neurosarcoidosis: A Single Center Investigation – Sama Noroozi Gilandehi, KaHo Wong, Melissa Ann Wright, Jennifer Lord, Josef Stehlik, Line Kemeyou, Stacey Clardy

P9.5-005

Neurosarcoidosis Complicated by Systemic Vasculitis – Alexander Carvajal- Gonzalez, Octavio Arevalo, Oleg Y. Chernyshev

P9.5-006

Rare Case of Neurosarcoidosis presenting as Isolated Longitudinal Extensive Transverse Myelitis (LETM) – Gurveer Singh Khosa, Shaweta Khosa, Sanjay Anandaram, Rupinder Buttar

P9.5-007

Tumefactive Neurosarcoidosis – Gabriela Alejandra Bou, Sally El Sammak, Ling Chen Chien, Julien Cavanagh, Spencer Hutto

P9.5-008

A Familial Analysis of Neurosarcoidosis Utilizing the Utah Population Database – Paul Daniel Crane, Justin Abbatemarco, Zhe Yu, Ankita Date, Michael Joseph Madsen, Alison Fraser, Ka-Ho Wong, Jennifer Lord, Tammy L. Smith, Stacey Clardy

P9.5-009

Tracking Motor Impairment in People with Neurosarcoidosis – Brandon P. Moss, Nicholas Thompson, Daniel Culver

P9.5-010

Neurosarcoidosis presenting as Brown-Sequard Syndrome: A Case Report – Kajol Snehal Patel, Matthias Dunse, Walter G. Husar

P9.5-011

Seizures in Neurosarcoidosis – Henssey Ngo, Spencer Hutto

P9.5-012

COVID-19 Outcomes in Neurosarcoidosis – Sally El Sammak, Gabriela Alejandra Bou, Spencer Hutto

P9.5-013

Amyloid beta-related angiitis in a patient with light chain systemic Amyloidosis: A rare co-morbidity –Bushra Javed, Christopher Edward Jensen, Sascha A. Tuchman, Astia R. Allenzara, Rumey Ishizawar, Benjamin Cho, Edward Yap, Irena Dujmovic Basuroski

P9.5-014

Vasculitis in the Central Nervous System: Treatment and Outcomes in a Large Single-Center Cohort – Yoji Hoshina, Alen Delic, Ka-Ho Wong, Stephanie Lyden, Robert Kadish, Stacey Clardy

P9.5-015

Rapidly Progressive, Lethal Microangiopathy of the Brain: Two Cases of Malignant Susac Syndrome?

– Shannon Tierney, Serdar Kazanci, Jonathan Weinstein, W. T. Longstreth, Arielle Davis, Desiree A. Marshall, Rebecca Anne Yoda

P9.5-016

Giant Cell Arteritis with concurrent anti-MOG antibodies: Case Report – Naila Kausar, Andrea McWilliams, Gira Ileana Graciano, Janice Michelle Rivera, Claudia Maria Prospero Ponce

P9.5-017

Potential Relationship Between Hodgkin Lymphoma and CNS Angiitis – Lydia Sobhi, Tatjana Jarvis, Andi Liang, Rajesh K. Gupta

P9.5-018

Intracranial Pachymeningitis: A Case-Series

Describing Clinical Features, Imaging, Serological and Cerebrospinal Fluid Markers, Biopsy Findings and Management – Aditi Vian Varma-Doyle, Giovanna Manzano, Nagagopal Venna

P9.5-019

Impact of Neurological Complications on QoL in Sjögren’s Patients – Matt Makara, Katherine Morland Hammitt, Lane Destro, Janet Church

P9.5-020

Chorea as the Initial Manifestation of Antiphospholipid Syndrome – Amaris Alayon, Caleene R. Goodis, Marc H. Feinberg, Stuart N. Kieran, Elizabeth Wirkowski

P9.5-021

Neuromuscular Disorders (Neuropathy and Myopathy) Associated with Late Onset of Stills Disease – Shrikant Mishra, Shaweta Khosa, Gurveer Singh Khosa, Bhavesh Trikamji

P9.5-022

Prevalence of depression, and subclinical cognitive deficit in patient of SLE: A study from a tertiary health care centre – Sanjay Ganpat Ramteke, Smruti Ramteke

P9.5-023

No Rheum at The Insula: Rheumatoid Leptomeningitis as Cause of Focal Seizure – Sagi

Hassan ElHassan

P9.5-024

A Rare Case of Rheumatoid Meningitis – Chelsea Schmoll, Stefanie Jordan Rodenbeck, Brian Graner

P9.5-025

WITHDRAWN

P9.5-026

Primary Antiphospholipid Syndrome Presenting with Cerebellar Stroke and Positive Titres of Anti-ß2 Glycoprotein-1 Antibody Only: A Case Report – Aditya Shah, Stavan Vimal Shah, Akhil Nagrani

P9.5-027

Refractory Seizures in the Setting of Lupus – Bryan Paulo Lopez Canlas, Shreeja Kadakia, Azima Shaji, Jonathan P. Hosey

P9.5-028

Risk of acute stroke in young patients with newonset lupus nephritis: a case series – Danwei Wu, May Han, Sarah Lee

P9.5-029

The absence of antibodies in longitudinally extensive transverse myelitis and the impact on prognosis – Chiara Rocchi, Mirasol Forcadela, Anu Jacob, Shahd Hassan Mahmoud Hamid, Saif Huda

P9.5-030

Are Neurological Manifestations a Predictor of Poor Prognosis in Patients with NeuroAutoimmune Disease? – Afaaq Ahmed, Mohsen Ahmed, Nabeel Ahmed, Sania Azhar, Umair Azhar, Nizar Souayah

P9.5-031

A Case of Idiopathic Immunotherapy-Responsive Autoimmune Hemichorea – Rachel Rodin, Nagagopal Venna, Denis Tan Kerim Balaban

P9.5-032

Treatment Utilization in Dermatomyositis: An Analysis of Electronic Medical Records in the United States – Adrian Kielhorn, Zheng Wang, Kristin Moy, Lisa Christopher-Stine, Ingrid Lundberg, Hector Chinoy, Kaniah J. Gunter, Rohit Aggarwal

6 Pain

Pain: Research Studies

P9.6-001

Mirror Visual Feedback as a Therapeutic Modality in Complex Regional Pain Syndrome type I - A Randomized Controlled Trial – Stanislav Machac, Soroush Kakawand, Lída Chasakova, Lubomir Stepanek, Jan Vejvalka, Rudolf Bohumil Cerny

P9.6-002

Placebo and nocebo responses in painful diabetic neuropathy: systematic review and meta-analysis

– Elisa Frisaldi, Jan Vollert, Husam Al Sultani, Sowsan Hafuth, Fabrizio Benedetti, Aziz I. Shaibani

P9.6-003

Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain In A Community Practice

Setting: A Prospective Study – William D. Schnapp, Kenneth Martiatu, Gaetan J. Delcroix

P9.6-004

Association between Thyroid autoimmunity and Fibromyalgia: Single center retrospective study –Prasanna Venkatesan Eswaradass, C Eswaradass, Sathvika Thermalingem, Sibi Thirunavukkarasu, Obuli Srinivasan Gurunathan

P9.6-005

Developing Biomarkers for Chronic Low Back Pain

Using Arterial Spin Labeling – Ruiyi Yuan, Madalina Tivarus, Anika Tahsin, Samuel Stuart Alldritt, Paul Geha

6 Pain

Pain: Case Series and Case Reports

P9.6-006

Trench Foot: Waging a War Against Pediatric Small Fiber Neuropathy – Jesse Levine, Meagan Newell, Alyssa Domingue, Gary D. Clark

P9.6-007

Pseudo Orofacial Lingual Dyskinesia as a Manifestation of Burning Mouth Syndrome –Sunjeet Brar, Alan R. Hirsch

P9.6-008

An Iatrogenic Cause of Proximal Tibial Mononeuropathy Resulting in Undiagnosed Foot

Pain – Austin J. Priaulx, John Keith Evans

P9.6-009

Treatment of Medication-Resistant Neuropathic Pain in a Tetraplegic Patient Using Repetitive Transcranial Magnetic Stimulation (rTMS): A case report – Lingxuan Li, Joshua Kuluva, Gabrielle Paras, Sam Mohammad

Neuro Trauma and Critical Care

Neurocritical Care: Critical Care Complications

P9.7-001

Pulmonary Embolism in Patients with Traumatic Brain Injury in the United States During 2016-2020 – Carlos Garcia Rodriguez, Maggie Moran, David Momtaz, Paola Martinez, Kevin Chen, Ali Seifi

P9.7-002

CHANTER Syndrome: Have We Been Overlooking This Catastrophic Opioid Neurotoxicity? –Mohammad Ravi Ghani, Muhammad Ismail Khalid Yousaf, Nicholas Kemper, Ping Shi, Vishwanath Sagi

P9.7-003

Intracranial Hypertension in Aseptic Meningitis associated with MOGAD (Myelin Oligodendrocyte Glycoprotein Antibody Disorder) – Kaitlin Schoder, Joseph Zachariah

P9.7-004

Cerebellar Hippocampal and Basal Nuclei Transient Edema with Restricted Diffusion (CHANTER): A Case Report with Literature Review

– Jesse Menville, Ziqi Wang, Emily Weisbach, Glenn Albert Tung, Jason B. Richards

P9.7-005

Erosive Squamous Cell Carcinoma of the Scalp with Dural Involvement and Subsequent Neurologic Complications – William Beaty, Isaac Smith, Michael John McAree, Ting Zhou

P9.7-006

Highlighting Paradoxical Cerebral Fat Embolism: Potentially Fatal Sequela of Road Traffic Accident . – Ahmer Asif, Evan Fields, Noor Mahmoud, Maria Shoaib, Nidhiben A. Anadani

8

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Acquired Myopathies

P9.8-001

MxA Protein Expression and Histological Characteristics on Muscle Biopsy in Myositis

– Jaya Raghav Trivedi, Changhong Xing, Nicole Bitencourt, Chunyu Cai

P9.8-002

Handheld Muscle Ultrasound as a Tool to Assess Muscle Strength and Function in Sporadic

Inclusion Body Myositis – Aliya Shabbir, Carolyn Black, Leo Hong-Li Wang, Haibi Cai

P9.8-003

Efficacy of Rapamycin in a Xenograft Model of Inclusion Body Myositis – Chiseko Ikenaga, Andrew Wilson, Nicole Reed, Thomas E. Lloyd

P9.8-004

Clinical Subsets of Inclusion Body Myositis –Kenichiro Taira, Madoka Mori-Yoshimura, Toshiyuki Yamamoto, Yasushi Oya, Ichizo Nishino, Yuji Takahashi

P9.8-005

Scapular Winging In Patients With Anti-Hydroxy Methyl Glutaryl CoA Reductase (HMGCR) Antibody

Positive Immune Mediated Necrotizing Myopathy (IMNM): A Case Series – Nakul Katyal, Neelam

Goyal

P9.8-006

Idiopathic Inflammatory Myopathies and Malignancy Screening: A Survey of the Current Practices Amongst Canadian Neurologists and Rheumatologists – Maria Jekielek, Rosane Nisenbaum, Ophir Vinik, Charles Kassardjian

P9.8-007

Amyloid Myopathy as Initial Manifestation of ATTRwt: A Rare Phenomenon – Mario Bovino, Jin Young, Peter Pytel, Nitin V. Nadkarni, Pritikanta Paul

P9.8-008

Cancer-associated Regional Ischemic Myopathy: A Rare Immune Myopathy – Andre Granger, Pannathat Soontrapa, Christopher J. Klein, Margherita Milone

P9.8-009

Amyloid inflammatory myopathy: report of two cases and literature review – Himanshu Gupta, Sankalp V. Bhavsar, Faiha Fareez, Mark Tarnopolsky, Jian-Qiang Lu

P9.8-010

Anti-Ku myositis in clinical practice: A case series and review of the literature – Christine Meadows, Mustafa Al-Kharsan, Jonathan Cauchi

P9.8-011

Camptocormia, a late complication of statinassociated autoimmune myopathy (SAM) –Bhavya Narapureddy, Deborah Young Bradshaw

P9.8-012

Anti-HMGCR myopathy frequently coexists with other myositis-specific autoantibodies in Korean patients – Seung-Ah Lee, Eunkyoung Oh, Kee Duk Park, Young-Chul Choi, Hyung Jun Park

P9.8-013

A Case of Hydroxychloroquine-Induced Neuromyopathy Causing Severe Ventilatory Failure – Kelsey Rachel Barrell, Paul Daniel Crane, Joshua M Klonoski, Kyle Mahoney

P9.8-014

Creatine Kinase in SARS-CoV-2-Related Encephalopathy as a Prognostic Biomarker for Post-Acute Sequelae of COVID-19 (PASC) – Iqra Faiz, Narjis Jaffry, Shriya Mandava, Mustafa Jaffry, Ronak Trivedi, Kranthi Kiran Mandava, Anam Khalid Shaikh, Kazim Jaffry, Muhammed Ors, Pratibha Surathi, Toluwalase Oluwakemi Tofade, Evan Huff, Sviatoslav Redko, Nizar Souayah

P9.8-015

A Case of Smoldering Anti-HMGCR antibody Myopathy – Kathie Lin

9

Neuromuscular and Clinical Neurophysiology (EMG)

Autonomic Disorders 2

P9.9-001

Cold Hands and Feet in Multiple System Atrophy – A Useful Diagnostic Marker? – Wolfgang Singer, Jade Gehrking, Tonette Gehrking, David Michael Sletten, Jennifer Anderson, Mariana Suarez, Phillip A. Low

P9.9-002

Urinary Symptom Profile in Early Multiple System Atrophy – Jessie Iregui, Amy Wynn, Kaitlyn Rose Hay, Cynthia Wong, David A. Stamler, Daniel O. Claassen

P9.9-003

Study Design of TAK-341-2001: A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-341 in Subjects With Multiple System Atrophy – Jaya Padmanabhan, Elena Ratti, Polyna Khudyakov, Wei Yin, Stephen Zicha, Olga Golonzhka, Tairmae Kangarloo, Brian Harel, Nancy Goodman, Emmanuelle Magueur, Craig Shering, Thor Ostenfeld, Antonio Laurenza, Arthur Simen

P9.9-004

Effect of headache on quantitative symptom scores in children and young adults with postural orthostatic tachycardia syndrome – Luke Heyliger, Christopher Taylor, Melissa M. Cortez

P9.9-005

Rapid Recovery of Post-Stroke Cardiovascular Autonomic Dysfunction Correlates with Neurological Improvement and Initiation of Cardiovascular Medication . – Max Josef Hilz, Sebastian Moeller, Harald Marthol, Martin Koehrmann, Rainer Kollmar, Stefan Schwab, Bernd Kallmünzer, Ruihao Wang

P9.9-006

Autonomic Neuropathy as a Predictor of Morbidity and Mortality in People Living with HIV: A Retrospective, Longitudinal Cohort Study – Patrick Myungjoong Kwon, Steven Anthony Lawrence, Alex Figueroa, Jessica Robinson Papp

P9.9-007

Patients With Postural Orthostatic Tachycardia Syndrome Who Have Psychiatric Disorders Experience Increased Treatment Failures –Samantha Jean Stallkamp Tidd, Amy Nowacki, Tamanna Singh, Robert G. Wilson

9 Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Fetal/Neonatal Neurology 1

P9.9-008

Dual Genetic Diagnoses: PhelanMcDermid Syndrome and Mitochondrial Neurogastrointestinal Encephalomyopathy –Mikael Guzman Karlsson, Varun Kannan, Jonathan M. Yarimi, Lisa T. Emrick

P9.9-009

A Novel Homozygous Variant in the CHRNE Gene in 2 Siblings with Congenital Myasthenic Syndrome – Cassie Naomi Chan, Lucy K. Emery, Ermal Aliu, Sunil C. Naik, Dustin Jacob Paul, Ashutosh Kumar

P9.9-010

MEGF10 gene mutations causing a recessive congenital multiminicore myopathy – Larissa Maria Ferrarez Faria, Andre Vinícius Soare Barbosa, Bruna Ribeiro Ribeiro Torres, Carlos Eduardo De Menezes E Souza Filho, Laura Thiersch, Thaís De Almeida Fon Oliveira

P9.9-011

Longitudinal Imaging in Kleefstra SyndromeCase Report and Literature Review – Giovanni Castellucci, Csaba Juhasz, Aimee Luat

P9.9-012

Prechtl’s General Movements performed at writhing age may help target MRI use in the NICU – Allison Jeanne Chirigos, Vera Joanna Burton, Nathalie Maitre, Betsy Ostrander

10

Infectious Disease

Infectious Disease: Spirochetes 1

P9.10-001

Lyme Encephalomyeloradiculitis Presenting with Brachial Diplegia – Idelle Aschen, Gavin Xavier McLeod, Mary Kane-Brock, Daniel Brooks, Kunal V. Desai

P9.10-002

Multiple Cranial Neuropathies with Orbital Myositis as an Initial Presentation of Lyme Disease – Grace Marie Nicole Biso, Karan Philip, Pradeep Chevula, Ahmed El-Dokla

P9.10-003

A Perplexing Case of Borrelia Burgdorferi –Ashmeet Singh Sahni, Maria Elisa Samaniego, Jordan Gregory Gates

P9.10-004

A Case of Facial Diplegia Secondary to Lyme Neuroborreliosis – Irene Chu, Sayyeda Zahra, Satinderpal Singh, Jay D. Varrato

P9.10-005

Syndrome of Inappropriate Antidiuretic Hormone Secretion - A Rare Initial Presentation of Lyme Neuroborreliosis – Satinderpal Singh, Sayyeda Zahra, Irene Chu, Atef Kokash, Jay D. Varrato

P9.10-006

A 74 year old man with a rash, facial droop and multifocal intracranial stenosis – Yasmin Aghajan, Philippe-Antoine Bilodeau, Saef Izzy

P9.10-007

Meningitis Masquerading as Migraine – Muthu Kuzhali Ganapathy, Ioana Medrea

11 Movement Disorders

Movement Disorders: Ataxias 2

P9.11-001

Gambling Associated Risk-Taking Decision in Cerebellar Ataxia – Ruo-Yah Lai, Natasha Desai, Christian Amlang, Chi-Ying Lin, Tiffany Chen, Michael Jonathan Minyetty, Nadia Amokrane, Sheng-Han Kuo

P9.11-002

The Mechanism of Disease of Tri-Nucleotide Repeat Expansion Diseases – Piet C De Groen

P9.11-003

Clinical, Electroencephalographic and Neuroimage Findings of Patients with Cerebellar Ataxia and Epilepsy – Emanuel Cassou, Luciano De Paola, Salmo Raskin, Paula Marques, Quratulain Zulfiqar Ali, Farah Qaiser, Danielle M. Andrade, Helio Afonso Ghizoni Teive

P9.11-004

Spinocerebellar ataxia 21 and phenotypic variability within a single family – Mariam Hull, Mered Parnes, Joseph Jankovic

P9.11-005

Early-life social determinants of SCA6 age at onset, severity, and progression – Tiffany Chen, Hannah Casey, Chi-Ying Lin, Theresa Ann Boyle, Jeremy D. Schmahmann, Gilbert J. L’Italien, ShengHan Kuo, Christopher Gomez

P9.11-006

Progressive Ataxia with Palatal Tremor: A Case Series – Mattia Wruble, Anoopum Gupta, Jeremy D. Schmahmann, Denis Tan Kerim Balaban

P9.11-007

Deep phenotyping in ataxia: The Massachusetts General Hospital (MGH) Ataxia Center: A threedecade retrospective – Grace Crotty, Jin Yun Helen Chen, Miranda Leigh Mize, Anoopum Gupta, Christopher D. Stephen, Jason MacMore, Jeremy D. Schmahmann

P9.11-008

POLG-Related Ataxia and Ophthalmoplegia: A Case Report – Taylor Kay Peabody, Danielle Spengler Shpiner

P9.11-009

A Patient with Late-Onset Cerebellar Ataxia and a Novel FAT2 Gene Variant Concerning for Spinocerebellar Ataxia Type 45: A Case Report –Andrew Nader Ameri, Marc Rosenbaum, Alana E. Kirby

P9.11-010

Novel Mutation In The APT13A2 Gene Associated With Ataxia, Cerebellar Tremor, Bipolar Disease and Epilepsy – Muhammad Ismail Khalid Yousaf, Talita D’Aguiar Rosa, Mohammad Ravi Ghani, Peter Hedera

P9.11-011

First report of spastic ataxia of CharlevoixSaguenay cases in Mexico Novel SACS gene mutations identified – Guido Guenther Manzano

11 Movement Disorders

Movement Disorders: Atypical Parkinsonisms 2

P9.11-012

4 mA tDCS improves walking ability in PSP: A case study – Durjoy Lahiri, Carlos Roncero, Alice Tongmeng Zhang, Howard M. Chertkow

P9.11-013

OPTN: A Possible Genetic Cause of Both CBS and ALS – Matthew Feldman, Michael G. Benatar, Efrat Saraf Lavi, Kumarie Latchman, Carlos Singer

P9.11-014

Using the iNPH Radscale as a Radiological Predictor of Clinical Outcomes after Ventriculoperitoneal Shunt Placement in Patients with Idiopathic Normal Pressure Hydrocephalus (iNPH) – Debolina Ghosh, Patrick Donovan Gilson, Avery Kundrick, Brendan Baugher, James Liao, Philippe Salles, Claire Sonneborn, Olivia Hogue, Corey Fellows, Hubert H. Fernandez, Sean Nagel

P9.11-015

Correlation of 18F-PM-PBB3 (18F-florzolotau) Tau PET Imaging with Postmortem Neuropathological Findings in A Case with Progressive Supranuclear Palsy – Hironobu Endo, Nobuyuki Araki, Takahiro Takeda, Yuhei Takado, Kenji Tagai, Kiwamu Matsuoka, Chie Seki, Keisuke Takahata, Naruhiko Sahara, Hitoshi Shinotoh, Kazunori Kawamura, Ming-Rong Zhang, Kazuhiro Honda, Hitoshi Shimada, Makoto Higuchi

P9.11-016

P9.12-006

Patterns of Medication Utilization and Migraine Frequency in Adults Using Rimegepant for Both Preventive and Acute Treatment for Migraine: Results From a 52-Week, Open-Label Extension Study – Susan Hutchinson, Kathleen B. Mullin, Jelena M. Pavlovic, Richard B. Lipton, Christopher Jensen, Alexandra Thiry, Lisa Kamen, Robert Croop

P9.12-007

P9.13-003

A Case of Infant-type Hemispheric Glioma with NTRK1 fusion – Mekka Rae Garcia, Lena Bell, Aaron Lane Nelson, Claire Miller, Devorah Segal

P9.13-004

Seeing Double: a Case of a Massive Type B2 Thymoma Presenting with Pseudo-Internuclear Ophthalmoplegia – Maja Ostojic, Matthew Hart, Sean Michael Farrell, Megan E. Esch

P9.13-005

Video-oculographic Differences between Parkinson Disease and Multiple System Atrophy –Hyunji Kim, Sung-Hee Kim, Sumin Kim, Yoonkyung Chang, Kee Duk Park, Ji Young Yun 12

Rimegepant for the Acute and Preventive Treatment of Migraine in Women: Results From 4 Randomized, Placebo-Controlled Clinical Trials – Susan Hutchinson, Jelena M. Pavlovic, Jessica Ailani, Kathleen B. Mullin, Robert Croop, Alexandra Thiry, Beth Morris, Lisa Kamen, Chandra Coleman Abbott

P9.12-008

Headache

Headache: The Gepant Pipeline

P9.12-001

Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial – Richard B. Lipton, Andrea Harriott, Julia Ma, Jonathan H. Smith, Lawrence Severt, Jonathan Stokes, Pranav Gandhi, Krutika Jariwala-Parikh, Joel M. Trugman, David W. Dodick

P9.12-002

A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10 mg Nasal Spray for the Acute Treatment of Migraine – Robert Croop, Jennifer Madonia, Jennifer D. Hould, Linda Mosher, Meghan Lovegren, Richard B. Lipton

P9.12-003

Efficacy of Zavegepant Nasal Spray for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials – Shivang Joshi, Timothy R. Smith, Jelena M. Pavlovic, Kathleen B. Mullin, Robert Croop, Jennifer Madonia, Linda Mosher, Meghan Lovegren, Micaela Forshaw, Richard B. Lipton

P9.12-004

Concentration QT Interval Modeling of Intranasally Administered Zavegepant in Healthy Subjects – Richard Bertz, Joseph Stringfellow, Rajinder K. Bhardwaj, Mary Kathleen Donohue, Jennifer Madonia, Matt Anderson, Beth Morris, Vladimir Coric, Robert Croop

P9.12-005

Effects of Zavegepant and Concomitant Sumatriptan on Blood Pressure and Pharmacokinetics in Healthy Adult Participants –Richard Bertz, Rajinder K. Bhardwaj, Mary Kathleen Donohue, Jennifer Madonia, Joseph Stringfellow, Matt Anderson, Beth Morris, Vladimir Coric, Robert Croop

Pharmacokinetics, Disposition, and Biotransformation of 5 mg [14C]-Zavegepant in Healthy Male Subjects After a Single Intravenous Infusion Dose – Rajinder K. Bhardwaj, Mary Kathleen Donohue, Joseph Stringfellow, Jennifer Madonia, Matt Anderson, Beth Morris, Vladimir Coric, Robert Croop, Richard Bertz

P9.12-009

Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Black and African American Adults: Results From 3 Randomized, Placebo-Controlled Clinical Trials – Larry Charleston, Cynthia Emilie Armand, Wendell R. Helveston, Teshamae Monteith, Hope O’Brien, Robert Croop, Alexandra Thiry, Beth Morris, Micaela Forshaw, Chandra Coleman Abbott

P9.12-010

CGRP Receptor Antagonist Use for the Acute Treatment of Migraine in Pediatrics – Konstantinos Tourlas, Sara Pavitt

P9.12-011

Effects of the Strong CYP3A4 and P-glycoprotein Inhibitor Itraconazole on the Pharmacokinetics of Oral and Intranasal Zavegepant – Rajinder K. Bhardwaj, Jo Ann Malatesta, Joseph Stringfellow, Jennifer Madonia, Matt Anderson, Beth Morris, Vladimir Coric, Robert Croop, Richard Bertz

13 Neuro-oncology

Neuro-oncology: Cases in Neurooncology

P9.13-001

A Case of Capmatinib used in MET Amplification Glioblastoma – Catherine Boldig, Sepideh Mokhtari

P9.13-002

Rare Dual Genotype IDH-Mutant Glioma: Two Cases of True “Oligoastrocytoma” – Isabella Sutherland, John DeWitt, Alissa Ashley Thomas

Paraneoplastic Neurological Syndromes: A Single-Center Retrospective Study in Argentina –Francisco Caiza Zambrano, Fabio Gonzalez, Julio Cesar Galarza Menoscal, Mauricio Benetti, Marcela Uribe Roca, Pablo Bonardo, Manuel Fernandez

Pardal, Luciana Vanesa Leon Cejas, Ricardo C. Reisin

P9.13-006

Progression of Multiple Myeloma Presenting as Subdural Plasmacytoma – James Leonard West, John Morgan Mason

1 Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): EEG and Seizure Detection Technology

P10.1-001

Characterizing EEG and Serum Biomarker Trends in Immune Effector Cell-Associated Neurotoxicity: A Case Series – Andrew M. Nguyen, Lila Renteria, Paul V. Motika, H. E. Hinson

P10.1-002

Algorithm to Annotate Epileptiform Abnormalities in EEG Reports – Rachel Sera Choi, Puneet Kumar Uppal, Yilun Chen, Emily Jean Gilmore, Lawrence J. Hirsch, Adithya Sivaraju, M. Brandon Westover, Jennifer A. Kim

P10.1-003

EEG patterns in Refractory Epilepsy with Focal Cortical Dysplasia and predictors of outcome after surgery – Anuja R. Patil, S. Sita Jayalaxmi, Sudhindra Vooturi

P10.1-004

A simultaneous intracranial EEG- surface EMG analysis of generalized tonic-clonic seizures –Aybuke Acar, Hemani Ticku, Neel Fotedar

P10.1-005

Provider and Patient Opinions on Real-Time Seizure Detection via Over-the-Ear Device – Pooja Venkatesh, Zhuoran Yao, Jamie Nicole Lehnen, Kan Ding, VP Nguyen, J. H. Harvey

P10.1-006

Automated Seizure Detection and Management using CERIBELL: A single center cohort study –Ajay Rajshekar, James E. Siegler, Jared Craig Wolfe, Miranda Flamholz, Kenyon W. Sprankle, Manisha Koneru, Stefan Gillen

P10.1-007

Clarity Interpretation of Ceribell Rapid Response Electroencephalography Use Shows Limited Influence on Patient Disposition and Outcome

– Michael Alexander Connerney, Vahid Eslami, Melissa Reider-Demer, Marc R. Nuwer, Inna Keselman

P10.1-008

The role of the perioperative use of EEG as a predictor/diagnostic tool for post-operative delirium: Systematic Review – Maria J. Bruzzone, Jessie Ann Walker, Benjamin Chapin, Marcos Santana Firme, Faith Kimmet, Sabaina Ahmed, Estefania Perera, Shawna Amini, Catherine Price

P10.1-009

Automated Detection of Central-positive Complexes & Postictal Generalized EEG Suppression in ECT-induced Seizures – An Illustrative Case Report – Chetan Nayak, Mohammad Mehdi Kafashan, Fabio Nascimento, Ben Julian Agustin Palanca, Robert E. Hogan

P10.1-010

Signs of Electro-cortical Disconnection revealed by Hd-EEG in Acute Stroke Patients: a Case Study

– Elena Monai, Brinda Sevak, Klevest Gjini, Aaron F. Struck, Melanie Boly

P10.1-011

EEG Analysis of Eye Movement Artifact in Parietal and Occipital Lobe Seizures: A Search for Epileptic Nystagmus – Aybuke Acar, Anthony Peter Zampino, Marshall Kirsch, Neel Fotedar

P10.1-012

Temporal dynamics of triphasic waves and generalized periodic discharges – George Plummer, Ryan Raut, Bingni Brunton, Shahin Hakimian

2

Education, Research, and Methodology

Education, Research, and Methodology: Residency and Fellowship Application

P10.2-001

The Role of Neurology Residency Programs Presence on Social Media During Residency Application – Cleo Zarina Alejo Reyes, Erafat Rehim, Harry Zobel

P10.2-002

@NMatch2023: A Student-Led Social Media-Based Initiative to Guide Adult and Child Neurology Residency Applicants and Programs in a Digital Era – Nupur N Goel, Vera Pertsovskaya, Andrea Mendez Colmenares, Melanie Orr, Hiba Naveed, Rohan Yarlagadda, Ryan Emmanuel

P10.2-003

A Systematic Review of Epilepsy Fellowship Programs’ Online Presence – Fnu Rameez, Shayan Marsia, Sayed Mustafa Mahmood Shah, Alishba Kamran, Shan E. Abbas

P10.2-004

Survey on the Fellowship Application Timeline for UCNS-accredited Behavioral Neurology and Neuropsychiatry Programs – Sylvia Josephy, Roy H. Hamilton

P10.2-005

A Survey of Medical Education Pathways in Neurology Residency Programs – Taha Qarni, Laura Ashley Stein

3 MS and Inflammatory Disease

MS Neuroimaging 1

P10.3-001

Novel Pathways Correlating with MS-Related Tremor, A Case-Control Study – Ahmed Amr Mohmed Bayoumi, Khader Hasan, John A. Lincoln

P10.3-002

Quantification of Thalamic Volume in Multiple Sclerosis: From the Multicenter INNI Dataset Towards the Clinical Application – Loredana Storelli, Elisabetta Pagani, Patrizia Pantano, Gioacchino Tedeschi, Nicola De Stefano, Paolo Preziosa, Maria Assunta Rocca, Massimo Filippi

P10.3-003

Third Ventricle Width is a Reliable and ClinicallyFeasible Marker of Brain Atrophy in the Multiple Sclerosis Clinical Care Setting – Sarah Ann Levy, Jasmin Patel, James F. Sumowski

P10.3-004

Correspondence Among Gray Matter Damage and Neurotransmitter Maps Is Clinically Relevant in Multiple Sclerosis – Paolo Preziosa, Alessia Fiore, Nicolò Tedone, Monica Margoni, Carmen Vizzino, Damiano Mistri, Mor Gueye, Maria Assunta Rocca, Massimo Filippi

P10.3-005

Myelin Density in Normal-Appearing White Matter in Measurements by q-Space Diffusional MRI Correlates with Clinical Disability in Multiple Sclerosis – Haruhiko Motegi, Kenji Kufukihara, Koji Sekiguchi, Satoshi Kitagawa, Junichi Hata, Hirokazu Fujiwara, Masahiro Jinzaki, Hideyuki Okano, Masaya Nakamura, Jin Nakahara

P10.3-006

Loss of gyrification is associated with disability progression in multiple sclerosis – Jonadab Dos Santos Silva, Francesco La Rosa, William Andrew Mullins, Prasanna Parvathaneni, Josefina Maranzano, Daniel Reich, Erin Savner Beck

P10.3-007

Gray Matter Microstructure Alterations in People with Multiple Sclerosis Based on Cell Body and Neurite Density Imaging – Eva Angela Krijnen, Andrew Russo, Elsa Salim Karam, Menno M Schoonheim, Susie Y. Huang, Eric Klawiter

P10.3-008

Functional Connectivity Modifications in Monoaminergic Circuits Occur in Fatigued MS Patients Treated With Fampridine and Amantadine – Maria Assunta Rocca, Paola Valsasina, Maria Teresa Lamanna, Bruno Colombo, Paolo Preziosa, Vittorio Martinelli, Massimo Filippi

P10.3-009

Choroid Plexus Enlargement in Pediatric Multiple Sclerosis: Clinical Relevance and Effect of Sex –Monica Margoni, Mor Gueye, Alessandro Meani, Elisabetta Pagani, Lucia Moiola, Paolo Preziosa, Massimo Filippi, Maria Assunta Rocca

P10.3-010

The Insula Modulates the Effects of Aerobic Training on Cardiovascular Function and Ambulation in Multiple Sclerosis – Matteo Albergoni, Loredana Storelli, Paolo Preziosa, Maria Assunta Rocca, Massimo Filippi

P10.3-011

Progression independent of relapses in multiple sclerosis is associated with spinal cord and brain atrophy – Kunio Nakamura, Scott Husak, Robert A. Bermel, Jeffrey Alan Cohen, Daniel Ontaneda

P10.3-012

Upper Cervical Cord Volume and Its Association with Brain Metrics in MS – Nur Neyal, Jiye Son, Christopher Schwarz, Elizabeth Atkinson, Holly Morrison, John D. Port, Kejal Kantarci, Orhun H. Kantarci, Burcu Zeydan

P10.3-013

Vitreomacular Interface Abnormalities in Multiple Sclerosis; A Novel Signature of Disability – Hussein Moussa, Grigorios Kalaitzidis, Henrik Ehrhardt, Olwen Murphy, Eleni Vasileiou, Gelareh Ahmadi, Kathryn Fitzgerald, Sahi Nandini Wuppukondur, Sujata Rijal, Scott Douglas Newsome, Elias S. Sotirchos, Peter A. Calabresi, Amir H. Kashani, Shiv Saidha

P10.3-014

Time-Varying Functional Connectivity of the Hippocampus Is Associated With Cognitive Performance in Multiple Sclerosis Patients –Monica Margoni, Paola Valsasina, Olga Marchesi, Carmen Vizzino, Damiano Mistri, Massimo Filippi, Maria Assunta Rocca

P10.3-015

Radiomics-based Unsupervised Clustering of Acute Multiple Sclerosis Lesions – Bastien Cyprien Caba, Arie Gafson, Despoina Ioannidou, Xiaotong Jiang, Elizabeth Fisher, Douglas L. Arnold, Colm Elliott, Nikos Paragios, Shibeshih Belachew

P10.3-016

Choroid Plexus Enlargement In Systemic Lupus Erythematosus: Relationship With Auto-Antibody Status And Neuropsychiatric Involvement – Mor

Gueye, Paolo Preziosa, Giuseppe A. Ramirez, Enrica Bozzolo, Valentina Canti, Monica Margoni, Alessandro Meani, Patrizia Rovere-Querini, Angelo Manfredi, Maria Assunta Rocca, Massimo Filippi

P10.3-017

Myelin Water Fraction of Slowly Evolving Lesions is Associated With Disability in Multiple Sclerosis – Rebecca Zhuang, Irene Vavasour, Colm Elliott, Douglas L. Arnold, David Clayton, Stefano Magon, Ulrike Bonati, Corrado Bernasconi, Laura Gaetano, Anthony Traboulsee, Shannon Kolind

P10.3-018

Longitudinal Changes of Functional Connectivity Dynamism Are Relevant for Disability Worsening in Multiple Sclerosis: A 2 .5-Year Study – Giulia D’Amore, Paola Valsasina, Paolo Preziosa, Monica Margoni, Massimo Filippi, Maria Assunta Rocca

4

General Neurology

General Neurology: Intracranial Hypertension and Other Pathologies 1

P10.4-001

Cerebrospinal fluid biomarkers in Idiopathic Intracranial Hypertension: an exploratory SWATH proteomics analysis – Awadh K. Pandit, Shubham Misra, Gyaninder Pal Singh, Swati Phuljhele, Achal K. Srivastava, Deepti Vibha, Ajay Garg, Dheeraj Mohania, Garima Shukla, Kameshwar Prasad

P10.4-002

Reduced Frequencies of Post-Lumbar Puncture (LP) Headaches and Epidural Blood Patch Needs with Modifications of Standard LP Procedure –Jay-Jiguang Zhu, Anindita Ghosh, Joshua Keetae Nahm

P10.4-003

Idiopathic Intracranial Hypertension Causing Polyradiculopathy and Areflexia – Joel Sullivan, Anjali Kamath, Carolina Parker, Shruti Prabodh Agnihotri

P10.4-004

Role of Obstructive Sleep Apnea in Idiopathic Intracranial Hypertension – Mangayarkarasi Thandampallayam Ajjeya, Padmaja Sudhakar

P10.4-005

Chiari I malformation: Clinical Characteristics, Symptoms, and Presentations – Yazan Samer AlZamer, Samah Khalil Aburahma, Ruba Khasawneh, Ethar Hazaimeh, Omar Fatehi Jbarah

4

General Neurology

General Neurology: Leukodystrophy

P10.4-006

The Queen Square Adult Leukodystrophy Group: 10 years-experience of a multidisciplinary diagnostic service – Charles Louis Feinmann Wade, Thomas Edward Williams, Aine P. Merwick, Rebekah M. Ahmed, Justin Kinsella, Frederik Barkhof, Nevin Alex John, Jason Warren, Catherine Mummery, Jonathan Schott, Wallace Brownlee, Matthew Adams, Indran Davagnanam, Henry Houlden, Elaine Murphy, David S. Lynch, Jeremy S. Chataway

P10.4-007

Five Creutzfeldt-Jakob Disease Cases Within One Year in Spectrum Health Hospitals in Grand Rapids, Michigan – Ling Ling Rong, Nicholas Lannen, Evan Christopher Tank, Jessica Feistel, Anvita Potluri, Michelle Del Castillo DeJesus Brazitis, Muhib Khan, Jiangyong Min

5

Autoimmune Neurology

Autoimmune Neurology: Inflammatory Neuropathy / Inflammatory Myopathy / Neuroimmunology / Clinical Care

P10.5-001

Rapidly Progressive AIDP Secondary To Waldenström’s Macroglobulinemia, A Rare Cause With Fatal Respiratory Depression And Autonomic Instability – Hongxuyang Yu, Badria Munir, Nathaniel J. Mohney

P10.5-002

Guillain-Barré Syndrome Following Primary Cytomegalovirus Infection in a Patient with Liver Transplantation: a Case Report – Jaime Toro, Jairo Alejandro Gaitan Alfonso, Thomas Medina, Saul Reyes

P10.5-003

A Curious Case of Cocaine-Induced Hypokalemic Periodic Paralysis Mimicking Guillain-Barre Syndrome – Elizabeth Gene Baumann, Hassnain Ali Rizvi, Amaris Alayon, Tyler Kendall, Sydney Margaret Shaffer, Stephan Mouhanna, Sean T. Kenniff

P10.5-004

Neutrophil-to-lymphocyte ratio as a biomarker for Guillain-Barré Syndrome: A systematic review with meta-analysis – Miguel Francisco Cabanillas Lazo, Carlos Rodrigo Quispe Vicuña, Claudia Cruzalegui Bazán, Milagros Del Pilar Pascual-Guevara, Nicanor Mori, Carlos Alva-Diaz

P10.5-005

Ataxic variant of Guillain-Barre syndrome, with positive GD1b antibodies in an elderly male: a case report – Camelia Valhuerdi Porto, Aya Naji Shnawa, Ivanna Joseph, Lisa Scott

P10.5-006

Global Mortality of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Intravenous Immunoglobulin versus Steroid Therapies – Kazim Jaffry, Mustafa Jaffry, Ronak Trivedi, Muhammed Ors, GM Fahad Bin Mostafa, Anam Khalid Shaikh, Kranthi Kiran Mandava, Iqra Faiz, Hafiz Khan, Nizar Souayah

P10.5-007

Design of a Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, ParallelGroup Study of Nipocalimab in Participants with Active Idiopathic Inflammatory Myopathies (SPIREA) – Catherine Najem, Jagriti Craig, Lisa Christopher-Stine, Federico Zazzetti, Wim Noel, Sindhu Ramchandren, Christopher Blango, Chetan Karyekar, Rohit Aggarwal

P10.5-008

Preclinical Assessment of EPO-Derived Peptide JM4 in Experimental Autoimmune Neuritis –Gabriel Reynaldo Arismendi, Yun-Beom Choi, Walter G. Husar, Peter C. Dowling, Wei Lu

P10.5-009

An Atypical Presentation of Immune-mediated, Demyelinating Polyneuropathy with Multiple Antibodies to Nerve and Myelin Proteins Following SARS-CoV2 mRNA Vaccination – Rachel Joy Saban, Jarrett Leech, Aaron M. Carlson, Brian M. Sauer, Thomas E. Ragole

P10.5-010

Ibrutinib in Anti-MAG Neuropathy with Waldenstrom Macroglobulinemia – Zabeen Kaizar Mahuwala, Vishakhadatta Mathur Kumaraswamy, Mangayarkarasi Thandampallayam Ajjeya, Saniya

Pervin

P10.5-011

Cellular and In Vivo Preclinical Pharmacodynamics and Pharmacology of Nipocalimab, an Anti-FcRn Blocking Therapeutic Antibody – Leona Ling, Amit Choudhury, Steven M. Tyler, William Avery

P10.5-012

SARS-CoV-2 Vaccine Immune Response on Anti-Complement Therapy, Eculizumab – Neda

Sattarnezhad, Julia Sumera, Jamie C. McDonald, Esther H. Nie, Anna Jessica Tomczak, Yamuna Joseph, Sujatha Kalle, Tara Tripathi Sarkar, Lucas Kipp, Christopher Lock, Jeffrey E. Dunn, May Han

P10.5-013

Intravenous Immunoglobulin Therapy for Autoimmune Dysautonomia in children: A Case Series – Alexander Bolufer, Vikram Prakash

P10.5-014

Diagnosed in the Autoimmune Neurology Clinic: Two patients with different phenotypes of spinocerebellar ataxia type 27 – Yoji Hoshina, Melissa Ann Wright, Judith E A Warner, Tyler J. Richards, Karen Salzman, Stefan M. Pulst, Emily Spoth, Stacey Clardy

P10.5-015

Do Statins Have a Protective Effect Against NeuroAutoimmune Disease and Comorbidity? – Afaaq Ahmed, Mohsen Ahmed, Nabeel Ahmed, Sania Azhar, Umair Azhar, Nizar Souayah

P10.5-016

Are Insulin Mimetics Protective Against Comorbidity in Patients With Neuro-Autoimmune Disease? – Sania Azhar, Mohsen Ahmed, Nabeel Ahmed, Afaaq Ahmed, Umair Azhar, Nizar Souayah

P10.5-017

Epilepsy and Dysimmune Diseases: A Continuum?

– Amal Abbes, Rihab Ben Dhia, Mariem Mhiri, Yasmine Saad, Narjes Gouta, Mouna Aissi, Mahouba Frih

P10.5-018

Evidence of Neuroinflammation and Immunotherapy Responsiveness in Individuals with Down Syndrome Regression Disorder

– Jonathan Santoro, Rebecca Partridge, Runi Tanna, Dania Pagarkar, Mellad Khoshnood, Ryan Kammeyer, Grace Gombolay, Jane El Dahr, Alison L. Christy, Lina Patel, Melanie Manning, Heather Van Mater, Michael S. Rafii, Eileen A. Quinn

P10.5-019

Machine learning-driven Interferon Signaling

Gene Expression Score predicts Aicardi Goutières Syndrome – Adeline Vanderver, Russell D’Aiello, Asako Takanohashi, Francesco Gavazzi, Justine Shults, Sarah Woidill, Laura Ann Adang

P10.5-020

Recurrent Bickerstaff Encephalitis: Clinical Manifestation and Potential Treatment Options

– Ketevan Amirkhanashvili, Kelvin Kai Yin Chang, Jessalyn Shen, Niki Holtzman-Hayes, Garrett Michael Friedman, Lauren Gluck, Mark Milstein

P10.5-021

Neuromyelitis Optica Spectrum Disorder (NMOSD) Relapse Triggered by Secondary Syphilis: A Case Report – Luiza Lima, Gustavo Schafascheck, Carolina Braga Moura, Viviane Tavares Carvalho, Alexandra Seide Cardoso, Vanessa Cristina Colares Lessa, Priscila Santos Mageste, Rodrigo Cutrim Gaudio, Caroline Bittar Braune

P10.5-022

Acute transverse myelitis (ATM) associated with COVID 19 infection and vaccination, A case report and literature review . – Srinivas Medavarapu, Yaacov Anziska

P10.5-023

COVID-19 Infection Linked to MOG AntibodyAssociated Disease (MOGAD): Case Report – Gira Ileana Graciano, Mohammad Ghatali

P10.5-024

Osmotic Demyelinating Syndrome Secondary to Breast Cancer Chemotherapy: a Case Report –Jairo Alejandro Gaitan Alfonso, Saul Reyes, Daniela Sofia Rodriguez, Vanessa Salej, Jorge M. Otero, Jaime Toro

P10.5-025

A Tale of Two Cases: When to Use PLEX That is The Question – Siddharth Dalal, Michael Grunstein, Julia Rachel Schneider, Simona Vasilica Proteasa

P10.5-026

Cryoglobulinemia and Neuromyelitis optica: a case of progressive weakness and neurocognitive decline – Aimalohi Esechie, Ahmed Khalid Salman Harazeen, Nelitza Ivemaris Rivera Vega, Neeharika Thottempudi, Arun Singh Chhabra, Hashem M. Shaltoni, Muhammad Zeeshan Memon, Anand Vilaschandra Patel, Laura J. Wu

P10.5-027

AMPA receptor antibody encephalitis in a patient with Myasthenia Gravis post thymectomy –Samantha De Gannes, Aimalohi Esechie, Heitor Cabral Frade, Kelly Cronin, Suyuan Tan, Puneet Singh, Anand Kumar, Mohammed Fathi Zaidan, Chilvana V. Patel, Xiang Fang

P10.5-028

A diagnostic conundrum in the time of a pandemic: a subtle, isolated myelopathy – Federica Boso, Bruno Giometto

P10.5-029

Isolated Brainstem Involvement and Low Titer MOG antibody as the Initial Presentation of MOG Antibody Disease – Cynthia X. Wang

P10.5-030

Post Infectious Triggered Anti-Myelin Oligodendrocyte Glycoprotein AntibodyAssociated Disease (MOGAD) via CMV in an Immunocompetent Host – Jerry L Chen, Patrick Myungjoong Kwon

P10.5-031

“Novel Psychiatric Manifestations of Anti-MOG Antibody Disease” – Baljinder Singh, Faiza Ahmed, Claudia Maria Prospero Ponce

6 Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Fluid Biomarkers

P10.6-001

Cerebrospinal Fluid Neurofilament Light as a Marker of Neuro-axonal Injury in Normal Pressure Hydrocephalus – Carly Davenport, Foad Taghdiri, Anna Vasilevskaya, Chloe Anastassiadis, Simrika Thapa, Nico Paulo Maniago Dimal, Namita Multani, Alfonso Fasano, David F. Tang-Wai, Carmela Tartaglia

P10.6-002

Feasibility of Neurofilament Light Chain as a Blood-Based Biomarker for Screening Across Neurological Diseases – Briana Cameron, Anisha Patel, Bryan Cobb, Ivonne Suridjan, Nikki Win

P10.6-003

Plasma metabolites associated with clinically diagnosed Alzheimer’s Disease and the association is augmented using blood-based biomarkers . – Vrinda Kalia, Dolly Reyes-Dumeyer, Saurabh Dubey, Renu Nandakumar, Annie Lee, Rafeal Lantigua, Martin Antonio Medrano, Diones Rivera Mejia, Lawrence S. Honig, Richard P. Mayeux, Badri Vardarajan

P10.6-004

Association Between Cerebrospinal Fluid Biomarkers of Amyloid and Tau and Neuropsychiatric Symptoms Among Participants from the National Alzheimer’s Coordinating Center Uniform Data Set – Michael Walsh, Brandon Edward Frank, Landon Hurley, Kaj Blennow, Henrik Zetterberg, Yorghos Tripodis, Brett Martin, Jason L. Weller, Wendy Qui, Ann C. McKee, Thor D. Stein, Robert Stern, Jesse B. Mez, Michael Alosco

P10.6-005

Association of Alzheimer’s Plasma Biomarker Concentrations with Body Mass Index in Older Adults – Serena Surina Hoost, Adam Brickman, Annie Lee, Yian Gu, Danurys Sanchez, Dolly ReyesDumeyer, Lawrence S. Honig, Jennifer J. Manly, Rafeal Lantigua, Min Suk Kang, Jeffrey Dage, Richard P. Mayeux

P10.6-006

Identification of Plasma Biomarkers for Brain Endothelial Function – Jenifer Cordon, Michael R. Duggan, Heather Elizabeth Dark, Zhongsheng Peng, Krishna Pucha, Dimitrios Kapogiannis, Julian Candia, Gabriela Teresa Gomez, Keenan Walker

P10.6-007

Plasma neurofilament light chain associated with Impaired regional cerebral blood flow in healthy individuals – Fardin Nabizadeh

P10.6-008

Assessment of Plasma Biomarkers by ImmunoMagnetic Reduction in Parkinson’s Disease Dementia and Dementia with Lewy Bodies – Giovanni Roy Malaty, Lih Fen Lue, Holly A. Shill, Boris Decourt, Marwan N. Sabbagh

P10.6-009

Influencing factors of plasma BACE1 and its relationship with plasma Aß: A cross-sectional study of a cognitively normal population of Shunyi cohort – Ziang Pan, Feng Gao, Ding-Ding Zhang, Ming Yao, Jun Ni, Lixin Zhou, Yong Shen, Yi-Cheng Zhu

P10.6-010

Plasma neurofilament light chain predicts Alzheimer’s pathology and progression of cognitive decline in patients with subjective cognitive decline and mild cognitive impairment: a longitudinal study – Salvatore Mazzeo, Silvia Bagnoli, Sonia Padiglioni, Giulia Giacomucci, Assunta Ingannato, Filippo Emiliani, Valentina Moschini, Giulia Galdo, Carmen Morinelli, Sandro Sorbi, Benedetta Nacmias, Valentina Bessi

P10.6-011

Identification of diagnostic biomarkers in Alzheimer’s disease using metabolic-pathway related genes . – Nour Nedal Al-Bzour, Yaman Ahmed, Anas Alaa Al-Khalili, Ammar Iyad Hamza, Ruaa Ibrahim, Ayah Al-Bzour

7 Neuro Trauma and Critical Care

Neurocritical Care: Neuroimaging

P10.7-001

Reversible Splenial Lesion Syndrome (RESLES) in Sickle Cell Crisis Mimicking Marchiafava-Bignami Disease – Yohannes Simeneh Mulatu, Joseph YoungHun Yoon, Srinath Ramaswamy, Biniyam Simeneh Mulatu, Cappi C Lay

P10.7-002

An Unusual Case of Posterior Fossa Predominant Posterior Reversible Encephalopathy Syndrome (PRES) Leading to Acute Hydrocephalus – Shalane Alexa Morales-Nunez, Axel Manuel Baez-Lugo, Nilufer Yalcin, Manan Shah, Klepper A. Garcia, Fenwick T. Nichols

P10.7-003

A Case of Brainstem Predominant PRES – Yvonne Hao, Jonathan Rosenthal, Leah P. Dickstein

P10.7-004

Cranial ultrasound image acquisition in a moving ambulance feasibility for pre-hospital EMS applications: A review of literature – Benjamin Malinda, Aarti Sarwal, Sahil Kapoor

P10.7-005

Recurrent PRES after initiation of R-EPOCH & Methotrexate: A Case Study – Lauren Riley Nelson, Dana Klavansky, Brian Sumner, Agnieszka Pabich, Alexandra S. Reynolds

P10.7-006

Severe Hypoglycemic Brain Injury Associated with Diffuse Restricted Diffusion on MRI Brain Sparing Cerebellar Lobes – Estevao Pereira Ribeiro, Philion Gatchoff, Claire Emmanuelle Delpirou Nouh, JoonShik Moon

8

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Amyotrophic Lateral Sclerosis 2

P10.8-001

Healthy astrocytes provide neuroprotection against apolipoprotein B-100-induced motor neuron degeneration – Rose Putnam Griffin, Ivy Gao, Jamie Wong, Saud A. Sadiq

P10.8-002

Bax inhibitor protects against apolipoprotein B-100-induced human motor neuron degeneration in vitro – Ivy Gao, Rose Putnam Griffin, Jamie Wong, Saud A. Sadiq

P10.8-003

Non-Invasive Mechanical Ventilation slows motor decline in Amyotrophic Lateral Sclerosis: a population-based study – Maurizio Grassano, Emanuele Koumantakis, Cristina Moglia, Antonio Canosa, Umberto Manera, Rosario Vasta, Francesca Palumbo, Stefano Callegaro, Giulia Marchese, Paolina Salamone, Giuseppe Fuda, Federico Casale, Andrea Calvo, Gabriele Mora, Adriano Chio

P10.8-004

A large kindred with familial ALS due to the KIF5A p Arg1007Lys mutation – Jaroslaw Dulski, Audrey Strongosky, Rana Hanna AL-Shaikh, Zbigniew K. Wszolek

P10.8-005

Clinical and genetic characteristics associated with ALS diagnostic timeline: a population-based study – Ton Fang, Peter Paul Pacut, Yuyao Sun, Jeff Gao, Brooke Bloom, Shravan Sivakumar, Eduardo Inacio Nascimento Andrade, Mehdi Ghasemi

P10.8-006

Motor Nerve Conduction Slowing in Amyotrophic Lateral Sclerosis – Kranthi Kiran Mandava, Anam Khalid Shaikh, Mustafa Jaffry, Kazim Jaffry, Muhammed Ors, Ronak Trivedi, Iqra Faiz, Ajay Gandhi, Tejas Patel, Abu Nasar, Ankit Pahwa, Howard W. Sander, Nizar Souayah

P10.8-007

Evaluation of Gastrointestinal Symptoms in an ALS

Cohort – Rizamarie Empeno, John Furey, Terry D. Heiman-Patterson

P10.8-008

Long-term follow-up of five families from Turkey with UBQLN2 variants – Hacer Durmus, Arman Cakar, Fatma Yesim Parman

P10.8-009

At-Home Telespirometry (AHT) in Amyotrophic Lateral Sclerosis (ALS): Digital Health Technology and Quality Control – Bhavya Narapureddy, Benjamin R. Brooks, Jenny Meyer, Dongliang Wang, Birendra Sah, Dragos Manta, Urvi G. Desai, Eufrosina I. Young

P10.8-010

C9orf72-related Familial Amyotrophic Lateral Sclerosis Manifesting as Monomelic Amyotrophy of the Lower Extremity – Clover Youn, Michael D. Weiss

P10.8-011

Analysis of Amyotrophic Lateral Sclerosis (ALS) Clinical Trials Posted on www clinicaltrials .gov from 1999-2022 – Aaron Simon Zelikovich, Eric Anderson, Michael Rubin, Jinsy Andrews

P10.8-012

Real World Data as a control group, an ALS case study – Matteo Locatelli, Alex Berger, Alexander Sherman

P10.8-013

Association Between Amyotrophic Lateral Sclerosis Age at Diagnosis and Comorbid Conditions – Muhammed Ors, Mustafa Jaffry, Kazim Jaffry, Kranthi Kiran Mandava, Ronak Trivedi, Anam Khalid Shaikh, Iqra Faiz, Nizar Souayah

P10.8-014

Small Molecule Modulators of Metabolic Dysfunction as a Therapeutic Strategy For ALS –Daniel Kaganovich, John Thomson

P10.8-015

Parasympathetic cardiac dysfunction in Amyotrophic Lateral Sclerosis – Cecilia Quarracino, Natalia Bohorquez Morera, Francisco Capani, Santiago Perez-Lloret, Gabriel Rodriguez

9 Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Fetal/Neonatal Neurology 2

P10.9-001

Fetal Neurology Practice Survey – Tomo Tarui, Charulata Venkatesan, Dawn L. Gano, Monica E. Lemmon, Sarah Beth Mulkey, Andrea Pardo, Lisa T. Emrick, Mark S. Scher, Sonika Agarwal

P10.9-002

Relationship Between Maternal Antibodies to Fetal Brain and Prenatal Stress Exposure in Autism

Spectrum Disorder – David Q. Beversdorf, Amy Costa, Bradley Ferguson, Emily Hawkins, Adriana Coman, Joseph Schauer, Alex Ramierez-Celis, Patrick Hecht, Danielle Bruce, Michael Tilley, Zohreh Talebizadeh, Judy Van De Water

P10.9-003

Epilepsy surgery in a neonate: Resection of Right Temporal Neocortical Focal Cortical Dysplasia in a Three-Week-Old Infant – Prasanna Gangishetti, Allahshukur Ilgarli, Sindhura Tadisetty, Farhan Mirza, Zahra Haghighat

P10.9-005

Microglia Maintain Homeostatic Conditions in the Developing Rostral Migratory Stream – Sarah Jane Meller, Charles A. Greer

P10.9-006

Temporal Silencing of Purkinje Cell Neurotransmission Reveals a Dynamic Role for Cerebellar Function in Neurodevelopment – Jason Singh Gill, Megan Nguyen, Roy Sillitoe

9

Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Genetics/Metabolic/ Nutritional Disorders 1

P10.9-007

Midbrain Dopamine Neurons Derived from Induced Pluripotent Stem Cells from Patients with Lesch Nyhan Disease and Gene-Edited KnockIn HPRT1 Mutations – Fatemeh Seifar, Diane J. Sutcliffe, H. A. Jinnah

P10.9-008

Distinct Etiologies of RANBP2-negative Acute Necrotizing Encephalopathy of Childhood –Vaishnavi Lakshmi Vaidyanathan, Somayeh Bakhtiari, Brian L. Appavu, Derek Neilson, Michael C. Kruer

P10.9-009

Longitudinal Assessment of High- and LowContrast Visual Acuity in Normally-Sighted Children – John Rainer Sollee, Amy Lavery, Geraldine Liu, Maxwell Pistilli, Gui-shuang Ying, Amy T. Waldman

P10.9-010

Valproic Acid is an Effective Anti-Emetic Treatment in Alexander Disease – Emily Sergio, Kathryn Gallison, Giulia Stefania Porcari, Joshua Joung, Walter Faig, Geraldine Liu, Amy T. Waldman

P10.9-011

Natural History of Seizures in Alexander Disease – Kathryn Gallison, Giulia Stefania Porcari, Emily Sergio, Amy T. Waldman

P10.9-012

Top Caregiver Concerns for Individuals with the Ultra-Rare X-linked HNRNPH2-Related Neurodevelopmental Disorder – Juliana Nitis, Jennifer M. Bain

10 Infectious Disease

Infectious Disease: Noncryptococcal Fungal Infections

P10.10-001

Candida dubliniensis Meningitis in Immunocompetent Adults - case report and review of literature – Lucas Horta, Emily I. White, Tatiana Greige, Asra Askari, Anna Marisa CervantesArslanian

P10.10-002

Neuroaspergillosis: Challenging Diagnosis and Management – Stephen Jaworski, Cleo Zarina Alejo Reyes, Hussam A. Yacoub

P10.10-003

The Many Manifestations of Rhino-OrbitalCerebral Mucormycosis: An Illustrative Case Report – Megan Elizabeth Trenz, Lindsay Tetreault

P10.10-004

Invasive Optic Nerve Aspergillosis with Intracranial Extension in an Immunocompetent Patient –Sukhraj Gill, Christopher J. Whiting, Muhammad Taimur Ahmad Malik

P10.10-005

Invasive Fungal Infection of the Duramater as the Presenting Manifestation of Disseminated Sarcoidosis – Arunmozhimaran Elavarasi, Gagandeep Singh, Pinky Chhatterpal, Naveet Wig, Saurabh Mittal, Mehar Chand Sharma, Sumanta Das, Ajay Garg, Amandeep Jagdevan, Shamim Ahmed Shamim, Manjari Tripathi, Deepti Vibha, Rajesh Kumar Singh

Infectious Disease

Infectious Disease: Spirochetes 2

P10.10-006

Bilateral Disc Edema Heralding Ocular Syphilis: A Case Series – Taylor R. Anderson, Laura Hayse, Aileen Antonio

P10.10-007

Neurosyphilis Presenting as Limbic Encephalitis: a Case Report – Calvin Hu, Guy El Helou, Nayrobi Pena Cotui, Asma Balobaid, Mayra Montalvo Perero

11 Movement Disorders

Movement Disorders: Clinical Care in PD

P10.11-001

Reducing the Receipt of Contraindicated Medications for Patients with Parkinson’s Disease

– Caroline Goldin, Elisa Worledge, Jarrett Bremmer, Kathryn Tremolet De Villers, Robbie Cummins, Michelle Fullard

P10.11-002

Community-Academic Initiative to Measure and Improve Underrepresented Group Participation in Parkinson’s Disease Research – Anabel Marre, Emily Zivin, Karen Williams, Maxwell Edwin Shramuk, Nicola Lancki, Jennifer Adrissi, Danielle Larson

P10.11-003

Leveraging patient-reported outcomes to discern mobility trajectories in Parkinson’s disease – Doug Gunzler, Steven Alexander Gunzler, Farren Briggs

P10.11-004

Functional Outcomes of an Intensive Multimodal Rehabilitation Intervention for Moderately Advanced Parkinson’s Disease – Priyanka Moondra, Amanda Persaud, Catherine Claro, Mara Mccrossin, Lyubov Rubin, Alessandro Di Rocco

P10.11-005

Distance Travelled by patient for appointment with the Movement disorder clinic at Kentucky Neuroscience Institute – how to solve the problem? – Sindhura Tadisetty, Prasanna Gangishetti, Tarek Emran Ali, Zain Guduru, Julie A. Gurwell, John T. Slevin, Tritia Reina Yamasaki

P10.11-006

Prioritizing Racial Representation in Treating People with Parkinson’s Disease: An Assessment of Racial Inclusion Among Parkinson’s Disease Clinical Trials between 1999-2022 – Maya Pandit, Dawood Rashid, Ralph-Montas Moise Osias, Liana Dawson, Gular Mammadli, Mill Etienne

P10.11-007

Neurologists’ Likelihood of Prescribing Injectable Parkinson’s disease (PD) Therapies Increases With Education on Patient Attitudes – Rajeev Kumar, Josh Rossol

P10.11-008

Continued usage of Parkinson’s worsening drugs in patients diagnosed with Parkinson’s disease – What can be done to solve this problem –Sindhura Tadisetty, Saikumar Reddy Pasya, Tritia Reina Yamasaki, Zain Guduru

P10.11-009

Evaluation of the Clinical Outcomes and Disease Burden in Advanced Parkinson’s Disease Patients: PROSPECT Study Preliminary Results – Alberto J. Espay, Pilar Sanchez Alonso, Ramsey A. Falconer, Carrie Ferguson, Kazuko Hasegawa, Meredith Hatcher, Pavnit Kukreja, Koray Onuk, Connie H. Yan, Jorge Zamudio, Victor Fung

P10.11-010

Improving Shared Decision-Making for Women with Parkinson’s Disease – Michelle Fullard, Megan Morris, Ashley Dafoe, Erika Shelton, Drew S. Kern, Dan Matlock

P10.11-011

Neurological Exam Findings Predictive of Falls in Patient’s with Parkinson’s Disease – Allison Rae Valerius

P10.11-012

Clinical Utility of Home-to-Home Teleneuropsychology (TeleNP) in the Assessment of Post-Operative Deep Brain Stimulation (DBS) Outcomes in Parkinson’s disease (PD) Patients –Hannah Margaret Bullock, Scott Harcourt, Dayana Rodriguez, Annelly Buré-Reyes, Corneliu C. Luca, Jonathan Jagid, Bonnie E. Levin, Julia See, Ihtsham Haq, Marina Sarno

P10.11-013

Feasibility and Utility of Electrophysiology-Based DBS Programming in Clinical Practice – Dylan Franco Del Papa, Matthew Feldman, Sarah Marmol, Jonathan Jagid, Ihtsham Haq, Corneliu C. Luca

P10.11-014

Assessment of Virtual Reality Devices as a Means of Objectively Monitoring Parkinson’s Disease –Siegfried Stefano Hirczy, Meagen Salinas

P10.11-015

Characterizing Hospital Admissions in Persons with Parkinson’s Disease: 10-Year Retrospective Study of Administrative Data in Alberta, Canada –Yasamin Mahjoub, Steven R. Peters

12 Headache

Headache: Towards Precision Medicine 1

P10.12-001

Persistence to OnabotulinumtoxinA or Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy Among Patients With Migraine: A Retrospective Cohort Study – Brian Talon, Christine Sullivan, Meghana Karnik-Henry, Seema SoniBrahmbhatt, Carlton Anderson, Steven Kymes, Stephane Regnier

P10.12-002

Initiation of Fremanezumab Earlier in the Treatment Cycle may Result in Cost Savings to Payors in the United States – Stewart J. Tepper, Mario Ortega, Maurice Driessen, Olawemimo Odebiyi, Timothy M. Klein, Lee Smolen

P10.12-003

Efficacy and safety of different doses of subcutaneous galcanezumab in chronic and episodic migraine: A pooled analysis of 3651 patients – Mohamed Zaazouee, Ahmed Bostamy Elsnhory, Rokaya Y. Ebrahim, Ghaidaa Alaraj, Ahmed Saad, Ibram Zaki, Mustafa Hussein Ali, Omar Khaled Fahmy Fawy, Hadi F. Ahmed, Mohamed Elshennawy, Mohammed Eleyan, Ziad Alahmad, Reem Ibrahim Abo Hamra, Hazem Gamal AbuElEnien, Rasha Abdo Elromely, Alaa Elshanbary

P10.12-004

Real-world Adherence to Subsequent CGRP mAb Treatment Among Chronic Migraine (CM) Patients Initially Treated with OnabotulinumtoxinA: A Retrospective Claims Analysis – Yanan Dong, Amanda Vida Gusovsky, Darshini Shah, Tae Jin Park, Changgeng Zhao

P10.12-005

Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine – Elise Ruth Hennessy, Amira Salim, Sudipa Biswas, Aarushi Suneja, Maryann Mays, Zubair Ahmed, Ignacio Mata

P10.12-006

Treatment with Galcanezumab in Patients with Episodic Migraine: Results from the Open-Label Phase of the PERSIST Study – Shengyuan Yu, Jiying Zhou, Junpeng Zhuang, Hui Vicky Liu, Chenxi Qian

P10.12-007

Adherence and Persistence among Patients with Migraine Initiating Concomitant Use of Self-Injectable Calcitonin Gene-related Peptide Monoclonal Antibody and Novel Acute Migraine Medications – Oralee Johnson Varnado, Tania Gulati, Margaret Hoyt, Anthony Wheeler, Jerry Hall

P10.12-008

Beyond migraine headache day reduction: Clinically meaningful improvement in disability (MIDAS score) in the absence of greater than 50% reductions in monthly migraine days with galcanezumab – Bert B. Vargas, Amaal J. Starling, Robert A. Nicholson, Pepa Polavieja, Zaza Katsarava, Lars Viktrup, Maurice Borges Vincent, Richard B. Lipton

P10.12-009

Long-Term Safety and Tolerability of Zavegepant

10 mg Nasal Spray During Concomitant Use of CGRP Monoclonal Antibodies: Results From a

1-Year Open-label Safety Trial – Gary D. Berman, Kathleen B. Mullin, Jelena M. Pavlovic, Timothy R. Smith, Robert Croop, Jennifer Madonia, Linda Mosher, Jennifer D. Hould, Richard B. Lipton

P10.12-010

Effects of Rimegepant 75 mg on Monthly Migraine Days: a 52-Week, Open-Label Extension Study

– Robert Croop, Jessica Ailani, David B. Kudrow, Timothy R. Smith, Richard B. Lipton, Alexandra Thiry, Christopher Jensen, Lisa Kamen

P10.12-011

Medication Preference, Satisfaction, and Clinical Improvement Among Adults Receiving LongTerm Treatment With Rimegepant for Migraine

– Kathleen B. Mullin, Jelena M. Pavlovic, Susan Hutchinson, Richard B. Lipton, Christopher Jensen, Alexandra Thiry, Lisa Kamen, Robert Croop

P10.12-012

Post Hoc Analysis of PROGRESS: Evaluating the Safety of Atogepant in Participants With Chronic Migraine and Cardiovascular Risk Factors –Patricia Jeanne Markovi Best, Andrea Harriott, Teshamae Monteith, Cristina Tassorelli, Stephanie J. Nahas, Yingyi Liu, Brett Dabruzzo, Rosa Liliana De Abreu Ferreira, Jonathan H. Smith

13 Neuro-oncology

Neuro-oncology: CNS Metastases

P10.13-001

Neurological Outcomes of Radiosurgery for Brain Metastases in the Motor Cortex – Shefalika Prasad, Juan Diego Alzate Ramirez, Reed Mullen, Tanxia Qu, Kenneth Bernstein, Joshua Silverman

P10.13-002

Peritumoral edema measurements provide additional information to RANO-BM based assessment of lung cancer brain metastases after Gamma Knife therapy – Manpreet Kaur, Gabriel Ignacio Cassinelli Petersen, Marc Von Reppert, Leon Jekel, Sunitha Varghese, Irene Dixe de Oliveira Santo, Antonio M. P. Omuro, Veronica Chiang, Mariam Aboian

P10.13-003

An Efficient Approach to Mapping the Distribution of Renal Cell Carcinoma (RCC) Brain Metastases

(BrM) – David Olayinka Kamson, Ardit Feinaj, Roy Elias, Anirudh Yerrapragada, Chetan Bettegowda, Nirmish Singla, Yasser Ged

P10.13-004

CNS-Isolated Blast Crisis in A Patient with Chronic Myeloid Leukemia on Dasatinib – Benjamin John Puccio, Jorge Luis Rodriguez Lee, Nancy Song

P10.13-005

Missing the Mark: CSF CA 19-9 secures diagnosis of rare Pancreatic Leptomeningeal Carcinomatosis

– Sydnie Jones

P10.13-006

Outcomes of Patients with Neoplastic Meningitis

Undergoing Ventriculoperitoneal Shunting and Intrathecal Chemotherapy, A Single Institution

Retrospective Review – Amulya Gottiparthy, Lauren Orda-Nguyen, Emily Morrow, Monica Elena Loghin

1

Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 1

P11.1-001

Fenfluramine Treatment Is Associated With Improvement in Everyday Executive Function in Adults With Lennox-Gastaut Syndrome: Post-Hoc Analysis of Dose Effects From a Phase 3 Trial

Rationale – Kim I. Bishop, Peter Isquith, Kelly G. Knupp, Joseph Sullivan, Rima Nabbout, Antonio GilNagel, Ingrid E. Scheffer, Stéphane Auvin, J. Helen Cross, Renzo Guerrini, Robert Roth, Gerard A. Gioia, Amelie Lothe, Shikha Polega

P11.1-002

Efficacy of Soticlestat Treatment by Seizure Type in Patients with Dravet Syndrome or Lennox–Gastaut Syndrome in a Phase 2, Randomized, Placebocontrolled Study (ELEKTRA) – Naga Venkatesha

Murthy Pathi Jagannatham, Dennis J. Dlugos, Yasir Pervaiz Khan, Sam Hsiao, Arturo I. Benitez, Mahnaz Asgharnejad

P11.1-003

12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis – Vicente Villanueva, Wendyl J. D’Souza, R Edward Faught, Pavel Klein, Markus Reuber, Felix Rosenow, Javier SalasPuig, Victor Soto Insuga, Adam Strzelczyk, Jerzy P. Szaflarski, Herve Besson, Tony Daniels, Florin Floricel, Cedric Laloyaux, Veronica Sendersky, Sophia Zhou, Bernhard Steinhoff

P11.1-004

Early and Sustained Treatment Effect of Adjunctive Perampanel in Patients with Seizures Associated with Lennox-Gastaut Syndrome (LGS): A Post Hoc Analysis – Anna Patten, Marcia E. Morita-Sherman, Stella Leock Ngo

P11.1-005

Long-Term Efficacy of Perampanel Monotherapy in Patients with Newly Diagnosed/Currently Untreated Recurrent Focal-Onset Seizures: FREEDOM Study 342 Extension Phase Analysis by Seizure Type – Sung Chul Lim, Anna Patten, Marcia E. Morita-Sherman, Stella Leock Ngo, Takamichi Yamamoto

P11.1-006

Concomitant Drug Load Reduction During Adjunctive Cenobamate Therapy: Post-hoc Analysis of a Phase 3, Open-Label Study – Sami M. Aboumatar, Louis Ferrari, Sean Stern, Clarence Wade, Mindl M. Weingarten, Gregory S. Connor, William E. Rosenfeld

P11.1-007

Effects of Cenobamate on Weight: Post-hoc Analyses of Global Phase 2 and 3 Studies – Louis Ferrari, William E. Rosenfeld

P11.1-008

Perampanel for Treatment of Focal and Generalized Epilepsy in Everyday Clinical Practice: Evidence from PERMIT and PROVE – Eugen Trinka, Robert T. Wechsler, Wendyl J. D’Souza, Tony Wu, Imad M. Najm, Stella Leock Ngo, Rob McMurray, Vicente Villanueva

P11.1-009

Long-Term Quality of Life in Patients With Focal Seizures Treated With ESL: Pooled Analysis From 3 Phase III Open-Label Extension Studies –David Cantu, Suparna R. Krishnaiengar, Daniel R. Thomases, Darshan Mehta, Diane Hall, Ian Zhang, Helena Gama, Ana Pereira, Todd Grinnell

P11.1-010

Effectiveness and Tolerability of Brivaracetam by Number of Lifetime Antiseizure Medications in Adults with Focal Onset Seizures: Pooled Data

From Two Real-world Studies – Melinda S. Martin, Dimitrios Bourikas, Fiona Catherine Brock, Prashant Dongre, Sami Elmoufti, Iryna Leunikava, Allison Little, Anne-Liv Schulz

P11.1-011

ELEVATE Study 410: Assessment of Cognition (EpiTrack®) Following Perampanel (Monotherapy/ First Adjunctive) in Patients with Epilepsy and a History of Psychiatric/Behavioral Events – Vineet Punia, Omar Samad, Stella Leock Ngo, Dinesh Kumar, Manoj Malhotra

P11.1-012

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of XEN1101 as an Adjunctive Therapy in the Treatment of Primary Generalized Tonic-Clonic Seizures – Antonio Gil-Nagel, David G. Vossler, Elinor Ben-Menachem, W. Curt LaFrance, Cynthia L. Harden, Jenny Qian, Gregory N. Beatch, Christopher Kenney

2Education, Research, and Methodology

Education, Research, and Methodology: Developing a Pathway to a Neurology Career

P11.2-001

Assessing Undergraduate Neurology Pipeline Programs: A Systematic Review – Ramisha Aymon, Ishah Yusaf, Khushalee Oza, Jane Ekhtman, Naomi Sara Lebowitz, Aarti Raj Katara, Mia T. Minen, Caitlin Plovnick

P11.2-002

Novel BIPOC+ Next-Generation Summer Neuroscience Research Internship Initiative –Ka-Ho Wong, Emily Dennis, Lilly Fagatele, Kacey Madsen, Megan McKay, Elise Longnecker, Annie Fukushima, Gloria Slattum, Stephanie Lyden, Kathleen B. Digre, Michelle Miranda, Elisabeth Wilde, Karla Patricia Figueroa, Abby Forrest, Amir Manzoor Arain, Laura Beeler, Marissa Marie Castillo, Trieste Francis, Nicholas A. Frost, Sama Noroozi Gilandehi, Crystal Neate, Angela Yvonne Peters, Sarah Shapiro, Stefan M. Pulst, John W. Rose, Adam De Havenon, Stacey Clardy

P11.2-003

An Advocacy Leadership Training in Neurology for High School Students: A Pilot Study – Tyler Gumpel, Alexandra Boubour, Mia T. Minen

P11.2-004

A Retrospective Observation of Medical Students Matching into Neurology Residencies Following a Change to Clerkship Curriculum – Rick R. Gill, Ravi Garg, Ashley Raedy, Zachary Pardieck

P11.2-005

How to Increase the Neurology Pipeline? A Critical Systematic Review of K-12 Neurology Pipeline Programs – Naomi Sara Lebowitz, Jane Ekhtman, Ramisha Aymon, Aarti Raj Katara, Khushalee Oza, Ishah Yusaf, Caitlin Plovnick, Mia T. Minen

P11.2-006

Preclinical Neuroscience Education: Planting the Seed for a Career in Neurology – Jeremy J. Laukka, Mehmood Rashid

3 MS and Inflammatory Disease

MS Neuroimaging 2

P11.3-001

Longitudinal Brain Volume Findings in an Outpatient Practice of Young People with MS –Kimberly O’Neill, Laura Couvreur, Jiyuan Hu, Yan Zhang, Shayna Pehel, Anna Sosa, Djemo Fade, Elayne Feld, Jingyun Chen, Nuno Pedrosa De Barros, Thibo Billiet, Annemie Ribbens, Lauren B. Krupp

P11.3-002

Multifaceted Evaluation of Double Inversion Recovery Brain MRI in Detection of Cervical Spine

Multiple Sclerosis Lesions – Shivam Patel, Marina Creed, Abner Gershon, Leo Wolansky, Jaime Imitola

P11.3-003

Functional and Structural MRI Changes Associated With Cognitive Worsening in Multiple Sclerosis: A 3-Year Longitudinal Study – Matteo Azzimonti, Paolo Preziosa, Paola Valsasina, Elisabetta Pagani, Olga Marchesi, Nicolò Tedone, Carmen Vizzino, Massimo Filippi, Maria Assunta Rocca

P11.3-004

Early detection of silent brain function changes in multiple sclerosis using magnetoencephalography (MEG): Towards an imaging biomarker –Mouhamad Hammami, Basil Memon, Anza Memon, Susan M. Bowyer

P11.3-005

Quantitative brain 18F-FDG PET/CT analysis in seronegative autoimmune encephalitis –Samantha Roman, Mohammad Sadaghiani, Luisa Alejandra Diaz-Arias, Marion Le Marechal, Arun Venkatesan, John Probasco

P11.3-006

Deep Learning Reconstruction of Lesion-Free Representations of the Brain in Multiple Sclerosis

Patients – Quentin Spinat, Bastien Cyprien Caba, Despoina Ioannidou, Arie Gafson, Olivier Teboul, Xiaotong Jiang, Vincent Lepetit, Douglas L. Arnold, Refaat E. Gabr, Enrica Cavedo, Colm Elliott, Nikos Paragios, Shibeshih Belachew

P11.3-007

Neural effects of fatigue on cognition in relapsing multiple sclerosis detected by magnetoencephalography: Towards an imaging biomarker – Anza Memon, Mouhamad Hammami, Basil Memon, Susan M. Bowyer

P11.3-008

The Challenges of MRI in Clinical Practice –Tamara Hoyt, Angelene Christensen, John F. Foley

P11.3-009

Imaging Chronic Active Lesions in Multiple Sclerosis: a Consensus Statement from the North America Imaging in Multiple Sclerosis Cooperative

– Francesca Bagnato, Pascal Sati, Christopher Hemond, Colm Elliott, Susan Gauthier, Daniel Harrison, Caterina Mainero, Jiwon Oh, David Pitt, Russell T. Shinohara, Seth A. Smith, Bruce D. Trapp, Christina Azevedo, Peter A. Calabresi, Roland G. Henry, Cornelia Laule, Daniel Ontaneda, William Rooney, Nancy L. Sicotte, Daniel Reich, Martina Absinta

P11.3-010

Predicting MRI Changes in Patients with MS in the Absence of Acute Inflammation – Carmen Tur, Zhaonan Sun, Daniel P. Bradley, Cynthia Grossman, Xavier Montalban, Alex Rovira, Mar Tintore, Nolan Campbell, Elizabeth Fisher

P11.3-011

Impact of natalizumab on chronic active lesions

– Marjo Nylund, Markus Matilainen, Marcus Sucksdorff, Eero Polvinen, Laura Airas

P11.3-012

Association between retinal layer thickness and cortical lesions at the onset of clinically isolated syndrome – Kyriakoula Varmpompiti, Geoffrey Chow, Michael Anthony Foster, Srikirti Kodali, Marios Yiannakas, Baris Kanber, Ferran Padros, Indran Davagnanam, Olga Ciccarelli, Ahmed Toosy, Sara Collorone

P11.3-013

International Consensus on Smoldering Disease in Multiple Sclerosis using the Delphi Method –Francesca Bagnato, Antonio Scalfari, Jiwon Oh, Laura Airas, Stefan Bittner, Massimiliano Calabrese, Jose Manuel Garcia Dominguez, Cristina Granziera, Benjamin M. Greenberg, Kerstin Hellwig, Zsolt Laszlo Illes, Jan Nils Lycke, Anthony Traboulsee, Veronica Popescu, Gavin Giovannoni

P11.3-014

TMS Targets for Multiple Sclerosis Related Depression Derived Using a Precomputed Functional Connectome – William Drew, Rohit Bakshi, Michele Cavallari, Tanuja Chitnis, Bonnie Glanz, Charles R.G. Guttmann, Miklos Palotai, Michael D. Fox, Shan Siddiqi

P11.3-015

Exploring New Imaging Biomarkers: 3D Conformational Analysis Of The Medulla And Upper Cervical Spinal Cord In People With Relapsing Multiple Sclerosis – Tatum Moog, Janneke Van Wingerden, Bruno Padrazzi, Svend Geertsen, Andreea Rawlings, Darin T. Okuda

P11.3-016

Overlapping and Distinguishing Features Among MS, NMOSD, MOGAD and Other Atypical Demyelinating Syndromes of the Central Nervous System – Bade Gulec, Samet Cam, Ugur Bilge, Melih Tutuncu, Sabahattin Saip, Ugur Uygunoglu, Aksel Siva

P11.3-017

African Americans with multiple sclerosis (MS) are more likely to have paramagnetic rim lesions (PRLs) compared to Caucasians – Nara Michaelson, Melanie Marcille, Elizabeth Margaret Sweeney, Ulrike Kaunzner, Jai Perumal, Nancy M. Nealon, Thanh Nguyen, Susan Gauthier

P11.3-018

Brain MRI Activity During the Year Before Pregnancy Can Predict Long-Term Clinical Worsening in Patients with Multiple Sclerosis

– Omri Zveik, Shahar Kahila, Netta Levin, Ariel Rechtman, Nitsan Haham, Adi Vaknin-Dembinsky

4 General Neurology

General Neurology: Intracranial Hypertension and Other Pathologies 2

P11.4-001

Neurologic Implications of Spaceflight – Mark Joshua Rosenberg, Donna Roberts, Maria Barbara Grimberg, Jonathan C. Edwards, Brian Saway, Sami Alkasab

P11.4-002

Infratentorial Superficial Siderosis and Spontaneous Intracranial Hypotension: Type, Time course, and Treatment of underlying Spinal Cerebrospinal Fluid Leak – Jennifer Harris, Wouter Schievink, Marcel Maya, Javier Lenin Galvan, Rachelle Tache

P11.4-003

Orthostatic Hemifacial Spasm, Trigeminal Paresthesias, and Pulsatile Tinnitus in the Setting of Idiopathic Intracranial Hypertension – Madison Michelle Patrick, Raya Haley Kleinbart, Sydney Elizabeth Gilbert, Galen Postma, Brenda Trokthi, Charles Maitland

P11.4-004

Gauging the pressure: The clinical dilemma with Chiari! – Elelia Phillips, Chandra Sekhar Mannyam, Sameer Sharma

4 General Neurology

General Neurology: Neurogenetics 1

P11.4-005

Neurological Manifestations of Wilson Disease in Treatment-Naive Patients and in Patients Receiving Standard of Care – Peter Hedera, Aurelia Poujois, Danny Bega, Charles Liu, Jeff M. Bronstein, David J. Nicholl, Anna Czlonkowska

P11.4-006

A Case of Pantothenate Kinase-Associated Neurodegeneration (PKAN) in a Patient with One Known Pathologic Variant and One Variant of Unknown Significance – Carlos Andres Cevallos, Bryn Rubin, Rachel Rhinehart, David J. Houghton

P11.4-007

A Comparison of Phenotypic and Genotypic Features in Identical Twins with Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-like Episodes (MELAS) – Joyce Mbiziwo-Tiapo, Andrew Dugue, Richard Libman

5

Cerebrovascular Disease and Interventional Neurology

Cerebrovascular Disease and Interventional Neurology: Neuroimaging and Secondary Stroke Prevention

P11.5-001

Optical Coherence Tomography Angiography (OCTA) Retinal Imaging Can Detect Burden of Small Vessel Disease and Amyloid Deposition in the Brain – Camilo Bermudez, Timothy Lesnick, Swati More, Vijay K. Ramanan, David S. Knopman, Prashanthi Vemuri, Ronald C. Petersen, Jonathan Graff-Radford, John J. Chen

P11.5-002

Remote Ischemic Conditioning with Novel Optical Sensor Feedback Device in Acute Ischemic Strokea feasibility study – Robert Joseph Cruz Sarmiento, Radhika Nair, Ashfaq Shuaib, Brian Hilton Buck, Michel Gauthier, Vivian Mushahwar, Martin Ferguson-Pell, Mahesh Pundlik Kate

P11.5-003

3-Dimensional Subcortical Vascular Maps – Sally Ladsaria, Tanzina Islam, Daniel Antoniello

P11.5-004

Analysis of clinical and imaging characteristics of patients with freezing of gait in cerebral small vessel disease – Ning Su, Hejiao Mao, Jiangxia Zhang, Wencheng Zhu, Fei Han, Ming Yao, Lixin Zhou, Jun Ni, Xiangmin Fan, Feng Tian, Yi-Cheng Zhu

P11.5-005

White matter hyperintensity volume (WMHV) association with APOE e4 carriers and non-carriers

– Faissal Stipho, Fawaz Stipho, Michael Ahmadi

P11.5-006

White matter disease and recovery following endovascular thrombectomy after acute ischemic stroke – Nicholas Vigilante, Manisha Koneru, Mary Penckofer, Kenyon W. Sprankle, Pratit Dhirajlal Patel, Jane Khalife, Renato Oliveira, Scott Kamen, Jesse Thon, James E. Siegler

P11.5-007

Clinical and Radiological Features of Intracerebral Hemorrhage in Pregnant and Postpartum Patients

– Mehriban Sariyeva, Noora Camile Haghighi, Whitney Alexandra Booker, Nils Petersen, Randolph S. Marshall, Eliza Cushman Miller

P11.5-008

Evaluation of Imaging Techniques for the Measurement of Extracranial Internal Carotid Stenosis: A Systematic Scoping Review – Marc Lawrence, Holly Sim, Brian Dewar, Robert Fahed, Michel C. Shamy

P11.5-009

Framingham Risk Score and White Matter Disease

Progression – Hossam Youssef, Nihas Raja Mateti, Mutlu Demirer, Erik Middlebrooks, Thomas G. Brott, Nilufer Taner, James F. Meschia, Michelle P. Lin

P11.5-010

Expediting emergent MRI in acute ischemic stroke by extending CT scout image: a simple intervention to decrease time to treatment –Yasmin Aghajan, Rajiv Gupta, Cristy Savage, Frederick McNulty, Michael H. Lev, Aneesh B. Singhal

P11.5-011

Multi-territorial Acute Ischemic Stroke with low T2* signal—an MRI marker for differentiating infective endocarditis from cancer-related stroke – Akira Machida

P11.5-012

Reversible Cerebral Vasoconstriction Syndrome associated to Cervical Artery Dissection: Two Cases and Review of the Literature – Mario Emiliano Ricciardi, Maia Gomez Schneider, Maria Agustina Ruiz Yanzi, Oscar Emanuel Garat, Lucas Alessandro, Daiana Elizabeth Dossi, Virginia Andrea Pujol Lereis, Sebastian F. Ameriso

P11.5-013

Penumbra without core in acute hemispheric stroke syndrome: an imaging biomarker for underlying atherosclerotic intracranial stenosis –Gyanendra Kumar, Ali Turkmani

P11.5-014

To Investigate When and What to Do for Deep Subcortical White Matter Hyperintensity (DSWMH) in a Large Cohort Study – Yoshinori Nishimoto, Kyoko Hiyoshi-Arai, Higashino Sadanori, Hidetaka Takeda, Takahiro Amano

P11.5-015

A Cross-Sectional Study of Home Blood Pressure Monitoring after Stroke – Melissa Mariscal, Rachel Forman, Catherine Viscoli, Katherine Meuer, Kevin N. Sheth, Lauren Hachmann Sansing, Adam De Havenon, Richa Sharma, Walter N. Kernan

P11.5-016

Identifying optimal cut points of National Institutes of Health Stroke Scale to Predict Mortality: A Population-based Assessment – Robert Stanton, David Robinson, Mathew J. Reeves, Lili Ding, Jane Khoury, Mary Haverbusch, Kathleen Alwell, Opeolu Adeoye, Elisheva Ruth Coleman, Felipe De Los Rios La Rosa, Stacie Leigh Demel, Simona Ferioli, Matthew L. Flaherty, Adam S. Jasne, Pooja Khatri, Jason S. Mackey, Sharyl R. Martini, Eva Mistry, Sabreena J. Slavin, Michael Jonathan Star, Daniel Woo, Kyle Walsh, Brett M. Kissela, Dawn O. Kleindorfer

P11.5-017

Ischemic Changes in Carotid Endarterectomies are More Severe in Left-Sided Procedures –Amir Mina, Katherine Du, Vinay Pedapati, Allison Bradley, Jeremy Espino, Kayhan Batmanghelich, Parthasarathy Thirumala, Shyam Visweswaran

P11.5-018

Diagnosis and Prognosis of Stroke Using Artificial Intelligence and Imaging – Kathleen Miao, Julia Miao

P11.5-019

Stroke and Transient Ischemic Attack Care Transitions Clinic: Providing Timely, EvidenceBased Care – Shivani Daryani, Halina White, Saad Abdul Sami Mir, Dana Leifer, Ava L. Liberman, Alan Z. Segal, Matthew E. Fink, Hooman Kamel, Babak Navi, Neal S. Parikh

P11.5-020

A Systematic Review on the Duration of Antipsychotic Exposure and the Risk of Cerebrovascular Events in Elderly Patients –Gregory Peter Devine, Aksha Memon

P11.5-021

Very early neurological deterioration after thrombolysis – Ying-Chi Sandy Shen, Shin-Joe Yeh, Sung-Chun Tang, Jiann-Shing Jeng

P11.5-022

Distinct lesion features and underlying mechanisms in patients with acute multiple infarcts in multiple cerebral circulations – Yuhui Sha, Guangsong Han, Yuehui Hong, Juanjuan Wu, Mingyu Tang, Lixin Zhou, Yi-Cheng Zhu, Jun Ni

P11.5-023

Stroke Etiology of Large Vessel Occlusion Acute Ischemic Stroke (LVO-AIS) In a Racially Diverse Young Adult Cohort Using ASCOD Classification –Jonathan William Handshoe, Rahul Chandra, Kriti Bhayana, Maria Gabriela Martucci, Conor Reid, Maariyah Kharal, Hiba Afroze Saleem, Ehaab Naim Saleem, Andrew Schuster, Abbas Kharal

P11.5-024

Multidisciplinary approach to Patent Foramen Ovale (PFO) closure for Cryptogenic Stroke: Brain-Heart Board Experience – Muhib Khan, Philip Michael McCarthy, Diana Haggerty, Jiangyong Min, Malgorzata Miller, Jenny Peih-Chir Tsai, William Merhi, Duane Berkompas, Nabil Wees, Nadeem I. Khan, Asad Ahrar, Elizabeth Evans, Musa Issa Dahu, Andre Gauri, Tarah Moelker, Nagib Chalfoun

P11.5-025

Vascular risk factors, cerebral collateral efficiency and burden of small vessel disease in anterior circulation large vessel occlusion stroke – Nadia McMillan, Filipa Carvalho, Filipa Carvalho, Sydni Cole, Magdy H. Selim, Vasileios-Arsenios Lioutas

P11.5-026

Case Series of Apixaban Failure in Active Cancer Patients – Ping Shi, Mohammad Ravi Ghani, Muhammad Ismail Khalid Yousaf, Zarmina Mufti, Wei Liu

P11.5-027

LACE+ is marginally predictive of 30-day readmission after stroke – Muhib Khan, Freddie Hildreth, Diana Haggerty, Jay Knight, Malgorzata Miller, Jenny Peih-Chir Tsai, Victoria Scott, Tricia Tubergen, Elizabeth Evans, Nadeem I. Khan, Nabil Wees, Asad Ahrar, Jiangyong Min, Michelle Del Castillo DeJesus Brazitis, Laurel Packard

P11.5-028

Clinical Review 32 Cases of Medullary Infarction from a Tertiary Center – Prasanna Venkatesan Eswaradass, C Eswaradass, Iswariya Mani, Balakrishnan Ramasamy

P11.5-029

Infarction in the Anterior Choroidal Artery Territory: A Retrospective Study – Amal Abbes, Mariem Mhiri, Yasmine Saad, Rihab Ben Dhia, Narjes Gouta, Mouna Aissi, Mahouba Frih

P11.5-030

Association of Co-morbidities with Functional Outcomes in Stroke Patients with Atrial Fibrillation on long-term Oral anticoagulation – Muhammad Ayub, Junaid Ansari, Mohammad Abdurrehman

Sheikh, Omar Elsekaily, Prabandh Reddy

Buchhanolla, Amir Neshatfar, Maithreyi Chappidi, Arvin Parvathaneni, Rachel Elizabeth Triay, Alexandra Gaudet, Nimer Abushehab, Hugo CuellarSaenz, Roger E. Kelley, Vijayakumar Javalkar

P11.5-031

Quality of Life and Emotional Health of Stroke Survivors and Caregiver After Stroke Camp –Sarah Syed Zaheer, Zachary Langston, Lauren A. Fowler, Joseph P. Hanna

P11.5-032

Diagnostic Yield of Extended Cardiac Patch Monitoring in Cryptogenic Stroke Patients –Victoria Michelle Rice, Tomas Lucioni, Gregory Aiello, Tamra Ishan Jayendra Ranasinghe

6 Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Neuroimaging 1

P11.6-001

Stepwise functional brain architecture from disease epicenter correlates with atrophy in progressive supranuclear palsy – Edoardo G. Spinelli, Alma Ghirelli, Ilaria Bottale, Silvia Basaia, Camilla Cividini, M. Antonietta Volonte, Sebastiano Galantucci, Giuseppe Magnani, Francesca Caso, Elisa Canu, Veronica Castelnovo, Paola Caroppo, Sara Prioni, Cristina Villa, Keith A. Josephs, Jennifer Louise Whitwell, Federica Agosta, Massimo Filippi

P11.6-002

Volumetric Analysis of Hippocampal Subregions and Subfields in Left and Right Predominant

Semantic Dementia – Arenn Faye Carlos, Stephen Weigand, Rene Utianski, Joseph Duffy, Heather Clark, Mary M. Machulda, Nha Trang Thu Pham, Christopher Schwarz, Clifford R. Jack, Jennifer Louise Whitwell, Keith A. Josephs

P11.6-003

Characterization of FTLD spectrum through advanced diffusion-weighted MRI metrics: a connectome approach – Federica Agosta, Silvia Basaia, Federica Facente, Camilla Cividini, Edoardo G. Spinelli, Elisa Canu, Veronica Castelnovo, Giuseppe Magnani, Francesca Caso, Paola Caroppo, Sara Prioni, Cristina Villa, Lucio Tremolizzo, Ildebrando H. Appollonio, Vincenzo Silani, Massimo Filippi

P11.6-004

123I-Ioflupane SPECT Striatal Binding Ratio Predicts Progression of Parkinsonism in a Dementia with Lewy Bodies Cohort – Emily Maly, James B. Leverenz, Frank DiFilippo

P11.6-005

Early detection of mild cognitive impairment (MCI) using MEG – Mouhamad Hammami, Fernando Maestu, María Eugenia Lopez, Susan M. Bowyer

P11.6-006

APOE e4 Influences Within and Between Network Functional Connectivity in Atypical Alzheimer Disease – Neha Atulkumar Singh, Peter Martin, Jonathan Graff-Radford, Mary M. Machulda, Minerva Carrasquillo, Nilufer Taner, Keith A. Josephs, Jennifer Louise Whitwell

P11.6-007

Periventricular White Matter Fractional Anisotropy as a Biomarker of Cerebral Small Vessel Disease – Banafsheh Shakibajahromi, Sudipto Dolui, Christopher A. Brown, William Tackett, Pulkit Khandelwal, Shokufeh Sadaghiani, Mohammad Taghvaei, Paul Yushkevich, David A. Wolk, John A. Detre

P11.6-008

Age - related vulnerability of the human brain connectome – Federica Agosta, Camilla Cividini, Silvia Basaia, Edoardo G. Spinelli, Veronica Castelnovo, Michela Leocadi, Elisa Canu, Massimo Filippi

P11.6-009

Effect of Amyloid PET on Clinical Management of Alzheimer’s Disease Medication Therapy: The Khatib Study – Taylor Ariko, Marisa Marie Modjeski, Lun-Ching Chang, Megan Merrifield, Karen Ripper, Danae Clark Dowd, James E. Galvin, Christian J. Camargo

7 Neuro Trauma and Critical Care

Neurocritical Care: Neuromonitoring

P11.7-001

Validation of a Non-Invasive Method Using Mechanical Extensometer for the Estimation of Intracranial Compliance Using Repeated Measures Agreement Analysis – Hayley Gibler Williams, Sanem Pinar Uysal, Nicholas Thompson, Catherine Hassett, Joao Antonio Gomes

P11.7-002

Hypertonic Saline Solution versus Mannitol in Children with Intracranial Hypertension: A Systematic Review and Meta-Analysis – Artur Menegaz de Almeida, Paloma Soares Oliveira, Patricia Mendes Viana, Sergio Walmir de Araujo, Helen Michaela Oliveira, Julyana Dantas, Amanda Cyntia Lima Fonseca Rodrigues, Acza Kalica Buarque Silva, Ana Vitoria Cordeiro Rocha, Carlos Alberto Campello, Amanda Godoi, Isabela Reis Marques, Jessica Cristine Da Si Garcia, Antonia Vitoria Gomes Barreiros, Ana Carolina Toguchi, Gabriel Marinheiro Marinheiro Dos Santos-Bezerra, Allan Dias Polverini

P11.7-003

Functional near-infrared spectroscopy as a tool to assess residual and covert consciousness in the intensive care unit – Karnig Kazazian, Androu Abdalmalak, Loretta Norton, Sergio Luiz Junio, Reza Moulavi Moulavi Ardakani, Matthew Kolisnyk, Teneille Gofton, Adrian Owen, Derek Debicki

P11.7-004

The Use of Standardized Interpretation & Reporting for Multimodality Neuromonitoring

– Rudy Luna, Barbara Basil, Davis Leon Ewbank, Moshe Albert Mizrahi, Laura Ngwenya, Brandon P. Foreman

P11.7-005

Quantitative Pupillometry is Not Impacted By IV Opioid or Sedative Bolus Dosing – Joshua Battley, Jade Marshall, DaiWai Olson, Sonja Stutzman, Ranier G. Reyes

P11.7-006

Quantitative Pupillometry in Patients with Surgical Decompression – Ciara Hupp, Michael Francis Maimon Cronin, Ivy So Yeon Kim, Charlene Jennifer Ong

8 Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Peripheral Neuropathy 1

P11.8-001

Sural Nerve Biopsy Assessment by Individual Histologic Preparations: An Observational Cohort Study of 100 Consecutive Cases – Pannathat

Soontrapa, Peter J. Dyck, P. James B. Dyck, JaNean Engelstad, Jenny Davies, Shahar Shelly, William Scott Harmsen, Jayawant Narayan Mandrekar, Robert Spinner, Cris M. Ida, Christopher J. Klein

P11.8-002

Multiparametric Quantitative MRI of Peripheral Nerves to Differentiate Axonal from Demyelinating Neuropathies – Yongsheng Chen, Jacob David Baraz, Stephanie Yan Xuan, Sadaf Saba, Xue Yang, Ryan Castoro, Yang Xuan, Alison Roth, Richard Dortch, Jun Li

P11.8-003

Genotypic And Phenotypic Features of Patients with GJB1 Mutations: Single Center Experience

– Fatma Yesim Parman, Arman Cakar, Ayse Candayan, Hacer Durmus, Esra Battaloglu

P11.8-004

Neuropathy as an adverse effect of proteasomal inhibitors in multiple myeloma treatment: a network meta-analysis – Anisha Garg, Avash Das, Sughajit Das Gupta, Shaji Kunnathu Kumar, Bhaskar Roy

P11.8-005

Peripheral Nerve Pathology in Antibody Positive Paraneoplastic Neurological Syndromes – Andre Granger, Tina Rajnauth, Divyanshu Dubey, John R. Mills, Michelle L. Mauermann, Sarah E. Berini, P. James B. Dyck, Christopher J. Klein

P11.8-006

Novel Biomarker for Demyelination in Diabetic Distal Symmetric Polyneuropathy: A Prospective Study – Kazim Jaffry, Anam Khalid Shaikh, Mustafa Jaffry, Kranthi Kiran Mandava, Ronak Trivedi, Muhammed Ors, Iqra Faiz, Tejas Patel, Ankit Pahwa, Hongxin Chen, Timothy Cunningham, Howard W. Sander, Nizar Souayah

P11.8-007

Characteristics of Carpal Tunnel Syndrome in Wild-Type Transthyretin Amyloidosis – Angela C. Russell, Shahin Khayambashi, Nowell M. Fine, Sameer Chhibber, Christopher Hahn

P11.8-008

Use of Point of Care Device Assessing Sudomotor Function in the Diagnostic Work Up of Small Fiber Neuropathy: Experience From a Large UK Single Centre Cohort . – Saba Azizi Torkanpour, Dinesh Selvarajah, Channa Adithya Hewamadduma

P11.8-009

Single Center Experience of RETREG1-related Hereditary Sensory Autonomic Neuropathy in Turkey – Arman Cakar, Gulandam Bagirova, Hacer Durmus, Oya Zehra Uyguner, Fatma Yesim Parman

P11.8-010

Clinical features and real-world outcomes of Guillain–Barré syndrome in the Philippines –Adrian Isidoro Espiritu, Karl Josef Niño Jimenez Separa, Francis Jordan Chavez Milla, Karen Joy Bernarte Adiao, Carl Froilan Leochico, Roland Dominic Jamora

P11.8-011

Motor Nerve Conduction Slowing in Diabetic Distal Symmetrical Polyneuropathy: A Novel Approach –Mustafa Jaffry, Kazim Jaffry, Kranthi Kiran Mandava, Anam Khalid Shaikh, Ronak Trivedi, Muhammed Ors, Iqra Faiz, Ankit Pahwa, Tejas Patel, Abu Nasar, Howard W. Sander, Nizar Souayah

P11.8-012

Kappa Light Chain Deposition Disease Presenting with Axonal Sensorimotor Polyneuropathy in the Absence of Clinically Significant Renal Pathology –Nadia Khalil, Anthony M. Bradshaw

P11.8-013

Clinical Implications of Specific Autoantibodies in Chronic Inflammatory Neuropathies – Victor Bushlyar, Adeel Zubair, Ylec Mariana Cardenas Castillo, Kevin O’Connor, Daniel DiCapua, Kunal V. Desai, Richard J. Nowak, Bertrand Paul Tseng, Bhaskar Roy

P11.8-014

Expanded Reference Tissue Methylome for Tissueof-origin Deconvolution of Cell-free DNA in Plasma from ALS Patients – Mai Yamakawa, Christa Caggiano, Noah Zaitlen, Jessica E. Rexach

P11.8-015

Presence of deep tendon reflexes may not exclude a diagnosis of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) –James Strathdee, Edrich Joseph Rodrigues, Mahima Kapoor, Wenwen Zhang, Mark Faragher, Bruce J E Day, Elspeth Hutton, Richard Stark

9

Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Education/Sleep/Behavior

P11.9-001

Implementation of Depression Screening and Interventions Protocol in a Pediatric Neurology Residents’ Continuity Clinic: A Quality Improvement Project – Purva Choudhari, Jocelyn Bailosis Lorenzo, Rana R. Said

P11.9-002

SIGnature Libraries: A Roadmap for the Formation of ‘Living Libraries’ within Special Interest Groups

– Young-Min Kim, Rose Gelineau-Morel, Jennifer Ann O’Malley, Jenny Wilson, Bhooma Rajagopalan Aravamuthan

P11.9-003

Social Behavioral Impairments in SYNGAP1-related Intellectual Disability – Hajera Naveed, Maria McCormack, Jimmy Holder

P11.9-004

A Cross-Sectional Study of the Neuropsychiatric Phenotype of CACNA1C-Related Disorder –Rebecca Jeannette Levy, Katherine Wilson Timothy, Jack F G Underwood, Jeremy Hall, Jon Bernstein, Sergiu Pasca

P11.9-005

Sandman Send Me a Dream: Case of Non-24-Hour Sleep-Wake Disorder in a Sighted Pediatric Patient

– Matthew Hart, Alyssa Marie Smith, Anne M. Morse

P11.9-006

Acute psychosis as initial presentation for Neurofibromatosis Type 2 – Alyssa Domingue, Alexander Sandweiss, Karla Salazar, Jason Singh

Gill

P11.9-007

Adding Tools to Our Toolkit: How to Care for Children with Autism and Challenging Behaviors

– Christina Massrey, Douglas Aaron Wells, Karen Gibbs, Jaime Choate, Tanya Nelson Hall, Elizabeth Klinepeter

9 Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Genetics/Metabolic/ Nutritional Disorders 2

P11.9-008

Mitochondrial Complex I Deficiency Associated with Biallelic NDUFA13 Variants Lead to Leigh Syndrome – Rauan Kaiyrzhanov, Rauan Kaiyrzhanov

P11.9-009

Scurvy presenting with difficulties to walk and weakness in pediatric patients; 2 case reports –Anastasia Railean, Jaclyn Martindale

P11.9-010

“Confounding Contractures” A Non-Lethal Presentation of a Lethal Disorder – Gerard Mullane, Eoghan Donlon, Shane Smyth

P11.9-011

Large-Cohort Characterization of Pediatric Small Fiber Neuropathy – Alexander James Mills, David Dredge, Madeleine Klein, Heather Downs, Khosro Farhad, Max M. Klein, Anne Louise Oaklander

P11.9-012

Disease Impact and Burden in Patients with SCN2A-Related Developmental and Epileptic Encephalopathy – Kelley Dalby, Ted Snyder, Lillian G Matthews, Elli Brimble, Geoffrey Beek, Alexandra Berk, Michael Stefan Oldham

Infectious Disease

Infectious Disease: WNV and Emerging Viral Pathogens 2

P11.10-001

Rapid Reversal of Locked-in Syndrome from Acute Neuroinvasive West Nile Virus with High-dose Steroids – Sumayya Mohammed, Ai Aileen Ohno, Lisa Herring Sovory

P11.10-002

A Case of Monkeypox-associated Encephalomyelitis—Colorado, July–August, 2022

– Kelli Money, Markus Hannan, Betsy Anne Kleiner, Cindy Yuen, Elizabeth Michelle Ferriman, Elizabeth Matthews, John David Beckham, Lakshmi Chauhan, Amanda Lee Piquet, Kenneth L. Tyler, Daniel Pastula

P11.10-003

Neurological Manifestations of Human Monkeypox: A Systematic Review – Bahadar Singh Srichawla, Maria Alejandra Garcia-Dominguez

P11.10-004

Lumbar Polyneuropathy, Chorioretinal Lesions, Sensorineural Hearing Loss: Neuroinvasive Manifestations of West Nile Virus Infection –Matthew William Flounders, Katharine Dermigny, Leana Doherty

Infectious Disease

Infectious Disease: Herpes Viruses 1

P11.10-005

Persistent CMV in Brain Tissue of a Patient with Congenital CMV Following Resolution of Viremia

– Jeffrey Kuerbitz, Gail J. Demmler Harrison, Lisa T. Emrick

P11.10-006

HHV-7 Encephalitis: The Rare Infection and Its Outcome on a Child – Ítalo Barros Andrade, Rafaela Oliveira Marques, Heitor De Sousa Mota

P11.10-007

A Case of Bilateral Cytomegalovirus Retinitis in a Patient with a CD4+ count of > 200 cells/µL –Sophie Xie, Tikku George, Aninda Acharya

11 Movement Disorders

Movement Disorders: Dystonia 1

P11.11-001

Deep Brain Stimulation of the Subthalamic Nucleus in a Patient With X-Linked Dystonia-Parkinsonism

– Sviatoslav Redko, Brian Kopell, Winona Tse

P11.11-002

Improvement in Cervical Dystonia – Outcomes of a Prospective, Multicenter, International Registry of Deep Brain Stimulation (DBS) – Alberto Albanese, Roshini Jain, Lilly Chen, Joachim Krauss

P11.11-003

Long-term Safety of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia in Phase 3, Open-label, Multicenter ASPEN-OLS Trial – Peter J. McAllister, H. A. Jinnah, Virgilio Gerald H. Evidente, Atul T. Patel, Todd Gross, Roman Rubio, Domenico Vitarella

P11.11-004

Dystonia is Associated with Macro and Microstructural Abnormalities of the Cerebellum: Analysis of Volumetric and Diffusion-Weighted MRI Data in the UK Biobank – Xenos Mason, Elizabeth Haddad, Neda Jahanshad

P11.11-005

Clinical and Pathological Characterization of VPS16 Dystonia – Mariel Yvonne Pullman, Deborah Raymond, Walter J. Molofsky, Naomi Lubarr, Katherine Emily Leaver, Roberto P. Ortega, Maya Rawal, Steffany Bennett, Evan Bushnik, Azita Khorsandi, Fedor Panov, Jean Paul Vonsattel, Laurie J. Ozelius, Rachel J. Saunders-Pullman, Susan B. Bressman

P11.11-006

Efficacy and Safety of DaxibotulinumtoxinA for Injection Over Successive Treatments in Adults With Cervical Dystonia in the Phase 3 ASPEN-1 and ASPEN-OLS Trials – Cynthia L. Comella, Richard L. Barbano, Carlos Singer, Alberto B. Vasquez, Todd Gross, Roman Rubio, Kristie Kooken, Domenico Vitarella

P11.11-007

Preseptal and Pretarsal Botulinum Toxin Injection in Hemifacial Spasm and Blepharospasm: A 10year Comparative Study – Chutithep Teekaput, Kitti Thiankhaw

P11.11-008

Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant – Nikolai Gil Diwa Reyes, Daniel Garbin Di Luca, Vanda McNiven, Anthony E. Lang

P11.11-009

Wearable device to measure disease severity in cervical dystonia – Shameer Rafee, Tom Fitzgerald, Michael Hutchinson, Richard Reilly

11 Movement Disorders

Movement Disorders: Tic Disorders and Drug-induced Movement Disorders 1

P11.11-010

Global Improvements and Psychiatric Stability in Adults with Tardive Dyskinesia: Post Hoc Analyses of Two Long-Term Valbenazine Studies – Andrew Cutler, Rakesh Jain, Alon Bloom, Scott Siegert, Leslie Lundt

P11.11-011

Symptom severity, impairment and health outcomes in patients with Functional Tic Like Behaviours – Lindsay Berg, Tamara M. Pringsheim, Davide Martino

P11.11-012

Sustained Treatment Response with Long-Term Valbenazine in Patients with Tardive Dyskinesia

– Christoph Correll, Jean-Pierre Lindenmayer, Khody Farahmand, Eric Jen, Scott Siegert, Eduardo Dunayevich

P11.11-013

The Association Between Gender Minority Identity and Functional Tic-Like Behaviors During the COVID-19 Pandemic – Davide Martino, Lindsay Berg, Z Paige L’Erario, Tamara M. Pringsheim

P11.11-014

Characterizing Functional Tics – Anh-Tho Antoinette Thi Nguyen, Sean K. Wang, Jennifer Anne Vermilion, Jaclyn Martindale

P11.11-015

Etiological factors associated with functional tic-like behaviours during the COVID-19 pandemic

– Lindsay Berg, Tamara M. Pringsheim, Davide Martino

P11.11-016

Black and Hispanic Individuals with Tourette Syndrome are Under-Represented in Specialty Clinics – Marisela E. Dy-Hollins, Lori B. Chibnik, Evan Realbuto, Vinod Rao, Nutan Sharma, Elyse Park, Carol Mathews, Jeremiah M. Scharf

Wednesday, April 26 | 11:45 a.m.–12:45 p.m.

12 Headache

Headache: Evaluating Paradigms for Optimal Outcomes

P11.12-001

A Cross-Sectional Survey of Prevailing Opinions from Headache Specialists Regarding Status Migrainosus Management – Jennifer Victoria Robblee, Robert Vann, Christopher J. Fitzpatrick, Michelle Murphy, Sutapa Ray, Stephen Bevan Shrewsbury, Sheena K. Aurora

P11.12-002

Botulinum Toxin Off Label Use in Chronic Migraine Patients: An American Headache Society Clinical Survey Study – Ashhar Ali, Kendra K. Davis, Paul G. Mathew

P11.12-003

Clinical features and ICHD headache diagnoses for patients with prominent craniofacial pain referred by a rhinologist to headache specialists – Odei Alayyas, Jyotika Singh, Abdulmalik Saleem, John Craig, Ashhar Ali

P11.12-004

Positive Establishment of a Digital Working Alliance with a Prescription Digital Therapeutic in Patients with Migraine – Cassandra Snipes, Alexander Kuka, Olya Besedina, Laura Taraboanta, Brendan Hare, Alankar Gupta, Shaheen E. Lakhan

P11.12-005

Cervical Dystonia in a Headache Population: General Medical Education (GME) Training to Standardize Screening – Ryoichi Inoue, Kenneth Riley Dalton, Nawaz Hack, Virginia Baker

P11.12-006

Real-world Treatment Combinations of Migrainespecific Prescription Medications – Ali Mohajer, Gilbert J. L’Italien, Linda Harris

P11.12-007

ZAPTed (Zygomatic Arch and Point Triggers)

Protocol for Botulinum Toxin Injections in the Management of Refractory Trigeminal Neuralgia –Arun Aggarwal

P11.12-008

Continuous Ketamine Infusion for Treatment of Refractory Headache in the Inpatient Setting – Byoungchul Kim, Sojung Kara Park, Andersen Shemme, Tracy J. Koehler, Joel N. Phillips

12 Headache

Headache: Epidemiology and Population Health 1

P11.12-009

A History of Abuse is Associated with More Severe Migraine- and Pain-Related Disability: Results from the American Registry of Migraine Research (ARMR) – Meesha Trivedi, Gina Dumkrieger, Catherine Daniela Chong, Todd J. Schwedt

P11.12-010

Prevalence and risk factors of primary headache disorders among Healthcare professionals in México, results of a multicenter survey – Rodolfo Manuel Roman Guzman, Ildefonso RodriguezLeyva, Gamaliel Aguilera Barragán Pickens, Sandra Badial, Melissa Hernández Vega

P11.12-011

Epidemiological Study on Clinical and Functional Disability of Migraine Patients Visiting Neurological Centers in Nepal – Ayush Chandra, Avinash Chandra

P11.12-012

Headache in acute ischemic stroke Results from two Mexican databases – Alejandro R. MarfilRivera, Jennifer Riojas, Juan Fernando Gongora Rivera

13 Neuro-oncology

Neuro-oncology: Genetics and Biology of Brain Tumors

P11.13-001

Low-dose radiation followed by on-target inhibition of Galectin-3 in combination with anti-4-1BB monoclonal antibody regulates immune responses in Group 3 and Group 4 medulloblastoma mouse model – David Cachia, Ramin Eskandari, Daniel McDonald, Libby Kosnik Infinger, William A. Vandergrift, Abhay K. Varma, Sunil J. Patel, Alicia M. Zukas, Scott Lindhorst, Arabinda Das

P11.13-002

Cell Lineage and Pseudotime Inference for Singlecell Transcriptomics Analysis of Chemoresistance in GBM – Isabelle Charlotte Preddy, Ella Perrault, Atique U. Ahmed

P11.13-003

Patient-Derived Organoids Recapitulate Intrinsic Immune Landscapes and Progenitor Populations of Glioblastoma – Fumihiro Watanabe, Ethan Hollingsworth, Mark Hester, Paula Schiapparelli, Alfredo Quinones-Hinojosa, Jaime Imitola

P11.13-004

Modeling of Aryl Hydrocarbon Receptor Pathway Intrinsic Immunometabolic Role using Glioblastoma Stem Cells and PatientDerived Organoids – Fumihiro Watanabe, Ethan Hollingsworth, Jenna Bartley, Paula Schiapparelli, Alfredo Quinones-Hinojosa, Jaime Imitola

P11.13-005

Co-targeting CK1ε and PIK3CB/p110ß as a Therapeutic Approach for Glioblastoma – Eileen Xu, Zhi Sheng

1 Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): Clinical Epilepsy

P12.1-001

Auras in Persons with Focal and Generalized Epilepsy: Types and Patient Numbers from a Tertiary Level Epilepsy Center – Fahham Asghar, Sumayya Naz, Vicki A. Ramsey-Williams, Ajaz Sheikh, Sidra Saleem, Hira Pervez, Imran I. Ali, Anum Hamid Riaz

P12.1-002

Seizure Triggers in Persons with Epilepsy (PWE): A Cohort of 1975 Patients – Fahham Asghar, Meghana Ranabothu, Sumayya Naz, Hira Pervez, Sidra Saleem, Ajaz Sheikh, Anum Hamid Riaz, Imran I. Ali, Vicki A. Ramsey-Williams

P12.1-003

Reduced Bone Mineral Disease in Men with Epilepsy: a Cross-Sectional Study with 178 Subjects – Jéssica Daniele Marques, Aline Fatima Dias, Lucas Scárdua Silva, Fernando Cendes, Clarissa L. Yasuda

P12.1-004

The Outcome of Traumatic Intra-diploic Meningoencephalocele with Recurrent seizures - A case report and literature review of 20 cases

– Faisal Abdulmunim Alsallom, Majed Alzahrany, Jorge Gonzalez, Lara Jehi

P12.1-005

A Case of Cardioneuroablation Treating Ictal Bradyarrhythmia and Expanding Seizure Therapy Options – Stephen Manu, Chinasa Nwankwo, John Clark

P12.1-006

Encephalitis and Risk of Epilepsy – Shirin Jamal Omidi, Katherine Marie Johns Harris, Rodrigo Hasbun

P12.1-007

Associations of small vessel disease and seizures among hospitalized stroke patients – Alain Zingraff Lekoubou Looti, Paddy Ssentongo, Jonathon Maffie, Kunal Debroy, Michelle S. Kwon, Clever Nguyen, Benjamin Watt, Justin Andrew Ceasar, Nadia Ndinunno, Vivek Satyasi, Leonardo F. G. Bonilha, Vernon Michael Chinchilli

P12.1-008

Emergency Department Treatment of AlcoholRelated Seizures: A Retrospective Chart Review –Adel Hijazi, Nicole Sukkarieh, Manik Tetarbe, Niveta Aravind, Maysaa Merhi Basha, Deepti Zutshi

P12.1-009

NUS1 Exon 2 Deletion: A Crossover Between Epilepsy and Movement Disorders – Lauren A. Terpak, Nicholas Schuck, Kaleb Logan Culpepper, Natalya Shneyder, Suparna R. Krishnaiengar, Katherine A. Zarroli

P12.1-010

White matter tract abnormalities are associated with executive dysfunction in temporal lobe epilepsy and hippocampal sclerosis – Marina Solti, Joao Vitor Mahler Ferreira Oliveira, Carla Adda, Rosa Valerio, Carmen Lisa Jorge, Katarina Lyra, Bruno Pastorello, Claudia Leite, Maria Otaduy, Luiz H. Castro

P12.1-011

Improving SUDEP educational resources for Neurology health professionals and patients –Jaudat Masood, Maysaa Merhi Basha

P12.1-012

Sudden Unexpected Death in Epilepsy During the Cenobamate Clinical Development Program – William E. Rosenfeld, Louis Ferrari, Marc Kamin, Michael R. Sperling

Education, Research, and Methodology

Education and Research Framework Related to Neurodegenerative and Cognitive Disorders

P12.2-001

Implementing Extension of Community Healthcare Outcomes (ECHO) Framework to Educate Rural Populations in Complex Parkinson Disease Management – Lee Einar Neilson, Jennifer Wilhelm, Lisa Mann, Suvi Neukam, Jeff Kraakevik

P12.2-002

An Adaptation of a Community-Based Participatory Research Framework to Promote Engagement of Native Hawaiian’s in Parkinson’s Disease Research – Emma Krening, Connie Mah Trinacty, Damien Pekelo Hanakeawe, Fay Gao, Web Ross, Michiko K. Bruno

P12.2-003

Preparing Clinicians to Provide Equitable Alzheimer’s Disease (AD) Care: What Continuing Medical Education (CME) Can Achieve – Carole Drexel, Eve J. Wilson, Emily J. Bixler, Goldie S. Byrd, Jessica Zwerling, Angela Marie Allen, Nancy Lynn

P12.2-004

A Patient-centric Approach to Neuro-recovery after Acute Neurologic Injuries – Muhammad Aemaz Ur Rehman, Kristi Emerson, Michael Young, Lidia Maria Veras Rocha Moura, David Lin, Sahar Fatima Zafar

P12.2-005

Standardized Curriculum Improves Physician and Nurse Confidence and Competence in Brain Death – Zachary Hodosevich, Jamie LaBuzetta

3 MS and Inflammatory Disease

MS, COVID, and Clinical Practice

P12.3-001

Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis – Shruthi Venkatesh, Claire Riley, Amar Dhand, Nandini Kamlesh Doshi, Katelyn S. Kavak, Elle Levit, Christopher Perrone, Bianca Weinstock-Guttman, Erin Longbrake, Philip De Jager, Zongqi Xia

P12.3-002

COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD during the Omicron BA .1/2 wave in Singapore – Kevin Tan, Siew Noi Janis Tye, Xuejuan Peng, Daniel Yi Jie Wong, Tianrong Yeo

P12.3-003

COVID-19 Antibody Response by Vaccine Type and Lymphocyte Count in RMS Patients on Ponesimod: Results From Phase 2 Long-term Extension Study AC-058B202 – Janice Chun Yee Wong, Nina Hertoghs, Alexandre Lemle, Philippe Linscheid, Nandini Raghavan, Amita Singh, Tatiana Sidorenko

P12.3-004

AMA-VACC: Clinical trial assessing the immune response to SARS-CoV-2 mRNA vaccines and booster vaccination in siponimod treated patients with secondary progressive multiple sclerosis – Tjalf Ziemssen, Marie Groth, Veronika Eva Winkelmann, Tobias Bopp

P12.3-005

Reduced humoral immune response after mRNA vaccination correlates with breakthrough SARSCoV-2 infection in ocrelizumab-treated multiple sclerosis patients – Frederik Novak, Hamza Bajwa, John Eugenio Coia, Anna Christine Nilsson, Christian Nielsen, Dorte Kinggaard Holm, Kamilla Ostergaard, Mathilde Vilhelmine Mil Hvidt, Keld-Erik Byg, Isik Somuncu Johansen, Kristen Mittl, William Rowles, Scott S. Zamvil, Riley Bove, Joseph J. Sabatino, Tobias Sejbaek

P12.3-006

Recombinant antibodies binding to cytoskeletal structural proteins in post Covid-19 vaccination demyelination syndromes – Amol Raisingani, Jiayuan Liu, Jerry Lin, Qijiang Yan, Saud A. Sadiq

P12.3-007

Anti-JC Virus Serostatus Changes Before and During the COVID-19 Pandemic in US Patients with Multiple Sclerosis (MS) Treated with Natalizumab – Stephen Krieger, Susie Sinks, Furong Huang, Guohua Wen, Julie Steverson, Linda A. Piccinini, Tamar and Rony Kalina, Kurt White, Robin L Avila

P12.3-008

Acute Fulminant Encephalitis in the Setting of Acute COVID-19 Infection – Bassil Kherallah, Luis Guillermo Manrique, Swetha Vennavaram, Elias Samaha

P12.3-009

MOG Antibody-Associated Bilateral Optic Neuritis Associated with Johnson and Johnson COVID-19

Vaccination – Frighton Brighton Mutete, Naluca Mwendaweli, Melody Tunsubilege Asukile, Mulubwa Serenje, Willard Mumbi, Deanna Saylor

P12.3-010

Neurological Manifestations Post-COVID-19

Vaccination: A Review of Case Studies – Katherine Elizabeth Beard, Samiksha Srivastava, Kanika Sharma, Omar Basha, Pramod Kumar Jha, Shitiz K. Sriwastava

P12.3-011

Management of Ocrelizumab in MS patients during the Covid-19 pandemic: an observational registrybased study – Alvino Bisecco, Federica Matrone, Marco Alfonso Narduc Capobianco, Giovanna De Luca, Massimo Filippi, Franco Granella, Giacomo Lus, Gerolama Marfia, Massimiliano Mirabella, Francesco Patti, Maria Trojano, Agnese Mascolo, Massimiliano Copetti, Gioacchino Tedeschi, Antonio Gallo

P12.3-012

Changing Treatment Trends for MS Patients

Recently Initiated on Their First DMT – Emma McFadden

P12.3-013

Cerebral Vasculitis in a patient receiving Risankizumab, an Inhibitor of Interleukin-23: First Case Report – Juan Pablo Cabrera Pulla, Hasmik Amirjanyan, Qian Wu, Gracia Chu-wai Mui, Jaime Imitola, Hamza Coban

P12.3-014

High-dose cyclophosphamide as a rescue treatment for fulminant Marburg multiple sclerosis: A case report – Matthew Roberts, M. Samy Abdullah, Amy Shoga, Tania Reyna, Alicia S. Parker

P12.3-015

Multiple Sclerosis Related Trigeminal Neuralgia – Clinical Characteristics, MRI Correlates and Treatment Outcomes – Sarah Germaine, Sheila Steiner, John W. Rose

P12.3-016

A Familial Cohort of Adult-Onset Alexander Disease – Laura Rebecca Wolf, Edward J. Gettings, Louis Goodrich

P9.5-017

WITHDRAWN

P12.3-018

Diagnosis of Coexistent Neurodegenerative Dementias in Multiple Sclerosis – Diana

P. Londono, Kogul Arumaithurai, Eleni Constantopoulos, Michael Basso, Ross Reichard, Eoin P. Flanagan, Mark Keegan

4 General Neurology

General Neurology: Neurogenetics 2

P12.4-001

The genetic counselor: recognizing their critical role in neurology clinics in the era of genomic medicine – Jin Yun Helen Chen, Jeremy D. Schmahmann

P12.4-002

Clinical Management of Rett Syndrome in the Real World: A Physician Survey – Jeffrey Neul, Damian Michael May, Ambika Satija, Wendy Cheng, Neema Lema, Andra-Ecaterina Boca, Patrick Lefebvre, Jesus Eric Pina-Garza

P12.4-003

Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is commonly misdiagnosed as Frontotemporal Dementia (FTD), Multiple Sclerosis (MS,) Alzheimer’s disease (AD), or other adult-onset leukodystrophies – Leslie Leahy, Angela Pontius, Samantha Zappia, Matthew Brennan, Spyridon Papapetropoulos, Zbigniew K. Wszolek

P12.4-004

Substantial Burden of Illness and Mortality in Adult Men with Adrenomyeloneuropathy: A Retrospective Study of Real World Data – Joshua Bonkowsky, Bridget Healey, Naomi Sacks, Ronae McLin, Philip Cyr, Eileen Sawyer, Christopher D. Stephen, Florian Eichler

P12.4-005

Evaluation of methodologies for indirect comparison of eplontersen and vutrisiran for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy – Chafic Y. Karam, Julian D. Gillmore, Gengshi Chen, Nia Caitlin Jenkins, Mike Hale, Gemma Taylor, Jersey Chen, Nicholas Viney, Eugene Schneider 4

General

Neurology

General Neurology: Aging

P12.4-006

Regeneration and Immortality: Aging of the Jellyfish Turritopsis dohrnii – Valentina Velasco, Mateo Uribe, Santiago Andrés Suarez, Antonio Villamizar, Isabel Cristina Vasquez-Velez, Carlos Cano-Gutierrez

5 Cerebrovascular Disease and Interventional Neurology

Cerebrovascular Disease and Interventional Neurology: Interesting Cases 4

P12.5-001

Undifferentiated Inflammatory Vasculopathy: A Case Presentation – Sorleen Trevino, Justin A. Salerian, Akm Muktadir, Cade Daniel Picou

P12.5-002

Large vessel occlusion stroke presenting with coma: Not uncommon and poor prognostic sign – Michael Young, Amine Mohamed Marc Awad, Alexander Andreev, Anna Katharina Bonkhoff, Markus D. Schirmer, James D. Rabinov, Christopher Stapleton, Aneesh B. Singhal, Natalia S. Rost, Aman Patel, Robert W. Regenhardt

P12.5-003

A Case of Progressive Left Leg Weakness and Vision Changes: Focal Inflammatory Cerebral Amyloid Angiopathy Masquerading as a Glioma –Cameron Mohammadi, Sigmund Lilian, Huanwen Chen, Michelle Offit, Mark Mu-Quan Lin, Nicholas Samuel Streicher, Priyanka Sabharwal

P12.5-004

Posterior Spinal Cord Infarct: To Make the Diagnosis, Think of the Unthinkable! – Krystian Solis, Rana K. Zabad

P12.5-005

A Rare Familial Case of MELAS in a 66-Year-Old Female and Her 33-Year-Old Son – Radostina Iordanova, Eric Ray Wong, Pamela K. Cheng

P12.5-006

The Writing is on the Wall - Interesting Case of Peduncular Hallucinosis in an Adult Patient – Sahil Suvarna, Shadi Shams, Matthew Broderick

P12.5-007

The Gummies Strike Again: An Emerging Stroke Mimic in New York City’s Unsuspecting Hotel Housekeepers – Miryam Alkayyali, Nbaa Masood, Louise Marian McCarthy, DeWitt D. Pyburn

P12.5-008

Mania and Hemiballismus: A rare presentation of subthalamic stroke – Harinoor Mann, Kevin M. Kelly, Timothy Leichliter

P12.5-009

Multiple dural arteriovenous fistulas as the mystery of rapidly progressive dementia with bilateral thalamic lesions – Murad Al-Nusaif, Zhang Yu, Chunbo Dong

P12.5-010

Acute Flaccid Paralysis as Initial Presentation of Spinal Cavernoma – Sumayya Naz, Khaled Gharaibeh, Sidra Saleem, Naeem Mahfooz

P12.5-011

An Atypical Manifestation of Lateral Medullary Syndrome – Zheming Yu, Connor Bluntson, Sameer Sharma

P12.5-012

Alteplase-induced facial orolingual angioedema

– Juan Carlos Ayala Alvarez, Ivan Roque Sanchez, Amado Jimenez-Ruiz, Enrique Gomez Figueroa, Omar Cardenas-Sanchez, Jose Luis Ruiz-Sandoval

P12.5-013

Bronchoscopy-Associated Cerebral Arterial Air Embolism Presenting with Acute Ischemic Stroke and Status Epilepticus – Harry William Sutherland, Christine Gummerson, Richa Sharma

P12.5-014

A Case of Internal Carotid Artery Dissection Presenting With Dysgeusia – Ivanna Joseph, Valeria Ariza Hutchinson, Aya Naji Shnawa, Siddharth Sehgal

P12.5-015

Black Cohosh Induced Posterior Reversible Encephalopathy Syndrome – Hanah Ayesha Imam, Hisham Raza Alim Salahuddin

P12.5-016

Acute Paraparesis Syndrome after a Ruptured Aneurysm of the Azygos Anterior Cerebral Artery –Daniel Moreno-Zambrano, Joyce Antonella Jimenez Zambrano, Jose Francisco Ortega Tola, Luis Yepez, Wilson Cueva

P12.5-017

Transient Left MCA Syndrome Triggered by a Diagnostic Lumbar Puncture in a Case of Atypical Moyamoya Syndrome – Naman Bareja, Mustafa Al Gburi, Aya Naji Shnawa

P12.5-018

A Tangled, Clotted Web: Multi-modal imaging of a thrombosed carotid web – Rebecca Merrill, Ian James Kinney, Benjamin Daniel, Patrick S. Reynolds

P12.5-019

The great masquerader: recurrent ischemic strokes secondary to meningo-vascular syphilis in a 62-year-old patient with stroke risk factors – Sadia Waheed, Octavio Carranza-Renteria, Fawad Yousuf

P12.5-020

Acute and Subacute Neurovascular Impact of Cryptogenic Air Emboli – Christine Gummerson, Melvin Parasram, Teng Jiao Peng, John Michael Picard, Peter Kahn, Evan Angelus, Shivani Bhatt, Adam De Havenon, Adam S. Jasne, Jessica MagidBernstein

P12.5-021

Reversible Neuroimaging findings associated with Kratom use – Sindhu Reddy Pisati, Syed Yahya Shah, Andrew Thaliath, Shashi Keerthan Maryala, Hesham Abdelazz Allam

P12.5-022

Pulmonary Hypertension and Patent Foramen Ovale: A Rare Risk Factor for Stroke – Jacob Arkin, Ryna Then, Loheetha Ragupathi

P12.5-023

Patient with Recurrent Acute Ischemic Strokes Found to have Cryptococcal Meningitis: A Case Report – Lauren Thaete, Rikka Laurel Azuma

P12.5-024

Isolated and Spontaneous Common Carotid Artery Dissection: A Case Report – Shima Zargar, Ahmed

Abd Elazim

P12.5-025

Atypical Presentation of CNS Vasculitis Resembling a Stroke – Chirag L. Patel, Samuel Durojaye, Anna Kafka

P12.5-026

Ischemic Cerebellar Stroke in a Young Patient with Neurofibromatosis Type 2, a Case Report – Ariadne Ivy Trautman, Divyajot S. Sandhu

P12.5-027

Steal Syndrome Becomes Symptomatic While Playing Golf – Deema Sawass Najjar, Qingliang Wang

P12.5-028

Transient Focal Neurologic Episodes in NonTraumatic Convexity Subarachnoid Hemorrhage

– Timothy Lee, Avi Landman, Carlos Eduardo Garcia Ocasio, Elmira M. Veselinovic, Adriana Ochoa, Mustafa Mohamed, Muhammad-Atif Zubairi

P12.5-029

Case of a Pure Arterial Malformation and Review of the Literature . – Rashid Ali Ahmed, Robert W. Regenhardt, Justin E. Vranic, Adam A. Dmytriw, James D. Rabinov

P12.5-030

Management of Peri-mesencephalic Hemorrhage leading to acute hydrocephalus in an infant following Mild Trauma – Jacklyn Johnson, Xue Ming, Keyvan Heshmati

P12.5-031

Acute Bilateral Hippocampal Injury Secondary to Recreational Fentanyl Use – Sayyeda Zahra, Victoria Qizhi Tay, Preet M. Varade

P12.5-032

Invasive Bacterial Sinusitis Causing Pontine Infarct In An Immunocompromised Patient – Alex Kumar Verma, Gitanjali Das 6

Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Neuroimaging 2

P12.6-001

Participant-specific interrogation of populationbased data to predict cognitive decline from neuropsychiatric symptoms and neuroimaging biomarkers: A machine learning approach – Jay Shah, Jeremy Syrjanen, Janina Krell-Roesch, Walter Kremers, Prashanthi Vemuri, Maria Vassilaki, Ronald C. Petersen, Erica Forzani, Teresa Wu, Yonas E. Geda

P12.6-002

The differential effects of APOE e4 on cerebral volumetric structures in different lifespan in community-dwelling populations – Mingyu Tang, Ning Su, Ding-Ding Zhang, Yi Dai, Ming Yao, Lixin Zhou, Liying Cui, Shuyang Zhang, Yi-Cheng Zhu, Jun Ni

P12.6-003

Red Nucleus Volume Decrease in Healthy Aging –Mikolaj Pawlak, Ping I. Chiang, Mirna Hamada

P12.6-004

Within-person changes in the aging white matter: a meta-analysis and systematic review of longitudinal diffusion tensor imaging studies – Andrea Mendez Colmenares, Ben Prytherch, Michael Thomas, Agnieszka Burzynska

P12.6-005

Diagnostic Application of Automated Brain MRI Volumetry in Comparing Alzheimer Disease, Behavioral Variant Frontotemporal Dementia and Traumatic Brain Injury – Somayeh Meysami, Cyrus A. Raji, Verna R. Porter, David Merrill, Mario F. Mendez

P12.6-006

Nucleus Basalis of Meynert degeneration predicts cognitive decline in Corticobasal Syndrome –Daniele Urso, Salvatore Nigro, Benedetta Tafuri, Roberto De Blasi, Joana Pereira, Giancarlo Logroscino

P12.6-007

Association of protein-based indices with brain volume and cognition in the Baltimore Longitudinal Study of Aging (BLSA) – Gulzar Nasiruddin Daya, Heather Elizabeth Dark, Michael R. Duggan, Zhongsheng Peng, Ann Zenobia Moore, Toshiko Tanaka, Julian Candia, Keenan Walker

P12.6-008

White Matter and Gray Matter Changes Related to Cognition in Community populations – Wenxin Li, Jing Yuan, Fei Han, Lixin Zhou, Jun Ni, Ming Yao, Shu-Yang Zhang, Zheng-Yu Jin, Liying Cui, Feifei Zhai, Yi-Cheng Zhu

P12.6-009

Visuospatial Dysfunction in Alzheimer’s Disease Maps to a Brain Network – Sheena Baratono, Michael D. Fox, William Drew

P12.6-010

Predicting Alzheimer’s Disease from Clinical Dementia Rating, Estimated Total Intracranial Volume, Atlas Scaling Factor: Incorporating Ensemble Approach into Automated Machine Learning – Ali Haider Bangash, Sakina Batool

7 Neuro Trauma and Critical Care

Neurocritical Care: Spinal Cord and Neuromuscular Disease

P12.7-001

A Case of Surfer’s Myelopathy– Insights Into Early Management Leading to Radiographic and Neurologic Improvement – Joo Won Choi, Nathaniel Villanueva, Dylan Singh, Sarah E. Bellatti, Ferdinand K. Hui, Stacy C. Brown

P12.7-002

Serum immunoglobulin G level reduction as a predictor of short-term improvement in patients with myasthenia gravis undergoing plasmapheresis – Shingo Konno, Hideo Kihara, Mari Matsushima, Hideki Sugimoto, Toshiki Fujioka

P12.7-003

A Case of Botulism After Intramuscular Injection of Botulinum Toxin – Marc Daou, Aya Naji Shnawa, Valeria Ariza Hutchinson, Ivanna Joseph, Aleksandra Yakhkind

P12.7-004

A Therapeutic Dilemma of Venous Thromboembolism in the Setting of Odontogenic Brain and Intramedullary Spinal Cord Abscesses: Case Report and Review of Literature – Courtney Venegas, Kiley Cameron, Jennifer Shaw, Subin Mathew

P12.7-005

Spinal cord infarction after transcatheter aortic valve replacement: a case report – Talita D’Aguiar Rosa, Randall Brown, Muhammad Ismail Khalid Yousaf, Vishwanath Sagi

P12.7-006

Guillain-Barré Syndrome Mimicking Brainstem Death Following Traumatic Intracerebral Hemorrhage – Eoin Finegan, John Ryan, Michael J. Hennessy, Kevin Murphy, Seamus Crowley, Marwa Elamin

8

Neuro-rehabilitation

Neuro-rehabilitation

P12.8-001

Botulinum Toxin-A Treatment of Post-Stroke Spasticity Is Associated with Changes in Interhemispheric Parietal Cortex Connectivity –Petr Hlustik, Pavel Hok, Tomas Veverka, Markéta Trnecková, Pavel Otruba, Jana Zapletalova, Zbynek Tudos, Martin Lotze, Petr Kanovsky

P12.8-002

Prediction of Post-stroke Motor Recovery Benefits from Measures of Sub-acute Widespread Network Damages – Elvira Pirondini, Maria Giulia Preti, Dimitri Van De Ville, Adrian Guggisberg, Cyprien Rivier

P12.8-003

A Gamified Electromyographic Computer Interface to Study the Emergence of Motor Control Abnormalities after Stroke – Adarsh Mavathaveedu, Ania Busza

P12.8-004

MS Rehabilitation Research During the COVID Pandemic: Participant and Therapist Satisfaction with Remote Delivery – Michelle Cameron, Andrea Hildebrand, Andrea Susan Serdar, Jeff Schlimgen, Lucinda L. Hugos

P12.8-005

The Efficacy of Vestibular Rehabilitation Therapy for Mild Traumatic Brain Injury: A Systematic Review and Meta-analysis – Ammar Aljabri, Alhussain Khalid Halawani, Alaa Adel Ashqar, Omar Alageely, Adel Ali Alhazzani

P12.8-006

Survival in Amyotrophic Lateral Sclerosis Patients Treated with Edaravone – a Pooled Analysis of 2845 Patients – Anas Zakarya Nourelden, Ibrahim Kamal Ibrahim, Abdelrahman G. Younis, Mahmoud M. Elhady, Abdulrahman Ibrahim Hagrass, Ahmed Hashem Fathallah, Mohamed Sayed Zaazouee

P12.8-007

A Novel Tele-rehabilitation Program Aimed at Fall Prevention in Parkinson’s Disease – Andrea Hernandez, Mitra Afshari, Christopher Goetz

P12.8-008

Facial Emotion Processing Changes in Functional Seizures after Neurobehavioral Therapy – Jerzy P. Szaflarski, Jane B. Allendorfer, Adam M. Goodman, Rodolphe Nenert, Tyler Elyse Gaston, Leslie Elaine Perry Grayson, Noah Philip, Stephen Correia, W. Curt LaFrance

P12.8-009

Moderate-to-high Intensity Group Exercise

Improves Function of Stroke Survivors – Se Hee Jung, Hyejung Cho, Gilhyeon Yoon

P12.8-010

Leg Activity Measure (LegA) sensitivity to change following treatment of lower limb spasticity with a single cycle of abobotulinumtoxinA in an ambulant population – Stephen Ashford, Jorge Jacinto, Richard Zorowitz, Francoise Calvi-Gries, Pascal Maisonobe, Christian Hannes, Simon Page, Alberto Esquenazi

P12.8-011

Abnormal Thalamic Functional Connectivity

Correlates With Cardiorespiratory Fitness and Physical Activity in Progressive Multiple Sclerosis – Francesco Romano, Maria Assunta Rocca, Paola Valsasina, Maria Pia Amato, Giampaolo Brichetto, Nicolo Bruschi, Jeremy S. Chataway, Nancy Chiaravalloti, Gary Raymond Cutter, Ulrik Dalgas, John DeLuca, Rachel A. Farrell, Peter Feys, Jennifer Freeman, Maria Matilde Inglese, Cecilia Meza, Amber Salter, Brian M. Sandroff, Anthony Feinstein, Robert W Motl, Massimo Filippi

P12.8-012

Treating Upper Limb Spasticity With OnabotulinumtoxinA: Subgroup Analysis of US Practice Patterns From the ASPIRE Study – Gerard E. Francisco, Wayne W. Feng, Michael C Munin, Kenneth T. Ngo, Marc Schwartz, Marjan Sadeghi, Aleksej Zuzek, Alberto Esquenazi

P12.8-013

Real-World Clinical Utilization Differences of onabotulinumtoxinA and abobotulinumtoxinA in Upper Limb Spasticity – Mariana Nelson, Aleksej Zuzek, Marc Schwartz, Rita Singh

8

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Peripheral Neuropathy 2

P12.8-014

The Canadian Registry for Amyloidosis Research: A national multi-disciplinary registry for realworld evidence – Rami Massie, Diego Delgado, Christopher Venner, Vera Bril, Donna Reece, Steven Kent Baker, Victoria Hodgkinson, Kira Boyartchuk, Margot Davis, Nowell M. Fine, Dina Namiranian

P12.8-015

Predictors of Mechanical Ventilation Among 1960 Obese Patients Admitted With GuillainBarré syndrome in the United States – Sailaja Sanikommu, Shaheen Sombans, Kamleshun Ramphul, Renuka Verma, Nomesh Kumar, Yogeshwaree Ramphul, Indu Meena, Komal Kumari, Stephanie Gonzalez Mejias, Petras Jairam Das Lohana, Fnu Arti

9

Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Autoimmune Encephalitides/ Demyelinating Disorders/Infections

P12.9-001

Identification of Neuropsychological Phenotypes in Pediatric Multiple Sclerosis Using Unsupervised Machine Learning – Damiano Mistri, Monica Margoni, Alessandro Meani, Carmen Vizzino, Lucia Moiola, Massimo Filippi, Maria Assunta Rocca

P12.9-002

Analysis Of Differentially Expressed Genes By RNA-Sequencing In 38 Cases of Rasmussen

Encephalitis: New Insights on Non-Inflammatory Pathways – Luca Bartolini, Felix Chan, Karen Lob, Qing Wu, Ece Uzun, Chima Oluigbo, William D. Gaillard, Julia Walin Chang, Gary W. Mathern, Judy Liu

P12.9-003

Rates of Depression and Suicidality in PediatricOnset Multiple Sclerosis: A Pilot Study – Isabella Sobejano, Sarah Stoney, Elizabeth Kunzelman, Chelsea Black, Amy T. Waldman, Sarah E. Hopkins, Sona Narula, Brenda Banwell

P12.9-004

The Spatiotemporal Progression of Myelination Drives Pathology in Canavan Disease – Amanda Marie Nagy, Stacy Maciel, Cary Peregoy, Lizbeth De la Rosa Abreu, Otto Rapalino, Florian Eichler

P12.9-005

Complications, Sequelae and Case Fatality Rate in Pediatric Patients with Meningitis in Dominican Republic . – Danilo Alejandro Peralta, Angelica G Montilla, Maria Vianney Gomez, Sayira Paola Paola Mueses Jimenez, Dolores Magdalena Mejia

P12.9-006

Clinical and Neurophysiological Features of Epilepsy in Pediatric Patients with Vanishing White Matter Disease- A single institute experience and literature review – Fiza Khaliq Laheji, Andrea R. Lowden

P12.9-007

Effects of Remote Learning during the COVID-19 Lockdown on Children’s Visual Health: A Systematic Review – Maria Camila CortesAlbornoz, Sofia Ramirez Guerrero, William Andres Rojas Carabali, Ligia Alejandra De la Torre Cifuentes, Claudia Talero-Gutierrez

P12.9-008

Energy Expenditure Index Correlates with Motor and Sensory Impairments and Disease Severity in Adrenomyeloneuropathy – Manouchehr

Amanat, Christopher Joseph, Jennifer Keller, Gerald Raymond, Bela Turk, Seyed Ali Fatemi, Amena Smith Fine

P12.9-009

Decreased RNA polymerase III Expression Leads to Several Defects in Oligodendrocyte-Lineage

Development – Julia Macintosh, Mackenzie A. Michell-Robinson, Xiaoru Chen, Geneviève Bernard

P12.9-010

The ABCDs of CMV – Manasa Sudheendra, Peter Whitney Campbell, Jimmy Holder, Lisa T. Emrick

P12.9-011

Characterization of Childhood Neurodegeneration and Associated Ataxia in UBTF-Related Disorder

– Amanda Marie Nagy, Anoopum Gupta, Francine Molay, Lizbeth De la Rosa Abreu, Catherine Becker, Anoopum Gupta, Florian Eichler

P12.9-012

Pediatric FLAMES and Status Epilepticus: A Heated Combination – Alexander Ankar, Jonathan M. Yarimi, Meagan Newell, Varun Kannan, Daniel Davila-Williams, Nikita Shukla, Sarah R. Risen

10

Infectious Disease

Infectious Disease: Herpes Viruses 2

P12.10-001

Chronic Herpes Simplex Virus Encephalitis: Two Surgical Cases with Novel Neuropathologic Findings – Kirsten Sjonnesen, Juan Appendino, Walter J. Hader, Qi Xu, Julia Jacobs, Paolo Federico, Kristopher Langdon

P12.10-002

HSV-2 Retinitis and Encephalitis Masquerading as Giant Cell Arteritis and Acute Ischemic Stroke of the Midbrain – Harry William Sutherland, Christine Gummerson, Adam De Havenon

P12.10-003

Postherpetic pruritus successfully treated with Onabotulinum toxin: A case report – Juliana Stoilova, Rebekah Grace Torres, Kenneth P. Martinez

P12.10-004

A Case of HSV-2 Meningitis Retention Syndrome

– Raissa Aoun, Gayatri Raj Ghosh, Philip Thomas Kuball, Nicolas Julian Abreu

P12.10-005

Herpes Simplex Virus (HSV), Varicella-Zoster Virus (VZV), and Cryptococcal Infections Associated With Sphingosine-1-Phosphate Receptor (S1PR)

Modulators: A Review – Kanika Sharma, Pramod Kumar Jha, Shreyashi Khanal, Shitiz K. Sriwastava

P12.10-006

Reactivation of Varicella-Zoster Virus: Consequence of COVID-19? – Gurveer Singh Khosa, Shaweta Khosa, Namrata Shetty

11

Movement Disorders

Movement Disorders: Dystonia 2

P12.11-001

Hypermanganesemia with Dystonia Type 2: A Rare Entity – Bhaswar Bhattacharya, Venkata Sriram Chintha, Kuntal Biswas, Debarup Das, Uddalak Chakraborty, Adreesh Mukherjee

P12.11-002

A Comparison of Cervical Dystonia in Parkinson’s Disease and Idiopathic Isolated Cervical Dystonia

– Stewart A. Factor, Lenora A. Higginbotham, Sahyli Perez Parra, Laura M. Scorr, H. A. Jinnah

P12.11-003

Effects of Onabotulinum toxin type A in patients with Meige’s syndrome – Alexia Duarte, Leo Coutinho, Francisco M. Branco Germiniani, Helio Afonso Ghizoni Teive

P12.11-004

Lingual dystonia secondary to medication use: a review of case reports – Alexia Duarte, Helio Afonso Ghizoni Teive

P12.11-005

Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Anterocollis and Retrocollis – Khashayar Dashtipour, Joseph Jankovic, P. David Charles, Shyamal Mehta, Marc Schwartz, Marjan Sadeghi

P12.11-006

SYNCHRONIZE: Real-World Retrospective Review of Safety in Patients Treated With OnabotulinumtoxinA for More Than 1 Therapeutic Indication: An Epidemiologic Perspective – Grace Forde, Ken Martinez, Angeli Mayadev, Benjamin Brucker, Atul Patel, Kimberly Ifantides, Ritu Singh, Aleksej Zuzek, Ahunna Ukah, Christopher Rhyne

P12.11-007

Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults – Cynthia L. Comella, Michael Hast, Angelika Hanschmann

P12.11-008

Adherence to Botulinumtoxin Treatment: A 2-year Retrospective Claims Database Analysis – David M. Simpson, Jonathan Bouchard, Simon Page, Dean Spurden, Seth Goldfarb, Atul T. Patel

P12.11-009

Benefit of Multiple IncobotulinumtoxinA Injections for Pain Reduction in Adult Patients with Limb Spasticity: an Analysis of Pooled Data from Phase 2 and 3 Studies – Jorg Wissel, Alexandre CamoesBarbosa, Georg Comes, Michael Althaus, Astrid Scheschonka, David M. Simpson

11 Movement Disorders

Movement Disorders: Tic Disorders and Drug-induced Movement Disorders 2

P12.11-010

Effects of Videogaming on Attention and Conduct in Adolescents with Tourette’s Syndrome –Brendan Colgan, Bichum Ouyang, Anjali Gera, Aikaterini Kompoliti

P12.11-011

Design of a Phase 3 Maintenance-of-Effect Trial of Ecopipam in Tourette Syndrome – Timothy Cunniff, Donald Gilbert, Stephen Wanaski, Richard M. Bittman, Jordan Scott Dubow, Atul Mahableshwarkar

P12.11-012

Substance misuse in adults with primary tic disorders – Christelle Nilles, Emmanuel Roze, Andreas Hartmann, Yulia Worbe, David Bendetowicz, Natalia Szejko, Naoual Abdi Serari, Julian Fletcher, Davide Martino, Tamara M. Pringsheim

P12.11-013

Gender Identity and Treatment Response in Patients with Functional Tic-Like Behavior –Sushma Kola, Danielle Larson

P12.11-014

Dystonia as a Manifestation of Methadone Withdrawal – Pukhraj Nijhar, Manmeet Singh Sahni, Alan R. Hirsch

P12.11-015

Case Report: Acquired Transient Generalized Dyskinesia Secondary to Fentanyl in a Patient with Parkinson’s Disease – Ann Nguyen Ly, Christian Adolfo Sam, David D. Song

P12.11-016

Imperfect Pitch: a Cellist’s Struggle with Tics, PRRT2, and Carbamazepine – Matthew Feldman, Sarah Marmol, Jennifer Hislop, Danielle Spengler Shpiner, Ihtsham Haq, Jason H. Margolesky

Headache

Headache: Clinical Trials and Real World Studies 2

P12.12-001

Benefit-Risk Assessment of Atogepant: A Post Hoc Analysis of the ADVANCE Trial – Stephanie J. Nahas, Jessica Ailani, Peter J. McAllister, Rashmi B. Halker Singh, Richard B. Lipton, Julia Ma, Pranav Gandhi, Jonathan H. Smith, Yingyi Liu, Natty Chalermpalanupap, Brett Dabruzzo

P12.12-002

Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study – Messoud

Ashina, Dimos Dimitrios D. Mitsikostas, Faisal Amin, Pinar Kokturk, Gürdal Sahin, Christoph J. Schankin, Paul Dorman, Patricia Pozo-Rosich, Leonidas Lyras, Coleen Myers, Andrew H. Ahn, Cristina Tassorelli, Verena Ramirez Campos

P12.12-003

Long-Term Preventive and Acute Treatment of Migraine With Rimegepant Improves Health Related Quality of Life – Jelena M. Pavlovic, Ira

M. Turner, Paul Winner, Richard B. Lipton, Gilbert J. L’Italien, Christopher Jensen, Alexandra Thiry, Lisa Kamen, Robert Croop

P12.12-004

Real-Life Experience with Erenumab Therapy in the Episodic and Chronic Migraine – Fatemah Alshawaf, Samar Farouk Ahmed, Raed Alroughani, Jasem Yousef Al-Hashel

P12.12-005

No ‘Wearing-Off Effect’ Seen with Fremanezumab in the Real-World: Retrospective, Claims-Based Analysis of Migraine-Related Healthcare Resource and Acute Medication Use – Jessica Ailani, Handing Xie, Maurice Driessen, Mario Ortega, Yitong Wang, Verena Ramirez Campos, Sangtaeck Lim

P12.12-006

Safety and Tolerability of Rimegepant Every Other Day for Preventive Treatment of Migraine Plus AsNeeded for Acute Treatment of Migraine: Results from A 52-Week, Open-Label Extension Phase – Richard B. Lipton, David B. Kudrow, Timothy R. Smith, Jessica Ailani, Peter Goadsby, Lisa Kamen, Alexandra Thiry, Christopher Jensen, Robert Croop

P12.12-007

Adherence and Persistence of Calcitonin GeneRelated Peptide Monoclonal Antibodies in Patients with Migraine: A Real-World Study – Oralee Johnson Varnado, Brenna Brady, Anthony J Zagar, Yvonne Robles, Margaret Hoyt, Jerry Hall

P12.12-008

Assessment of the Potential for Drug–Drug Interactions Between INP104 and Gepants for Migraine Management Using a Model-based Approach – Sutapa Ray, Brad Torphy, Shivang Joshi, Robert Vann, Brett Downing, Daniella Louise Fonseca, Stephen Bevan Shrewsbury, Sheena K. Aurora

P12.12-009

Real-World Effectiveness of Eptinezumab after Treatment with Subcutaneous CGRP Monoclonal Antibodies in Patients with Migraine – Emily Casaletto, Qiu Zi Yang, John Waters, John Curran, Austin Lowe, Hsiangkuo Yuan 12 Headache

Headache: Towards Precision Medicine 2

P12.12-010

Headwork as innovative tool for monitoring MABs efficacy in migraine and their influence on work activity – Danilo Antonio Montisano, Gloria Vaghi, Alberto Raggi, Grazia Sances, Cristina Tassorelli, Licia Grazzi

P12.12-011

Final results of the SPECTRE study: real-world data giving an insight into the treatment of migraine patients with erenumab in Germany – Charly Gaul, Mirja Koch, Cordula Weiss

P12.12-012

Galcanezumab effects on incidence of headache after occurrence of triggers, prodromes, and aura in responders, non-responders, super-responders and super non-responders – Sait Ashina, Agustin Melo Carrillo, Toluwanimi Ajayi, Edina Szabo, David Borsook, Rami Burstein

13 Neuro-oncology

Neuro-oncology: Neurologic Complications of Cancer

P12.13-001

Can Endoplasmic Reticulum Stress Responses Predict the Development of CIPN in Patients Receiving Paclitaxel-based Therapy? – Michael Edward Limia, Miriam M. Foneca, Oriana Gelblung, David I. Shalowitz, Michael Kelly, Fang-Chi Hsu, Cristina Furdui, Juan Cubillos-Ruiz, Edgar Alfonso Romero-Sandoval, Roy E. Strowd

P12.13-002

Diagnostic Factors associated with Meningeal Dissemination of Lymphoid Neoplasms – Giselle Socarras Castillo, Nathalia Gallego-López, Valentina Mejia-Quinones, Gabriel D. Pinilla Monsalve, Juan Pablo Fernandez

P12.13-003

Nivolumab-induced Central Nervous System (CNS) Vasculitis Brought on by a Steroid Taper – Nishika Karbhari, Brahyan Galindo Mendez, Nathaniel Michael Robbins

P12.13-004

Neurological Complications of Immune Checkpoint Inhibitors – Abida P. Babu, Esha Sharda, Avinash Simhachala Kolli, Karla Alejandra Mora-Rodriguez, Catherine Boldig, Tyra Gatewood, Tyra Gatewood, Jennifer Lynn Swank, Yolanda Pina, Edwin N. Peguero, Muhammad Hasanayn Jaffer, Sepideh Mokhtari, Neha Verma

P12.13-005

Delayed Onset ICANS Leading to Bilateral Cranial Neuropathies: Two Case Reports – Kelsey Beck, Shemonti Hasan, Shyamal Mehta, Cristina Valencia Sanchez

P12.13-006

Delayed malignant cerebellar posterior reversible encephalopathy syndrome secondary to (CLAG-M) and venetoclax regimen – Isha Snehal, Subin Mathew

Thursday, April 27 | 8:00 a.m.–9:00 a.m. ET

1

Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): Pediatric Epilepsy

P13.1-001

Diagnosing Infantile Epileptic Spasms: Can Smartphone Videos Replace EEG in Resourcelimited Settings? – Christine Shrock, Margaret Savage, Lauren Sham, Jacqueline French, Orrin Devinsky, Jo Wilmshurst, Archana Anil Patel

P13.1-002

A paradigm shift in the diagnosis of Hypsarrythmia and its prognostic value in children with epileptic spasms – Yumiko Okahashi, Dipali P. Nemade, Keionna Brown, Jun Tae Park

P13.1-003

Increased Perirolandic Cortical Excitability May Facilitate Sensory Motor Mapping in Children –Majed Alzahrany, Mirela V. Simon

P13.1-004

The Utilization of EEG Monitoring in Premature Infants with High-Grade Intraventricular Hemorrhage – Khaled Al Robaidi, Monisha Goyal, Kathryn Bowdoin Lalor, Vivek Shukla, Salman

Rashid

P13.1-005

EEG Findings in a Pediatric Patient with 3q29 Microdeletion Syndrome – Irfan Sahail Sheikh, Fabio Nascimento, Shelley R. Waite, Alice D. Lam

P13.1-006

Trends in COA Use and Regulatory Acceptance for Epileptic Encephalopathy and Developmental Epileptic Encephalopathy Indications – Christina Graham, Michael Chladek, Alise Nacson, Laurie Batchelder, Laura Gleeson, Ana Margarita Buenfil, Emily Kim, Oren Meyers, Betsy N. Williams

P13.1-007

Efficacy and Safety of Fenfluramine in LennoxGastaut Syndrome: A Systematic Review –Muhammad Qasim Qureshi, Rutaab Kareem, Zainab Mehdi, Aimen Nadeem, Zuha Majid, Umer Hassan, Bakhtawar Ahmad, Muhammad Aemaz Ur Rehman, Sadaf Iftikhar, Muhammad Abbas Khokhar

P13.1-008

A Case Series in the Use of Topiramate for Neonatal Seizures – Cynthia Zheng, Monica Hall, Adam Connell Kneepkens, Sonya Grace Wang

P13.1-009

Anti-epileptic Prophylaxis for Early or Late Posttraumatic Seizures in Children with Traumatic Brain Injury: A Systematic Review – Obada Ahmad Al Jayyousi, Ethar Hazaimeh, Ali Freitekh, Siya Sawan, Omar Fatehi Jbarah, Qais A. Samara

P13.1-010

Seizures in the Contralateral hemisphere in Rasmussen Encephalitis after Disconnective hemispherectomy – True or False lateralizing?

– Prashant Natteru, Majed Alzahrany, William Bingaman, Ahsan Moosa Naduvil Valappil

P13.1-011

Real-world Outcomes of Cannabidiol For The treatment of Refractory Epilepsy in Pediatric Patients – Ismail Mohammed Fahad, Kiley Cameron, Erin Dennis, Daniel Zhou, Geetanjali Singh Rathore

2Education, Research, and Methodology

Education, Research, and Methodology: Continuing Medical Education (CME) and Quality Improvement

P13.2-001

Teaching neurologists through microlearning: the first 4 years of the eLearning experience with NeuroBytes – Adam Quick, Alexandra M. Miller, James E. Siegler, Robert A. Rook, Michaela Morris, Zach Cramer, Xiaoyu Sun, Calli Leighann Cook, Behnam Sabayan, Jeff Kraakevik, Jeremy Moeller, Richard S. Isaacson, Zachary N. London, Roy E. Strowd

P13.2-002

Addressing Deficiencies in Knowledge and Skills Regarding the Management of Women with Multiple Sclerosis Throughout the Reproductive Years – Katie Robinson, Jennifer Frederick, Jenna Gentile, Robert Esgro, Emily Scully

P13.2-003

Continuing Medical Education Increases Knowledge, Competence, and Confidence Related to the Use of Non-Oral Acute Migraine Therapies Among Neurologists – Christine Considine, Thomas Finnegan, Kathy Merlo, Richard B. Lipton

P13.2-004

Curriculum-based CME-certified Migraine Programming Results in Comprehensive Improvements Across The Care Spectrum for Neurologists – Piyali Chatterjee, Thomas Finnegan, Kathy Merlo, Stewart J. Tepper

P13.2-005

Quality Improvement of Quality Improvement –Elizabeth Monohan, Sergio L. Angulo Castro, Shruthi Sree Sivakumar, Jonathan Perk, Susanna O’Kula, Susan W. Law

P13.2-006

A Quality Improvement Strategy to Improve Recognition and Identification of Atypical Stroke Presentations in the Pre-Hospital Setting – Cleo Zarina Alejo Reyes, Harry Zobel, Kathryn E. Ess

3 MS and Inflammatory Disease

MS Clinical Assessments and Outcome Measures

P13.3-001

Experimental Improvement of Attention / Cognitive Speed Does Not Improve Memory in Multiple Sclerosis – Emily Dvorak, Ilana B. Katz Sand, James F. Sumowski

P13.3-002

Cognitive and MRI Profiles in Primary and Secondary Progressive Multiple Sclerosis –Damiano Mistri, Laura Cacciaguerra, Paola Valsasina, Elisabetta Pagani, Paolo Preziosa, Maria Assunta Rocca, Massimo Filippi

P13.3-003

Integration of the Expanded Disability Status

Scale with ambulation, visual and cognitive tests improves disability assessment – Francesco Sacca, Antonio Carotenuto, Marcello Moccia, Roberta Lanzillo, Maria Petracca, Vincenzo Brescia Morra, Cinzia Valeria Russo

P13.3-004

Cognitive impairment in relapsing remitting multiple sclerosis patients: the role of white matter – Mahmoud Elkhooly, Fen Bao, Adam D. Lazar, Zena Azo, Amanda Reyes, Samiksha Srivastava, Emily Pelc, Chiara Casiglia, Jacob Rube, Muhammad Faraz Raghib, Carla E. SantiagoMartinez, Shireen Khan, Evanthia Bernitsas

P13.3-005

Declines in Work Productivity in Persons With Multiple Sclerosis by PDDS Score – Caroline K. Geiger, Nicole Gidaya Bonine, Vanessa Di Felice, Amber Salter

P13.3-006

Impact of Early-stage Relapsing Remitting Multiple Sclerosis on Quality of Life – Tamara CastilloTrivino, Rocío Gómez, Mónica Borges Guerra, Jesus Manuel Martin Martinez, Javier Sotoca Fernandez, Ana María Alonso Torres, Ana Belen Caminero Rodriguez, Laura Borrega Canelo, Jose Luis Sanchez Menoyo, Francisco Barrero-Hernandez, Carmen Calles, Luis Brieva Ruiz, Rosario Blasco Quilez, Julio Dotor Garcia-Soto, Maria Campo Amigo, Laura Navarro, Eduardo Aguera Morales, Moises Garces Redondo, Olga Carmona, Gabaldon Torres Laura, Lucía Forero, Mariona Hervas Pujol, Paloma López-Laiz, Jorge Maurino, Susana Sainz de la Maza

P13.3-007

Disability progression and worse cognitive status are associated with higher concurrent brain atrophy rates – Maria Alejandra Garcia-Dominguez, Christopher Hemond

P13.3-008

Slow information processing speed elucidates impairment in executive function tests in people with Multiple Sclerosis – Maria Sol Román, Lara Bardoneschi, Ariadna Gatti, Loana De Los Santos, Juan Manuel Iglesias Passada, Florencia Micaela Daniele, Maria Laura Saladino, Fernando J. Caceres, Sandra Vanotti

P13.3-009

EDSS and MS duration is associated with cognitive impairment in a large Argentinian cohort of patient with multiple sclerosis – Barbara Eizaguirre, Natalia Ciufia, Berenice Silva, Orlando Garcea, Ricardo Alonso, Aldana Marinangeli

P13.3-010

The MS-LINK Outcomes Study Cohort: Study design and a descriptive analysis of baseline key PROs, disease, and sociodemographic characteristics – Jeffrey B. English, Carlo S. Tornatore, Emily S. Riser, Gabriel Pardo, Leorah Aude Emmanuelle Freeman, Jacob Alexander Sloane, Elizabeth Piette, Christina Caon, Terrie Livingston

P13.3-011

Severity of Symptoms Among Persons With Multiple Sclerosis by PDDS Score – Nicole Gidaya Bonine, Caroline K. Geiger, Vanessa Di Felice, Amber Salter

P13.3-012

WITHDRAWN

P13.3-013

Impact of treatment over thickness of the retinal layers in patients with demyelinating diseases

– Enrique Gomez Figueroa, Roberto Rodriguez, Veronica Rivas, Teresita Corona Vazquez, Jose Jesus Flores-Rivera

P13.3-014

Characterizing the Contribution of White Matter on Ambulation in Relapsing Multiple Sclerosis

– Cristina Jageka, Fen Bao, Mahmoud Elkhooly, Muhammad Faraz Raghib, Emily Pelc, Adam D. Lazar, Zahid Latif, Carla E. Santiago-Martinez, Jacob Rube, Evanthia Bernitsas

P13.3-015

Cognitive-motor interaction: relationship with employment status in relapsing-remitting multiple sclerosis – Barbara Eizaguirre, Natalia Ciufia, Maria Sol Román, Berenice Silva, Orlando Garcea, Fernando J. Caceres, Ricardo Alonso, Sandra Vanotti

P13.3-016

In early MS, the vasopressin peptide copeptin in serum is not a suitable surrogate for hypothalamopituitary-adrenal axis activity – Maike Schlingmann, Muriel Stoppe, Klara Mayer, Christian Schinke, Sarah Haars, Elisa Schmidt, Florian Then Bergh

P13.3-017

Race and Social Determinants of Health in Performance Outcomes among Relapsing Remitting Multiple Sclerosis Patients – Justin Abbatemarco, Daniel Ontaneda, Mary R. Rensel, Devon Conway, Marisa P. McGinley, Robert A. Bermel, Scott Husak, David Bruckman, Jesse Schold, Deja Rose, Deborah M. Miller

P13.3-018

Sexual Behavior and Multiple Sclerosis – Matt Kennis, Elijah W Hale

4 General Neurology

General Neurology: Neuromuscular

P13.4-001

Michigan Neuropathy Screening Instrument: A tool for diabetic peripheral neuropathy diagnosis in a rural area in Ecuador – Daniella Alejandra Bustamante, Kiara N. Velez, Jorge Torres Ortiz

P13.4-002

Acute, Transient, Brain Lesions on Magnetic Resonance Imaging in X-linked Charcot-MarieTooth type 1 – Kholoud Yaser Altarazi, Yu-Ting Chen, Ram Mohan R. Sankaraneni

P13.4-003

Severe Porphyric Neuropathy: A Tale of Two Challenging Cases – Elizabeth Gilley, Ryan Chapman, Kelsey H. Carr, Lindsey Michael Ladd, Mary Alissa Willis

P13.4-004

Effect of complement C3 inhibition with pegcetacoplan in an iPSC-derived ALS neuromuscular junction model of neuroinflammation – Scott Baver, Virginia M. Smith, Yan Li, Sarah Kristine Skinner, Ashley Robertson, Leticia Lenkiu, Heather Dawn Cannon-Patron, Daisy Marie Martinez, Hannah Hanson, James J. Hickman, David Eyerman

P13.4-005

Immunosuppression Status Did Not Affect COVID-19 Incidence in a Retrospective Survey of Myasthenia Gravis Patients – Amanda Breaux, Aziz I. Shaibani, Thy Nguyen

P13.4-006

Role of the Pharmacist in Monitoring Patients

Receiving Oral Edaravone for Amyotropic Lateral Sclerosis – Christine Miller, Barbara Prosser, Timothy Walton

P13.4-007

Female Binge Drinkers may be at Higher Risk of Acute Alcoholic Neuropathy – Angelica Carolina Cornejo, Thy Nguyen

5 Autoimmune Neurology

Autoimmune Neurology: NMOSD / MOGAD / Optic Neuritis

P13.5-001

Temporal Relationship of Breast Cancer and Paraneoplastic Neuromyelitis Optica Spectrum Disorder (NMOSD) – Shravan Sivakumar, Bahadar Singh Srichawla, Seyedeh Nasim Cheraghi

P13.5-002

Long-term Safety of Satralizumab in Adults with Aquaporin-4-IgG-seropositive (AQP4-IgG+)

Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from SAkuraMoon – Brian G. Weinshenker, Michael R. Yeaman, Jerome De Seze, Francesco Patti, Ivana Vodopivec, Kathleen Blondeau, Gaelle Klingelschmitt, Carole Marcillat, Benjamin M. Greenberg

P13.5-003

Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study – Friedemann Paul, Romain Marignier, John William Lindsey, Ho Jin Kim, Dewei She, Daniel M. Cimbora, Kristina Rae Patterson, Bruce A. C. Cree

P13.5-004

Misdiagnosis of Multiple Sclerosis in Neuromyelitis

Optica: Results from multi-institutional database analysis from the United States – Ka-Ho Wong, Sama Noroozi Gilandehi, Trieste Francis, Alen Delic, Sarah Germaine, Melissa Ann Wright, Jonathan Ross Galli, Robert Kadish, M. Mateo Paz Soldan, Julia Klein, John E. Greenlee, John W. Rose, Tammy L. Smith, Stacey Clardy

P13.5-005

A Phase II, Randomized, Double-blind, ShamControlled Clinical Trial of Transcutaneous Electrical Nerve Stimulation (TENS) Therapy for the Treatment of Neuropathic Pain in Neuromyelitis

Optica Spectrum Disorders – Anastasia

Vishnevetsky, Gabriela Romanow, Michael Levy

P13.5-006

Metabolomics profiling implicates altered lipid metabolism in neuromyelitis optica spectrum disorder – Elina Misicka, Farren Briggs

P13.5-007

Patient Experience and Quality of Life in Mexican Patients with Neuromyelitis Optica Spectrum

Disorder: A Sub-analysis of an International Multicenter Cross-sectional Survey in Latin America – Guillermo Ruben Delgado-Garcia, Miguel Alexis Garcia Sarreon, Enrique Gomez Figueroa, Veronica Rivas, Jacinta Behne, Megan Behne, Michael R. Yeaman, Teresa V. Corona Vazquez

P13.5-008

Characterization of HLA Class II Alleles in Patients with Neuromyelitis Optica in Bogotá, Colombia –Jaime Toro, Jairo Alejandro Gaitan Alfonso, Habib Georges Moutran Barroso, Helena Groot, Juan Sebastian Rivera Perez, Thomas Medina, Daniela

Sofia Rodriguez, Laura Andrea Serna, David

Felipe Cuellar Giraldo, Carolina Restrepo, Mariana

Alexandra Torres, Cesar Franco Ruiz, Fabián Cortés, Daniel León Tramontini, Diana Narváez, Juliana

Lago, Luisa Maria Marquez, Saul Reyes

P13.5-009

Acute NMOSD Attack in the Setting of Pembrolizumab Therapy: A Case Report –Margaret Elizabeth Upchurch, Nicole Caunt, Jessica

McDermott, Jeffrey L. Bennett, Amanda Lee Piquet

P13.5-010

Satralizumab Treatment in Adult Patients With AQP4-IgG–Seropositive Neuromyelitis Optica

Spectrum Disorder: A Case Series – Hesham

Ahmed Abboud, Brian Steingo, Diana Vargas, Julie Patel, Nancy M. Nealon, Mary Alissa Willis, Yang

Mao-Draayer, Dmitry Khaitov, Jose Avila-Ornelas, Adnan Subei, Clifford A. Reed, Lisa Ferayorni, Xavier Laucirica, Shervin Gholizadeh

P13.5-011

Characterizing the Impact of NMOSD on Mobility, Daily Activities, and Social Activities Through Patient Interviews – Evanthia Bernitsas, Benjamin Joseph Osborne, Natalie Rene Taylor, Fanyang Zeng, Milena Anatchkova, Adrian Kielhorn

P13.5-012

Diseases associated antibodies anti-MOG and double seronegative NMOsd during the COVID-19 pandemic Interim analysis of a cohort study –Roberto Rodriguez, Leonardo Aguilar-Gonzalez, Veronica Rivas, Jose Jesus Flores-Rivera, Teresita Corona Vazquez

P13.5-013

A Case of Seronegative NMOSD-Related Myelitis

Masquerading as VZV-Related Myelitis – Qasem N. Alshaer, Julien Cavanagh, Eleni Antzoulatos

P13.5-014

Neuromyelitis Optica Spectrum Disorder

Mimicking Pontine Stroke - A Cautionary Tale: Case Report and Systematic Literature Review –Brendan Huang, Rohan Arora, Joseph A. Diamond, Spencer Churchill McFarlane, Souhel Najjar

P13.5-015

Inebilizumab Reduces Attack Risk Independent of Low Affinity IgG Fc Region Receptor III-A Gene Polymorphisms in Neuromyelitis Optica Spectrum Disorder – Brian G. Weinshenker, Jeffrey L. Bennett, Bruce A. C. Cree, Friedemann Paul, Ho Jin Kim, Hans-Peter Hartung, Kristina Rae Patterson, Michael Smith, William Rees, Dewei She, Orhan Aktas

P13.5-016

Association of Disease Characteristics with Utilization of Behavioral Medicine in Patients with NMOSD and MOGAD – Carol Swetlik, Devon Conway, Julie Widmar, Amy Kunchok, Grace Tworek, Amy B. Sullivan, Rachel Galioto, Albert Aboseif, Justin Abbatemarco

P13.5-017

Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges –Ilya Ayzenberg, Susanna Asseyer, Gero Lindenblatt, Katinka Fischer, Refik Pul, Sinem-Hilal Oezalp, Lisa Lohmann, Katrin Giglhuber, Vivien Haeussler, Michael Karenfort, Kerstin Hellwig, Friedemann Paul, Judith Bellmann-Strobl, Carolin Otto, Klemens Ruprecht, Tjalf Ziemssen, Alexander Emmer, Veit Rothhammer, Florian Nickel, Klemens Angstwurm, Ralf Linker, Clemens Warnke, Sven Oliver Jarius, Mirjam Korporal-Kuhnke, Brigitte Wildemann, Stephanie Wolff, Maria Seipelt, Yavor Yalachkov, Nele Retzlaff, Uwe Zettl, Paulus Stefan Rommer, Markus Kowarik, Jonathan Wickel, Christian Geis, Martin W. Hümmert, Corinna Trebst, Makbule Senel, Luisa Hildegard Klotz, Ralf Gold, Christoph Kleinschnitz, Sven G. Meuth, Orhan Aktas, Achim Berthele, Marius Ringelstein

P13.5-018

Comparison of visual acuity recovery in 3-,5-, and 7-day schedules of intravenous methylprednisolone in patients with optic neuritis: a case-control study – Fernando Cavalcanti de Falcão, Sara Terrim, Guilherme Diogo Silva, Samira Apostolos-Pereira, Dagoberto Callegaro

P13.5-019

Real-world application of the updated criteria of optic neuritis – Fernando Cavalcanti de Falcão, Sara Terrim, Guilherme Diogo Silva, Samira Apostolos-Pereira, Dagoberto Callegaro

P13.5-020

MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes – Soon-Tae Lee, Sung-Min Kim, Kon Chu, Sang Kun Lee, Woo-jin Lee

P13.5-021

Spinal Glioblastoma Mimicking Myelin

Oligodendrocyte Glycoprotein Antibody Disease

Transverse Myelitis – Ada Breitenbucher, Connor David Welsh, Michael Vincent Robers

P13.5-022

Clinical and Radiologic Features of a Cohort of Adult and Pediatric Patients in the Pacific Northwest with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) – Kayla Martin, Priya Srikanth, Dhanalakshmi Angappan, Anagha Srikanth, Anandraj Kanwar, Tatevik Mazmanyan, Julie Falardeau, David Pettersson, Vijayshree Yadav

P13.5-023

Comparing Lesion Distribution on Presentation of Pediatric and Adult Patients with MOG AntibodyAssociated Disease (MOGAD) – Ibrahim Ahmad, Ilya Kister

P13.5-024

FLAIR-hyperintense lesions in anti-MOGassociated Encephalitis with Seizures (FLAMES) mimicking new daily persistent headache Updating the diagnostic paradigm with recommendations for timely diagnosis and management – Nara Michaelson, Donald Joseph Langan, Ulrike Kaunzner

P13.5-025

Cognitive sequelae in MOG antibody-associated disease – Xiaoyang Li, Michael Basso, John J. Chen, Jan-Mendelt Tillema, Sean J. Pittock, Eoin P. Flanagan

P13.5-026

Placental transmission of MOG-IgG to neonate from mother with MOGAD – Vyanka Redenbaugh, John J. Chen, Jessica Ann Sagen, Sean J. Pittock, Eoin P. Flanagan

P13.5-027

Healthcare Utilization of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Patients – Kelsey Stefan, Ribal Najib Haddad, Derrick Robertson

P13.5-028

Timing and Predictors of T2-Lesion Resolution in MOGAD – Laura Cacciaguerra, Vyanka Redenbaugh, John J. Chen, Elia Sechi, Alfonso Sebastian Lopez, Jan-Mendelt Tillema, Massimo Filippi, Maria Assunta Rocca, Sean J. Pittock, Eoin

P. Flanagan

P13.5-029

Treatment Response Variation in Myelin Oligodendrocyte Glycoprotein AntibodyAssociated Disease presenting as Acute Disseminated Encephalomyelitis: Two Case Illustrations – Pankhuri Banerjee, Heitor Cabral Frade, Alexander Brown, Camila Narvaez Caicedo, Awab Kamal Mamoud Elnaeem, Sandeep Bhatt, Laura J. Wu, Anish Bhardwaj, Alok Dabi

P13.5-030

Prognostic Factors in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Single Center Experience – Murat Kurtuncu, Volkan Mert Abayli, Tuncay Gunduz, Mefkure Eraksoy

P13.5-031

Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) in conjunction with Allogeneic Bone Marrow Transplantation and Autoimmune Neutropenia: A study of two companion cases and institutional review of the MOGAD clinical phenotype spectrum – Esther H. Nie, Jamie C. McDonald, Jeffrey E. Dunn, May Han

P13.5-032

Systematic Review of Literature of MOG Antibody Positive Patients with Probable Diagnosis of MS –Ryane Adams, Rajesh K. Gupta

Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Non-Alzheimer’s Disease Dementias

P13.6-001

Memory Performance in Asymptomatic and Prodromal Familial Frontotemporal Lobar

Degeneration: Findings from the ALLFTD Consortium – Bradley F. Boeve, Julie A. Fields, Jeremy Syrjanen, Walter Kremers, Adam Staffaroni, Edward D. Huey, Katya Rascovsky, Eliana Marisa Ramos, Leah Kathleen Forsberg, Hilary Heuer, Adam L. Boxer, Howard J. Rosen

P13.6-002

EEG correlates in the three variants of Primary Progressive Aphasia – Giordano Cecchetti, Federica Agosta, Silvia Basaia, Camilla Cividini, Marco Cursi, Elisa Canu, Michela Leocadi, Roberto Santangelo, Francesca Caso, Giovanna Franca Fanelli, Fabio Minicucci, Giuseppe Magnani, Massimo Filippi

P13.6-003

FTD Disorders Registry (FTDDR) Research

Readiness Survey: Assessing awareness and attitudes to increase research participation –Sweatha Reddy, Sherry Harlass, Lakecia Vincent, Diana Wheaton

P13.6-004

Semantic Variant Primary Progressive Aphasia

Associated with the C9orf72 Hexanucleotide

Expansion – A Longitudinal Case Report – Aaron Ross Switzer, Julie A. Fields, Kejal Kantarci, Val John Lowe, Nick Corriveau-Lecavalier, David T. Jones, Hugo Botha, David S. Knopman, Vijay K. Ramanan, Ralitza H. Gavrilova, Maria Lapid, Leah Kathleen Forsberg, Kevin Michael Nelson, Tyler William Kolander, Bradley F. Boeve

P13.6-005

Cognitive correlates of ADL impairment in Lewy body dementia – Nidhi Desai, Huma Nawaz, Nitai Das Mukhopadhyay, Kathryn Wyman-Chick, Sarah Kathryn Lageman, Matthew J. Barrett

P13.6-006

Clinical Predictors of Survival in Probable

Dementia with Lewy Bodies – Stuart McCarter, Patrick Steven Brennan, Jeremiah Aakre, David S. Knopman, Neill R. Graff-Radford, Kejal Kantarci, Leah Kathleen Forsberg, Julie A. Fields, Gregory S. Day, Rodolfo Savica, Hugo Botha, David T. Jones, Vijay K. Ramanan, Christian Lachner, Ronald C. Petersen, Dennis W. Dickson, Ross Reichard, Bradley F. Boeve, Tanis J. Ferman, Jonathan GraffRadford

P13.6-007

Correlates of Fluctuations in Moderate-Advanced Dementia with Lewy Bodies – Tracy Tholanikunnel, Brian LaBarre, Kaitlin Sovich, Li Zhigang, James E. Galvin, Henry L. Paulson, Susan M. Maixner, Carol A. Manning, Julie A. Fields, Angela Lunde, Bradley F. Boeve, Leah Kathleen Forsberg, Angela Taylor, Melissa Armstrong

P13.6-008

Imaging regional histone deacetylase expression in dementia with Lewy bodies with [11C] Martinostat – Anna Goodheart, Chi-Hyeon Yoo, Robin Striar, Moqing Quan, Hsiao-Ying Monica Wey, Changning Wang, Stephen Neil Gomperts

P13.6-009

Characterizing a Language Phenotype of Dementia with Lewy Bodies: A Clinicopathological Series – Camille Merhi, Anna C. Sullivan, Vaidehi Bhavaraju, Jamie Walker, Kevin Frank Bieniek, M. Samy Abdullah, Arash Salardini, James F. Rini, Alicia S. Parker

7 Neuro Trauma and Critical Care

Neurocritical Care: Subarachnoid Hemorrhage Complications

P13.7-001

Reduced abundance of Akkermansia muciniphila in Delayed Cerebral Ischemia following Subarachnoid Hemorrhage – James Walker Wiggins, P Ganesh, Huimahn Alex Choi

P13.7-002

Fingolimod Reduces Cardiac Macrophage Infiltration after Experimental Subarachnoid Hemorrhage – Joseph Ryan Geraghty, Neil Saini, Fernando Testai

P13.7-003

A Machine Learning Tool to Predict Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage – Dhruv Patel, Maharshi Pandya, Sabrina Ashley Mann

P13.7-004

Refractory intracranial pressure elevation (ICP) treatment in acute aneurysmal subarachnoid hemorrhage via the novel neurapharesis CSF management system – Marc Alain Babi, Spiros Blackburn, Andrew Grande, Omar Choudri, Erick Hauck, Christopher Kellner

P13.7-005

Characterizing the Use of Intrathecal Nicardipine for Post Traumatic Cerebral Vasospasm – Erika Sigman, Katleen Chester, Jason Sciarretta, Jonathan Ratcliff, Ofer Sadan

P13.7-006

Decreased Timing to Vasospasm Prevention Medication Improves Outcomes Among Patients with Aneurysmal Subarachnoid Hemorrhage on Prehospital CCBs, ARBs, or ACE-inhibitors –Donald Frei, Stephanie Jarvis, Yasaman Pirahanchi, Lauren DiSalvo, Nicholas Wenz, David Bar-Or

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Peripheral Neuropathy 3

P13.8-001

Femoral Neuropathy: A Comprehensive Clinical and Electrodiagnostic Review – Ashley Santilli, Jennifer Marie Martinez-Thompson, Scott Speelziek, Ruple S. Laughlin

P13.8-002

A Case of Mononeuopathy Multiplex in the Setting of Durvalumab Therapy – Abby Scurfield, Amanda Kelly, Ninad Desai, Sandhya Dhanjal

P13.8-003

Bilateral Sequential Brachial Plexus Neuritis Following Immune Checkpoint Inhibitor Combination Treatment – Osman Ozel, Merry Chen, Karin Woodman

P13.8-004

Skin Denervation Occurrence in Patients with Small Fiber Neuropathy Associated Symptoms Following Covid19 Vaccination and Infection –Mailam Eltity, Daniela Noa Zohar, Amir Dori

P13.8-005

Neuromuscular respiratory dysfunction due to vitamin B12 deficiency: a case report – Ahmed Ibrahim, Jenny Meyer

P13.8-006

Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy after Ad26 COV2 S COVID-19 Vaccination – Ventaka Bendi, Yu-Ting Chen, Laura Danielson

P13.8-007

POEMS syndrome associated with vitiligo – Avi Landman, Freddy Escobar-Montealegre, Rupin Singh, Jorge Luis Morales, Fabian H. Rossi

P13.8-008

Severe Tibial Neuropathy and Myonecrosis After Prolonged Surgery in Lithotomy Position – Osman Ozel, Sebnem Nash, Karin Woodman

P13.8-009

A Case of Acute Motor Sensory Axonal Neuropathy, a Rare Form of Guillain-Barre Syndrome, Developing After Multiple COVID-19 Infections – Camila Narvaez Caicedo, Abhijit Rao, Chilvana V. Patel, Laura J. Wu

P13.8-010

FOSMN Syndrome Presenting with Bulbar Onset Preceding Trigeminal Sensory Loss – Adam Uppendahl, Christina Tan, Ron Josef Danziger, Richard A. Lewis

P13.8-011

Atypical presentation of Miller Fisher Syndrome –Milena Lobaina, Xianping Li, Elena Shanina

P13.8-012

Severe painful neuropathy as the presenting feature of POEMS syndrome – Rodrigo Queiroz, Thiago Pinheiro, Lya Moore Marques, Tairine Luiza Esteves Silva, Caroline Bittar Braune

P13.8-013

Microscopic Polyangiitis Mimicking Chronic Inflammatory Demyelinating Polyneuropathy – Eric Stulberg, Michael Stagg Chamberlain, Yoji Hoshina, Piotr Tekiela, Kyle Mahoney

P13.8-014

When To Use CSI (Combined Senory Index) in Electro-diagnostic Testing for Carpal Tunnel Syndrome (CTS) – Joseph Francis Imbs, Amna Ramzan, David French, Solomon Neba Ambe, Thy Nguyen

P13.8-015

Characteristics of a single-center cohort of patients with hereditary transthyretin amyloidosis

– Nicolas Sarmiento Bustamante, Taha Qarni, Felipe Simoes Jones, Sami L. Khella, Brian Drachman, Janice Pieretti, Chafic Y. Karam

9 Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Cerebral Palsy/Autism Spectrum Disorder/Neurodevelopmental Disorders

P13.9-001

Clinical Implications of Genetic Testing in Adults with Neurodevelopmental Disabilities (NDD)

– Kaitlin Christine Smith, Moriah Mabry, Sharon Scarbro, Jessica Sanders

P13.9-002

High Sensitivity for Monogenic Causal

Diagnoses in Autism, Including De Novo Variants Representing Novel Disorders, with Trio Whole Genome Sequencing and Data Reanalysis in a Non-Academic Center – Omri Bar, Laurie Ebenau, Mark Mintz, Richard Gregory Boles

P13.9-003

Whole Genome Sequencing to Resolve the Genomic Architecture of Cerebral Palsy in a Canadian Cohort – Maryam Oskoui, Mehdi Zarrei, Worrawat Engchuan, Neal Sondheimer, Bhooma Thiruv, Edward Higginbotham, Ritesh Thapa, Tarannum Behlim, Sabrina Aimola, John Wei, Prakroothi Surendra Danthi, Giovanna Pellecchia, Karen Ho, Jill De Rijke, Jennifer L. Howe, Thomas Nalpathamkalam, Roozbeh Manshaei, Joe Andrew Whitney, Rohan Vikram Patel, Omar Hamdan, Rulan Shaath, Shannon Knights, Brett Trost, Dawa Samdup, Anna McCormick, Carolyn Pasifull Hunt, Adam Kirton, Anne Kawamura, Ronit Mesterman, Jan Wllem Willem Gorter, Nomazulu Dlamini, Daniele Merico, Ryan Yuen, Michael I. Shevell, James Stavropoulos, Richard Wintle, Darcy L. Fehlings, Stephen W. Scherer

P13.9-004

Elevated Healthcare Resources Utilization and Costs among Individuals Diagnosed with Rett syndrome – Tigwa Davis, Purva Parab, Damian Michael May, Charles Ruetsch

P13.9-005

Trofinetide for the treatment of Rett syndrome: an open-label study in girls 2 to 4 years of age –Alan K. Percy, Robin Ryther, Eric D. Marsh, Timothy Feyma, David N. Lieberman, Jeffrey Neul, Timothy A. Benke, Daniel Glaze, Elizabeth M. Berry-Kravis, Amitha Ananth, Colleen Marie Buhrfiend, Srdjan Stankovic, Kathie M. Bishop, Mona Darwish, James Maurice Youakim

P13.9-006

Treatment with trofinetide shows benefit compared to placebo for the ability to communicate in individuals with Rett syndrome: a secondary analysis of the LAVENDER study

– Jeffrey Neul, Alan K. Percy, Timothy A. Benke, Elizabeth M. Berry-Kravis, Daniel Glaze, Sarika Peters, Eric D. Marsh, Di Di An, Kathie M. Bishop, James Maurice Youakim

P13.9-007

Evaluation of Clinical Findings and Molecular Genetic Results of the Patients with CACNA1A Variants: Single Center Experience – Sinem Seleme Ovunc, Aysel Kalayci Yigin, Serhat Guler, Cisem Cinar, Deniz Agirbaslo, Mehmet Seven

P13.9-008

Autistic Burnout: A Report of Treatment Success –Elijah W Hale, Jessica Sanders

P13.9-009

Hereditary Spastic Paraparesis presenting as a Cerebral Palsy Mimic via Telemedicine – Dylan Franco Del Papa, Ramon Flores-Gonzalez, Jason H. Margolesky

P13.9-010

A Qualitative Analysis of Transition from Pediatric to Adult Care for Patients with Autism and Intellectual Disabilities – Sydney Carter, Jalon Chambers

P13.9-011

Human Cerebellar Expression of Autism Associated Genes – Seema Balasubramaniam, Peter Tsai, Vikram Jakkamsetti

P13.9-012

Utilizing an EMR Tool to Demonstrate Increased Feasibility of Autism Diagnosis – Douglas Aaron Wells, Mikael Guzman Karlsson, Christina Massrey, Meagan Newell, Steven M. Lazar, Kristen Fisher

Infectious Disease

Infectious Disease: HIV and PML

P13.10-001

Vascular Age and Cognitive Outcomes in an Acute HIV Cohort After Six Years of ART – Kathryn Holroyd, Carlo Sacdalan, Suteeraporn Pinyakorn, Varaporn Unsombut, Somchai Sriplienchan, Robert H. Paul, Nittaya Phanuphak, Denise Hsu, Sandhya Vasan, Serena Spudich, Phillip Chan

P13.10-002

Neurosyphilis with Atypical CNS Lesions in HIV Patient Show Marked Response to Penicillin –Ilana Green, Allison P. Navis, Katie Ann Dunleavy, Oscar Klein, Alan Jeffrey Cohen

P13.10-003

Neuroimaging Features and Outcomes of Progressive Multifocal Leukoencephalopathy (PML): A Single-Center Experience – Hongxuyang Yu, Kanika Sharma, Subapriya R, Shitiz K. Sriwastava

P13.10-004

Progressive Multifocal Leukoencephalopathy

Secondary to Possible Covert Administration of Osimertinib, a Case Report . – Brook Centofanti, Mohammad Alkhoujah, Mirjon Bishja

P13.10-005

Fatal Isolated Brainstem Lesion in a Patient With Progressive Multifocal Leukoencephalopathy –Jordan Gregory Gates, Maria Elisa Samaniego

11 Movement Disorders

Movement Disorders: Miscellaneous

Movement Disorders 1

P13.11-001

Deep Brain Stimulation in Woodhouse Sakati Syndrome: A Single Institution Retrospect Analysis

– Yara O. Alkhodair, Hend Al Hodaif, Faisal Alotaibi, Amaal AlDakheel

P13.11-002

Enabling Opioid Dose Reduction for Refractory Restless Legs Syndrome through Adjunctive Tonic Motor Activation (TOMAC) Therapy – Mark Buchfuhrer, Stephanye Argentina Rodriguez, Jonathan Charlesworth

P13.11-003

Movement Disorders Associated with Cerebral Artery Stenosis: A Nationwide Study – Sun Ju Chung, Nari Choi, Eungseok Oh, Ho-Sung Ryu, Sooyeoun You, Bum Joon Kim, Seung Hyun Lee, Kye Won Park

P13.11-004

Use of Liver Transplantation for Pure Neurologic Indications in Wilson Disease – Sarah Marmol, Matthew Feldman, Jennifer Hislop, Danielle Spengler Shpiner, Jason H. Margolesky

P13.11-005

The Clinical And Molecular Spectrum Of ZFYVE26Associated Hereditary Spastic Paraplegia (SPG15)

– Afshin Saffari, Catherine Jordan, Alisa Mo, Bo Zhang, Mustafa Sahin, Craig D. Blackstone, Edward Yang, Darius Ebrahimi-Fakhari

P13.11-006

Late-onset POLR3-related Leukodystrophy: report of a novel compound heterozygous mutation in the POLR3A gene and review of the phenotype –Laura Andrea Pesantez Pacheco, Mark Hallett

P13.11-007

Caspr2 Antibody-Mediated Ataxia, Parkinsonism, and Epilepsy: A Case for Escalating Immunotherapy – Dana Alyse Sugar, Natalie P. Witek

P13.11-008

Predictors of good and bad outcomes of hematopoietic stem cell transplantation in CSF1R-related leukoencephalopathy – Zbigniew K. Wszolek, Michael Heckman, Launia White, Jaroslaw Dulski

P13.11-009

Radiological Profile of Patients with Wilson’s Disease Attending Tertiary Care Neurology Centre – Aminu Aliyar, Divya M. Radhakrishnan, Ajay Garg, Achal K. Srivastava, Roopa Rajan, Awadh K. Pandit, Animesh Das, Ayush Agarwal

11 Movement Disorders

Movement Disorders: Non-surgical Therapeutics in Parkinson’s Disease 1

P13.11-010

Anti-neuroinflammation effect of zonisamide in early Parkinson’s disease: A chronological PET study – Takashi Matsudaira, Tatsuhiro Terada, Tomoyasu Bunai, Takanori Hashizume, Masamichi Yokokura, Hirotsugu Takashima, Takashi Konishi, Tomokazu Obi, Yasuomi Ouchi

P13.11-011

Initiating dopamine agonists rather than levodopa in early Parkinson’s disease does not delay the need for DBS – Diana Angelika Olszewska, Alfonso Fasano, Renato Puppi Munhoz, Carolina Ramírez Gómez, Anthony E. Lang

P13.11-012

Subgroup Analyses of Effect of Treatment With Levodopa Inhalation Powder (CVT-301) 84mg by Severity of OFF Symptoms in People with Parkinson’s Disease, as Assessed by the Unified Parkinson’s Disease Rating Scale Part III (UPDRSIII) – Ron Cohen, Ping Zhao, Richard Marini, Burkhard Blank, Donald Grosset

P13.11-013

WITHDRAWN

P13.11-014

Intrajejunal Levodopa Infusion for Parkinson’s Disease over 11 years: A Canadian Experience –Chetan Chandrakant Vekhande, Moath Hamed, Genise Ane Tremain, Jennie W. Mah, Aakash Shantharam Shetty, Oksana Suchowersky

P13.11-015

Impact of Istradefylline on Levodopa Dose Escalation in Parkinson’s Disease: Results of the ISTRA ADJUST PD Randomized, Controlled Study – Taku Hatano, Osamu Kano, Renpei Sengoku, Naotake Yanagisawa, Hiroshi Nagayama

P13.11-016

Use of Real-World Data to Evaluate the Importance of Antiemetic Pretreatment for Apomorphine hydrochloride [APO, Apokyn®] subcutaneous

Injection Initiation and Maintenance in People with Parkinson Disease – Cindy Marie Happel, Mindy Grall, Andrea Formella

12 Headache

Headache: Therapeutics 1

P13.12-001

Efficacy of AXS-07 (MOSEIC™ Meloxicam and Rizatriptan) in Patients with Risk Factors for Inadequate Response to Acute Migraine Medications – Stewart J. Tepper, Amanda Jones, Angad Chhabra, Shawn Alter, Zachariah Thomas, Herriot Tabuteau

P13.12-002

Safety and Efficacy of Concomitant Erenumab and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients – Zubair Ahmed, Robert Vann, Christopher J. Fitzpatrick, Sutapa Ray, Stephen Bevan Shrewsbury, Sheena K. Aurora

P13.12-003

Interim Analysis of Subject Impression Data for STS101 From the Phase 3 Open-Label ASCEND Study – Jessica Ailani, Larry Charleston, Detlef Albrecht

P13.12-004

Interim Analysis of Long-Term Safety and Tolerability Data of STS101 From the Phase 3 Open-Label ASCEND Study – Stewart J. Tepper, Amaal J. Starling, Detlef Albrecht

P13.12-005

Consistency of Response to Liquid Celecoxib in Adults With Migraine: Post Hoc Analysis of Results From Two Randomized, Placebo-Controlled Studies – Daniel Serrano, Stewart J. Tepper, Mancia M. Ko, Todd Kunkel, Richard B. Lipton

P13.12-006

Interim Analysis of STS101 Nasal Safety Data From the Phase 3 Open-Label ASCEND Migraine Study – Egilius L H Spierings, Detlef Albrecht, Alan M. Rapoport

12 Headache

Headache: Towards Precision Medicine 3

P13.12-007

Real-World Effectiveness of Fremanezumab in Patients with Migraine who Switched From Another mAb Targeting the CGRP Pathway (Subgroup Analysis From FINESSE) – Andreas Straube, Gregor Broessner, Charly Gaul, Xenia Hamann, Joachim Hipp, Torsten Kraya, Isabel Schauerte, Lars Neeb

P13.12-009

Lack of “wearing off” effect with eptinezumab in the preventive treatment of migraine – Roger Cady, Meghana Karnik-Henry, Divya Asher, Seema Soni-Brahmbhatt, David W. Dodick

P13.12-010

Fremanezumab for Migraine Prevention: Interim Analysis of the Non-Interventional FINESSE Study

– Andreas Straube, Gregor Broessner, Charly Gaul, Xenia Hamann, Torsten Kraya, Isabel Schauerte, Lars Neeb

P13.12-011

Effect of Eptinezumab on Utility Scores in Patients with Migraine: Results from the DELIVER Study –Linus Jonsson, Stephane Regnier, Steven Kymes, Brian Talon, Susanne Awad, Xin Ying Lee, Peter Goadsby

P13.12-012

Impact of eptinezumab on work productivity beyond reductions in monthly migraine days: Post hoc analysis of the DELIVER trial – Piero Barbanti, Susanne Awad, Stephane Regnier, Xin Ying Lee, Peter Goadsby

Neuro-oncology

Neuro-oncology: Prognosis and Survival in Brain Tumors

P13.13-001

GESTALT (GammaTile Enhanced Stupp Alternative): Feasibility Study of Resection and GammaTile®

Followed by Concomitant External Beam Radiation Therapy (EBRT)/Temozolomide (TMZ) and Adjuvant

TMZ in Newly Diagnosed Glioblastoma (GBM) –Erin M. Dunbar, David Jason McCracken, Adam Wayne Nowlan, Kathryn Dusenbery, Clara Ferreira, Kenneth Stuart Lee, Matthew Peach, Robert Allan Corns, Clark Chen

P13.13-002

Prognostic Markers in Glioblastoma Patients

Treated with Temozolomide – Nadia McMillan, Shuodan Zhang, Matthew McGuinness, Stephen Forrest Trudeau, Erik Uhlmann

P13.13-003

Molecular markers impacting survival in patients receiving concurrent chemoradiation and Tumor-Treating Fields (TTF) in patients with newly diagnosed glioblastoma: secondary analysis of SPARE trial – Allison Nancy Kayne, Spencer Poiset, Ayesha Ali, Ryan Miller, Muneeb Niazi, Louis Cappelli, Iyad Alnahhas, Wenyin Shi

P13.13-004

Survival and Clinical Characteristics of Patients with Glioblastoma with Primitive Neuronal Component – Tresa McGranahan, Patrick J. Cimino, Katelyn Costanza

P13.13-005

Investigating the Effects of Tumor Treating Fields and Genetic Mutations in Patients With Glioblastoma – Andy Yu-Der Wang, Knarik Arkun

P13.13-006

Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis – Almira Doreen Abigail Apor, Julette F. Batara, Christianne Mojica, Mark Willy Mondia

1 Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 2

P14.1-001

Treatment Outcomes During Brivaracetam Treatment by Seizure Freedom Status at Baseline: Post hoc Analysis of a Real-world, US Study – Hina N. Dave, Jacqueline French, Heidi L. Henninger, Hamada Hamid Altalib, Roger J. Porter, Michael Gelfand, Melinda S. Martin, Prashant Dongre, Sami Elmoufti, Anne-Liv Schulz, Svetlana Dimova, Michael R. Sperling

P14.1-002

Cognitive debrief of the Clinical Global Impression of Improvement for Nonseizure Symptoms measure in Dravet syndrome (DS) and Lennox–Gastaut syndrome (LGS): The Caregiver Perspective – Drishti Shah, Jeffrey Scott Andrews, Alise Nacson, Tara Symonds, Sophie Bethany Hughes, Arturo I. Benitez, Lara Sams

P14.1-003

Efficacy, Safety, and Tolerability of Adjunctive Eslicarbazepine Acetate in Focal Seizure Patients With Focal to Bilateral Tonic-Clonic Seizures at Baseline – Steve S. Chung, Samy M. Guirguis, David Cantu, Joana Moreira, Luis Magalhaes, Diane Hall, Ian Zhang, Todd Grinnell

P14.1-004

Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) for Seizures Associated With Tuberous Sclerosis Complex (TSC): 3-Year Results

From GWPCARE6 Open-Label Extension (OLE) –Elizabeth Thiele, E Martina Bebin, Francis M. Filloux, Floor Jansen, Patrick Kwan, Rachel Loftus, Farhad Sahebkar-Moghaddam, Steven Paul Sparagana, John Lawson, James W. Wheless

P14.1-005

Predictors of Sustainability of Response With Cenobamate: Post-hoc Subset Analysis of a Phase 3, Open-Label, Study – Sean Stern, Robert T. Wechsler, Wesley Kerr, Clarence Wade, David G. Vossler, William E. Rosenfeld

P14.1-006

Seizure Outcomes With Cannabidiol (CBD) in Pediatric Versus Adult Patients With LennoxGastaut Syndrome (LGS) and Dravet Syndrome (DS): Subgroup Analysis of BECOME, a Caregiver Survey – Timothy B. Saurer, Anne T. Berg, Tracy Dixon-Salazar, Mary Anne Meskis, Sherry Danese, Ngoc Minh Dang Le, M. Scott Perry

P14.1-007

Cognitive and Behavioral Effects of Adjunctive Brivaracetam in Children and Adolescents with Focal Seizures: Final Data From an Open-label Follow-up Trial – Jan-Peer Elshoff, Sofia Grigory Fleyshman, Christine M De la Loge, Najla Dickson, Christoph Reichel, Florin Floricel, Patricia Maria Smeyers

P14.1-008

Nonseizure Outcomes With Cannabidiol (CBD) in Pediatric Versus Adult Patients With LennoxGastaut Syndrome (LGS) and Dravet Syndrome (DS): Subgroup Analysis of BECOME, a Caregiver Survey – Tracy Dixon-Salazar, Anne T. Berg, Mary Anne Meskis, Sherry Danese, Timothy B. Saurer, Ngoc Minh Dang Le, M. Scott Perry 1

Epilepsy/Clinical Neurophysiology (EEG)

Epilepsy/Clinical Neurophysiology (EEG): Women with Epilepsy 2

P14.1-010

Pregnancy and Breastfeeding: A Survey of People with Epilepsy about their Experiences and Attitudes – Laura Anne Kirkpatrick, Elizabeth Gerard, Paula Emanuela Voinescu, Denise Li, Erica Kemp, Page B. Pennell

P14.1-011

Seizure Control in Women with Epilepsy

Undergoing Assisted Reproductive Technology –Aisha Abdulrazaq, Alessandra Ainsworth, Jeffrey W. Britton, Chandra Shenoy, Samir Babayev, Gregory D. Cascino, Kelsey Marie Smith

2

Education, Research, and Methodology

Education, Research, and Methodology: Education for Epilepsy and Related Disorders

P14.2-001

SAFE-TE: Staff Awareness and Familiarity with Epilepsy through Technology and Education –Johnny Chen, Neishay Ayub

P14.2-002

Implementation and Assessment of A Pilot Workshop on Inpatient First Time Seizure History Taking and Counseling – Erafat Rehim, Harry Zobel, Zehra Husain

P14.2-003

Online CME-Certified Expert Panel Discussion Improves Awareness Among Neurologists Regarding Seizure Freedom in Patients with Epilepsy – Thomas Finnegan, Jovana Lubarda, Steve S. Chung

P14.2-004

Creating a Sustainable Model for Epilepsy Transition with Objective Outcome Measurements – Elizabeth Baylee Edwards, Kathryn Bowdoin Lalor, Quynh Vo

P14.2-005

A New Era in the Management of Rett Syndrome: Are Neurologists Ready for a Changing Management Landscape?– Colleen Compton, Carole Drexel, David N. Lieberman, Paige Nues

3 MS and Inflammatory Disease

MS Clinical Practice

P14.3-001

Patient Characteristics and Persistence Among Commercially Insured Patients With Multiple Sclerosis Initiating Cladribine Tablets – Chris M. Kozma, Emily L. Evans, Lori Lebson, Amy L. Phillips, Carroline Lobo

P14.3-002

Unilateral ‘Ophthalmic nerve pattern’ of sensory loss from a demyelinating lesion in lateral cervical cord: a lesson in neuroanatomy – Mirza Omari, Rajan Jain, Ilya Kister

P14.3-003

Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review – Fardin Nabizadeh

P14.3-004

Delayed Onset Cryptogenic Organizing Pneumonia in Alemtuzumab Treatment Patient – Yao Cheng, Nicholas Lannen

P14.3-005

Tolosa Hunt Syndrome, A Variant of Neuroinflammation: A Case Report – Jonathon Chon Teng Chio, Marc Gebara, Sorleen Trevino, Elizabeth Crabtree-Hartman

P14.3-006

Respiratory impairment in multiple sclerosis: A Single-Center Study in 371 People with MS – Ivan Murrieta-Alvarez, Carlos Alberto Perez, Andres Aurelio Leon Pena, José María Benítez Salazar, I Would Like a Quota Manuel Gallardo Pérez, Juan Carlos Olivares-Gazca, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Arguelles

P14.3-007

Balo’s Concentric Sclerosis presenting as Sensorineural Hearing Loss – Anvita Potluri, Maria Elisa Samaniego, Nicholas Lannen

P14.3-008

Real-world effectiveness of switching treatment after initial platform injectable disease-modifying therapies in pediatric multiple sclerosis in the US –Aaron Wachtenheim Abrams, Michael Waltz, Theron Charles Casper, Gregory S. Aaen, Leslie A. Benson, Leigh Elkins Charvet, Tanuja Chitnis, Carla Marina Francisco, Mark Gorman, Manu S. Goyal, Jennifer Graves, Lauren B. Krupp, Timothy E. Lotze, Soe Soe Mar, Mary R. Rensel, Moses Rodriguez, John W. Rose, Alice Rutatangwa, Teri Schreiner, Nikita Shukla, Jan-Mendelt Tillema, Bianca WeinstockGuttman, Yolanda Wheeler, Emmanuelle Waubant, Kristen M. Krysko

P14.3-009

Cost, efficacy and safety comparison between early intensive and escalating strategies for multiple sclerosis: a Systematic Review and Meta-analysis – Leonardo Zumerkorn Pipek, Joao Vitor Mahler Ferreira Oliveira, Rafaela Farias Vidigal Nascimento, Samira Apostolos-Pereira, Guilherme Diogo Silva, Dagoberto Callegaro

P14.3-010

Extended Interval Dosing of Ocrelizumab in Patients with Multiple Sclerosis Is Not Associated with Meaningful Differences in Disease Activity –Nicole Bou Rjeily, Kathryn Fitzgerald, Ellen M. Mowry

P14.3-011

Natalizumab Extended Interval Dosing (EID) is Associated with a Reduced Risk of Progressive Multifocal Leukoencephalopathy (PML) Compared with Every-4-Week (Q4W) Dosing: Updated Analysis of the TOUCH® Prescribing Program Database – Lana Zhovtis Ryerson, John F. Foley, Ilya Kister, Gary Raymond Cutter, Ryan Metzger, Judith Goldberg, Xiaochun Li, Evan Riddle, Karen Smirnakis, Liesel DSilva, Susie Sinks, Nolan Campbell, Tyler Lasky, Karthik Bodhinathan

P14.3-012

A Real-life study of Alemtuzumab in patients with Multiple Sclerosis: Kuwait’s Experience – Raed Alroughani, Malak AlMojel, Jasem Yousef Al-Hashel, Samar Farouk Ahmed

P14.3-013

Approach to Balancing Risk in Multiple Sclerosis

Management: a Worldwide Practice Survey –Jodie Roberts, Aravind Ganesh, Luca Bartolini, Tomas Kalincik

P14.3-014

Experience at a tertiary level-of-care center in the Use of Rituximab for Patients Diagnosed with Primary Progressive Multiple Sclerosis – Roberto Rodriguez, Montserrat Masso Paez, Jose Jesus Flores-Rivera, Teresita Corona Vazquez, Veronica Rivas

P14.3-015

Autologous hematopoietic stem cell transplantation in multiple sclerosis: A 20-year single center’s experience in Mexico . – Mario Enrique Rodriguez Estrada, Luis Enrique Molina Carrion

P14.3-016

The Role of C3 and C4 Complement Levels in the Differential Diagnosis of Central Nervous System

Demyelinating Diseases – Melike Cakan, Bariscan Cimen, Nazire Pinar Acar Ozen, Rana Karabudak, Asli Tuncer

P14.3-017

Ixekizumab-associated transverse myelopathy in a patient with psoriatic arthritis – Mattia Rosso, Nicholas Milano, Ezequiel Gleichgerrcht

P14.3-018

Remote Monitoring of Neurological Patients –Marc Fischer

4 General Neurology

General Neurology: COVID-related Neurologic Symptoms

P14.4-001

GFAP astrocytopathy presenting after COVID-19 infection with meningoencephalomyelitis and good recovery with immunotherapy – Kun-Wei Song, Landon Oetjen, George Kyle Harrold, Jorg Dietrich, Kien-Ninh Ina Ly, Nagagopal Venna

P14.4-002

Association between Diabetic Control (HbA1C) and the Risk of Developing Neurological Post-Acute Sequelae of COVID-19 (PASC) – Muhammed Ors, Anam Khalid Shaikh, Mustafa Jaffry, Kranthi Kiran Mandava, Kazim Jaffry, Ronak Trivedi, Iqra Faiz, Firas Gerges, Michel Boufadel, Nizar Souayah

P14.4-003

Fatigue, Somnolence and Depression Persist After Six Month In Recovered Individual After The Acute Covid-19 – Rafael Joao, Lucas Scárdua Silva, Alex De Castro Carvalho, Italo Karmann Aventurato, Beatriz Costa, Mariana Rabelo De Brito, Mateus Nogueira, Marina Koutsodontis Alvim, Fernando Cendes, Clarissa L. Yasuda

P14.4-004

Fulminant Idiopathic Intracranial Hypertension

Refractory to Treatment Associated to SARSCoV-2: A Case Report – Ricardo Murguia Fuentes, Jose Murguia Fuentes, Abdullahi Musa Adamu, Alexander Carvajal- Gonzalez, Muhammed Ikbal Arvas

P14.4-005

Long Covid Infection and Peripheral Neuropathy –Initial Presentation of Eosinophilic Granulomatous Polyangiitis (EGPA) – Kereisha Nicole Donegal, Nuri Jacoby, Simona Treidler

P14.4-006

Vaccine-induced immune thrombotic thrombocytopenia: an emerging disease during the COVID-19 pandemic – Raimundo Marcial de Brito Neto, Naiade Couto, Gabriel Da Silva Avellar, Raimundo Marcial de Brito Neto, Jonadab Dos Santos Silva

P14.4-007

Mild Encephalopathy with Reversible Splenium Lesion Associated with SARS-CoV-2 Infection –Atef Kokash, Cleo Zarina Alejo Reyes, Hussam A. Yacoub

5 Cerebrovascular Disease and Interventional Neurology

Cerebrovascular Disease and Interventional Neurology: Clinical Science 2

P14.5-001

A Nationwide Analysis of Ischemic Stroke Outcomes in Patients with COVID-19 – Aayushi

Garg

P14.5-002

Stroke Metrics During Covid-19: a Comprehensive Stroke Center Experience – Lara Carvalho de Oliveira, Ana Ponciano, Suzete Nascimento Farias Da Guarda, Nima Kashani, Aravind Ganesh, Ashby Turner

P14.5-003

Compare complications during hospitalization between patients with and without dysphagia following acute stroke – Sandra Badial, Ildefonso Rodriguez-Leyva, Juan Francisco Hernandez-Sierra

P14.5-004

Outcomes of Multiple Sclerosis Patients following Admission for Acute Ischemic Stroke in the United States – Sailaja Sanikommu, Shaheen Sombans, Kamleshun Ramphul, Renuka Verma, Yogeshwaree Ramphul, Petras Jairam Das Lohana, Indu Meena, Komal Kumari, Stephanie Gonzalez Mejias, Nomesh Kumar, Fnu Arti

P14.5-005

Clinical Profile and Outcomes of Chronic Kidney Disease Patients with Intracerebral Hemorrhage in a Specialized Kidney Center in the Philippines – A Retrospective Study – Judy Opao, Miguela Marie Alicante Senga, Judy Opao

P14.5-006

Long Term Follow Up of Patients with Stroke after SARS-CoV-2 infection and Incidence of Neurological Post-Acute Sequelae of COVID-19 –Anam Khalid Shaikh, Mustafa Jaffry, Ronak Trivedi, Kranthi Kiran Mandava, Kazim Jaffry, Muhammed Ors, Iqra Faiz, Firas Gerges, Michel Boufadel, Nizar Souayah

P14.5-007

Does Elevated Inflammatory Markers Predict Functional Outcomes in Hospitalized Patients with COVID-19 and Acute stroke? – Omar Elsekaily, Junaid Ansari, Mohammad Abdurrehman Sheikh, Muhammad Ayub, Rachel Elizabeth Triay, Alexis Angelette, Alexandra Gaudet, Roger E. Kelley

P14.5-008

Feasibility of the mobile app Destroke for clinical stroke monitoring based on the NIH Stroke Scale – Evan Noch, Dan Pham, Tomoko Kitago, Marissa Wuennemann, Susan Wortman-Jutt, Cristina Falo

P14.5-009

Stroke Patient Characteristics Associated with 30-day Hospital Readmissions: A Retrospective, Intra-hospital network Study – Kevin Spiegler, Hannah Irvine, Jose L. Torres, Myrna Cardiel, Ariane Lewis, Koto Ishida, Kara R. Melmed

P14.5-010

Rapid Development of High-Grade Dural Arteriovenous Fistula During Pregnancy: A Case Report – Nazanin Sheibani, Barbara Voetsch, Emanuele Orru, David P. Lerner, Collin Culbertson

P14.5-011

Asymptomatic Moyamoya Disease: An experience from Eastern India – Shambaditya Das, Souvik Dubey, Biman Kanti Ray

P14.5-012

No Association Between Outcomes And AntiFactor Xa Levels For Heparin Monitoring In Patients With Cerebral Venous Thrombosis –Yasaman Pirahanchi, Kristin Salottolo, Christian J.W. Burrell, Xu Tang, Lauren DiSalvo, David Bar-Or, Russell E. Bartt

P14.5-013

Risk Factors and Outcome of Cerebrovascular Complications in Transplant Recipients – Angel

Joel Cadena Tejada, Shelly D. Ozark, Mathew Gregoski, Parneet Kaur Grewal

P14.5-014

A Novel Mechanism of the “Three Territory Sign” in Acute Ischemic Stroke – Michael Anthony Figueroa, Felipe Kazmirczak, Solmaz Ramezani Hashtjin, Christopher Streib

P14.5-015

Disorders of Consciousness and Delays in Ischemic Stroke Treatment – Benjamin M. Jadow, Peter C. Mabie

P14.5-016

A Retrospective Analysis of Co-morbidities in Stroke Patients with COVID – Mohammad Abdurrehman Sheikh, Junaid Ansari, Omar Elsekaily, Muhammad Ayub, Rachel Elizabeth Triay, Alexis Angelette, Alexandra Gaudet, Roger E. Kelley

P14.5-017

Association of Blood Pressure Parameters in Unsecured Aneurysmal Subarachnoid Hemorrhage and Outcomes – Ariyaporn

Haripottawekul, Saba S. Paracha, Deena Ahmed Haque, Elijah Malik Persad-Paisley, Alizeh Shamshad, Aiden Meyer, Michael E. Reznik, Karen L. Furie, Shadi Yaghi, Ali Mahta

P14.5-018

IMPETUS Stroke: Implementing a Uniform Stroke Care Pathway in Medical Colleges: Baseline assessment of systems of care – Rohit Bhatia, Manish Salunkhe, Partha Haldar, Deepshikha

Prasad, Shweta Gupta, M.V.Padma Srivastava, Mamta Singh Bhushan, Vishnu VY, Deepti Vibha, Awadh K. Pandit, Ayush Agarwal, Sanjeev Kumar

Bhoi, Menka Jha, Sucharita Anand, Samhita Panda, Niraj Kumar, Ashutosh Tiwari, Mritunjai Kumar, Butchi Raju Garuda, Gopi S, Dr MPS Chawla, Jyoti Garg, Biman Kanti Ray, Amit Bhardwaj, Alok Verma, Nikhil Dongre, Gurpreet Singh, Thomas Iype, Raminderpal Singh Sibia, Rupinderjeet Kaur, Paresh Zanzmera, Ravinder Garg, Sulena Singh, Ashok Kumar, Abhay Ranjan, Vijay Sardana, Dilip Maheshwari, Bharat Bhushan, Alvee Saluja, Pramod Darole, Kiran Bala, Surekha Dabla, Inder Puri, Shalin Dipin Shah, G S Ranga, Smita Nath

P14.5-019

Blunt Traumatic Cerebrovascular Injury and Stroke: The Need for a High Index of Suspicion when Initial Vascular Imaging is Negative - A Single Center Case Series – Ahmer Asif, Sara Habib, Danny Samkutty

P14.5-020

Study of Risk Factors and Outcome Evaluation in Patients with Stroke with Intracranial versus Extracranial Atherosclerotic Arterial Disease –Samir Patel, Aashka Ponda

P14.5-021

Impact of COVID19 on Cerebrovascular Disease Related Deaths in the United States – Ram Balu, Linda Henry, James Paik

P14.5-022

Iron Deficiency Anemia and Ischemic Stroke in Premenopausal Women – Hanah Ayesha Imam, Hisham Raza Alim Salahuddin

P14.5-023

Acute Neurological Consultation in Patients with Cervical Orthopedic Intervention – Ashwini Gadalay, Raja Hassan Imtiaz, Navreet Kaur, Hesham Masoud

P14.5-024

Age-related Macular Degeneration, Incident Ischemic Stroke, and Cognitive impairment –Bhrugun Anisetti, Michael Wesley Stewart, Eric R. Eggenberger, Nilufer Taner, James F. Meschia, Michelle P. Lin

P14.5-025

Relationships among Hospital Acute Ischemic Stroke Volumes, Hospital Characteristics, and Outcomes in the US – Louise Marian McCarthy, David Daniel, Daniel Santos, Mandip Singh Dhamoon

P14.5-026

Prevalence of Neurogenic Stress Cardiomyopathy in Acute Ischemic Stroke and Relationship with Leukocytosis – Laura Rebecca Wolf, Darshil Shah, Tyrone Kwesi Coleman, Michael T. Mullen, Lauren Koffman

P14.5-027

Clinical, Anatomical, and Demographic features associated with the use of PatientSpecific Advanced Visualization Modeling in Cerebrovascular Disease – Vishal N. Bhimarasetty, Korak Sarkar

P14.5-028

Patients with COVID-19 Infection and Stroke have Higher than Expected Mortality, Regardless of the Primary Presentation – Jintong Liu, Riley Gillette, Sharon Poisson, Kerri Jeppson, Brandy Christine Ravare, Max Wohlauer

P14.5-029

Outcome of Lacunar vs Non-lacunar Infarcts in a Prospective Stroke Database – Prabandh Reddy Buchhanolla, Amrita Pandey, Shyamal Chandra Bir, Vijayakumar Javalkar, Roger E. Kelley

P14.5-030

Unvaccinated: An unrecognized risk factor for stroke – Divya Gupta, Rachel Pearson

P14.5-031

Systemic inflammatory response syndrome deteriorates the outcomes of mechanical thrombectomy in acute stroke – Mostafa Jafari, Kalman Katlowitz, Carlos De la Garza, Alexander Sellers, Shawn Moore, Hayden William Joseph Hall, Aaron Desai, Vikramjeet Singh, Rahul Damani

P14.5-032

Metabolic Syndrome as a Risk Factor in Latin American Patients with Intracerebral Hemorrhage – Juan Carlos Ayala Alvarez, Ivan Roque Sanchez, Enrique Gomez Figueroa, Omar Cardenas-Sanchez, Amado Jimenez-Ruiz, Jose Luis Ruiz-Sandoval, Antonio Arauz, Fabiola Eunice Serrano-arias

6Aging, Dementia, Cognitive, and Behavioral Neurology

Aging and Dementia: Social Determinants of Health in Dementia

P14.6-001

Association of Life’s Simple 7 with Brain Imaging Outcomes Among Hispanics/Latinos Results from the Study of Latinos-Investigation of Neurocognitive Aging-MRI (SOL-INCA-MRI)

Ancillary Study – Gabriela Trifan, Ariana Stickel, Jianwen Cai, Martha Daviglus, Mayra L. Estrella, Olga Garcia-Bedoya, Linda C Gallo, Carmen Isasi, Robert Kaplan, Melissa Lamar, Gregory Anthony Talavera, Wassim Tarraf, Donglin Zeng, Hector M. Gonzalez, Charles S. DeCarli, Fernando Testai

P14.6-002

Ethnic Disparities in Clinical Presentation of Patients with Early-Onset Alzheimer’s Disease –Meredith F. Yang, Suemin Jasmine Yoon, Rachel Covaciu, Kaitlin Seibert

P14.6-003

Examining Age-Specific Barriers and Facilitators to Research Participation in Underrepresented Americans – Nicole R. Nissim, Michelle Fudge, Christian Lachner, Neill R. Graff-Radford, John A. Lucas, Gregory S. Day

P14.6-004

The Cost Burden of Alzheimer’s Disease on Care Partners – Julie Hviid Hahn-Pedersen, Luis Rafael Solís-Tarazona, Tove Holm-Larsen

P14.6-005

Online CME-certified Survey Identifies Sources for Clinical Practice Gaps Among Neurologists and PCPs Regarding the Early Recognition of Alzheimer’s Disease – Piyali Chatterjee, Lisette Arnaud-Hevi, Thomas Finnegan, Sharon Cohen

P14.6-006

Financial Toxicity in Dementia Caregiving –Danielle M. Hart, Brandon Leggins, Clara Sanches, Winston Chiong

P14.6-007

The Impact of Social History on the Development of Alzheimer’s Disease – Madisen Lanier Faulkner, Paige Novota, Jonathan Wade, Lauren A. Fowler, John R. Absher

P14.6-008

WITHDRAWN

P14.6-009

Cognitive Health in Underrepresented Populations—Early Learnings From INTUITION: A Brain Health Study – Matt Hobbs, Rhoda Au, Andrew Becker, Monroe Butler, Hanson Lenyoun, Sean Kenny, Roland Brown, Paramita SahaChaudhuri, Matt T. Bianchi, James Rhys Williams, Audrey Gabelle, Shibeshih Belachew

P14.6-010

The Impact of Alzheimer’s Disease on Care Partners – Julie Hviid Hahn-Pedersen, Luis Rafael Solís-Tarazona, Tove Holm-Larsen

7 Neuro Trauma and Critical Care

Neurocritical Care: Traumatic Brain Injury

P14.7-001

Evaluating the Performance of the IMPACT Model in the Prehospital TXA for TBI Trial – H. E. Hinson, Shannon McWeeney, Adam Ferguson, Martin Allan Schreiber, Susan Rowell

P14.7-002

Relationship Between White Matter Hyperintensities and Blood Biomarkers of Axonal Injury and White Matter Integrity – Abbie Chan, Alexa Walter, James J. Gugger, Cillian Lynch, Andrea Lauren Christman Schneider, Danielle Sandsmark, Ramon R. Diaz-Arrastia

P14.7-003

Relationship Between Time of Hospital Arrival and Clinical and Fluid Biomarker Outcomes in Traumatic Brain Injury – Aaron Anandarajah, Alexa Walter, James J. Gugger, Cillian Lynch, Andrea Lauren Christman Schneider, Danielle Sandsmark, Ramon R. Diaz-Arrastia

P14.7-004

Interventions to Optimize Spinal Cord Perfusion in Patients with Acute Traumatic Spinal Cord Injury: An Updated Systematic Review – David Ethan Kahn, Lindsay Tetreault

P14.7-005

Resting State fMRI for Neuroprognostication in Traumatic Brain Injury: Clinical Experience of Evaluation for Covert Consciousness and Epileptogenic Networks in Acute Coma – Fazila Aseem, Tamara Strohm, Julia Carlson, Olivia Gilbert, Kirsten Gillette, Varina Boerwinkle

P14.7-006

Delayed Posttraumatic Intracranial Hemorrhage in a Patient not on Antithrombotic Therapy – Victoria Qizhi Tay, Sayyeda Zahra, Preet M. Varade

8

Neuromuscular and Clinical Neurophysiology (EMG)

Neuromuscular Disease: Peripheral Neuropathy 4

P14.8-001

Early Post Radiation Neuropathy: Complex Pathogenesis Including Microvasculitis and Tumor Spread – Michael Paul Skolka, Joon H. Uhm, Daniel Ma, Ashley Santilli, James Bryan Meiling, Paola Sandroni, Nathan P. Staff, Marcus Vinicius Rocha Pinto, P. James B. Dyck, Christopher J. Klein

P14.8-002

Title: Exploring Relationships Between Ultrasound-Measured Pre-Operative Median Nerve Echointensity and Successful Carpal Tunnel Release -A Retrospective Review – Yohei Harada, Thapat Wannarong, Megan Neely, John W. Williams, Tyler Steven Pidgeon, Lisa Hobson-Webb

P14.8-003

Morphological Changes on Neuromuscular Ultrasound in Nerves Distal to Gunshot Injuries – Patrick Fagan, Christopher D. Geiger, David C. Preston

P14.8-004

Serum Neurofilament Light Chain Levels in Small Fiber Neuropathy Patients with Skin Denervation and Ongoing Neuropathic Symptoms – Daniela Noa Zohar, Lamis Qassim, Mailam Eltity, Daria

Sarah Keren, Efrat Shavit, Joab Chapman, Amir Dori

P14.8-005

Recognizing Neuropathic Pain as a Symptom of Charcot-Marie-Tooth Disease that impacts Quality of Life – Seo Youn Chang, Catherine Imossi, Simon Gelman, Allison Moore, Robert N. Moore, Joy Aldrich, Florian P. Thomas

P14.8-006

A Phase 2/3 Placebo-Controlled, Parallel Group, Randomized Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: the ARISE study – Lisa M. Ford, Janice Chun Yee Wong, Eriene Youssef, Robert Murray, Pilar Lim, Eduardo Nobile-Orazio, Ingemar S.J. Merkies, David R. Cornblath, Hong Sun

P14.8-007

Small Vessel Vasculitis in Small Fiber Neuropathy with TS-HDS, FGFR-3, or Plexin D1 antibodies –Lawrence A. Zeidman

P14.8-008

Anti-Plexin D1 Antibodies in Axonal Polyneuropathy – Isheeta Subodh Govardhan, Yu-Ting Chen

P14.8-009

Description of a Rare Compound Heterozygous Transthyretin Mutation Val30Met/Val122Ile

Conferring Early Onset Hereditary Amyloidosis with Severe Features – Joshua Nardin, Rebecca Traub

P14.8-010

Characterization of Polyneuropathy in Patients Receiving Enfortumab Vedotin for the Treatment of Metastatic Urothelial Carcinoma – Melody Badii, Nataliya Mar, Ali A. Habib

P14.8-011

Clinical Characteristics, Treatment and Outcomes of Patients with Paraneoplastic Neuropathies A Retrospective Single-Center Study in Argentina

– Francisco Caiza Zambrano, Fabio Gonzalez, Julio Cesar Galarza Menoscal, Mauricio Benetti, Marcela Uribe Roca, Pablo Bonardo, Manuel Fernandez Pardal, Luciana Vanesa Leon Cejas, Ricardo C. Reisin

P14.8-012

Presentations of Peripheral Neuropathy with AntiFibroblast Growth Factor Receptor-3 Antibodies

– Clover Youn, Michael D. Weiss

P14.8-013

Surgical Release of Ulnar and Median Nerves in CMT1A: Prevention and Treatment of a Second Hit – Will McKeen, Nakul Katyal, Sarada Sakamuri, Thomas J. Wilson, Maxwell Andrew Greene

P14.8-014

A Case of Charcot-Marrie-Tooth 1F Mimicking Chronic Inflammatory Demyelinating Polyradiculopathy – Nasrin Rahimian, Adeolu Oluwaseun Morawo, Sahara Cathcart, Yu-Ting Chen

P14.8-015

Evidence of Lumbosacral Plexus Involvement on MR Neurography in Early Guillain-Barré Syndrome

– Ashley Weng, Darryl Sneag, Pantelis Parissis Pavlakis

9 Child Neurology and Developmental Neurology

Child Neurology and Developmental Neurology: Headaches/Stroke/Neurooncology

P14.9-001

Falsely Reassuring Head CT Delays Diagnosis in Childhood Arterial Ischemic Stroke – Vivian Chiang, Dwight Barry, Catherine M. Amlie-Lefond

P14.9-002

Arachnoid cyst in children who underwent surgical treatment: Natural history and clinical presentation

– Raghav Talreja, Laura Daniela Fonseca, Mahesh Chikkannaiah, Ajay Goenka, Gogi Kumar

P14.9-003

Migraine Disability Evaluation in Indian Children by Pediatric Migraine Disability Assessment (PedMIDAS) Scale: A Prospective Observational Study – Lokesh Saini, Pradeep Kumar Gunasekaran, Pooja Jindal

P14.9-004

Cow’s Milk Anemia In Childhood Manifesting As Severe Cerebral Venous Sinus Thrombosis –Catherine M. Amlie-Lefond, Kristin Maher

P14.9-005

Utility of Neuroimaging in Children Presenting to the Emergency Department with Altered Mental Status – Giovanni Castellucci, Camila Ospina Jimenez, Birce Dilge Taskin, Alana Kistou, Nirupama Kannikeswaran, Lalitha Sivaswamy

P14.9-006

Peripheral Neuropathy in a Pediatric ALL Patient –Douglas Aaron Wells, Jeffrey Kuerbitz, Kristen Fisher

P14.9-007

Neurocognitive Manifestations of Individuals with NF1 Microdeletions – Jenny Paola Garzon, Andrea Ruth Patete, Carolyn R. Serbinski, Madison Hankins, Michael Sawin, Allison Goetsch Weisman, Katherine H. Kim, Joel Charrow, Robert Listernick, Carlos E. Prada

P14.9-008

Development and internal validation of a clinical risk score to predict incident renal and pulmonary tumors in people with tuberous sclerosis complex – Frédéric Loubert, Andrew A. House, Catherine Larochelle, Philippe Major, Mark Robert Keezer

P14.9-009

Outcomes in Children with Shaken Baby Syndrome and Seizures – Katelyn Stebbins, Nasser Mohammed, Aashit K. Shah

P14.9-010

Metabolic Stroke as a Clinical Manifestation of ZhuTokita-Takenouchi-Kim (ZTTK) Syndrome: A Case Series – Jorge Luis Morales, Angie El-said, Gian Carlo Rossi, Neha Longani

P14.9-011

Association between nutritional status and migraine in the pediatric population: A systematic review and meta-analysis – Carlos Rodrigo Quispe Vicuña, David R. Soriano-Moreno, Abraham De Los Rios Pinto, Luz Antonella Antonella Díaz Ledesma, Daniel Fernandez-Guzman, Carlos Alva-Diaz

P14.9-012

Trends in Early MRI Utilization in Critically Ill Children with Severe TBI: a Single Center Experience, 2010-2021 – Anna Janas, Kristen Campbell, Chris Ruzas, Ricka Messer, Nicholas Stence, Derek Samples, Jordan Matthew Wyrwa, Ericka Fink, Aline Bernard Maddux

10 Infectious Disease

Infectious Disease: Parasitic Infections

P14.10-001

WITHDRAWN

P14.10-002

Under Pressure: Neurocysticercosis Manifests Itself as Intracranial Hypertension – Sarah Hillhouse, Kelsey H. Carr, Brian Monk, Chandra Sekhar Mannyam, Erin Harrison Britt, Tulip A. Jhaveri, Manasa Gunturu

P14.10-003

Post-infectious Epilepsy from Probable Neurocysticercosis in a 32 Year Old Pregnant Female – Daniah Shamim, Obiefuna Andrew Nwabueze, John Leever, Gary S. Gronseth

P14.10-004

Neurotoxoplasmosis: a 5-year story in the Dominican Republic – María Fernanda Cedeño, Alana Agramonte, Julio Rivas, Génesis Chacón, Rosa Evalina Medrano Heredia, Angelica G Montilla, Ana Cristina Abreu Guaba, Ricardo Acra-Tolari, Rita Alexandra Rojas Fermin, Dolores Magdalena Mejia

P14.10-005

Post-malaria neurological syndrome - chronic ailments of the acute parasitic infection – Maria Andreina Hernandez, Roopa Sharma

11 Movement Disorders

Movement Disorders: Miscellaneous Movement Disorders 2

P14.11-001

Acetyl-L-Leucine for Niemann-Pick type C: A Multinational Double-blind Randomized Placebocontrolled Crossover Study – Tatiana Tatiana Bremova-Ertl, Taylor Fields, Kyriakos Martakis, Michael Strupp

P14.11-002

Lamotrigine as a First-line Agent in the Management of Paroxysmal Kinesigenic Dyskinesia – Heather Leduc-Pessah, Asif Doja

P14.11-003

Vertical supranuclear gaze palsy in Primary Familial Brain Calcification associated with a novel SLC20A2 mutation – Nikolai Gil Diwa Reyes, Anthony E. Lang

P14.11-004

Frequency, Classification, and Timing of Movement Disorders in Rapidly Progressive Dementia – Pierpaolo Turcano, Nihal Satyadev, Philip W. Tipton, Gregory S. Day

P14.11-005

A familial case of Congenital Mirror Movement (CMM) Syndrome Associated With A Novel DCC Variant – Ankur Nayyar, Marie Ynez Davis, Swati Rane Levendovszky

P14.11-006

Identification of novel compound heterozygous mutation in Niemann-Pick disease type C gene

– Ali Hussain Abusrair, Gabriel Amorelli, Justyna Sarna

P14.11-007

A Cross-Sectional Evaluation of Health Resource Use in Patients with Functional Neurological Disorders Referred to a Tertiary Neuroscience

Centre – Brian William O’Mahony, Mahinda Yogarajah, Robert Nelson-Sice

P14.11-008

Pain Reduction in Adult Patients with Limb Spasticity Following a Single IncobotulinumtoxinA Injection: an Analysis of Pooled Data from Phase 2 and 3 Studies – Jorg Wissel, Alexandre CamoesBarbosa, Georg Comes, Michael Althaus, Astrid Scheschonka, David M. Simpson

P14.11-009

The Economic Cost of Functional Neurological Disorders: A Systematic Review – Brian William O’Mahony, Mahinda Yogarajah

11 Movement Disorders

Movement Disorders: Non-surgical Therapeutics in Parkinson’s Disease 2

P14.11-010

Predicting Response to Acetylcholinesterase Inhibitors in Parkinson’s Disease: Focus on the Nucleus Basalis of Meynert – Adam James Gatch, Daniel Hebra Lench, Federico J. Rodriguez-Porcel

P14.11-011

WITHDRAWN

P14.11-012

WITHDRAWN

P14.11-013

Safety of opicapone after 5 years of postmarketing experience worldwide – Luis Guedes, Joana Graça, Maria Sampaio, Mariana Vieira, Francisco Rocha, Helena Gama

P14.11-014

Consistent Effects of Once-Daily Opicapone 50 mg on COMT Activity Across Participants: A Pooled Post Hoc Analysis of Two Phase 1 Studies –Gordon Loewen, Kurt Olson, Grace Lin Liang, Olga Klepitskaya

P14.11-015

Perspectives on Parkinson’s Disease Medications: A Qualitative Study of People with Parkinson’s Disease – Kristin Richards, Carolyn Brown, Michael Johnsrud, Steve Arcona, Rahul Sasane, Melissa Armstrong, Jeanne Feuerstein, Holly A. Shill, Lauren S. Talman, Sneha Mantri

P14.11-016

A novel retromer stabilizer as a potential treatment for Parkinson’s disease – Michele Persico, TracyShi Zhang Fang, Carly Laura Tucci, Darynaisha Crawford, David K. Simon, Simona Eleuteri

12 Headache

Headache: Epidemiology and Population Health 2

P14.12-001

Suicide in Veterans with Post-Traumatic Headache: An Analysis of Health Systems Data

– Sarah Anthony, Elizabeth Seng, Manali Phadke, Brenda Fenton, Hamada Hamid Altalib, Xiao M. Androulakis, Richard B. Lipton, Jason J. Sico

P14.12-002

The relationship between gender, peer victimization, mental health, and frequent headaches in adolescents: A Canadian populationbased observational study – Christelle Nilles, Jeanne Williams, Scott Patten, Tamara M. Pringsheim, Serena Orr

P14.12-003

Clinical characteristics and factors associated with headaches following COVID-19 vaccination: a cross-sectional cohort study – Melika Sadat Jameie, Mansoureh Togha, Mehdi Azizmohammad Looha, Nima Hemmati, Elham Jafari, Somayeh Nasergivehchi, Zeinab Ghorbani, Zhale Salami

P14.12-004

Migraine Prevalence in Gender Identity Minorities

– David Curtis Wegener, Jose R. McFaline-Figueroa, Robert Goldstein

P14.12-005

Twenty years of population-based studies in US adults with migraine reveal minimal improvement in care – Julia L. Jones, Jessica Ann Weaver, Nicole Coolbaugh, Philip Sjostedt, Elizabeth M. Reichard

P14.12-006

Different Experiences in Chronic Migraine Etiology, Treatment and Comorbidities of Hawaii’s Ethnic Groups – Michelle Xiaoyi Lu, Kacey L. Yamane, Dane Keahi, Michael Tong, Connor Goo, Devashri Prabhudesai, John J. Chen, Vimala Sravanthi Vajjala, Enrique Carrazana, Jason Viereck, Kore K. Liow

P14.12-007

Health concerns and treatment perspectives among US adults with current versus previous high-frequency headache/migraine and acute medication overuse: The Harris Poll Migraine Report Card Survey – Amaal J. Starling, Roger Cady, Dawn C. Buse, Meghan R. Buzby, Charles Spinale, Kathy Steinberg, Steven Kymes

Headache

Headache: Therapeutics 2

P14.12-008

Treatment Effects of Celecoxib Oral Solution in Migraine With Aura and Without Aura: Post-Hoc Analysis of Results From Two Randomized, Double-Blind Placebo-Controlled Trials – Stewart J. Tepper, Daniel Serrano, Mancia M. Ko, Todd Kunkel, Richard B. Lipton

P14.12-009

Efficacy of Celecoxib Oral Solution in Adults With and Without Baseline Nausea: Post Hoc Analysis of Results From Two Randomized, Double-Blind Placebo-Controlled Trials in the Acute Treatment of Migraine – Stewart J. Tepper, Daniel Serrano, Mancia M. Ko, Richard B. Lipton, Todd Kunkel

P14.12-010

Transnasal Evaporative Cooling Device for Migraine: A Randomized Trial – Larry Charleston IV, Amaal J. Starling, Nauman Tariq

P14.12-011

Safety of Concomitant Triptan and INP104 Use From the Phase 3 STOP 301 Study in Migraine

Patients – Alexander Feoktistov, Robert Vann, Judie Boisvert Gutierrez, Sutapa Ray, Stephen Bevan Shrewsbury, Sheena K. Aurora

P14.12-012

Assessing the Synergistic effect of Vitamin supplementation and Migraine preventative management in children and adolescents with chronic migraine- retrospective cohort analysis – Peyton Isabella Crest, Marley Lemons, Olivia Mccomb, Brianna Freeman, Jenny Schmidt, Tracee Ridley Pryor, Ankita Ghosh

13 Neuro-oncology

Neuro-oncology: Unusual Presentations in Neuro-oncology

P14.13-001

MALT Lymphoma Presenting as Symptomatic Optic Neuritis: A Case Report – Dan Tong Jia, Sarah Lott Wyckoff, Liza M. Cohen, Paul J. Bryar, Rimas Vincas Lukas, Karan S. Dixit

P14.13-002

All that enhances is not cancer: Cerebral amyloid angiopathy mimicking leptomeningeal enhancement in the two patients with advanced cancer – Sadia Waheed, Muhannad Seyam, Alissa Ashley Thomas

P14.13-003

A Case of CNS Lymphoma Imitating PostVaccination ADEM – Samuel Frank, Huda Alalami, Alexandra Marie Livingston, Jethro Hu, Nasima D. Shadbehr

P14.13-004

CNS Aspergillosis Following BTK Inhibitors Mimicking Secondary CNS Lymphoma – A Case Series – Naina Murthy, Maria Martinez-Lage, Jeremy Abramson, Andrew Branagan, Yongli Ji, Yi-Bin Chen, Alyssa R. Letourneau, Brian Nahed, Thomas Anthony Nelson, Isabel Arrillaga-Romany, Nancy Wang, Jorg Dietrich

P14.13-005

Stroke Like Presentation Of CNS Lymphoma –Deema Sawass Najjar, Qingliang Wang

P14.13-006

A Case Report of Primary Central Nervous System T-Cell Lymphoma Mimicking Autoimmune Encephalitis – Kristi Marie Anderson, Mazieyar Azad, Kaleb Logan Culpepper, Katherine A. Zarroli